Research

Elliott, C., Jackson, J., Findlay, J., Williams, G., Ghosh, A., Ribe, E., Ulmschneider, M., Khan, A., Ballard, C., Aarsland, D., Baillie, G. S., Harte, M., Killick, R. (2025) Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment. Cellular Signalling, 131, (doi: 10.1016/j.cellsig.2025.111716)

Berry, C., Camici, P. G., Crea, F., George, M., Kaski, J. C., Ong, P., Pepine, C. J., Pompa, A., Sechtem, U., Shimokawa, H., Zeitz, C., Escaned, J., van de Hoef, T. P., Beltrame, J. F., Bairey Merz, C. N. (2025) Clinical standards in angina and non-obstructive coronary arteries: a clinician and patient consensus document. International Journal of Cardiology, 429, (doi: 10.1016/j.ijcard.2025.133162)

Lip, S., Tran, T. Q.B., Hanna, R., Nichol, S., Guzik, T. J., Delles, C., McClure, J., McCallum, L., Touyz, R. M., Berry, C., Padmanabhan, S. (2025) Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure - LOCHINVAR. Journal of Hypertension, 43, pp. 1057-1065. (doi: 10.1097/HJH.0000000000004013)

Lyall, M., Kamdar, A., Sykes, R., Aekbote, B. L., Gadegaard, N., Berry, C. (2025) Measuring contractile forces in vascular smooth muscle cells. Vascular Pharmacology, 159, (doi: 10.1016/j.vph.2025.107488)

Rezig, A. O.M., Morsy, M., Caiazzo, E., Iaconelli, A., Ialenti, A., Hunter, D., Cuthbert, J. J., Kazmi, S., Guzik, T. J., Bruzzese, D., Cleland, J. G.F., Clark, A. L., Maffia, P., Pellicori, P. (2025) Neutrophil-to-lymphocyte ratio: association with congestion, inflammation, and mortality in ambulatory patients with heart failure. ESC Heart Failure, 12, pp. 1571-1582. (doi: 10.1002/ehf2.15240)

Sykes, R., Morrow, A. J., Stanley, B., Ang, D., Roditi, G., Stobo, D., Corcoran, D., Lang, N. N., Mahrous Abouzaid, A., Young, R., Carrick, D., McGeoch, R., McEntegart, M. B., Sidik, N. P., Berry, C. (2025) Exercise electrocardiography stress testing in suspected angina and non-obstructive coronary arteries. European Heart Journal, (doi: 10.1093/eurheartj/ehaf208)

Ismahel, H., Docherty, K. F. (2025) The role of finerenone in heart failure. Trends in Cardiovascular Medicine, (doi: 10.1016/j.tcm.2025.05.002)

Koay, Y. C., McIntosh, B., Huey Ng, Y., Cao, Y., Wang, X., Han, Y., Tomita, S., Bai, A. Y., Hunter, B., Misra, A., Loughrey, C. M., Bannon, P. G., Lal, S., Lusis, A. J., Kaye, D. M., Larance, M., O’Sullivan, J. F. (2025) The heart has intrinsic ketogenic capacity that mediates NAD+ therapy in HFpEF. Circulation Research, 136, pp. 1131-1133. (doi: 10.1161/CIRCRESAHA.124.325550)

Shapovalov, I., Rimal, P., Poudel, P., Lewtas, V., Bell, M., Kumar Panday, S., Laight, B. J., Harper, D., Grieve, S., Baillie, G. S., Nouri, K., Davies, P. L., Alexov, E., Greer, P. A. (2025) Quantification and structure-function analysis of calpain-1 and calpain-2 protease subunit interactions. Journal of Biological Chemistry,

Rubiś, P., Piórkowski, A., Winiarczyk, M., Nurzyńska, K., Dziewięcka, E., Wiśniowska-Śmiałek, S., Marzec, M., Lasek, J., Cleland, J. G.F., Augustyniak, P. (2025) Video thermography uncovers relationship between volume status and temperature in heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.3680)

Cleland, J. G.F. (2025) An iconic figure from CARE-HF: the Cardiac Resynchronization - Heart Failure trial. Heart Rhythm, 22, pp. 1131-1133. (doi: 10.1016/j.hrthm.2025.03.1960)

de Bakker, M., Welsh, P., Sattar, N., Lindahl, B., Hammarsten, O., Omland, T., Campbell, A., Hayward, C., Sudlow, C. L.M., Mills, N. L., Kimenai, D. M., Eggers, K. M. (2025) Cardiac troponin I and T ratio and risk of cardiovascular or non-cardiovascular events in a general population. Clinical Chemistry, 71, pp. 599-608. (doi: 10.1093/clinchem/hvaf016)

Kelly, M. P. et al. (2025) Cyclic nucleotide phosphodiesterases as drug targets. Pharmacological Reviews, 77, (doi: 10.1016/j.pharmr.2025.100042)

Elyan, B. M.P., Tan, B., Lambourg, E., McAllister, D. A., Jones, R. J., Lang, N. N., Mark, P. B., Lees, J. S., Bell, S. (2025) Incidence of cancer in people with CKD not requiring kidney replacement therapy: a systematic review and meta-analysis. Clinical Kidney Journal, 18, (doi: 10.1093/ckj/sfaf084)

Liu, Q., Celis-Morales, C., Lees, J. S., Sattar, N., Ho, F. K., Pell, J. P., Mark, P. B., Welsh, P. (2025) Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and mortality in the general population. Clinical Chemistry, (doi: 10.1093/clinchem/hvaf063)

Taylor-Rowan, M., Eton, D. T., McLeod, H. J., Rizeq, J., Kidd, L., Currie, G., Quinn, T. J., Mair, F. S., Gallacher, K. I. (2025) Validation and feasibility of PETS-stroke - a patient reported measure of treatment burden after stroke. Stroke,

Butt, J. H., Solomon, S. D., Vaduganathan, M., van Veldhuisen, D. J., Køber, L., Pitt, B., Zannad, F., Jhund, P. S., McMurray, J. J.V. (2025) Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction according to body weight. European Journal of Heart Failure, (doi: 10.1002/ejhf.3665)

Phanthaphol, N., Somboonpatarakun, C., Suwanchiwasiri, K., Yuti, P., Sujjitjoon, J., Augsornworawat, P., Baillie, G. S., Junking, M., Yenchitsomanus, P.-t. (2025) Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv. Journal of Translational Medicine, 23, (doi: 10.1186/s12967-025-06453-y)

Butt, J. H., Jhund, P. S., Henderson, A. D., Claggett, B. L., Desai, A. S., Lam, C. S.P., Brinker, M., Schloemer, P., Viswanathan, P., Lage, A., Rohwedder, K., Senni, M., Shah, S. J., Voors, A. A., Zannad, F., Pitt, B., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2025) Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the FINEARTS ‐ HF trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3649)

Jhund, P. S. (2025) Use of NT-proBNP for the screening, diagnosis and risk-stratification of left ventricular dysfunction. Diabetes, Obesity and Metabolism, (doi: 10.1111/dom.16388)

Dobbin, S. J. H., Mangion, K., Berry, C., Roditi, G., Basak, S., McClure, J. D., Brooksbank, K., Sonecki, P., Sourbron, S., Evans, J., White, J., Welsh, P., Butler, E., Venugopal, B., Touyz, R. M., Jones, R. J., Petrie, M. C., Lang, N. N. (2025) Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging. Heart, (doi: 10.1136/heartjnl-2024-325535)

Cleland, J., Anzar, D. (2025) Commentary on Wittes et al: Aspirin for primary prevention of CV events—rationally robust? Statistically significant? Clinically convincing. Clinical Trials, (doi: 10.1177/17407745251324865)

Hayman, M. M.E., Jones, W., Aman, A., Ward, J., Anderson, J., Lyall, D. M., Pell, J. P., Sattar, N., Welsh, P., Strawbridge, R. J. (2025) Association of GLP1R locus with mental ill-health endophenotypes and cardiometabolic traits: a trans-ancestry study in UK Biobank. Diabetes, Obesity and Metabolism, 27, pp. 1845-1858. (doi: 10.1111/dom.16178)

Skouri, H., Girerd, N., Monzo, L., Petrie, M. C., Böhm, M., Adamo, M., Mullens, W., Savarese, G., Yilmaz, M. B., Amir, O., Bayes‐Genis, A., Bozkurt, B., Butler, J., Chioncel, O., Mebazaa, A., Merino, J. L., Moura, B., Ponikowski, P., Seferovic, P., Rosano, G. M.C., Metra, M. (2025) Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association ( HFA ) of the ESC. European Journal of Heart Failure, 27, pp. 707-722. (doi: 10.1002/ejhf.3618)

Gainsborough, F., Welsh, P., Sattar, N., Panarelli, M. (2025) Elevated lipoprotein(a) is common in people with familial hypercholesterolemia and negative genetic screening. JACC: Advances, 4, (doi: 10.1016/j.jacadv.2025.101648)

Bahar, J., Rahman, A., Wong, G. W.Y., Sankaranarayanan, R., Ahmed, F. Z., Taylor, R., Fuat, A., Squire, I., Cleland, J. G.F., Lip, G. Y.H., Gamble, J. H.P., Masudi, S., Joseph, P. J. S., Wong, K. (2025) Outpatient treatment of decompensated heart failure: a systematic review and study level meta-analysis. ESC Heart Failure, 12, pp. 761-769. (doi: 10.1002/ehf2.14841)

Cleland, J. G. F. (2025) Staring into the AβYSS after myocardial infarction. How many pills and for how long after myocardial infarction? European Heart Journal,

Docherty, K. F., Buendia Lopez, R., Folkvaljon, F., de Boer, R. A., Chen, J., Hammarstedt, A., Kitzman, D. W., Kosiborod, M. N., Langkilde, A. M., Reicher, B., Senni, M., Wilderäng, U., Verma, S., Cowie, M. R., Solomon, S. D., McMurray, J. J.V. (2025) Wearable accelerometer-derived measures of physical activity in heart failure: insights from the DETERMINE trials. Journal of Cardiac Failure, 31, pp. 689-703. (doi: 10.1016/j.cardfail.2024.10.439)

Kamdar, A., Friday, J. M., Tran, T. Q.B., du Toit, C., Stevenson, A., Lewsey, J., Berry, C., Brown, D., Hastie, C. E., Fleming, M., Geue, C., Mackay, D., Dundas, R., Delles, C., Sattar, N., Padmanabhan, S., Pell, J. P., Ho, F. K. (2025) Secular trends in types of cardiovascular disease in the West of Scotland. Open Heart, 12, (doi: 10.1136/openhrt-2024-003003)

Stolfo, D. et al. (2025) How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, (doi: 10.1002/ejhf.3642)

Kondo, T., Jhund, P. S., Anand, I. S., Claggett, B. L., Desai, A. S., Docherty, K. F., Lam, C. S.P., Lefkowitz, M. P., Maggioni, A. P., Martinez, F. A., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., Packer, M., Solomon, S. D., McMurray, J. J.V. (2025) Effects of sacubitril/valsartan according to natriuretic peptide levels in patients enrolled in PARADIGM-HF and PARAGON-HF. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.12.010)

Docherty, K. F., McDowell, K., Welsh, P., Petrie, M. C., Anand, I., Berg, D. D., de Boer, R. A., Køber, L., Kosiborod, M. N., Martinez, F. A., O'Meara, E., Morrow, D. A., Ponikowski, P., Sabatine, M. S., Sattar, N., Schou, M., Hammarstedt, A., Sjöstrand, M., Langkilde, A. M., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2025) Interleukin-6 in heart failure with reduced ejection fraction and the effect of dapagliflozin : an exploratory analysis of the dapagliflozin and prevention of adverse outcomes in heart failure trial. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.12.012)

Monzo, L., Kobayashi, M., Ferreira, J. P., Lamiral, Z., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A. J., Rossignol, P., Cleland, J., Zannad, F., Girerd, N. (2025) Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial. Cardiovascular Diabetology, 24, (doi: 10.1186/s12933-025-02609-8)

Walker, H., Khan, S., Padmanabhan, S., Pell, J. P., Lewsey, J., Mackay, D., Dundas, R., Friday, J., Tran, T. Q. B., Brown, D., Ho, F., Hastie, C. E., Fleming, M., Geue, C., Stevenson, A., Du Toit, C., Jani, B. D., Gallacher, K., Mark, P. B., Sullivan, M. K. (2025) Analysis of the kidney failure risk equation implementation in routine clinical practice and health inequalities in chronic kidney disease care: a retrospective cohort study. BMC Nephrology, 26, (doi: 10.1186/s12882-025-04043-0)

Zahir Anjum, D., Garred, C. H., Carlson, N., Fosbol, E., Elmegaard, M., Jhund, P. S., McMurray, J. J.V., Petrie, M. C., Kober, L., Schou, M. (2025) Kidney status and events preceding death in heart failure: a real‐world nationwide study. European Journal of Heart Failure, (doi: 10.1002/ejhf.3631)

Simitev, R. D., Gilchrist, R. J., Yang, Z., Myles, R. C., Burton, F. L., Smith, G. L. (2025) A large population of cell-specific action potential models replicating fluorescence recordings of voltage in rabbit ventricular myocytes. Royal Society Open Science, 12, (doi: 10.1098/rsos.241539)

Butt, J. H., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Gustafsson, F., Kristensen, S. L., Bruun, N. E., Eiskjær, H., Brandes, A., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp‐Pedersen, C., Schou, M., Pehrson, S., Packer, M., McMurray, J. J.V., Køber, L. (2025) Anthropometric measures and long‐term mortality in non‐ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradox. European Journal of Heart Failure, 27, pp. 527-536. (doi: 10.1002/ejhf.3424)

Naeem, F., Penfold, R. S., Soiza, R. L., Von Haken, R., Lindroth, H., Liu, K., Nydhal, P., Quinn, T. J. (2025) Delirium assessment, management and barriers to effective care across Scotland: a secondary analysis of survey data from World Delirium Awareness Day 2023. Journal of the Royal College of Physicians of Edinburgh, 55, pp. 6-13. (doi: 10.1177/14782715241301486)

Liu, Q., Welsh, P., Celis-Morales, C., Ho, F. K., Lees, J. S., Mark, P. B. (2025) Discordance between Cystatin C-based and Creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis. Clinical Kidney Journal, 18, (doi: 10.1093/ckj/sfaf003)

Shah, S. J., Bonderman, D., Borlaug, B. A., Cleland, J. G. F., Lack, G., Lu, W., Voors, A. A., Zannad, F., Gladwin, M. T. (2025) Macitentan for heart failure with preserved or mildly reduced ejection fraction and pulmonary vascular disease: results of the SERENADE randomized clinical trial and open-label extension study. Circulation: Heart Failure, 18, pp. 227-239. (doi: 10.1161/CIRCHEARTFAILURE.123.011381)

Huethorst, E., Bishop, M. J., Burton, F. L., Denning, C., Gadegaard, N., Myles, R. C., Smith, G. L. (2025) Evidence for intermittent coupling of intramyocardial small, engineered heart tissues acutely implanted into rabbit myocardium. Cardiovascular Research, (doi: 10.1093/cvr/cvaf034)

Khin, H. H. E., Cuthbert, J. J., Koratala, A., Aquaro, G., Pugliese, N. R., Gargani, L., Stoumpos, S., Cleland, J. G.F., Pellicori, P. (2025) Imaging of congestion in cardio-renal syndrome. Current Heart Failure Reports, 22, (doi: 10.1007/s11897-025-00695-z)

Sze, S., Squire, I., Kalra, P. R., Cleland, J. G., Petrie, M. C., Kalra, P. A., Ahmed, F., Banerjee, P., Boos, C. J., Chapman, C., Cowburn, P. J., Dixon, L., Duckett, S., Lane, R., Foley, P., Lang, N. N., Lyons, K., Ray, R., Schiff, R., Thomson, E. A., Robertson, M., Ford, I., IRONMAN Study Group, (2025) Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: Insights from the IRONMAN trial. Heart, (doi: 10.1136/heartjnl-2024-324908)

Sykes, R., Ang, D. T.Y., Berry, C. (2025) Takotsubo is an acute myocardial ischaemic syndrome. European Heart Journal, (doi: 10.1093/eurheartj/ehaf020)

Sykes, R., Morrow, A. J., Mangion, K., McConnachie, A., McIntosh, A., Roditi, G., Peng, L., Rooney, C., Scott, K., Stobo, D. B., Berry, C., Church, C., Bayes, H. K. (2025) Radiological abnormalities persist following covid-19 and correlate with impaired Health-related Quality of Life: a prospective cohort study of hospitalized patients. BMJ Open Respiratory Research, 12, (doi: 10.1136/bmjresp-2023-001985)

Kuo, C.-W., Gök, C., Fulton, H., Dickson-Murray, E., Adu, S., Gallen, E. K., Mary, S., Robertson, A. D., Jordan, F., Dunning, E., Mullen, W., Smith, G. L., Fuller, W. (2025) Nanobody-thioesterase chimeras to specifically target protein palmitoylation. Nature Communications, 16, (doi: 10.1038/s41467-025-56716-x)

Nakada, S., Ward, J., Strawbridge, R. J., Welsh, P., Celis-Morales, C., Ho, F. K., Pell, J. P. (2025) Anxiety disorder, depression and coronary artery disease: associations and modification by genetic susceptibility. BMC Medicine, 23, (doi: 10.1186/s12916-025-03915-4)

Ho, F. K., Mark, P. B., Lees, J. S., Pell, J. P., Strawbridge, R. J., Kimenai, D. M., Mills, N. L., Woodward, M., McMurray, J. J.V., Sattar, N., Welsh, P. (2025) A proteomics-based approach for prediction of different cardiovascular diseases and dementia. Circulation, 151, pp. 277-287. (doi: 10.1161/CIRCULATIONAHA.124.070454)

de Sousa, D. A., Zedde, M., Katsanos, A. H., Li, L., Marti-Fabregas, J., Nolte, C. H., Podlasek, A., Poli, S., Purrucker, J., Roaldsen, M. B., Schellinger, P. D., Strbian, D., Tsivgoulis, G., Tsokani, S., Veroniki, A. A., Quinn, T. J. (2025) European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance) European Stroke Journal, (doi: 10.1177/23969873251316430)

Bonaca, M. P. et al. (2025) Cardiovascular safety in oncology clinical trials: JACC: CardioOncology Primer. JACC: CardioOncology, 7, pp. 83-95. (doi: 10.1016/j.jaccao.2024.09.014)

Yang, M., Kondo, T., Talebi, A., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2025) EuroQol 5-Dimension questionnaire in heart failure with reduced, mildly reduced, and preserved ejection fraction. JACC: Heart Failure, 13, pp. 277-292. (doi: 10.1016/j.jchf.2024.10.020)

Butt, J. H., Jhund, P. S., Henderson, A. D., Claggett, B. L., Desai, A. S., Viswanathan, P., Kolkhof, P., Schloemer, P., Amarante, F., Lam, C. S. P., Senni, M., Shah, S. J., Voors, A. A., Zannad, F., Pitt, B., Vaduganathan, M., Solomon, S. D., McMurray, J. J. V. (2025) Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial. Lancet Diabetes and Endocrinology, 13, pp. 107-118. (doi: 10.1016/S2213-8587(24)00309-7)

Cuthbert, J. J., Cleland, J. G. F., Pellicori, P., Clark, A. L. (2025) Natriuresis-guided diuresis in patients admitted to hospital with heart failure: barking up the wrong tree? Journal of Cardiac Failure, 31, pp. 465-468. (doi: 10.1016/j.cardfail.2024.09.021)

Tay, W. T., Teng, T.-H. K., Ouwerkerk, W., Angermann, C. E., Dickstein, K., Cleland, J. G.F., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Lam, C. S.P., Tromp, J. (2025) Quality of care delivery in patients with acute heart failure: Insights from the International REPORT-HF registry. EClinicalMedicine, 80, (doi: 10.1016/j.eclinm.2024.103031)

Elbassioni, A. A. M. et al. (2025) Targeting Runx1 protects against heart failure with preserved ejection fraction. bioRxiv, (doi: 10.1101/2025.01.24.634831)

McIntosh, B., Elbassioni, A., Raheem, A., MacDonald, E. A., Nicklin, S. A., Koay, Y. C., Cameron, E. R., Loughrey, C. M., O'Sullivan, J. F. (2025) Optimized protocols for commonly-used murine models of heart failure with preserved ejection fraction. bioRxiv, (doi: 10.1101/2025.01.22.634221)

Welsh, P., Kimenai, D. M., Woodward, M. (2025) Updating the Scottish national cardiovascular risk score: ASSIGN version 2.0. Heart, (doi: 10.1136/heartjnl-2024-324852)

Rankin, S., Fountain, C., Gemmell, A. J., Quinn, D., Henderson, A., McClure, J., Small, S., Venugopal, B., McKay, P., Slomka, P. J., Colville, D., Petrie, M. C., Meléndez, G. C., Lang, N. N. (2025) Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients. Clinical Science, 139, pp. 29-41. (doi: 10.1042/CS20241529)

Nakada, S., Welsh, P., Celis-Morales, C., Pell, J. P., Ho, F. K. (2025) Refining PREVENT prediction models for 10-year risk of cardiovascular disease using measures of anxiety and depression. Canadian Medical Association Journal, 197, pp. E1-E8. (doi: 10.1503/cmaj.240996)

Osmanska, J., Docherty, K. F., Berry, C., Jhund, P. S., Mangion, K., Mark, P. B., McMurray, J. J.V., Roditi, G., Sattar, N., Petrie, M. C., Campbell, R. T., Lee, M. M.Y. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF) European Journal of Heart Failure, (doi: 10.1002/ejhf.3570)

Solano, S., Yang, M., Tolomeo, P., Kondo, T., Shen, L., Jhund, P. S., Anand, I. S., Desai, A. S., Lam, C. S. P., Maggioni, A. P., Martinez, F. A., Rouleau, J. L., Vaduganathan, M., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Packer, M., Solomon, S. D., McMurray, J. (2025) Clinical characteristics and outcomes of patients with heart failure with preserved ejection fraction and with reduced ejection fraction according to the prognostic nutritional index: findings from PARADIGM‐HF and PARAGON‐HF. Journal of the American Heart Association, 14, (doi: 10.1161/JAHA.124.037782)

Lu, H., Inciardi, R. M., Abanda, M., Shah, A. M., Cikes, M., Claggett, B. L., Prasad, N., Lam, C. S.P., Redfield, M., McMurray, J. J.V., Pfeffer, M. A., Solomon, S. D., Hegde, S. M., Skali, H. (2025) Multiparametric assessment of right ventricular dysfunction in heart failure: an analysis from PARAGON‐HF. Journal of the American Heart Association, 14, (doi: 10.1161/jaha.124.037380)

Pontiroli, A. E., Tagliabue, E., Madotto, F., Leoni, O., Antonelli, B., Carluccio, E., Bandera, F., Galati, G., Pellicori, P., Lund, L. H., Ambrosio, G. (2025) Association of non-cardiac comorbidities and sex with long-term re-hospitalization for heart failure. European Journal of Internal Medicine, 131, pp. 125-132. (doi: 10.1016/j.ejim.2024.10.018)

Matsumoto, S., Henderson, A. D., Shen, L., Kondo, T., Yang, M., Campbell, R. T., Anand, I. S., de Boer, R. A., Desai, A. S., Lam, C. S.P., Maggioni, A. P., Martinez, F. A., Packer, M., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Vaduganathan, M., Zannad, F., Zile, M. R., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2025) Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 27, pp. 124-139. (doi: 10.1002/ejhf.3383)

Liu, Q., Celis-Morales, C., Lees, J., Mark, P., Welsh, P. (2025) Effect of exercise on kidney-relevant biomarkers in the general population: a systematic review and meta-analysis. BMJ Open, 15, (doi: 10.1136/bmjopen-2024-093017)

Badve, S. V., Bilal, A., Lee, M. M. Y., Sattar, N., Gerstein, H. C., Ruff, C. T., McMurray, J. J. V., Rossing, P., Bakris, G., Mahaffey, K. W., Mann, J. F. E., Colhoun, H. M., Tuttle, K. R., Pratley, R. E., Perkovic, V. (2025) Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes and Endocrinology, 13, pp. 15-28. (doi: 10.1016/S2213-8587(24)00271-7)

Di Fiore, V., Del Punta, L., De Biase, N., Pellicori, P., Gargani, L., Dini, F. L., Armenia, S., Vigni, M. L., Maremmani, D., Masi, S., Taddei, S., Pugliese, N. R. (2025) Integrative assessment of congestion in heart failure using ultrasound imaging. Internal and Emergency Medicine, 20, pp. 11-22. (doi: 10.1007/s11739-024-03755-9)

Cheng, L., Hammersley, D., Ragavan, A., Javed, S., Mukhopadhyay, S., Gregson, J., Han, J., Khalique, Z., Lota, A., Pantazis, A., Baksi, A. J., Carr‐White, G., de Marvao, A., Ware, J., Tayal, U., Pennell, D. J., Cleland, J. G.F., Prasad, S. K., Halliday, B. P. (2025) Long‐term follow‐up of the TRED ‐ HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remission. European Journal of Heart Failure, 27, pp. 113-123. (doi: 10.1002/ejhf.3475)

Tao, R., Robertson, A., Fuller, W., Gok, C. (2025) Palmitoylation and regulation of potassium-dependent sodium/calcium exchangers (NCKX) Bioscience Reports, 45, pp. 1-11. (doi: 10.1042/bsr20241051)

Lu, H., Claggett, B. L., Packer, M., Pfeffer, M. A., Lam, C. S.P., Zile, M. R., Desai, A. S., Jhund, P., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2025) Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON‐HF trial. European Journal of Heart Failure, 27, pp. 85-95. (doi: 10.1002/ejhf.3414)

Osmanska, J., Petrie, M. C., Docherty, K. F., Lee, M. M.Y., McMurray, J. J.V., Campbell, R. (2025) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, 11, pp. 94-104. (doi: 10.1093/ehjcvp/pvae083)

Lu, H., Claggett, B. L., Packer, M., Pfeffer, M. A., Swedberg, K., Rouleau, J., Zile, M. R., Lefkowitz, M., Desai, A. S., Jhund, P. S., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2025) Visit‐to‐visit changes in heart rate in heart failure: A pooled participant‐level analysis of the PARADIGM‐HF and PARAGON‐HF trials. European Journal of Heart Failure, 27, pp. 60-68. (doi: 10.1002/ejhf.3487)

Amir, O., Elbaz‐Greener, G., Carasso, S., Claggett, B., Barbarash, O., Zaman, A., Christersson, C., Kiatchoosakun, S., Anonuevo, J., Opolski, G., Vaghaiwalla, M. F., van der Meer, P., Zhou, Y., Mann, D. L., Kober, L., Steg, G., Jering, K., Kulac, I., De Pasquale, C. G., McMurray, J. J.V., Pfeffer, M. A. (2025) Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE ‐ MI trial data. European Journal of Heart Failure, (doi: 10.1002/ejhf.3542)

Petrie, M. C., Udell, J. A., Anker, S. D., Harrington, J., Jones, W. S., Mattheus, M., Gasior, T., van der Meer, P., Amir, O., Bahit, M. C., Bauersachs, J., Bayes-Genis, A., Chopra, V. K., Januzzi, J. L., Lopes, R. D., Ponikowski, P., Rossello, X., Schou, M., Zieroth, S., Brueckmann, M., Sumin, M., Bhatt, D. L., Hernandez, A. F., Butler, J. (2025) Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3548)

Grote Beverborg, N., Alnuwaysir, R. I.S., Markousis‐Mavrogenis, G., Hoes, M. F., van der Wal, H. H., Romaine, S. P.R., Nath, M., Koekoemoer, A., Cleland, J. G.F., Lang, C. C., Anker, S. D., Dickstein, K., Metra, M., Ng, L. L., van Veldhuisen, D. J., Voors, A. A., Samani, N. J., van der Meer, P. (2025) The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes. European Journal of Heart Failure, (doi: 10.1002/ejhf.3562)

Bradley, C. P., Orchard, V., Sykes, R. A., McKinley, G., McConnachie, A., Donnelly, P., Watt, J., Kellman, P., Quinn, T., Fullerton, N., Berry, C. (2024) Heart-brain microvascular MRI study: protocol for a multicentre, observational, cohort study in the UK assessing associations between small vessel disease of the heart and brain. BMJ Open, 14, (doi: 10.1136/bmjopen-2024-088372)

Foà, A., Pabon, M. A., Braunwald, E., Jering, K., Vaduganathan, M., Claggett, B. L., Køber, L., Lewis, E. F., Granger, C. B., van der Meer, P., Rouleau, J. L., Maggioni, A. P., McMurray, J. J.V., Solomon, S. D., Pfeffer, M. A. (2024) Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials. European Journal of Heart Failure, (doi: 10.1002/ejhf.3557)

Sosenko, F., Mair, F. S., Nicholl, B. I., Hanlon, P., Lewsey, J., Fleming, M., Mackay, D., Dundas, R., Du Toit, C., Friday, J., Stevenson, A., Geue, C., Brown, D., Hastie, C., Tran, T. Q. B., Ho, F. K., Pell, J., Padmanabhan, S., Jani, B. D. (2024) Cancer diagnosis after emergency presentation: impact of demographics, cancer types, and pandemic. Academia Oncology, 1, pp. 1-8. (doi: 10.20935/AcadOnco7422)

Wang, X., Vardeny, O., Claggett, B., Vaduganathan, M., Hegde, S. M., Skali, H., Pabon, M. A., Foà, A., Chatur, S., Kosztin, A., O'Meara, E., Rouleau, J., Redfield, M., Lam, C. S.P., Zile, M., Packer, M., Shah, A. M., Cikes, M., Gori, M., Merkely, B., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2024) Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON‐HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3535)

Carberry, J. et al. (2024) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI) European Journal of Heart Failure, (doi: 10.1002/ejhf.3560)

Leong, D. P., Joseph, P. G., Dokainish, H., Störk, S., McMurray, J. V.V., Mielniczuk, L. M., Sharma, S. K., Orlandini, A., Karaye, K. M., Bayes‐Genis, A., McCready, T., Grinvalds, A., Balasubramanian, K., Branch, K. R., Kragholm, K., Yusuf, S. (2024) The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries – A Global Congestive Heart Failure (G-CHF) study. European Journal of Heart Failure, (doi: 10.1002/ejhf.3550)

Sin, Y. Y., Giblin, A., Judina, A., Rujirachaivej, P., Corral, L., Glennon, E., Tai, Z., Feng, T., Torres, E., Zorn, A., Gorelik, J., Kyurkchieva, E., Yenchitsomanus, P.-t., Swindlehurst, C., Chan, K., Stirling, D., Baillie, G. S. (2024) Targeted protein degradation of PDE4 shortforms by a novel proteolysis targeting chimera. FEBS Journal, (doi: 10.1111/febs.17359)

Andonovic, M., Morrison, H., Allingham, W., Adam, R., Shaw, M., Quasim, T., McPeake, J., Quinn, T. (2024) Mechanisms underlying neurocognitive dysfunction following critical illness: a systematic review. Anaesthesia, (doi: 10.1111/anae.16494)

Ponikowski, P. et al. (2024) Hospitalization of symptomatic patients with heart failure and moderate to severe functional mitral regurgitation treated with MitraClip: insights from RESHAPE-HF2. JACC: Heart Failure, 84, pp. 2347-2363. (doi: 10.1016/j.jacc.2024.08.027)

Monzo, L., Bresso, E., Dickstein, K., Pitt, B., Cleland, J. G.F., Anker, S. D., Lam, C. S.P., Mehra, M. R., van Veldhuisen, D. J., Greenberg, B., Zannad, F., Girerd, N. (2024) Machine learning approach to identify phenotypes in patients with ischemic heart failure with reduced ejection fraction. European Journal of Heart Failure, (doi: 10.1002/ejhf.3547)

Montezano, A. C., Kuriakose, J., Hood, K. Y., Sin, Y. Y., Camargo, L. L., Namkung, Y., Castro, C. H., Santos, R. A., Alves-Lopes, R., Tejeda, G., Passaglia, P., Basheer, S., Gallen, E., Findlay, J. E., Awan, F. R., Laporte, S. A., MacLean, M. R., Baillie, G. S., Touyz, R. M. (2024) Ang-(1-7) and ET-1 interplay through Mas and ETB receptor interaction defines a novel vasoprotective mechanism. Hypertension, (doi: 10.1161/HYPERTENSIONAHA.124.22693)

Leong, D. P., Waliany, S., Abdel-Qadir, H., Atkins, K. M., Neilan, T. G., Lang, N. N., Liu, J. E., Blaes, A. H., Mian, H. S., Moore, H. N., Hajjar, L. A., Morgans, A. K., Ellis, P. M., Dent, S. (2024) Cardiovascular considerations during cancer therapy: Gaps in evidence and JACC: CardioOncology expert panel recommendations. JACC: CardioOncology, 6, pp. 815-834. (doi: 10.1016/j.jaccao.2024.06.005)

Cao, T. H., Tay, W. T., Jones, D. J.L., Cleland, J. G.F., Tromp, J., Emmens, J. E., Teng, T.‐H. K., Chandramouli, C., Slingsby, O. C., Anker, S. D., Dickstein, K., Filippatos, G., Lang, C. C., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Anand, I. S., Lam, C. S.P., Voors, A. A., Ng, L. L. (2024) Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT‐CHF (European) study with the ASIAN‐HF registry. European Journal of Heart Failure, 26, pp. 2518-2528. (doi: 10.1002/ejhf.3378)

Giannitsis, E., Frey, N., Jhund, P. S. (2024) Improving the rate of heart failure with improved ejection fraction. European Journal of Heart Failure, 26, pp. 2529-2531. (doi: 10.1002/ejhf.3427)

Anderson, J. J., Deo, S. V., Welsh, P., Mackay, D. F., Ho, F. K., Ferguson, L. D., Celis-Morales, C., Gill, J.R., Pell, J. P., Sattar, N. (2024) In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C-reactive protein? Diabetes, Obesity and Metabolism, 26, pp. 5786-5794. (doi: 10.1111/dom.15949)

Pabon, M. A., Vaduganathan, M., Claggett, B. L., Chatur, S., Siqueira, S., Marti‐Castellote, P., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., Jhund, P. S., McMurray, J. J.V., Solomon, S. D., Vardeny, O. (2024) In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure, 26, pp. 2532-2540. (doi: 10.1002/ejhf.3410)

Ho, F., Allan, M., Shao, H., Man, K. K.C., Jani, B. D., Lyall, D., Hastie, C., Fleming, M., Mackay, D., Cleland, J. G.F., Delles, C., Dundas, R., Lewsey, J., Ip, P., Wong, I., Welsh, P., Pearce, A., Wright, C. M., Minnis, H., Katikireddi, V., Pell, J. P. (2024) Maternal and pregnancy factors contributing to the association between area deprivation and infant mortality in England: a retrospective cohort study. Lancet Regional Health - Europe, 47, (doi: 10.1016/j.lanepe.2024.101075)

Butt, J. H., McMurray, J. J.V., Claggett, B. L., Jhund, P. S., Neuen, B. L., McCausland, F., Desai, A., Lam, C. S.P., Pitt, B., Pfeffer, M. A., Packer, M., Beldhuis, I., Voors, A. A., Zannad, F., Heerspink, H. J.L., Solomon, S. D., Vaduganathan, M. (2024) Therapeutic effects of heart failure medical therapies on standardized kidney outcomes: Comprehensive individual participant-level analysis of 6 randomized clinical trials. Circulation, 150, pp. 1858-1868. (doi: 10.1161/circulationaha.124.071110)

Kamdar, A., Sykes, R., Thomson, C. R., Mangion, K., Ang, D., Lee, M. A.W., Van Agtmael, T., Berry, C. (2024) Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions. Infectious Medicine, 3, (doi: 10.1016/j.imj.2024.100147)

De Biase, N., Del Punta, L., L'Hoyes, W., Pellicori, P., Cleland, J. G.F., Masini, G., Gargani, L., Moura-Ferreira, S., Hoedemakers, S., Di Fiore, V., Herbots, L., Stassen, J., Mengozzi, A., Armenia, S., Taddei, S., Masi, S., Verwerft, J., Pugliese, N. R. (2024) Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.3534)

Ang, D. T.Y., Carberry, J., Ford, T. J., Kamdar, A., Sykes, R., Sidik, N. P., Carrick, D., McCartney, P. J., Collison, D., Robertson, K., Shaukat, A., Rocchiccioli, J. P., McGeoch, R., Watkins, S., Hood, S., McEntegart, M., Lindsay, M., Eteiba, H., Oldroyd, K. G., Good, R., McConnachie, A., Berry, C. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677)

Ho, F. K., Dale, C., Mizani, M. A., Bolton, T., Pearson, E. R., Valabhji, J., Delles, C., Welsh, P., Nakada, S., Mackay, D., Pell, J. P., Tomlinson, C., Petersen, S., Bray, B., Ashworth, M., Rahimi, K., Mamas, M., Halcox, J., Sudlow, C., Sofat, R., Sattar, N., CVD-COVID-UK/COVID-IMPACT Consortium, (2024) Routine measurement of cardiometabolic disease risk factors in primary care in England before, during and after the COVID-19 pandemic: a population-based cohort study. PLoS Medicine, 21, (doi: 10.1371/journal.pmed.1004485)

Gupta, S. D., Butt, J. H., McMurray, E. G.M., Talebi, A., Matsumoto, S., Rizkala, A. R., Henderson, A. D., Desai, A. S., Lefkowitz, M., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2024) Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3515)

Seckin, M., Petrie, M. C., Stewart, S., Johnston, B. M. (2024) A descriptive qualitative study of breathlessness and its management of Turkish individuals with self-reported heart failure. BMJ Open, 14, (doi: 10.1136/bmjopen-2024-088335)

Averbuch, T., Lee, S. F., Zagorski, B., Pandey, A., Petrie, M. C., Biering‐Sorensen, T., Xie, F., Van Spall, H. G.C. (2024) Long‐term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.3499)

Liu, Q., Celis-Morales, C., Sattar, N., Welsh, P. (2024) Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank. Diabetes, Obesity and Metabolism, 26, pp. 5192-5201. (doi: 10.1111/dom.15865)

Zervou, S., McAndrew, D. J., Lake, H. A., Kuznecova, E., Preece, C., Davies, B., Neubauer, S., Lygate, C. A. (2024) Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity. Journal of Molecular and Cellular Cardiology, 196, pp. 105-114. (doi: 10.1016/j.yjmcc.2024.09.007)

Sudesh, S., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Friedman, D. J., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Cardiac resynchronization therapy in ischemic versus non-ischemic cardiomyopathy: patient-level meta-analysis of seven randomized clinical trials. JACC: Heart Failure, 12, pp. 1915-1924. (doi: 10.1016/j.jchf.2024.08.010)

Fletcher, R. A. et al. (2024) Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records. Lancet Public Health, 9, pp. e871-e885. (doi: 10.1016/S2468-2667(24)00215-9)

Butt, J. H., Shen, L., Inzucchi, S. E., Docherty, K. F., Jhund, P. S., Martinez, F. A., Sabatine, M. S., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2024) Dapagliflozin in heart failure, type 2 diabetes, and neuropathy. JACC: Heart Failure, 12, pp. 1946-1948. (doi: 10.1016/j.jchf.2024.07.017)

Mulholland, R. J., Ciminata, G., Quinn, T. J., Pollock, K. G., Lister, S., Geue, C. (2024) Delay and pay? Healthcare costs associated with late oral anti-coagulant prescribing in people with atrial fibrillation. PharmacoEconomics, 42, pp. 1241-1253. (doi: 10.1007/s40273-024-01419-2)

Valentova, M., Vatic, M., Garfias-Veitl, T., Sandek, A., Bekfani, T., Jankowska, E. A., Cleland, J. G.F., Clark, A. L., Lainscak, M., Ahmed, A., Jauert, N., Hasenfuss, G., Anker, S. D., Doehner, W., von Haehling, S. (2024) Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure − a propensity score-matched study. Diabetes Research and Clinical Practice, 217, (doi: 10.1016/j.diabres.2024.111864)

Doherty, D. J., Abdin, A., Docherty, K. F. (2024) Heart failure medical therapy in the last years of life: prognosis and practicalities. European Journal of Heart Failure, 26, pp. 2451-2452. (doi: 10.1002/ejhf.3450)

Main, A., Mary, S., Sin, Y. Y., Wright, T. A., Ling, J., Blair, C. M., Smith, G. L., Fuller, W., Baillie, G. S. (2024) SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenaline. International Journal of Biochemistry and Cell Biology, 176, (doi: 10.1016/j.biocel.2024.106668)

Rochmawati, I. D., Deo, S., Lees, J. S., Mark, P. B., Sattar, N., Celis-Morales, C., Pell, J. P., Welsh, P., Ho, F. K. (2024) Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20,656 patients with cardiovascular disease. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwae352)

Tvrdá, L., Mavromati, K., Taylor-Rowan, M., Quinn, T. J. (2024) Comparing the properties of traditional and novel approaches to the Modified Rankin Scale: systematic review and meta-analysis. European Stroke Journal, (doi: 10.1177/23969873241293569)

Cleland, J., Pellicori, P., Graham, F. J., Lane, R., Petrie, M. C., Ahmed, F., Squire, I. B., Ludman, A., Japp, A., Al-Mohammad, A., Clark, A. L., Szwejkowski, B., Critoph, C., Chong, V., Schiff, R., Nageh, T., Glover, J., McMurray, J. J.V., Thomson, E. A., Robertson, M., Ford, I., Kalra, P. A., Kalra, P. R. (2024) Adjudication of hospitalizations and deaths in the IRONMAN Trial of intravenous iron for heart failure. Journal of the American College of Cardiology, 84, pp. 1704-1717. (doi: 10.1016/j.jacc.2024.08.052)

Xiong, X., Lui, D. T.W., Ju, C., Zhou, Z., Xu, C., Welsh, P., Sattar, N., Celis-Morales, C., Pell, J. P., Wong, I. C.K., Wong, C. K.H., Ho, F. (2024) Associations of serum lipid traits with fracture and osteoporosis: a prospective cohort study from the UK Biobank. Journal of Cachexia, Sarcopenia and Muscle, (doi: 10.1002/jcsm.13611)

Dieden, A., Girerd, N., Ottosson, F., Molvin, J., Pareek, M., Melander, O., Bachus, E., Råstam, L., Lindblad, U., Daka, B., Leósdóttir, M., Nilsson, P. M., Olsen, M. H., Clark, A. L., Cleland, J. G.F., Delles, C., González, A., Lamiral, Z., Duarte, K., Rossignol, P., Zannad, F., Gudmundsson, P., Jujić, A., Magnusson, M. (2024) Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts. European Journal of Heart Failure, (doi: 10.1002/ejhf.3502)

Foley, P.W., Kalra, P.R., Cleland, J.G.F., Petrie, M.C., Kalra, P.A., Squire, I., Campbell, P., Chapman, C., Donnelly, P., Graham, F., Hannah, A., Lang, N.N., Matthews, I., Leslie, S.J., Pellicori, P., Piper, S., Ray, R., Savage, H.O., Spencer, C., Walsh, J., Wong, Y., Ford, I. (2024) Effect of correcting iron deficiency on the risk of serious infection in heart failure insights from the IRONMAN trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3504)

Lipina, T., Li, S., Petrova, E. S., Amstislavskaya, T. G., Cameron, R. T., Elliott, C., Gondo, Y., McGirr, A., Mullins, J. G.L., Baillie, G. S., Woodgett, J. R., Clapcote, S. J. (2024) PDE4B missense variant increases susceptibility to post-traumatic stress disorder-relevant phenotypes in mice. Journal of Neuroscience, 44, (doi: 10.1523/JNEUROSCI.0137-24.2024)

Kancheva, A. K., Lyall, D. M., Millard, L., Wardlaw, J. M., Quinn, T. J. (2024) Clinical phenotypes associated with cerebral small vessel disease: a study of 45,013 UK biobank participants. Neurology, 103, (doi: 10.1212/WNL.0000000000209919)

Costello, R. E. et al. (2024) Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry Data. BMJ Open, 14, (doi: 10.1136/bmjopen-2024-088710)

MacRae, J., Ciminata, G., Geue, C., Lynch, E., Shenkin, S. D., Quinn, T. J., Burton, J. K. (2024) Mortality among long-term care residents: a retrospective cohort study. BMJ Supportive and Palliative Care, (doi: 10.1136/spcare-2024-005163)

Varga, C. R., Cleland, J. G.F., Abraham, W. T., Lip, G. Y.H., Leyva, F., Hatamizadeh, P. (2024) Implantable cardioverter defibrillator and resynchronization therapy in patients with overt chronic kidney disease. Journal of the American College of Cardiology, 84, pp. 1342-1362. (doi: 10.1016/j.jacc.2024.05.081)

Friday, J. M., Cleland, J., Pellicori, P., Wolters, M., McMurray, J. J.V., Jhund, P. S., Forsyth, P., McAllister, D. A., Graham, F. J., Jones, Y., Lewsey, J. (2024) Loop diuretic utilisation with or without heart failure: impact on prognosis. European Heart Journal, 45, pp. 3837-3849. (doi: 10.1093/eurheartj/ehae345)

Lee, M., Petrie, M. C., Cleland, J. G.F., Donnelly, P., Francis, M., Hannah, A., Japp, A. G., Labinjoh, C., Lang, N. N., Mainsty, C., Petrie, C. J., Piper, S. E., Williams, S. G., Ford, I., Kalra, P. R., IRONMAN Trial Investigators, (2024) Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial. European Journal of Heart Failure, 26, pp. 2293-2295. (doi: 10.1002/ejhf.3394)

Liu, Q., Celis-Morales, C., Lees, J. S., Sattar, N., Ho, F., Pell, J. P., Mark, P. B., Welsh, P. (2024) Change in physical activity and its association with decline in kidney function: A UK Biobank-based cohort study. Journal of Cachexia, Sarcopenia and Muscle, 15, pp. 2046-2055. (doi: 10.1002/jcsm.13551)

Turgut, C., Fernando, J., Berry, C., Campbell, R.T., Docherty, K.F., Dreisbach, J.G., Jhund, P.S., Mangion, K., Mark, P.B., McMurray, J.J.V., Osmanska, J., Roditi, G., Petrie, M.C., Sattar, N., Lee, M. (2024) Effect of Empagliflozin on Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes, or Rrediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) (doi: 10.1093/eurheartj/ehae666.1018)

Docherty, K. F., Lopez, R. B., Folkvaljon, F., de Boer, R. A., Cowie, M. R., Hammarstedt, A., Kitzman, D. W., Kosiborod, M. N., Langkilde, A. M., Reicher, B., Senni, M., Shah, S. J., Verma, S., Solomon, S. D., McMurray, J. J.V. (2024) Effect of dapagliflozin on accelerometer-based measures of physical activity in patients with heart failure: an analysis of the DETERMINE trials. Circulation: Heart Failure, 17, (doi: 10.1161/CIRCHEARTFAILURE.124.012349)

Cleland, J. G.F. (2024) Home-time is good, but feeling well is better: patient-journey and quality-home-time as endpoints in heart failure trials and registries. Circulation: Heart Failure, 17, (doi: 10.1161/CIRCHEARTFAILURE.124.012263)

Shead, K. D., Huethorst, E., Burton, F., Lang, N., Myles, R. C., Smith, G. L. (2024) Human induced pluripotent stem cell-derived cardiomyocytes for preclinical cardiotoxicity screening in cardio-oncology. JACC: CardioOncology, 6, pp. 678-683. (doi: 10.1016/j.jaccao.2024.07.012)

Abdin, A., Jhund, P. S. (2024) Implementation of guideline‐directed medical therapy for heart failure: Progress achieved, work ahead! European Journal of Heart Failure, 26, pp. 2258-2260. (doi: 10.1002/ejhf.3438)

Sliwa, K., Rakisheva, A., Viljoen, C., Pfeffer, T., Simpson, M., Jackson, A. M., Petrie, M. C., van der Meer, P., Al Farhan, H., Jovanova, S., Mbakwem, A., Sinagra, G., Van Craenenbroeck, E., Hoevelmann, J., Johnson, M. R., Mindham, R., Chioncel, O., Kahl, K. G., Rosano, G., Tschöpe, C., Mebazaa, A., Seferovic, P., Bauersachs, J. (2024) Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology. European Journal of Heart Failure, 26, pp. 2143-2154. (doi: 10.1002/ejhf.3377)

Pellicori, P., Cuthbert, J. J., Clark, A. L., Cleland, J. G.F. (2024) Managing water and salt balance in heart failure: Is there anything else to consider other than diet and diuretics? European Journal of Heart Failure, 26, pp. 2140-2142. (doi: 10.1002/ejhf.3374)

Keene, D. et al. (2024) Predictors of the efficacy of His bundle pacing in patients with a prolonged PR interval: A stratified analysis of the HOPE‐HF randomized controlled trial. European Journal of Heart Failure, 26, pp. 2261-2268. (doi: 10.1002/ejhf.3367)

Chatur, S., Beldhuis, I. E., Claggett, B. L., McCausland, F. R., Neuen, B. L., Desai, A. S., Rouleau, J. L., Zile, M. R., Packer, M., Pfeffer, M. A., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2024) Sacubitril/valsartan in patients with heart failure and deterioration in eGFR to <30 mL/min/1.73 m2. JACC: Heart Failure, 12, pp. 1692-1703. (doi: 10.1016/j.jchf.2024.03.014)

McCallum, L., Lip, S., McConnachie, A., Brooksbank, K., MacIntyre, I., Doney, A., Llano, A., Aman, A., Caparrotta, T. M., Ingram, G., Mackenzie, I. S., Dominiczak, A. F., MacDonald, T. M., Webb, D. J., Padmanabhan, S. (2024) UMOD genotype-dependent effects of Torasemide on ambulatory blood pressure: a multicentre genotype-blinded trial. Hypertension, 81, pp. 2049-2059. (doi: 10.1161/HYPERTENSIONAHA.124.23122)

Yu, Y.-L. et al. (2024) Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart, 110, pp. 1180-1187. (doi: 10.1136/heartjnl-2023-323796)

Binning, L., Basquill, C., Tvrdá, L., Quinn, T. (2024) Epidemiology and outcomes associated with cognitive frailty and reserve in a stroke population: systematic review and meta-analysis. Cerebrovascular Diseases, pp. 1–21. (doi: 10.1159/000541670)

Knight, K., Finnegan, N., Rafter, A., Forbes, D., Black, D., Quinn, T. (2024) The feasibility and validity of sarcopenia assessment using standard of care stroke imaging. Cerebrovascular Diseases, (doi: 10.1159/000541649)

Gallacher, K. I., Petrie, D., Rasmussen McAdie, D., McGuire, P., Quinn, T. J. (2024) Stroke recovery – what are people talking about on Twitter? A content analysis. Disability and Rehabilitation, (doi: 10.1080/09638288.2024.2403722)

Wang, X., Pabon, M. A., Cikes, M., Jering, K., Mullens, W., Kober, L., Jhund, P. S., Kovacs, A., Merkely, B., Zhou, Y., McMurray, J. J.V., Shah, A. M., Hegde, S. M., Claggett, B., Pfeffer, M. A., Solomon, S. D. (2024) Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE‐MI echocardiographic substudy. European Journal of Heart Failure, (doi: 10.1002/ejhf.3472)

Jhund, P. S., Talebi, A., Henderson, A. D., Claggett, B. L., Vaduganathan, M., Desai, A. S., Lam, C. S.P., Pitt, B., Senni, M., Shah, S. J., Voors, A. A., Zannad, F., Solomon, S. D., McMurray, J. J.V. (2024) Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet, 404, pp. 1119-1131. (doi: 10.1016/S0140-6736(24)01733-1)

Greene, S. J. et al. (2024) Cardiovascular and renal treatment in heart failure patients with hyperkalemia or high risk of hyperkalemia: rationale and design of the CARE-HK in HF registry. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2024.08.048)

Kidd, L., Brown, J., Mason, H., Quinn, T., Gallacher, K. I., Jones, F., Fisher, R., Lebedis, T., Barber, M., Brennan, K., Gilmour, B., Fraser, C., Mooney, P., Taggart, A. (2024) A realist evaluation of mechanisms and contexts for facilitating the implementation of supported self-management in community stroke care (the IMPETUS study) Health and Social Care in the Community, 2024, (doi: 10.1155/2024/9198768)

Morrow, A. et al. (2024) Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial. Circulation, (doi: 10.1161/CIRCULATIONAHA.124.069901)

Al-Abdullah, L., Ahern, A., Welsh, P., Logue, J. (2024) A predictive model for medium-term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions. Diabetes, Obesity and Metabolism, 26, pp. 3653-3662. (doi: 10.1111/dom.15706)

Mc Causland, F. R., McGrath, M. M., Claggett, B. L., Barkoudah, E., East, C., Fernandez, A., Jering, K. S., Lewis, E. F., McMurray, J. J.V., Mody, F. V., Solomon, S. D., Tokmakova, M., van der Meer, P., Zhou, Y., Pfeffer, M. A. (2024) Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI. European Journal of Heart Failure, 26, pp. 1984-1992. (doi: 10.1002/ejhf.3386)

van der Meer, P., van Essen, B., Viljoen, C., Böhm, M., Jackson, A., Hilfiker-Kleiner, D., Hoevelmann, J., Mebazaa, A., Farhan, H. A., Goland, S., Ouwerkerk, W., Petrie, M. C., Seferović, P. M., Tromp, J., Sliwa, K., Bauersachs, J. (2024) Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry. European Heart Journal, (doi: 10.1093/eurheartj/ehae559)

Butt, J., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2024) Dapagliflozin and timing of prior heart failure hospitalization a patient-level meta-analysis of DAPA-HF and DELIVER. JACC: Heart Failure, 12, pp. 1586-1599. (doi: 10.1016/j.jchf.2024.01.018)

Seferović, P. M., Paulus, W. J., Rosano, G., Polovina, M., Petrie, M. C., Jhund, P. S., Tschöpe, C., Sattar, N., Piepoli, M., Papp, Z., Standl, E., Mamas, M. A., Valensi, P., Linhart, A., Lalić, N., Ceriello, A., Döhner, W., Ristić, A., Milinković, I., Seferović, J., Cosentino, F., Metra, M., Coats, A. J.S. (2024) Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. European Journal of Heart Failure, 26, pp. 1893-1903. (doi: 10.1002/ejhf.3347)

Ryan, M., Taylor, D., Dodd, M., Spertus, J. A., Kosiborod, M. N., Shaukat, A., Docherty, K. F., Clayton, T., Perera, D., Petrie, M. C., REVIVED-BCIS2 Investigators, (2024) Effect of PCI on health status in ischemic left ventricular dysfunction: insights from REVIVED-BCIS2. JACC: Heart Failure, 12, pp. 1553-1562. (doi: 10.1016/j.jchf.2024.03.010)

Abdin, A., Kondo, T., Böhm, M., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Desai, A. S., Køber, L., Sabatine, M. S., Petersson, M., Bachus, E., Solomon, S. D., McMurray, J. (2024) Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: an analysis of DAPA-HF and DELIVER. European Journal of Heart Failure, 26, pp. 1952-1963. (doi: 10.1002/ejhf.3350)

Rastogi, T., Gargani, L., Pellicori, P., Lamiral, Z., Ambrosio, G., Bayés-Genis, A., Domingo, M., Lupon, J., Simonovic, D., Riccardo Pugliese, N., Ruocco, G., Duarte, K., Coiro, S., Palazzuoli, A., Girerd, N. (2024) Prognostic implication of lung ultrasound in heart failure: pooled analysis of international cohorts. European Heart Journal: Cardiovascular Imaging, 25, pp. 1216-1225. (doi: 10.1093/ehjci/jeae099)

Reza, N., Pellicori, P., Starling, R. C. (2024) REVOLUTION in heart failure care and SELECT highlights from the European Society of Cardiology-Heart Failure Association Heart Failure and World Congress on Acute Heart Failure 2024. Journal of Cardiac Failure, 30, pp. 1157-1160. (doi: 10.1016/j.cardfail.2024.05.004)

Tabish, T. A., Hussain, M. Z., Zhu, Y., Xu, J., Huang, W. E., Diotallevi, M., Narayan, R. J., Crabtree, M. J., Khademhosseini, A., Winyard, P. G., Lygate, C. (2024) Synthesis and characterization of amine-functionalized graphene as a nitric oxide-generating coating for vascular stents. Applied Physics Reviews, 11, (doi: 10.1063/5.0192379)

McNeilly, S. et al. (2024) Collagen IV deficiency causes hypertrophic remodeling and endothelium-dependent hyperpolarization in small vessel disease with intracerebral hemorrhage. EBioMedicine, 107, (doi: 10.1016/j.ebiom.2024.105315)

Fontana, M. et al. (2024) Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. New England Journal of Medicine, (doi: 10.1056/NEJMoa2409134)

Yang, M., Kondo, T., Anand, I. S., de Boer, R. A., Campbell, R. T., Køber, L., Lam, C. S.P., Maggioni, A. P., Martinez, F. A., O'Meara, E., Packer, M., Sabatine, M. S., Kerr Saraiva, J. F., Shah, S. J., Zannad, F., Zile, M. R., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2024) Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment. European Journal of Heart Failure, (doi: 10.1002/ejhf.3417)

Matthewman, J., Mulick, A., Dand, N., Major-Smith, D., Henderson, A., Pearce, N., Denaxas, S., Iskandar, R., Roberts, A., Cornish, R. P., Brown, S. J., Paternoster, L., M. Langan, S. (2024) Disagreement concerning atopic dermatitis subtypes between an English prospective cohort (ALSPAC) and linked electronic health records. Clinical and Experimental Dermatology, 49, pp. 1537-1546. (doi: 10.1093/ced/llae196)

Graham, F. J., Guha, K., Cleland, J. G., Kalra, P. R. (2024) Treating iron deficiency in patients with heart failure: what, why, when, how, where and who. Heart, (doi: 10.1136/heartjnl-2022-322030)

Thongyim, S., Wright, T. A., Sattayawat, P., Kaewkod, T., Baillie, G. S., Tragoolpua, Y., Jangsutthivorawat, S., Panya, A. (2024) Clinacanthus nutans extract lowers periodontal inflammation under high-glucose conditions via inhibiting NF-κB signaling pathway. Frontiers in Pharmacology, 15, (doi: 10.3389/fphar.2024.1410419)

Cameron, A., Arnold, M., Katsas, G., Yang, J., Quinn, T. J., Abdul-Rahim, A. H., Campbell, R., Docherty, K., De Marchis, G. M., Arnold, M., Kahles, T., Nedeltchev, K., Cereda, C., Kaegi, G., Bustamante, A., Montaner, J., Ntaios, G., Foerch, C., Spanaus, K., Von Eckardstein, A., Dawson, J., Katan, M. (2024) Natriuretic peptides to classify risk of atrial fibrillation detection after stroke: analysis of the BIOSIGNAL and PRECISE cohort studies. Neurology, 103, (doi: 10.1212/WNL.0000000000209625)

Elyan, B. M.P., Sullivan, M. K., Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J., Lang, N. N., Mark, P. B., Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, (doi: 10.1038/s44276-024-00081-7)

Kazmi, S., Kambhampati, C., Rigby, A. S., Cleland, J. G.F., Kazmi, K. S., Cuthbert, J., Pellicori, P., Clark, A. L. (2024) Disease progression in chronic heart failure is linear: insights from multistate modelling. European Journal of Heart Failure, (doi: 10.1002/ejhf.3400)

Richardson, S. H., Mackenzie, J., Thekkethil, N., Feng, L., Lee, J., Berry, C., Hill, N., Luo, X., Gao, H. (2024) Cardiac perfusion coupled with a structured coronary network tree. Computer Methods in Applied Mechanics and Engineering, 428, (doi: 10.1016/j.cma.2024.117083)

Gustafsson, F., Petrie, M. C., Komtebedde, J., Swarup, V., Winkler, S., Hasenfuß, G., Borlaug, B. A., Mohan, R. C., Flaherty, J. D., Sverdlov, A. L., Fail, P. S., Chung, E. S., Lurz, P., Lilly, S., Kaye, D. M., Cleland, J. G.F., Cikes, M., Leon, M. B., Cutlip, D. E., van Veldhuisen, D. J., Solomon, S. D., Shah, S. J. (2024) 2-year outcomes of an atrial shunt device in HFpEF/HFmrEF: results from REDUCE LAP-HF II. JACC: Heart Failure, 12, pp. 1425-1438. (doi: 10.1016/j.jchf.2024.04.011)

Clares de Andrade, J. B., Quinn, T. J., Carbonera, L. A., Montanaro, V., Robles, A., Padua, R., Ribeiro, S., Sampaio Silva, G. (2024) An automated flowchart for the Modified Rankin Scale assessment: a multicenter inter-rater agreement analysis. International Journal of Stroke, 19, pp. 789-797. (doi: 10.1177/17474930241246157)

O'Hara, D. V., Lam, C. S.P., McMurray, J. J.V., Yi, T. W., Hocking, S., Dawson, J., Raichand, S., Januszewski, A. S., Jardine, M. J. (2024) Applications of SGLT2 inhibitors beyond glycaemic control. Nature Reviews Nephrology, 20, pp. 513-529. (doi: 10.1038/s41581-024-00836-y)

Lam, C. S.P., Køber, L., Kuwahara, K., Lund, L. H., Mark, P. B., Mellbin, L. G., Schou, M., Ely Pizzato, P., Gabrielsen, A., Gasparyan, S. B., Ghiretti, A., Hartleib‐Geschwindner, J., Housler, G. J., Fanti, P., Leonsson‐Zachrisson, M., McMurray, J. J.V., Solomon, S. D. (2024) Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial. European Journal of Heart Failure, 26, pp. 1727-1735. (doi: 10.1002/ejhf.3294)

Lassen, M. C.H., Ostrominski, J. W., Claggett, B. L., Packer, M., Zile, M., Desai, A. S., Shah, A. M., Cikes, M., Merkely, B., Gori, M., Wang, X., Hegde, S. M., Pfeffer, M. A., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2024) Cardiovascular‐kidney‐metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON‐HF. European Journal of Heart Failure, 26, pp. 1762-1774. (doi: 10.1002/ejhf.3304)

Rosano, G. M.C. et al. (2024) Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, 26, pp. 1669-1686. (doi: 10.1002/ejhf.3284)

Carberry, J., Petrie, M. C., Lee, M. M.Y., Brooksbank, K., Campbell, R. T., Good, R., Jhund, P. S., Kellman, P., Lang, N. N., Mangion, K., Mark, P. B., McConnachie, A., McMurray, J. J.V., Meyer, B., Orchard, V., Shaukat, A., Watkins, S., Welsh, P., Sattar, N., Berry, C., Docherty, K. F. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11, pp. 2001-2012. (doi: 10.1002/ehf2.14830)

Grobbee, D. E., Filippatos, G., Desai, N. R., Coats, A. J.S., Pinto, F., Rosano, G. M.C., Cleland, J., Kammerer, J., Ramirez de Arellano, A. (2024) Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure, 11, pp. 1821-1840. (doi: 10.1002/ehf2.14661)

Yang, M., Kondo, T., Jhund, P. S., Alcocer‐Gamba, M. A., Borleffs, C. J. W., Chiang, C.‐E., Comin‐Colet, J., Desai, A. S., Dobreanu, D., Drożdż, J., Han, Y., Janssens, S. P., Katova, T., Kosiborod, M. N., Lam, C. S.P., Merkely, B., Pham, V. N., Thierer, J., Vaduganathan, M., Verma, S., Solomon, S. D., McMurray, J. J.V. (2024) Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 26, pp. 1788-1803. (doi: 10.1002/ejhf.3352)

Docherty, K. F., McMurray, J. J.V., Kalra, P., Cleland, J. G.F., Lang, N. N., Petrie, M. C., Robertson, M., Ford, I. (2024) Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction. ESC Heart Failure, 11, pp. 1875-1879. (doi: 10.1002/ehf2.14742)

Kondo, T., Campbell, R., Jhund, P. S., Anand, I. S., Carson, P. E., Lam, C. S.P., Shah, S. J., Vaduganathan, M., Zannad, F., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2024) Low natriuretic peptide levels and outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 12, pp. 1442-1455. (doi: 10.1016/j.jchf.2024.04.027)

Minnis, M., Burton, J. K., Kelbling, E., Gallacher, K. I., Quinn, T. J. (2024) Not daily, sometimes not ever – mixed methods exploration of the contemporary relevance of tasks contained in extended activities of daily living scales. Age and Ageing, 53, (doi: 10.1093/ageing/afae185)

Matsumoto, S., McMurray, J. J.V., Nasu, T., Ishii, S., Kagiyama, N., Kida, K., Fujimoto, W., Kikuchi, A., Ijichi, T., Shibata, T., Ikeda, T., Kanaoka, K. (2024) Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry. Journal of Cardiology, 84, pp. 133-140. (doi: 10.1016/j.jjcc.2023.11.005)

Zahir Anjum, D., Strange, J. E., Fosbøl, E., Garred, C. H., Elmegaard, M., Andersson, C., Jhund, P. S., McMurray, J. J.V., Petrie, M. C., Kober, L., Schou, M. (2024) Use of medical therapy and risk of clinical events according to frailty in heart failure patients – A real‐life cohort study. European Journal of Heart Failure, 26, pp. 1717-1726. (doi: 10.1002/ejhf.3249)

Li, C., Wu, J., Lin, J., Wu, Y., Xu, R., Quian, J., Hau, W. K., Barbato, E., Johnson, N. J., Hennigan, B., Berry, C., Oldroyd, K. G., Song, L., Ge, J. (2024) Validation of a new non-hyperemic physiological index: the constant-resistance ratio (cRR) Journal of Invasive Cardiology, 36, (doi: 10.25270/jic/24.00047)

Ezad, S. M., McEntegart, M., Dodd, M., Didagelos, M., Sidik, N., Li Kam Wa, M., Morgan, H. P., Pavlidis, A., Weerackody, R., Walsh, S. J., Spratt, J. C., Strange, J., Ludman, P., Chiribiri, A., Clayton, T., Petrie, M. C., O’Kane, P., Perera, D., REVIVED-BCIS2 Investigators, (2024) Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy. Journal of the American College of Cardiology, 84, pp. 340-350. (doi: 10.1016/j.jacc.2024.04.043)

Schou, M., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Kitzman, D. W., Shah, S. J., Verma, S., Patel, S., Chinnakondepalli, K. M., Harring, S., Abildstrøm, S. Z., Liisberg, K., Kosiborod, M. N., STEP-HFpEF Trial Committees and Investigators, (2024) Semaglutide and NYHA functional class in obesity-related heart failure with preserved ejection fraction the STEP-HFpEF program. Journal of the American College of Cardiology, 84, pp. 247-257. (doi: 10.1016/j.jacc.2024.04.038)

Kelham, M., Vyas, R., Ramaseshan, R., Rathod, K., de Winter, R. J., de Winter, R. W., Bendz, B., Thiele, H., Hirlekar, G., Morici, N., Myat, A., Michalis, L. K., Sanchis, J., Kunadian, V., Berry, C., Mathur, A., Jones, D. A. (2024) Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management. European Heart Journal, 45, pp. 2380-2391. (doi: 10.1093/eurheartj/ehae245)

Rubiś, P. P., Dziewięcka, E., González, A., Cleland, J. G.F. (2024) High variability in assays of blood markers of collagen turnover in cardiovascular disease: Implications for research and clinical practice. European Journal of Heart Failure, (doi: 10.1002/ejhf.3375)

Churuangsuk, C., Catchpole, A., Talwar, D., Welsh, P., Sattar, N., Combet, E., Lean, M. E.J. (2024) Low thiamine status in adults following low-carbohydrate / ketogenic diets: a cross-sectional comparative study of micronutrient intake and status. European Journal of Nutrition, (doi: 10.1007/s00394-024-03459-y)

Berry, C., Sidik, N. P., McEntegart, M. B., CorCTA Investigators, (2024) Response by Berry et al to letter regarding article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial". Circulation, 150, pp. e5-e6. (doi: 10.1161/CIRCULATIONAHA.124.069708)

Ostrominski, J. W., Claggett, B. L., Miao, Z. M., Mc Causland, F. R., Anand, I. S., Desai, A. S., Jhund, P. S., Lam, C. S.P., Pfeffer, M. A., Pitt, B., Zannad, F., Zile, M. R., Bomfim Wirtz, A., Lay-Flurrie, J., Viswanathan, P., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2024) Cardiovascular-kidney-metabolic overlap in heart failure with mildly reduced or preserved ejection fraction a trial-level analysis. Journal of the American College of Cardiology, 84, pp. 223-228. (doi: 10.1016/j.jacc.2024.05.005)

Packer, M., Cleland, J. G.F., Bauersachs, J. (2024) Great debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction. European Heart Journal, 45, pp. 2186-2196. (doi: 10.1093/eurheartj/ehae300)

Espersen, C., Campbell, R. T., Claggett, B. L., Lewis, E. F., Docherty, K. F., Lee, M. M.Y., Lindner, M., Brainin, P., Biering-Sørensen, T., Solomon, S. D., McMurray, J. J.V., Platz, E. (2024) Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure. International Journal of Cardiology, 406, (doi: 10.1016/j.ijcard.2024.132036)

Carberry, J., Marquis-Gravel, G., O’Meara, E., Docherty, K. F. (2024) Where are we with treatment and prevention of heart failure in patients post myocardial infarction? JACC: Heart Failure, 12, pp. 1157-1165. (doi: 10.1016/j.jchf.2024.04.025)

Cannata, A., Mizani, M. A., Bromage, D. I., Piper, S. E., Hardman, S. M.C., Sudlow, C., de Belder, M., Deanfield, J., Gardner, R. S., Clark, A. L., Cleland, J. G.F., McDonagh, T. A. (2024) A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic. European Journal of Heart Failure, 26, pp. 1574-1584. (doi: 10.1002/ejhf.3306)

Collet, C. et al. (2024) A systematic approach to the evaluation of the coronary microcirculation using bolus thermodilution: CATH CMD. Journal of the Society for Cardiovascular Angiography and Interventions, 3, (doi: 10.1016/j.jscai.2024.101934)

Sin, Y. Y., Cameron, R. T., Schepers, M., MacLeod, R., Wright, T. A., Paes, D., van den Hove, D., Willems, E., Vanmierlo, T., Prickaerts, J., Blair, C. M., Baillie, G. S. (2024) Beta-amyloid interacts with and activates the longform phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. FEBS Letters, 598, pp. 1591-1604. (doi: 10.1002/1873-3468.14902)

Shead, K. D., Salyahetdinova, V., Baillie, G. S. (2024) Charting the importance of Filamin A posttranslational modifications. Biochemical Journal, 481, pp. 865-881. (doi: 10.1042/BCJ20240121)

Yang, M., Kondo, T., Talebi, A., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2024) Dapagliflozin and quality of life measured using the EuroQol 5-Dimension questionnaire in patients with HFrEF and HFmrEF/HFpEF. European Journal of Heart Failure, 26, pp. 1524-1538. (doi: 10.1002/ejhf.3263)

Burton, J. K., Soiza, R. L., Quinn, T. J., SIGN 168 guideline development group, (2024) Guideline summary: assessment, diagnosis, care and support for people with dementia and their carers [Scottish Intercollegiate Guidelines Network SIGN Guideline 168] Age and Ageing, 53, (doi: 10.1093/ageing/afae147)

Lee, M., Petrie, M., Lang, N., Cleland, J., Hannah, A., Japp, A., Donnelly, P., Francis, M., Piper, S., Petrie, C., Williams, S., Manisty, C., Labinjoh, C., Ford, I., Kalra, P. (2024) Heart Failure – Chronic Heart Failure, Pathophysiology and Mechanisms, Heart Failure with Reduced Ejection Fraction (HFrEF). Ferric Derisomaltose in Hospitalised and Ambulatory Patients with Heart Failure-Insights from the IRONMAN trial. (doi: 10.1002/ejhf.3326)

Lakhal-Littleton, S., Cleland, J. G. F. (2024) Iron deficiency and supplementation in heart failure. Nature Reviews Cardiology, 21, pp. 463-486. (doi: 10.1038/s41569-024-00988-1)

Martin, F. C., Quinn, T. J., Straus, S. E., Anand, S., van der Velde, N., Harwood, R. H. (2024) New horizons in clinical practice guidelines for use with older people. Age and Ageing, 53, (doi: 10.1093/ageing/afae158)

Anker, S. D. et al. (2024) Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials. European Journal of Heart Failure, 26, pp. 1608-1615. (doi: 10.1002/ejhf.3286)

Gardner, O. F.W., Bai, T., Baillie, G. S., Ferretti, P. (2024) Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little? Brain Communications, (doi: 10.1093/braincomms/fcae225)

Savarese, G., Lindberg, F., Christodorescu, R. M., Ferrini, M., Kumler, T., Toutoutzas, K., Dattilo, G., Bayes-Genis, A., Moura, B., Amir, O., Petrie, M. C., Seferovic, P., Chioncel, O., Metra, M., Coats, A. J.S., Rosano, G. M.C. (2024) Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice. European Journal of Heart Failure, 26, pp. 1408-1418. (doi: 10.1002/ejhf.3214)

Conrad, N., Molenberghs, G., Verbeke, G., Zaccardi, F., Lawson, C., Friday, J. M., Su, H., Jhund, P. S., Sattar, N., Rahimi, K., Cleland, J. G., Khunti, K., Budts, W., McMurray, J. J.V. (2024) Temporal trends and patterns in cardiovascular disease incidence: a population-based study in 22 million individuals. British Medical Journal, 385, (doi: 10.1136/bmj-2023-078523)

Shen, L., Lee, M. M.Y., Jhund, P. S., Granger, C. B., Anand, I. S., Maggioni, A. P., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Yusuf, S., McMurray, J. J.V. (2024) Revisiting race and the benefit of RAS blockade in heart failure. A meta-analysis of randomized clinical trials. JAMA: Journal of the American Medical Association, 331, (doi: 10.1001/jama.2024.6774)

Ravensberg, J., Poortvliet, R. K.E., Du Puy, R., Rodondi, N., Blum, M., Kearney, P., McCarthy, V. J.C., Quinn, T., Dekkers, O., Jukema, W., Mooijaart, S., Gussekloo, J. (2024) Patient-reported satisfaction with thyroid hormone replacement therapy for subclinical hypothyroidism in older adults: a pooled analysis of individual participant data from two randomized controlled trials. Thyroid, 34, pp. 702-712. (doi: 10.1089/thy.2023.0624)

Udell, J. A. et al. (2024) Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction. Journal of the American College of Cardiology, 83, pp. 2233-2246. (doi: 10.1016/j.jacc.2024.03.405)

Matsumoto, S., Henderson, A. D., Shen, L., Yang, M., Swedberg, K., Vaduganathan, M., van Veldhuisen, D. J., Solomon, S. D., Pitt, B., Zannad, F., Jhund, P. S., McMurray, J. J.V. (2024) Mineralocorticoid receptor antagonists in patients with heart failure and impaired renal function. Journal of the American College of Cardiology, 83, pp. 2426-2436. (doi: 10.1016/j.jacc.2024.03.426)

Rankin, S., Fountain, C., Gemmell, A., Quinn, D., Henderson, A., McClure, J., Small, S., Venugopal, B., McKay, P., Slomka, P. J., Colville, D., Petrie, M. C., Meléndez, G. C., Lang, N. N. (2024) Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients using 18F-FDG positron emission tomography. bioRxiv, (doi: 10.1101/2024.05.30.596741)

Chatur, S., Neuen, B. L., Claggett, B. L., Beldhuis, I. E., Mc Causland, F. R., Desai, A. S., Rouleau, J. L., Zile, M. R., Lefkowitz, M. P., Packer, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2024) Effects of sacubitril/valsartan across the spectrum of renal impairment in patients with heart failure. Journal of the American College of Cardiology, 83, pp. 2148-2159. (doi: 10.1016/j.jacc.2024.03.392)

Traub, J., Docherty, K. F., Frey, A. (2024) The link between heart failure and neurodegeneration insights from circulating biomarkers. JACC: Heart Failure, 12, pp. 1086-1088. (doi: 10.1016/j.jchf.2024.04.008)

Ang, D. T.Y., Abraham, G., Sim, K. Y.T., Sidik, N. P., Anwar, M., Ford, T. J., Berry, C., Hoole, S. P. (2024) Comparing pressure-bounded versus thermodilution-derived coronary flow reserve in unobstructed coronary arteries. American Journal of Cardiology, 222, pp. 165-166. (doi: 10.1016/j.amjcard.2024.05.014)

Tabish, T. A., Xu, J., Campbell, C. K., Abbas, M., Myers, W. K., Didwal, P., Carugo, D., Xie, F., Crabtree, M. J., Stride, E., Lygate, C. A. (2024) pH-sensitive release of nitric oxide gas using peptide-graphene co-assembled hybrid nanosheets. Nitric Oxide, 147, pp. 42-50. (doi: 10.1016/j.niox.2024.04.008)

Solomon, S. D. et al. (2024) Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial. European Journal of Heart Failure, 26, pp. 1334-1346. (doi: 10.1002/ejhf.3266)

Henderson, A. D. et al. (2024) Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis. eClinicalMedicine, 72, (doi: 10.1016/j.eclinm.2024.102638)

Pierson, J. B., Berridge, B., Blinova, K., Brooks, M. B., Eldridge, S., O'Brien, C. E., Pugsley, M. K., Schultze, A. E., Smith, G., Stockbridge, N., Valentin, J.-P., Vicente, J. (2024) Collaborative science in action: a 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee. Journal of Pharmacological and Toxicological Methods, 127, (doi: 10.1016/j.vascn.2024.107511)

Packer, M., Anker, S. D., Butler, J., Cleland, J. G.F., Kalra, P. R., Mentz, R. J., Ponikowski, P., Talha, K. M. (2024) Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure. European Journal of Heart Failure, 26, pp. 1298-1312. (doi: 10.1002/ejhf.3237)

Vaduganathan, M., Claggett, B. L., Lam, C. S.P., Pitt, B., Senni, M., Shah, S. J., Voors, A. A., Zannad, F., Desai, A. S., Jhund, P. S., Viswanathan, P., Bomfim Wirtz, A., Schloemer, P., Lay‐Flurrie, J., McMurray, J. J.V., Solomon, S. D. (2024) Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial. European Journal of Heart Failure, 26, pp. 1324-1333. (doi: 10.1002/ejhf.3253)

Ang, D. T.Y., Carrick, D., Kamdar, A., Sykes, R., McGeoch, R. J., Collison, D., McConnachie, A., Berry, C. (2024) Intracoronary adenosine–derived coronary flow reserve and index of microvascular resistance. Circulation: Cardiovascular Interventions, 17, (doi: 10.1161/circinterventions.123.013667)

Curtain, J. P., Talebi, A., McIntosh, A., McConnachie, A., O’Donnell, J., Welsh, P., Osmanska, J., Lee, M. M.Y., Sonecki, P., Akl, T., Seo, J., Gopinathan, V., Hurwitz, J., Thiagarajan, S., Pettit, S., Kalra, P. R., Patel, R. K., Mark, P. B., Lang, N. N., McMurray, J. J.V., Petrie, M. C., Gardner, R. S., Jhund, P. S. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26, pp. 1383-1392. (doi: 10.1002/ejhf.3290)

Friedman, D. J., Olivas-Martinez, A., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Relationship between sex, body size, and cardiac resynchronization therapy benefit: a patient level meta-analysis of randomized controlled trials. Heart Rhythm, 21, pp. 845-854. (doi: 10.1016/j.hrthm.2024.01.058)

Gök, C., Fuller, W. (2024) Rise of palmitoylation: a new trick to tune NCX1 activity. Biochimica et Biophysica Acta: Molecular Cell Research, 1871, (doi: 10.1016/j.bbamcr.2024.119719)

Tabish, T. A., Hussain, M. Z., Zervou, S., Myers, W. K., Tu, W., Xu, J., Beer, I., Huang, W. E., Chandrawati, R., Crabtree, M. J., Winyard, P. G., Lygate, C. A. (2024) S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications. Redox Biology, 72, (doi: 10.1016/j.redox.2024.103144)

Pabón, M. A., Wang, X., Lam, C. S.P., O’Meara, E., Vaduganathan, M., Claggett, B. L., Foà, A., Lu, H., Langkilde, A. M., De Boer, R. A., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Shah, S. J., Petersson, M., McMurray, J. J.V., Solomon, S. D., Vardeny, O. (2024) Sex differences in heart failure with improved ejection fraction. JACC: Heart Failure, 12, pp. 1119-1122. (doi: 10.1016/j.jchf.2024.03.011)

Lee, M., Petrie, M., Lang, N., Cleland, J., Hannah, A., Japp, A., Donnelly, P., Francis, M., Piper, S., Petrie, C., Williams, S., Manisty, C., Labinjoh, C., Ford, I., Kalra, P. (2024) Efficacy of Intravenous Ferric Derisomaltose in Hospitalised and Outpatient Settings: Insights from Ironman Trial. (doi: 10.1136/heartjnl-2024-BCS.135)

Lawson, C. A. et al. (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11, (doi: 10.1136/openhrt-2024-002662)

Loughrey, C. et al. (2024) A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic action: Pre-clinical and phase I study. British Journal of Pharmacology, 181, pp. 3401-3419. (doi: 10.1111/bph.16379)

Kondo, T., Mogensen, U. M., Talebi, A., Gasparyan, S. B., Campbell, R. T., Docherty, K. F., de Boer, R. A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2024) Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF. Journal of the American College of Cardiology, 83, pp. 1973-1986. (doi: 10.1016/j.jacc.2024.03.385)

Hernandez, A. F. et al. (2024) Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial. Circulation, 149, pp. 1627-1638. (doi: 10.1161/circulationaha.124.069217)

Lechner, I., Reindl, M., Stiermaier, T., Tiller, C., Holzknecht, M., Oberhollenzer, F., von der Emde, S., Mayr, A., Feistritzer, H.-J., Carberry, J., Carrick, D., Bauer, A., Thiele, H., Berry, C., Eitel, I., Metzler, B., Reinstadler, S. J. (2024) Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI. Journal of the American College of Cardiology, 83, pp. 2052-2062. (doi: 10.1016/j.jacc.2024.03.408)

Chung, Y. J., Hoare, Z., Baark, F., Yu, C. S., Guo, J., Fuller, W., Southworth, R., Katschinski, D. M., Murphy, M. P., Eykyn, T. R., Shattock, M. J. (2024) Elevated Na is a dynamic and reversible modulator of mitochondrial metabolism in the heart. Nature Communications, 15, (doi: 10.1038/s41467-024-48474-z)

Eerdekens, R., El Farissi, M., De Maria, G. L., van Royen, N., van ‘t Veer, M., van Leeuwen, M. A.H., Hoole, S. P., Marin, F., Carrick, D., Tonino, P. A.L., Pijls, N. H.J., Fineschi, M., Oldroyd, K. G., Berry, C., Banning, A. P., Fearon, W. F., Zimmermann, F. M. (2024) Prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction. Journal of the American College of Cardiology, 83, pp. 2066-2076. (doi: 10.1016/j.jacc.2024.02.052)

Naeem, F., Quinn, T. J. (2024) Frailty in stroke. Practical Neurology, (doi: 10.1136/pn-2023-003833)

Davis, J. A., Booth, D., McEwan, P., Solomon, S. D., McMurray, J. J.V., de Boer, R. A., Comin‐Colet, J., Bachus, E., Chen, J. (2024) Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: a pooled analysis of DAPA-HF and DELIVER data. European Journal of Heart Failure, 26, pp. 664-673. (doi: 10.1002/ejhf.3197)

Lassen, M. C. H., Ostrominski, J. W., Inzucchi, S. E., Claggett, B. L., Kulac, I., Jhund, P., de Boer, R. A., Hernandez, A. F., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., Desai, A. S., Petersson, M., Langkilde, A. M., Docherty, K. F., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2024) Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: a pre‐specified analysis of the DELIVER trial. European Journal of Heart Failure, 26, pp. 1539-1548. (doi: 10.1002/ejhf.3269)

Mavromati, K., Skovfoged, M., Tvrdá, L., Nemcova, V., Knoche, H., Quinn, T. J. (2024) Initial Experiences in Designing a Stroke-Specific Virtual Assistant.

Collet, C. et al. (2024) Influence of pathophysiological patterns of coronary artery disease on immediate percutaneous coronary intervention outcomes. Circulation, (doi: 10.1161/circulationaha.124.069450)

Hillary, R. F., Ng, H. K., McCartney, D. L., Elliott, H. R., Walker, R. M., Campbell, A., Huang, F., Direk, K., Welsh, P., Sattar, N., Corley, J., Hayward, C., McIntosh, A. M., Sudlow, C., Evans, K. L., Cox, S. R., Chambers, J. C., Loh, M., Relton, C. L., Marioni, R. E., Yousefi, P. D., Suderman, M. (2024) Blood-based epigenome-wide analyses of chronic low-grade inflammation across diverse population cohorts. Cell Genomics, 4, (doi: 10.1016/j.xgen.2024.100544)

Foà, A., Vaduganathan, M., Claggett, B. L., Pabon, M. A., Lu, H., Pfeffer, M. A., Packer, M., Vardeny, O., Rouleau, J. L., Lefkowitz, M., Mentz, R. J., Jhund, P. s., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2024) Sacubitril/Valsartan-related hypotension in patients with heart failure and preserved or mildly reduced ejection fraction. Journal of the American College of Cardiology, 83, pp. 1731-1739. (doi: 10.1016/j.jacc.2024.02.035)

McDowell, K., Kondo, T., Talebi, A., Teh, K., Bachus, E., de Boer, R. A., Campbell, R. T., Claggett, B., Desai, A. S., Docherty, K. F., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Simpson, J., Vaduganathan, M., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9, (doi: 10.1001/jamacardio.2024.0284)

Kondo, T., Jhund, P. S., Gasparyan, S. B., Yang, M., Claggett, B. L., McCausland, F. R., Tolomeo, P., Vadagunathan, M., Heerspink, H. J.L., Solomon, S. D., McMurray, J. J.V. (2024) A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials. Nature Medicine, 30, pp. 1432-1439. (doi: 10.1038/s41591-024-02941-8)

Abraham, G. R., Berry, C., Fu, Q., Hoole, S. P., Weir-McCall, J. R. (2024) Differences in quantitative myocardial perfusion mapping by CMR at 1.5 T and 3 T. American Heart Journal Plus: Cardiology Research and Practice, 41, (doi: 10.1016/j.ahjo.2024.100388)

Gilbert, M. P., Skelly, J., Hernandez, A. F., Green, J. B., Krychtiuk, K. A., Granger, C. B., Leiter, L. A., McMurray, J. J.V., Del Prato, S., Pratley, R. E. (2024) Effect of albiglutide on cardiovascular outcomes in older adults: a post hoc analysis of a randomized controlled trial. Diabetes, Obesity and Metabolism, 26, pp. 1714-1722. (doi: 10.1111/dom.15479)

Matsumoto, S., Yang, M., Shen, L., Henderson, A., Claggett, B. L., Desai, A. S., Lefkowitz, M., Rouleau, J. L., Vardeny, O., Zile, M. R., Jhund, P. S., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2024) Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF. European Journal of Heart Failure, 26, pp. 1125-1138. (doi: 10.1002/ejhf.3223)

Nurfianti, A., Kotronoulas, G., Quinn, T.J., Kidd, L. (2024) How Do Nurses Assess and Manage Post-stroke Cognitive Impairment (PSCI) in a Middle-income Country? A Mixed-methods Study in Indonesia.

Tabish, T. A., Crabtree, M. J., Townley, H. E., Winyard, P. G., Lygate, C. A. (2024) Nitric oxide releasing nanomaterials for cardiovascular applications. JACC: Basic to Translational Science, 9, pp. 691-709. (doi: 10.1016/j.jacbts.2023.07.017)

Kobayashi, M., Ferreira, J. P., Kevin, D., Bresso, E., Huttin, O., Bozec, E., Brunner La Rocca, H.-P., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F., Girerd, N. (2024) Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort. European Journal of Heart Failure, 26, pp. 1231-1241. (doi: 10.1002/ejhf.3202)

Tvrdá, L., Mavromati, K., Quinn, T. J. (2024) Reliability and Validity Across Existing Versions of the Modified Rankin Scale for Stroke: Systematic Review and Meta-Analysis.

Naeem, F., Quinn, T. J. (2024) Stroke Literature Synopsis (Clinical) Stroke, 55, pp. e138-e139. (doi: 10.1161/STROKEAHA.124.046761)

Mavromati, K., Skovfoged, M., Tvrdá, L., Nemcova, V., Knoche, H., Quinn, T. J. (2024) Stroke-specific Virtual Assistant as a Companion in Recovery.

Carlile, O., Briggs, A., Henderson, A. D., FC. Butler-Cole, B., Tazare, J., Tomlinson, L. A., Marks, M., Jit, M., Lin, L.-Y., Bates, C., Parry, J., CJ. Bacon, S., Dillingham, I., Dennison, W. A., Costello, R. E., Walker, A. J., Hulme, W., Goldacre, B., Mehrkar, A., MacKenna, B., Herrett, E., Eggo, R. M., The OpenSAFELY Collaborative ∙, (2024) The impact of Long COVID on Health-Related Quality-of-Life using OpenPROMPT. Lancet Regional Health - Europe, 40, (doi: 10.1016/j.lanepe.2024.100908)

Ray, R., Ford, I., Cleland, J. G.F., Graham, F., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Critoph, C., Kalra, P. A., Lane, R. E., Ludman, A., Pellicori, P., Petrie, M. C., Robertson, M., Seed, A., Squire, I., Kalra, P. R. (2024) The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction. Journal of Cardiac Failure, 30, pp. 682-690. (doi: 10.1016/j.cardfail.2023.10.006)

Mavromati, K., Smith, A., Minnis, M., Tvrdá, L., Quinn, T. J. (2024) Toward an Efficient, Relevant, and Robust Assessment of Independence in Activities of Daily Living.

Buendia, R., Karpefors, M., Folkvaljon, F., Hunter, R., Sillen, H., Luu, L., Docherty, K., Cowie, M. R. (2024) Wearable sensors to monitor physical activity in heart failure clinical trials: state-of-the-art review. Journal of Cardiac Failure, 30, pp. 703-716. (doi: 10.1016/j.cardfail.2024.01.016)

Butler, J. et al. (2024) Empagliflozin after acute myocardial infarction. New England Journal of Medicine, 390, pp. 1455-1466. (doi: 10.1056/NEJMoa2314051)

Butler, J. et al. (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet, 403, pp. 1635-1648. (doi: 10.1016/S0140-6736(24)00469-0)

Kancheva, A. K., Wardlaw, J. M., Lyall, D. M., Quinn, T. J. (2024) Clinical phenotypes associated with cerebral small vessel disease: an overview of systematic reviews. Neurology, 102, (doi: 10.1212/WNL.0000000000209267)

Veronese, N., Soysal, P., Barbagallo, M., Shenkin, S. D., Quinn, T. J. (2024) Commentary on: physical activity and exercise for mild cognitive impairment and dementia: a collaborative international guideline. Aging Clinical and Experimental Research, 36, (doi: 10.1007/s40520-024-02747-1)

Cleland, J. G.F., Kalra, P. A., Pellicori, P., Graham, F. J., Foley, P. W.X., Squire, I. B., Cowburn, P. J., Seed, A., Clark, A. L., Szwejkowski, B., Banerjee, P., Cooke, J., Francis, M., Clifford, P., Wong, A., Petrie, C., McMurray, J. J.V., Thomson, E. A., Wetherall, K., Robertson, M., Ford, I., Kalra, P. R., the IRONMAN Study Group, (2024) Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. European Heart Journal, 45, pp. 1410-1426. (doi: 10.1093/eurheartj/ehae086)

Cooke, S. F., Wright, T. A., Sin, Y. Y., Ling, J., Kyurkchieva, E., Phanthaphol, N., McSkimming, T., Herbert, K., Rebus, S., Biankin, A. V., Chang, D. K., Baillie, G. S., Blair, C. M. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, (doi: 10.1038/s41598-024-59451-3)

Ward, J., Cox, S. R., Quinn, T., Lyall, L. M., Strawbridge, R. J., Russell, E., Pell, J. P., Stewart, W., Cullen, B., Whalley, H., Lyall, D. M. (2024) Head motion in the UK Biobank imaging subsample: longitudinal stability, associations with psychological and physical health, and risk of incomplete data. Brain Communications, 6, (doi: 10.1093/braincomms/fcae220)

Kosiborod, M. N. et al. (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes. New England Journal of Medicine, 390, pp. 1394-1407. (doi: 10.1056/NEJMoa2313917)

Rankin, S., Elyan, B., Jones, R., Venugopal, B., Mark, P. B., Lees, J. S., Petrie, M. C., Lang, N. N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6, pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010)

Glen, C., Morrow, A., Roditi, G., Hopkins, T., Macpherson, I., Stewart, P., Petrie, M. C., Berry, C., Epstein, F., Lang, N. N., Mangion, K. (2024) Cardiovascular sequalae of trastuzumab and anthracycline in long-term survivors of breast cancer. Heart, 110, pp. 650-656. (doi: 10.1136/heartjnl-2023-323437)

Pellicori, P., Hunter, D., Khin, H. H. E., Cleland, J. G.F. (2024) How to diagnose and treat venous congestion in heart failure. European Heart Journal, 45, pp. 1295-1297. (doi: 10.1093/eurheartj/ehad883)

Hewitt, J., Azhari, H. F., O’Neill, M., Smith, A., Quinn, T., Dawson, J. (2024) Post-stroke diabetes management: a qualitative study. Frontiers in Neurology, 15, (doi: 10.3389/fneur.2024.1364217)

Misra, S. et al. (2024) Antiseizure Medications in Post-stroke Seizures: A Systematic Review and Network Meta-analysis. (doi: 10.1212/wnl.0000000000205632)

Fröhlich, A.-K., Porthun, J., Talha, K. M., Lena, A., Hadzibegovic, S., Wilkenshoff, U., Sonntag, F., Nikolski, A., Ramer, L. V., Zeller, T., Keller, U., Bullinger, L., Anker, S. D., Haverkamp, W., von Haehling, S., Doehner, W., Rauch, U., Skurk, C., Cleland, J. G.F., Butler, J., Coats, A. J.S., Landmesser, U., Karakas, M., Anker, M. S. (2024) Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer. Clinical Research in Cardiology, (doi: 10.1007/s00392-024-02400-x)

Watt, J. K., Dickie, D. A., Ho, F. K., Lyall, D. M., Dawson, J., Quinn, T. J., European Prevention of Alzheimer's Disease (EPAD) Consortium, (2024) Validation of the brain health index in the European Prevention of Alzheimer's Dementia cohort. Cerebral Circulation - Cognition and Behavior, 6, pp. 100214. (doi: 10.1016/j.cccb.2024.100214)

Lean, M. E.J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., McIlvenna, Y., Welsh, P., McConnachie, A., McIntosh, A., Sattar, N., Taylor, R. (2024) 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes and Endocrinology, 12, pp. 233-246. (doi: 10.1016/S2213-8587(23)00385-6)

Jackson, A. M., Goland, S., Farhan, H. A., Yaseen, I. F., Prameswari, H. S., Böhm, M., Jhund, P. S., Maggioni, A. P., van der Meer, P., Sliwa, K., Bauersachs, J., Petrie, M. C. (2024) A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry. European Heart Journal, 45, pp. 1430-1439. (doi: 10.1093/eurheartj/ehad888)

Yang, Y., Husmeier, D., Gao, H., Berry, C., Carrick, D., Radjenovic, A. (2024) Automatic detection of myocardial ischaemia using generalisable spatio-temporal hierarchical Bayesian modelling of DCE-MRI. Computerized Medical Imaging and Graphics, 113, (doi: 10.1016/j.compmedimag.2024.102333)

Minamisawa, M., Inciardi, R. M., Claggett, B., Cikes, M., Liu, L., Prasad, N., Biering‐Sørensen, T., Lam, C. S.P., Shah, S. J., Zile, M. R., O'Meara, E., Redfield, M. M., McMurray, J. J.V., Solomon, S. D., Shah, A. M. (2024) Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: the PARAGON‐HF study. European Journal of Heart Failure, 26, pp. 871-881. (doi: 10.1002/ejhf.3167)

Fudim, M., Dalgaard, F., Friedman, D. J., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Ali-Ahmed, F., Tang, A., Olivas-Martinez, A., Inoue, L. Y.T., Al-Khatib, S. M., Sanders, G. D. (2024) Comorbidities and clinical response to cardiac resynchronization therapy: patient-level meta-analysis from eight clinical trials. European Journal of Heart Failure, 26, pp. 1039-1046. (doi: 10.1002/ejhf.3029)

Peikert, A., Bart, B. A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J. V., Solomon, S. D., Vardeny, O. (2024) Contemporary use and implications of beta-blockers in patients with HFmrEF or HFpEF: the DELIVER Trial. JACC: Heart Failure, 12, pp. 631-644. (doi: 10.1016/j.jchf.2023.09.007)

Heerspink, H. J.L., Provenzano, M., Vart, P., Jongs, N., Correa-Rotter, R., Rossing, P., Mark, P. B., Pecoits-Filho, R., McMurray, J. J.V., Langkilde, A. M., Wheeler, D. C., Toto, R. B., Chertow, G. M. (2024) Dapagliflozin and blood pressure in patients with chronic kidney disease and albuminuria. American Heart Journal, 270, pp. 125-135. (doi: 10.1016/j.ahj.2024.02.006)

Peikert, A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Foà, A., Desai, A. S., Jhund, P. S., Carberry, J., Lam, C. S.P., Kosiborod, M. N., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Køber, L., Ponikowski, P., Sabatine, M. S., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2024) Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA-HF and DELIVER. European Journal of Heart Failure, 26, pp. 912-924. (doi: 10.1002/ejhf.3184)

Monzo, L., Girerd, N., Ferreira, J. P., Lamiral, Z., Anker, S. D., Cleland, J. G. F., Kondo, T., McMurray, J. J. V., Lam, C. S. P., Mehra, M. R., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2024) High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm: risk prediction score analysis from the COMMANDER-HF trial. Journal of Cardiac Failure, 30, pp. 618-623. (doi: 10.1016/j.cardfail.2023.11.020)

Clancy, U., Kancheva, A. K., Valdés Hernández, M. d. C., Jochems, A. C.C., Muñoz Maniega, S., Quinn, T. J., Wardlaw, J. M. (2024) Imaging biomarkers of VCI: a focused update. Stroke, 55, pp. 791-800. (doi: 10.1161/strokeaha.123.044171)

Kemi, O. J., Hoydal, M. A., Haram, P. M., Smith, G. L., Ellingsen, O., Koch, L. G., Britton, S. L., Wisloff, U. (2024) Inherited physical capacity: Widening divergence from young to adult to old. Annals of the New York Academy of Sciences, 1534, pp. 145-155. (doi: 10.1111/nyas.15130)

Lygate, C. A. (2024) Maintaining energy provision in the heart: the creatine kinase system in ischaemia–reperfusion injury and chronic heart failure. Clinical Science, 138, pp. 491-514. (doi: 10.1042/CS20230616)

Cuthbert, J. J., Brown, O. I., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S. C., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2024) Medicines optimization prior to discharge in patients admitted to hospital with heart failure. ESC Heart Failure, 11, pp. 950-961. (doi: 10.1002/ehf2.14638)

Osmanska, J., Petrie, M. C., Campbell, R. T. (2024) Reply: subcutaneous furosemide patch: heart failure decongestion "from the comfort of your home" European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 261-262. (doi: 10.1093/ehjcvp/pvae015)

Bai, M., Gallen, E., Memarzadeh, S., Howie, J., GAO, X., Kuo, C.-W. S., Brown, E., Swingler, S., Wilson, S. J., Shattock, M. J., France, D. J., Fuller, W. (2024) Targeted degradation of zDHHC-PATs decreases substrate S -palmitoylation. PLoS ONE, 19, (doi: 10.1371/journal.pone.0299665)

Knigge, P., Lundberg, S., Strange, J. E., Malik, M. E., Nouhravesh, N., Wagner, A. K., Gislason, G., Fosbøl, E. L., Carlson, N., Zahir, D., Andersson, C., Butt, J. H., Jhund, P., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2024) Temporal trends in the initiation of dialysis among patients with heart failure with or without diabetes: a nationwide study from 2002 to 2016. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032539)

Ashford, F., Kuo, C.-W., Dunning, E., Brown, E., Calagan, S., Jayasinghe, I., Henderson, C., Fuller, W., Wypijewski, K. (2024) Cysteine post-translational modifications regulate protein interactions of caveolin-3. FASEB Journal, 38, (doi: 10.1096/fj.202201497RR)

Campbell, P., Rutten, F. H., Lee, M. M. Y., Hawkins, N. M., Petrie, M. C. (2024) Heart failure with preserved ejection fraction: Everything the clinician needs to know. Lancet, 403, pp. 1083-1092. (doi: 10.1016/S0140-6736(23)02756-3)

Cleland, J. G.F. (2024) Nature and magnitude of the benefits of dapagliflozin and empagliflozin for heart failure. Circulation, 149, pp. 839-842. (doi: 10.1161/circulationaha.123.068089)

Astrauskaite, G., Mohanan, S., Williamson, L., Boland, E., Huethorst, E., Kinegawa, R., Smith, G., Muellenbroich, C. (2024) Remote Focusing for 2-photon Microscopy to Follow Action Potential Propagation Transmurally in Acute Rabbit Cardiac Slices. (doi: 10.1117/12.3002956)

Kite, T. A. et al. (2024) Complex percutaneous coronary intervention in patients unable to undergo coronary artery bypass grafting during the COVID-19 pandemic: insights from the UK-ReVasc Registry. Journal of Invasive Cardiology, (doi: 10.25270/jic/24.00030)

Mann, D. L., Nicolas, J., Claggett, B., Miao, Z. M., Granger, C. B., Kerkar, P., Køber, L., Lewis, E. F., McMurray, J. J.V., Maggioni, A. P., Núñez, J., Ntsekhe, M., Rouleau, J.-L., Sim, D., Solomon, S. D., Steg, P. G., van der Meer, P., Braunwald, E., Pfeffer, M. A., Mehran, R. (2024) Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI. Journal of the American College of Cardiology, 83, pp. 904-914. (doi: 10.1016/j.jacc.2024.01.002)

Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Anand, I. S., Desai, A. S., Fang, J. C., Hernandez, A. F., Jhund, P. S., Kosiborod, M. N., Sabatine, M. S., Shah, S. J., Vardeny, O., McMurray, J. J. V., Solomon, S. D., Gaziano, T. A. (2024) Cost effectiveness of dapagliflozin for heart failure across the spectrum of ejection fraction: an economic evaluation based on pooled, individual participant data from the DELIVER and DAPA-HF trials. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032279)

Ciminata, G., Burton, J.K., Quinn, T.J., Geue, C. (2024) Understanding Pathways into Care-homes using Data (UnPiCD study): a two-part model to estimate inpatient and care-home costs using national linked health and social care data. BMC Health Services Research, 24, (doi: 10.1186/s12913-024-10675-z)

MacDonald, A. S. et al. (2024) Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FIST. Journal of Human Hypertension, 38, pp. 307-313. (doi: 10.1038/s41371-024-00906-5)

Dimond, M. G., Ibrahim, N. E., Fiuzat, M., McMurray, J. J.V., Lindenfeld, J., Ahmad, T., Bozkurt, B., Bristow, M. R., Butler, J., Carson, P. E., Felker, G. M., Jessup, M., Murillo, J., Kondo, T., Solomon, S. D., Abraham, W. T., O’Connor, C. M., Psotka, M. A. (2024) Left ventricular ejection fraction and the future of heart failure phenotyping. JACC: Heart Failure, 12, pp. 451-460. (doi: 10.1016/j.jchf.2023.11.005)

Cleland, J. G.F., Pellicori, P., Lakhal-Littleton, S. (2024) Low serum ferritin might predict incident heart failure but why and is it clinically useful? JACC: Heart Failure, 12, pp. 549-551. (doi: 10.1016/j.jchf.2023.12.012)

Adamo, M., Metra, M., Claggett, B. L., Miao, Z. M., Diaz, R., Felker, G. M., McMurray, J. J.V., Solomon, S. D., Biering-Sørensen, T., Divanji, P. H., Heitner, S. B., Kupfer, S., Malik, F. I., Teerlink, J. R., GALACTIC-HF Investigators and Patients, (2024) Tricuspid regurgitation and clinical outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 12, pp. 552-563. (doi: 10.1016/j.jchf.2023.11.018)

Freeman, M., Huethorst, E., Boland, E., Dunne, M., Burton, F., Denning, C., Myles, R., Smith, G. (2024) A novel method for the percutaneous induction of myocardial infarction by occlusion of small coronary arteries in the rabbit. American Journal of Physiology: Heart and Circulatory Physiology, 326, pp. H735--H751. (doi: 10.1152/ajpheart.00657.2023)

Sliwa, K., van der Meer, P., Viljoen, C., Jackson, A. M., Petrie, M. C., Mebazaa, A., Hilfiker-Kleiner, D., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Tavazzi, L., Roos-Hesselink, J. W., Hamdan, R., Frogoudaki, A., Ibrahim, B., Farhan, H. A. F., Mbakwem, A., Seferovic, P., Böhm, M., Pieske, B., Johnson, M. R., Bauersachs, J. (2024) Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry. International Journal of Cardiology, 398, (doi: 10.1016/j.ijcard.2023.131596)

Olowoyo, P. et al. (2024) ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa. Journal of Human Hypertension, 38, pp. 193-199. (doi: 10.1038/s41371-024-00903-8)

Mulholland, R.J., Manca, F., Ciminata, G., Quinn, T.J., Trotter, R., Pollock, K.G., Lister, S., Geue, C. (2024) Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation. European Heart Journal Open, 4, (doi: 10.1093/ehjopen/oeae016)

Ferguson, L. D., Molenberghs, G., Verbeke, G., Rahimi, K., Rao, S., McInnes, I. B., McMurray, J. J.V., Sattar, N., Conrad, N. (2024) Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatology, 6, pp. e156-e167. (doi: 10.1016/S2665-9913(23)00338-7)

Butt, J. H., Jering, K., de Boer, R. A., Claggett, B. L., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Køber, L., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Shah, S. J., Vaduganathan, M., Langkilde, A. M., Bengtsson, O., Petersson, M., Sjöstrand, M., McMurray, J. J.V. (2024) Heart failure, investigator-reported sleep apnea and dapagliflozin: A patient-level pooled meta-analysis of DAPA-HF and DELIVER. Journal of Cardiac Failure, 30, pp. 436-448. (doi: 10.1016/j.cardfail.2023.08.027)

AI Abel, A., Samuel, N. A., Cuthbert, J. J., Brown, O. I., Pellicori, P., Kazmi, S., Cleland, J. G.F., Johnson, M. J., Clark, A. L. (2024) Hospital admissions in the last year of life of patients with heart failure. European Heart Journal: Quality of Care and Clinical Outcomes, 10, pp. 168-175. (doi: 10.1093/ehjqcco/qcad047)

Deo, S. V., Al-Kindi, S., Motairek, I., McAllister, D., Shah, A. S.V., Elgudin, Y. E., Gorodeski, E. Z., Virani, S., Petrie, M. C., Rajagopalan, S., Sattar, N. (2024) Impact of residential social deprivation on prediction of heart failure in patients with type 2 diabetes: External validation and recalibration of the WATCH-DM score using real world data. Circulation: Cardiovascular Quality and Outcomes, 17, pp. 267-276. (doi: 10.1161/circoutcomes.123.010166)

Sykes, R., Hanna, R., Berry, C. (2024) Prognostic importance of fractional flow reserve and left ventricular systolic dysfunction after percutaneous coronary intervention. JACC: Asia, 4, pp. 241-243. (doi: 10.1016/j.jacasi.2023.12.002)

Gulliver, C., Busiau, T., Byrne, A., Findlay, J. E., Hoffmann, R., Baillie, G. (2024) cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression. Molecular Oncology, 18, pp. 707-725. (doi: 10.1002/1878-0261.13572)

Bosserdt, M. et al. (2024) Age and computed tomography and invasive coronary angiography in stable chest pain: a prespecified secondary analysis of the discharge randomized clinical trial. JAMA Cardiology, 9, pp. 346-356. (doi: 10.1001/jamacardio.2024.0001)

Rudd, A. E., Horgan, G., Khan, H., Gamble, D. T., McGowan, J., Sood, A., McGeoch, R., Irving, J., Watt, J., Leslie, S. J., Petrie, M., Lang, C., Mills, N. L., Newby, D. E., Dawson, D. K. (2024) Cardiovascular and noncardiovascular prescribing and mortality after takotsubo comparison with myocardial infarction and general population. JACC: Advances, 3, (doi: 10.1016/j.jacadv.2023.100797)

Mellbin, L. G., Bhatt, D. L., David, J.-P., Ekström, K., Petrie, M. C., Rasmussen, S., Vilsbøll, T. (2024) Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials. European Heart Journal, 45, pp. 1371-1374. (doi: 10.1093/eurheartj/ehae028)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, (doi: 10.1038/s43856-024-00455-5)

Kelham, M., Vyas, R., Rameseshan, R., Rathod, K., de Winter, R.J., de Winter, R.W., Bendz, B., Thiele, H., Hirlekar, G., Morici, N., Myat, A., Michalis, L., Sanchis, J., Kunadian, V., Berry, C., Mathur, A., Jones, D. (2024) 100.03 Routine Invasive Versus Conservative Management of Non-ST Elevation Acute Coronary Syndromes in Patients With Previous Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. (doi: 10.1016/j.jcin.2024.01.082)

Pellicori, P., Felker, G. M., Cleland, J. G.F. (2024) Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ European Journal of Heart Failure, 26, pp. 528-528. (doi: 10.1002/ejhf.3159)

UK HFpEF Collaborative Group, , , (2024) Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry. Heart, 110, pp. 359-365. (doi: 10.1136/heartjnl-2023-323049)

Black, N., Bradley, J., Lewis, G., Lagan, J., Orsborne, C., Soltani, F., Farrant, J. P., McDonagh, T., Schmitt, M., Cavalcante, J. L., Ugander, M., Butler, J., Petrie, M. C., Miller, C. A., Schelbert, E. B. (2024) Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials. medRxiv, (doi: 10.1101/2024.02.07.24302443)

Wang, X., Lam, C. S.P., Vaduganathan, M., Kondo, T., Yang, M., Han, Y., Pham, V. N., Chiang, C.-E., Kitakaze, M., Miao, Z. M., Jhund, P. S., Desai, A. S., Inzucchi, S. E., de Boer, R. A., Martinez, F. A., Kosiborod, M. N., Hernandez, A. F., Claggett, B., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2024) Effects of dapagliflozin in patients in Asia: a post hoc subgroup analysis from the DELIVER trial. JACC: Asia, 4, pp. 108-118. (doi: 10.1016/j.jacasi.2023.10.005)

Pellicori, P., Cleland, J. G.F. (2024) Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good? European Journal of Heart Failure, 26, pp. 299-301. (doi: 10.1002/ejhf.3148)

Watt, J. K., Quinn, T. J. (2024) Critical Look at the NIHSS Visual Stimuli. Stroke, 55, pp. 452-453. (doi: 10.1161/strokeaha.123.045806)

Brum, W. S., Docherty, K. F., Ashton, N. J., Zetterberg, H., Hansson, O., McMurray, J. J. V., Blennow, K. (2024) Effect of neprilysin inhibition on Alzheimer disease plasma biomarkers: a secondary analysis of a randomized clinical trial. JAMA Neurology, 81, pp. 197-200. (doi: 10.1001/jamaneurol.2023.4719)

Vart, P., Butt, J. H., Jongs, N., Schechter, M., Chertow, G. M., Wheeler, D. C., Pecoits-Filho, R., Langkilde, A. M., Correa-Rotter, R., Rossing, P., McMurray, J. J. V., Heerspink, H. J. L. (2024) Efficacy and safety of dapagliflozin in patients with chronic kidney disease across the spectrum of frailty. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 79, (doi: 10.1093/gerona/glad181)

Welsh, P., Al Zabiby, A., Byrne, H., Benbow, H. R., Itani, T., Farries, G., Costa-Scharplatz, M., Ferber, P., Martin, L., Brown, R., Fonseca, A. F., Sattar, N. (2024) Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: a cohort study from the UK biobank. Atherosclerosis, 389, (doi: 10.1016/j.atherosclerosis.2023.117437)

Chybowska, A. D., Gadd, D. A., Cheng, Y., Bernabeu, E., Campbell, A., Walker, R. M., McIntosh, A. M., Wrobel, N., Murphy, L., Welsh, P., Sattar, N., Price, J. F., McCartney, D. L., Evans, K. L., Marioni, R. E. (2024) Epigenetic contributions to clinical risk prediction of cardiovascular disease. Circulation: Genomic and Precision Medicine, 17, (doi: 10.1161/CIRCGEN.123.004265)

Ammirati, E., Marchetti, D., Colombo, G., Pellicori, P., Gentile, P., D’Angelo, L., Masciocco, G., Verde, A., Macera, F., Brunelli, D., Occhi, L., Musca, F., Perna, E., Bernasconi, D. P., Moreo, A., Camici, P., Metra, M., Oliva, F., Garascia, A. (2024) Estimation of right atrial pressure by ultrasound-assessed jugular vein distensibility in patients with heart failure. Circulation: Heart Failure, 17, (doi: 10.1161/CIRCHEARTFAILURE.123.010973)

Butt, J. H., McDowell, K., Kondo, T., Desai, A. S., Lefkowitz, M. P., Packer, M., Petrie, M. C., Pfeffer, M. A., Rouleau, J. L., Vaduganathan, M., Zile, M. R., Jhund, P. S., Køber, L., Solomon, S., McMurray, J. J.V. (2024) Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan. ESC Heart Failure, 11, pp. 65-77. (doi: 10.1002/ehf2.14558)

Bull, C. J. et al. (2024) Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine, 100, (doi: 10.1016/j.ebiom.2024.104977)

Santos-Ferreira, D., Diaz, S. O., Ferreira, J. P., Girerd, N., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A.J., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Rossignol, P., Fontes-Carvalho, R., Cleland, J. G.F., Zannad, F. (2024) Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial. ESC Heart Failure, 11, pp. 209-218. (doi: 10.1002/ehf2.14465)

Olowoyo, P. et al. (2024) Priorities to reduce the burden of hypertension in Africa through ACHIEVE. Lancet Global Health, 12, pp. e192-e193. (doi: 10.1016/S2214-109X(23)00540-5)

Owen, R., Buchan, R., Frenneaux, M., Jarman, J. W.E., Baruah, R., Lota, A. S., Halliday, B. P., Roberts, A. M., Izgi, C., Van Spall, H. G.C., Michos, E. D., McMurray, J. J.V., Januzzi, J. L., Pennell, D. J., Cook, S. A., Ware, J. S., Barton, P. J., Gregson, J., Prasad, S. K., Tayal, U. (2024) Sex differences in the clinical presentation and natural history of dilated cardiomyopathy. JACC: Heart Failure, 12, pp. 352-363. (doi: 10.1016/j.jchf.2023.10.009)

Ali, M., Tibble, H., Brady, M. C., Quinn, T. J., Sunnerhagen, K. S., Venketasubramanian, N., Shuaib, A., Pandyan, A., Mead, G., on behalf of the VISTA collaboration, (2024) Validation of general pain scores from multidomain assessment tools in stroke. Frontiers in Neurology, 15, (doi: 10.3389/fneur.2024.1328832)

Vardeny, O., Desai, A. S., Jhund, P. S., Fang, J. C., Claggett, B., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., McCausland, F. R., Petrie, M. C., Vaduganathan, M., McMurray, J. J.V., Solomon, S. D. (2024) Dapagliflozin and mode of death in heart failure with improved ejection fraction: A post hoc analysis of the DELIVER trial. JAMA Cardiology, 9, pp. 283-289. (doi: 10.1001/jamacardio.2023.5318)

Omerovic, E., Petrie, M., Redfors, B., Fremes, S., Murphy, G., Marquis-Gravel, G., Lansky, A., Velazquez, E., Perera, D., Reid, C., Smith, J., van der Meer, P., Lipsic, E., Juni, P., McMurray, J., Bauersachs, J., Køber, L., Rouleau, J. L., Doenst, T. (2024) Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-pragmatic research and innovation through multinational experimentation. Trials, 25, (doi: 10.1186/s13063-024-07935-y)

Petrie, M. C., Rouleau, J. L., Claggett, B., Jering, K., van der Meer, P., Køber, L., Miao, Z. M., Lewis, E., Granger, C., De Pasqulae, C. G., Mann, D., Steg, P. G., Maggioni, A., Amir, O., Lefkowitz, M., Braunwald, E., Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A. (2024) Pulmonary congestion and left ventricular dysfunction after myocardial infarction: insights from the PARADISE-MI trial. Circulation, 149, pp. 335-38. (doi: 10.1161/CIRCULATIONAHA.123.066163)

Howie, J., Tulloch, L. B., Brown, E., Reilly, L., Ashford, F. B., Kennedy, J., Wypijewski, K. J., Aughton, K. L., Mak, J. K.C., Shattock, M. J., Fraser, N. J., Fuller, W. (2024) Glutathione-dependent depalmitoylation of phospholemman by peroxiredoxin 6. Cell Reports, 43, (doi: 10.1016/j.celrep.2024.113679)

Kosiborod, M. N., Verma, S., Borlaug, B. A., Butler, J., Davies, M. J., Jon Jensen, T., Rasmussen, S., Erlang Marstrand, P., Petrie, M. C., Shah, S. J., Ito, H., Schou, M., Melenovský, V., Abhayaratna, W., Kitzman, D. W., STEP-HFpEF Trial Committees and Investigators, (2024) Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial. Circulation, 149, pp. 204-216. (doi: 10.1161/circulationaha.123.067505)

Sidik, N. P., Stanley, B., Sykes, R., Morrow, A. J., Bradley, C. P., Mcdermott, M., Ford, T., Roditi, G., Hargreaves, A., Stobo, D., Adams, J., Byrne, J., Mahrous, A., Young, R., Carrick, D., McGeoch, R., Corcoran, D., Lang, N. N., Heggie, R., Wu, O., McEntegart, M. B., McConnachie, A., Berry, C. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149, pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751)

Nyman, M., Stølen, T. O., Johnsen, A. B., Garten, K., Burton, F. L., Smith, G. L., Loennechen, J. P. (2024) A comprehensive protocol combining in vivo and ex vivo electrophysiological experiments in an arrhythmogenic animal model. American Journal of Physiology - Heart and Circulatory Physiology, 326, pp. H203-H215. (doi: 10.1152/ajpheart.00358.2023)

Osmanska, J., Brooksbank, K., Docherty, K. F., Robertson, S., Wetherall, K., McConnachie, A., Hu, J., Gardner, R. S., Clark, A. L., Squire, I. B., Kalra, P. R., Jhund, P. S., Muntendam, P., McMurray, J. J.V., Petrie, M. C., Campbell, R. T. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073)

Zeitler, E. P., Dalgaard, F., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Friedman, D. J., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis. American Heart Journal, 267, pp. 81-90. (doi: 10.1016/j.ahj.2023.11.002)

Cleland, J. G. F. (2024) Defining iron deficiency in patients with heart failure. Nature Reviews Cardiology, 21, pp. 1-2. (doi: 10.1038/s41569-023-00951-6)

Lee, M. M.Y., Kondo, T., Campbell, R. T., Petrie, M. C., Sattar, N., Solomon, S. D., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2024) Effects of Renin-Angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomised controlled trials. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 68-80. (doi: 10.1093/ehjcvp/pvad067)

Sofianopoulou, E. et al. (2024) Estimating dose—response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and revised Mendelian randomization analyses. Lancet Diabetes and Endocrinology, 12, pp. E2-E11. (doi: 10.1016/S2213-8587(23)00287-5)

Pellicori, P., Cleland, J. G.F., Borentain, M., Taubel, J., Graham, F., Khan, J., Bruzzese, D., Kessler, P., McMurray, J. J.V., Voors, A. A., O’Connor, C. M., Teerlink, J. R., Felker, G. M. (2024) Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS‐986231) European Journal of Heart Failure, 26, pp. 142-151. (doi: 10.1002/ejhf.3077)

McDowell, K., Adamson, C., Jackson, C., Campbell, R., Welsh, P., Petrie, M. C., McMurray, J. J.V., Jhund, P., Herring, N. (2024) Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes. European Journal of Heart Failure, 26, pp. 107-116. (doi: 10.1002/ejhf.3085)

Jackson, A., Bauersachs, J., Petrie, M. C., van der Meer, P., Laroche, C., Farhan, H. A., Frogoudaki, A., Ibrahim, B., Fouad, D. A., Damasceno, A., Karaye, K., Goland, S., Maggioni, A. P., Briton, O., Sliwa, K. (2024) Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry. European Journal of Heart Failure, 26, pp. 34-42. (doi: 10.1002/ejhf.3055)

Chivardi, C. et al. (2024) Percutaneous revascularization for ischemic left ventricular dysfunction: Cost-effectiveness analysis of the REVIVED-BCIS2 trial. Circulation: Cardiovascular Quality and Outcomes, 17, (doi: 10.1161/circoutcomes.123.010533)

Schou, M., Claggett, B., Miao, Z. M., Fernandez, A., Filippatos, G., Granger, C., Jering, K., Maggioni, A. P., McCausland, F., Villota, J. N., Rouleau, J.‐L., Mody, F. V., van der Meer, P., Vinereanu, D., McGrath, M., Zhou, Y., Mann, D. L., Solomon, S. D., Steg, P. G., Braunwald, E., McMurray, J. J.V., Pfeffer, M. A., Køber, L. (2024) Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: insight from the PARADISE MI trial. European Journal of Heart Failure, 26, pp. 130-139. (doi: 10.1002/ejhf.3079)

Lala, A., Hamo, C. E., Bozkurt, B., Fiuzat, M., Blumer, V., Bukhoff, D., Butler, J., Costanzo, M. R., Felker, G. M., Filippatos, G., Konstam, M. A., McMurray, J. J.V., Mentz, R. J., Metra, M., Psotka, M. A., Solomon, S. D., Teerlink, J., Abraham, W. T., O’Connor, C. M. (2024) Standardized definitions for evaluation of acute decompensated heart failure therapies: HF-ARC expert panel paper. JACC: Heart Failure, 12, pp. 1-15. (doi: 10.1016/j.jchf.2023.09.030)

Docherty, K. F., McMurray, J. J.V., Diaz, R., Felker, G. M., Metra, M., Solomon, S. D., Adams, K. F., Böhm, M., Brinkley, D. M., Echeverria, L. E., Goudev, A. R., Howlett, J. G., Lund, M., Ponikowski, P., Yilmaz, M. B., Zannad, F., Claggett, B. L., Miao, Z. M., Abbasi, S. A., Divanji, P., Heitner, S. B., Kupfer, S., Malik, F. I., Teerlink, J. R. (2024) The effect of omecamtiv mecarbil in hospitalized patients as compared with outpatients with HFrEF: an analysis of GALACTIC-HF. Journal of Cardiac Failure, 30, pp. 26-35. (doi: 10.1016/j.cardfail.2023.08.020)

Corbin, L. J., Hughes, D. A., Bull, C. J., Vincent, E. E., Smith, M. L., McConnachie, A., Messow, C.-M., Welsh, P., Taylor, R., Lean, M. E.J., Sattar, N., Timpson, N. J. (2024) The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT) Diabetologia, 67, pp. 74-87. (doi: 10.1007/s00125-023-06019-x)

McFall, A., Graham, D., Nicklin, S. A., Work, L. M. (2024) Unscheduled changes in pre-clinical stroke model housing contributes to variance in physiological and behavioural data outcomes: a post hoc analysis. Brain and Neuroscience Advances, 8, (doi: 10.1177/23982128241238934)

Astrauskaitė, G., Williamson, L., Mohanan, S., Moreno, S. M., Kinegawa, R., Boland, E., Huethorst, E., Smith, G., Müllenbroich, C. (2024) Fast Axial Scanning with Remote Focusing for Multiphoton Microscopy of Acute Rabbit Ventricular Slices to Follow Action Potentials Transmurally. (doi: 10.1364/CLEO_SI.2024.SF2B.1)

McMahon, D., Dixon, D., Quinn, T., Gallacher, K. I. (2024) The Acceptability of post-stroke cognitive testing through the lens of the theory of acceptability, a qualitative study. Cerebral Circulation - Cognition and Behavior, 6, (doi: 10.1016/j.cccb.2023.100197)

Caiazzo, E., Sharma, M., Rezig, A. O.M., Morsy, M. I., Czesnikiewicz-Guzik, M., Ialenti, A., Sulicka-Grodzicka, J., Pellicori, P., Crouch, S. H., Schutte, A. E., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Circulating cytokines and risk of developing hypertension: a systematic review and meta-analysis. Pharmacological Research, 200, (doi: 10.1016/j.phrs.2023.107050)

Henderson, A. D., Carlile, O., Dillingham, I., FC. Butler-Cole, B., Tomlin, K., Jit, M., Tomlinson, L. A., Marks, M., Briggs, A., Lin, L.-Y., Bates, C., Parry, J., CJ. Bacon, S., Goldacre, B., Mehrkar, A., Herrett, E., Eggo, R. M. (2023) Cohort profile: OpenPROMPT. medRxiv, (doi: 10.1101/2023.12.21.23300369)

Lin, L.-Y., Henderson, A. D., Carlile, O., Dillingham, I., FC. Butler-Cole, B., Marks, M., Briggs, A., Jit, M., Tomlinson, L. A., Bates, C., Parry, J., CJ. Bacon, S., Goldacre, B., Mehrkar, A., MacKenna, B., Eggo, R. M., Herrett, E. (2023) Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study. medRxiv, (doi: 10.1101/2023.12.21.23300305)

Lee, M. M.Y., Lean, M. E.J., Sattar, N., Petrie, M. C. (2023) Appetite and its regulation: Are there palatable interventions for heart failure? Current Heart Failure Reports, 21, pp. 1-4. (doi: 10.1007/s11897-023-00637-7)

Jackson, A. M., Macartney, M., Brooksbank, K., Brown, C., Dawson, D., Francis, M., Japp, A., Lennie, V., Leslie, S. J., Martin, T., Neary, P., Venakatasubramanian, S., Vickers, D., Weir, R. A., McMurray, J. J.V., Jhund, P. S., Petrie, M. C. (2023) A 20-year population study of peripartum cardiomyopathy. European Heart Journal, 44, pp. 5128-5141. (doi: 10.1093/eurheartj/ehad626)

Kosiborod, M. N., Borlaug, B. A., Petrie, M. C. (2023) Semaglutide and heart failure with preserved ejection fraction and obesity. Reply. New England Journal of Medicine, 389, pp. 2398-2399. (doi: 10.1056/NEJMc2312296)

Glen, C., Adam, S., Coats, C. J., Lang, N. N. (2023) Reply: Cardiotoxicity of BRAF/MEK inhibitors according to HFA/ICOS cardiotoxicity risk category. JACC: CardioOncology, 5, pp. 850. (doi: 10.1016/j.jaccao.2023.10.003)

Ostrominski, J. W., Vaduganathan, M., Selvaraj, S., Claggett, B. L., Miao, Z. M., Desai, A. S., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Maria Langkilde, A., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: The DELIVER trial. Circulation, 148, pp. 1945-1957. (doi: 10.1161/CIRCULATIONAHA.123.065254)

Welsh, S. A., Hussey, K., Brittenden, J., Orr, D. J., Quinn, T. (2023) Frailty Assessment in Vascular OUtpatients Review (FAVOUR) PROTOCOL – single-centre prospective cohort study comparing feasibility and prognostic value of commonly used frailty assessment tools. BMJ Open, 13, (doi: 10.1136/bmjopen-2023-079387)

Welsh, P., Kimenai, D. M., Shah, A. S.V., Gadd, D. A., Marioni, R. E., Woodward, M., Sudlow, C. L.M., Campbell, A., Cleland, J. G.F., Pellicori, P., Hayward, C., Mills, N. L., Sattar, N. (2023) Multiple cardiac biomarkers to improve prediction of cardiovascular events: findings from the Generation Scotland Scottish Family Health Study. Clinical Chemistry, 70, pp. 403-413. (doi: 10.1093/clinchem/hvad205)

Taylor-Rowan, M., Alharthi, A., Noel-Storr, A. H., Myint, P. K., Stewart, C., McCleery, J., Quinn, T. J. (2023) Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment. Cochrane Database of Systematic Reviews, 2023, (doi: 10.1002/14651858.CD015405.pub2)

McMurray, J. J.V., Docherty, K. F., de Boer, R. A., Hammarstedt, A., Kitzman, D. W., Kosiborod, M. N., Langkilde, A. M., Reicher, B., Senni, M., Shah, S. J., Wilderäng, U., Verma, S., Solomon, S. D. (2023) Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials. Circulation, (doi: 10.1161/CIRCULATIONAHA.123.065061)

Vardeny, O., Fang, J. C., Desai, A. S., Jhund, P. S., Claggett, B., Vaduganathan, M., de Boer, R. A., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., Kosiborod, M. N., DeMets, D., O’Meara, E., Zieroth, S., Comin-Colet, J., Drozdz, J., Chiang, C.-E., Kitakaze, M., Petersson, M., Lindholm, D., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature Medicine, 29, pp. 3269-3269. (doi: 10.1038/s41591-023-02302-x)

Matsumoto, S., Kondo, T., Yang, M., Campbell, R. T., Docherty, K. F., de Boer, R. A., Desai, A. S., Lam, C. S.P., Packer, M., Pitt, B., Rouleau, J. L., Vaduganathan, M., Zannad, F., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2023) Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 25, pp. 2202-2214. (doi: 10.1002/ejhf.3044)

McErlane, J., McCall, P., Willder, J., Berry, C., Shelley, B. (2023) Cardiac biomarkers and right ventricular dysfunction are independently associated with one year mortality in patients with COVID-19 receiving mechanical ventilation: a prospective cohort study. CHEST Critical Care, 1, (doi: 10.1016/j.chstcc.2023.100015)

Fletcher, R. A., Jongs, N., Chertow, G. M., McMurray, J. J.V., Arnott, C., Jardine, M. J., Mahaffey, K. W., Perkovic, V., Rockenschaub, P., Rossing, P., Correa-Rotter, R., Toto, R. D., Vaduganathan, M., Wheeler, D. C., Heerspink, H. J.L., Neuen, B. L. (2023) Effect of SGLT2 inhibitors on discontinuation of renin–angiotensin system blockade: A joint analysis of the CREDENCE and DAPA-CKD trials. Journal of the American Society of Nephrology, 34, pp. 1965-1975. (doi: 10.1681/ASN.0000000000000248)

Kondo, T., Butt, J. H., Curtain, J. P., Jhund, P. S., Docherty, K. F., Claggett, B. L., Vaduganathan, M., Bachus, E., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2023) Efficacy of dapagliflozin according to heart rate: A patient-level pooled analysis of DAPA-HF and DELIVER. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.123.010898)

Da Silva Costa, A., Ghouri, I., Johnston, A., Mcglynn, K., McNair, A., Bowman, P., Malik, N., Hurren, J., Bingelis, T., Dunne, M., Smith, G. L., Kemi, O. J. (2023) Electrically stimulated in vitro heart cell mimic of acute exercise reveals novel immediate cellular responses to exercise: Reduced contractility and metabolism, but maintained calcium cycling and increased myofilament calcium sensitivity. Cell Biochemistry and Function, 41, pp. 1147-1161. (doi: 10.1002/cbf.3847)

Bhatt, A. S., Kosiborod, M. N., Claggett, B. L., Miao, Z. M., Vaduganathan, M., Lam, C. S. P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Fang, J. C., Han, Y., Comin‐Colet, J., Drożdż, J., Vardeny, O., Merkely, B., Lindholm, D., Peterson, M., Langkilde, A. M., McMurray, J. J. V., Solomon, S. D. (2023) Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial. European Journal of Heart Failure, 25, pp. 2177-2188. (doi: 10.1002/ejhf.3043)

Zahir Anjum, D., Strange, J. E., Fosbøl, E., Garred, C. H., Malik, M. E., Andersson, C., Jhund, P. S., McMurray, J. J.V., Petrie, M. C., Kober, L., Schou, M. (2023) Initiation of medical therapy for heart failure patients according to kidney function: a Danish nationwide study. Clinical Epidemiology, 15, pp. 855-866. (doi: 10.2147/clep.s412787)

Taylor-Rowan, M., Hafdi, M., Drozdowska, B., Elliott, E., Warlaw, J., Quinn, T. J. (2023) Physical and brain frailty in ischaemic stroke or TIA: shared occurrence and outcomes. A cohort study. European Stroke Journal, 8, pp. 1011-1020. (doi: 10.1177/23969873231186480)

Ali, M., Tibble, H., Brady, M. C., Quinn, T. J., Sunnerhagen, K. S., Venketasubramanian, N., Shuaib, A., Pandyan, A., Mead, G. (2023) Prevalence, trajectory and predictors of post stroke pain: retrospective analysis of pooled clinical trial datasets. Stroke, 54, pp. 3107-3116. (doi: 10.1161/STROKEAHA.123.043355)

Flett, A., Cebula, A., Nicholas, Z., Adam, R., Ewings, S., Prasad, S., Cleland, J. G.F., Eminton, Z., Curzen, N. (2023) Rationale and study protocol for the BRITISH randomised trial (using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with non-ischaemic cardiomyopathy and severe systolic heart failure) American Heart Journal, 266, pp. 149-158. (doi: 10.1016/j.ahj.2023.09.008)

Pabon, M., Cunningham, J., Claggett, B., Felker, G. M., McMurray, J. J.V., Metra, M., Diaz, R., Wang, X., Arias-Mendoza, A., Bonderman, D., Crespo-Leiro, M., Fonseca, C., Goncalvesova, E., Lund, M., O’Meara, E., Sliwa-Hahnle, K., Malik, F. I., Solomon, S. D., Teerlink, J. R. (2023) Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial. JACC: Heart Failure, 11, pp. 1729-1738. (doi: 10.1016/j.jchf.2023.07.029)

Nurfianti, A., Quinn, T.J., Kotronoulas, G., Kidd, L. (2023) Survey of Nurses’ Roles in, and Education Needs for, Assessing and Managing Post-Stroke Cognitive Impairment (PSCI) in Indonesia.

Nurfianti, A., Chaiyapoom, N., Quinn, T.J., Lumsden, J., Kidd, L. (2023) What are Nurses' Roles in Assessing and Managing Post-stroke Cognitive Impairment? A Systematic Review of Stroke Clinical Practice Guidelines.

Tabish, T. A., Zhu, Y., Shukla, S., Kadian, S., Sangha, G. S., Lygate, C. A., Narayan, R. J. (2023) Graphene nanocomposites for real-time electrochemical sensing of nitric oxide in biological systems. Applied Physics Reviews, 10, (doi: 10.1063/5.0162640)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7, pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Goudswaard, L. J., Smith, M. L., Hughes, D. A., Taylor, R., Lean, M., Sattar, N., Welsh, P., McConnachie, A., Blazeby, J. M., Rogers, C. A., Suhre, K., Zaghlool, S. B., Hers, I., Timpson, N. J., Corbin, L. J. (2023) Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome. Scientific Reports, 13, (doi: 10.1038/s41598-023-47030-x)

Chatur, S., Vaduganathan, M., Claggett, B. L., Cunningham, J. W., Docherty, K. F., Desai, A. S., Jhund, P. S., De Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A.-M., McMurray, J. J. V., Solomon, S. D. (2023) Outpatient worsening among patients with mildly reduced and preserved ejection fraction heart failure in the DELIVER trial. Circulation, 148, pp. 1735-1745. (doi: 10.1161/circulationaha.123.066506)

Belch, J. J.F., Elder, A., Bartlett, S., Fardon, T., Flinn, K., Hughes, R. C., Miller, M. R., Newby, D., Quinn, T., Slater, M. (2023) Children are especially vulnerable to air pollution: We need data on transport emissions near schools. British Medical Journal, 383, (doi: 10.1136/bmj.p2675)

Miranda, F., Gonzalez, F., Plana, M. N., Zamora, J., Quinn, T. J., Seron, P. (2023) Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings. Cochrane Database of Systematic Reviews, 11, (doi: 10.1002/14651858.CD013126.pub2)

Henriksen, P. A. et al. (2023) Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I–guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: The Cardiac CARE trial. Circulation, 148, pp. 1680-1690. (doi: 10.1161/CIRCULATIONAHA.123.064274)

Mc Causland, F. R., Claggett, B. L., Vaduganathan, M., Desai, A., Jhund, P., Vardeny, O., Fang, J. C., de Boer, R. A., Docherty, K. F., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Saraiva, J. F. K., McGrath, M. M., Shah, S. J., Verma, S., Langkilde, A. M., Petersson, M., McMurray, J. J. V., Solomon, S. D. (2023) Decline in estimated glomerular filtration rate after dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: A prespecified secondary analysis of the DELIVER randomized clinical trial. JAMA Cardiology, 9, pp. 144-152. (doi: 10.1001/jamacardio.2023.4664)

Chatur, S., Vaduganathan, M., Claggett, B. L., Mc Causland, F. R., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., Sabatine, M. S., Kober, L., Ponikowski, P., Merkely, B., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin in patients with heart failure and deterioration in renal function. Journal of the American College of Cardiology, 82, pp. 1854-1863. (doi: 10.1016/j.jacc.2023.08.026)

Leong, D. P., Joseph, P., McMurray, J. J.V., Rouleau, J., Maggioni, A. P., Lanas, F., Sharma, S. K., Núñez, J., Mohan, B., Celik, A., Abdullakutty, J., Ogah, O. S., Mielniczuk, L. M., Balasubramanian, K., McCready, T., Grinvalds, A., Yusuf, S. (2023) Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. European Heart Journal, 44, pp. 4435-4444. (doi: 10.1093/eurheartj/ehad595)

Ostrominski, J. W., Thierer, J., Claggett, B. L., Miao, Z. M., Desai, A. S., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC: Heart Failure, 11, pp. 1491-1503. (doi: 10.1016/j.jchf.2023.05.015)

Berry, C., McClure, J. D., Oldroyd, K. G. (2023) Coronary revascularization guided by instantaneous wave-free ratio compared with fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials. European Heart Journal, 44, pp. 4388-4390. (doi: 10.1093/eurheartj/ehad552)

Petermann-Rocha, F., Deo, S., Lyall, D., Orkaby, A. R., Quinn, T. J., Sattar, N., Celis-Morales, C., Pell, J. P., Ho, F. K. (2023) Association between the AHA Life's Essential 8 score and incident all-cause dementia: a prospective cohort study from UK Biobank. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2023.101934)

Lee, M., Welsh, P., Berry, C., Brooksbank, K. J. M., Campbell, R. T., Docherty, K. F., Osmanska, J., Roditi, G. I. L. E. S., Wetherall, K., McConnachie, A., Mark, P.B., McMurray, J.J.V., Jhund, P.S., Petrie, M.C., Sattar, N. (2023) Association of CA-125 with Markers of Congestion, and Effect of Empagliflozin on CA-125 in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) (doi: 10.1093/eurheartj/ehad655.921)

Vissing, C. R. et al. (2023) Cardiac remodeling in subclinical hypertrophic cardiomyopathy: the VANISH randomized clinical trial. JAMA Cardiology, 8, pp. 1083-1088. (doi: 10.1001/jamacardio.2023.2808)

Ho, L., Lloyd, K., Taylor-Rowan, M., Dawson, S., Logan, M., Leitc, S., Quinn, T. J., Shenkin, S. D., Parry, S. W., Jarman, H., Henderson, E. J. (2023) Comparing research priority-setting partnerships for older adults across international health care systems: a systematic review. Journal of the American Medical Directors Association, 24, pp. 1726-1745. (doi: 10.1016/j.jamda.2023.09.003)

Ostrominski, J. W., Claggett, B. L., Packer, M., Pfeffer, M. A., Lam, C. S.P., Zile, M. R., Desai, A. S., Jhund, P. S., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Duration of heart failure with preserved ejection fraction and outcomes with sacubitril/valsartan: insights from the PARAGON-HF trial. Journal of Cardiac Failure, 29, pp. 1494-1503. (doi: 10.1016/j.cardfail.2023.05.003)

Heerspink, H. J. L., Vart, P., Jongs, N., Neuen, B. L., Bakris, G., Claggett, B., Vaduganathan, M., McCausland, F., Docherty, K. F., Jhund, P. S.,, Solomon, S. D., Perkovic, V., McMurray, J. J. V. (2023) Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: a joint analysis of randomized controlled clinical trials. Diabetes, Obesity and Metabolism, 25, pp. 3327-3336. (doi: 10.1111/dom.15232)

Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Fonarow, G. C., Packer, M., Pfeffer, M. A., Shah, S. J., Shen, X., Cristino, J., McMurray, J. J.V., Solomon, S. D., Gaziano, T. A. (2023) Health and economic evaluation of sacubitril-valsartan for heart failure management. JAMA Cardiology, 8, pp. 1041-1048. (doi: 10.1001/jamacardio.2023.3216)

Butt, J. H., Lu, H., Kondo, T., Bachus, E., de Boer, R. A., Inzucchi, S. E., Jhund, P. S., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER. European Journal of Heart Failure, 25, pp. 2078-2090. (doi: 10.1002/ejhf.3000)

Purcell, C., Purvis, A., Cleland, J. G.F., Cowie, A., Dalal, H. M., Ibbotson, T., Murphy, C., Taylor, R. S. (2023) Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study) European Journal of Cardiovascular Nursing, 22, pp. 804-813. (doi: 10.1093/eurjcn/zvad004)

Farzi, M., Coveney, S., Afzali, M., Zdora, M.‐C., Lygate, C. A., Rau, C., Frangi, A. F., Dall'Armellina, E., Teh, I., Schneider, J. E. (2023) Measuring cardiomyocyte cellular characteristics in cardiac hypertrophy using diffusion‐weighted MRI. Magnetic Resonance in Medicine, 90, pp. 2144-2157. (doi: 10.1002/mrm.29775)

Cooper, N., Germeni, E., Freeman, S. C., Jaiswal, N., Nevill, C. R., Sutton, A. J., Taylor-Rowan, M., Quinn, T. J. (2023) New horizons in evidence synthesis for older adults. Age and Ageing, 52, (doi: 10.1093/ageing/afad211)

Burger, P. M. et al. (2023) Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: the LIFE-HF model. European Journal of Heart Failure, 25, pp. 1962-1975. (doi: 10.1002/ejhf.3028)

Sattar, N., Taheri, S., Astling, D. P., Chadwick, J., Hinterberg, M. A., Holmes, M. V., Troth, E. V., Welsh, P., Zaghloul, H., Chagoury, O., Lean, M., Taylor, R., Williams, S. (2023) Prediction of cardiometabolic health through changes in plasma proteins with intentional weight loss in the DiRECT and DIADEM-I randomised clinical trials of type 2 diabetes remission. Diabetes Care, 46, pp. 1949-1957. (doi: 10.2337/dc23-0602)

Martin, T. P., MacDonald, E. A., Bradley, A., Watson, H., Saxena, P., Rog-Zielinska, E. A., Raheem, A., Fisher, S., Elbassioni, A. A. M., Almuzaini, O., Booth, C., Campbell, M., Riddell, A., Herzyk, P., Blyth, K., Nixon, C., Zentilin, L., Berry, C., Braun, T., Giacca, M., McBride, M. W., Nicklin, S. R., Cameron, E. R., Loughrey, C. (2023) Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction. Cardiovascular Research, 119, pp. 2663–2671-2663–2671. (doi: 10.1093/cvr/cvad107)

Docherty, K. F. (2023) SGLT2 inhibitors and iron: more than meets the eye. JACC: Heart Failure, 11, pp. 1623-1625. (doi: 10.1016/j.jchf.2023.08.013)

Bradley, C. P., Orchard, V., McKinley, G., Heggie, R., Wu, O., Good, R., Watkins, S., Lindsay, M., Eteiba, H., McGowan, J., McGeoch, R., Corcoran, D., Kellman, P., McConnachie, A., Berry, C. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067)

Kondo, T., Gasparyan, S. B., Jhund, P. S., Bengtsson, O., Claggett, B. L., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Ponikowski, P., Sabatine, M. S., Shah, S. J., Sjostrand, M., Wilderang, U., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Use of win statistics to analyze outcomes in the DAPA-HF and DELIVER trials. NEJM Evidence, 2, (doi: 10.1056/EVIDoa2300042)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2023) Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study. European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 731-739. (doi: 10.1093/ehjqcco/qcac073)

Sri, S. et al. (2023) A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia. Cerebral Circulation - Cognition and Behavior, 5, (doi: 10.1016/j.cccb.2023.100189)

Fuller, W., Mejías, R. (2023) Editorial: Protein lipidation in health and disease. Frontiers in Physiology, 14, (doi: 10.3389/fphys.2023.1317031)

Gulliver, C., Huss, S., Semjonow, A., Baillie, G. S., Hoffmann, R. (2023) Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation, and alterations in DNA repair: implications for therapeutic strategies. British Journal of Cancer, 129, pp. 1462-1476. (doi: 10.1038/s41416-023-02417-5)

Selli, A. L., Ghasemi, M., Watters, T., Burton, F., Smith, G., Dietrichs, E. S. (2023) Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 31, (doi: 10.1186/s13049-023-01134-5)

Glen, C., Adam, S., McDowell, K., Waterston, A., Tan, Y. Y., Petrie, M. C., Coats, C. J., Lang, N. N. (2023) Cardiotoxicity of BRAF/MEK inhibitors: a longitudinal study incorporating contemporary definitions and risk scores. JACC: CardioOncology, 5, pp. 628-637. (doi: 10.1016/j.jaccao.2023.04.004)

McDonagh, T. A. et al. (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 44, pp. 3627-3639. (doi: 10.1093/eurheartj/ehad195)

Eisner, D., Neher, E., Taschenberger, H., Smith, G. (2023) Physiology of intracellular calcium buffering. Physiological Reviews, 103, pp. 2767-2845. (doi: 10.1152/physrev.00042.2022)

Rohde, L. E., McMurray, J. J.V. (2023) REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed. European Heart Journal, 44, pp. 3652-3654. (doi: 10.1093/eurheartj/ehad488)

Bozkurt, B., Desai, A. S., Ahmad, T., Deswal, A., Heidenreich, P. A., Ibrahim, N. E., McMurray, J., Pinney, S. P., Vaduganathan, M., Walsh, M. N. (2023) As we embark on a second year. JACC: Heart Failure, 11, pp. 1466-1469. (doi: 10.1016/j.jchf.2023.09.001)

Boonpor, J., Parra-Soto, S., Talebi, A., Zhou, Z., Carrasco-Marín, F., Petermann-Rocha, F., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R., Celis-Morales, C., Ho, F. K. (2023) Associations and predictive performance of eleven anthropometric measures with incident type 2 diabetes: a prospective cohort study from the UK Biobank. Obesity, 31, pp. 2648-2657. (doi: 10.1002/oby.23849)

Seckin, M., Johnston, B., Petrie, M. C., Stewart, S., Chan, Y.-K. (2023) Characteristics of symptoms and symptom change across different heart failure subtypes: a sex-stratified analysis. European Journal of Cardiovascular Nursing, 22, pp. 690-700. (doi: 10.1093/eurjcn/zvac099)

Butt, J., Docherty, K. F., Kosiborod, M. N., Inzucchi, S. E., Køber, L., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S., Jhund, P. S., McMurray, J. J.V. (2023) Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction. JACC: Heart Failure, 11, pp. 1411-1423. (doi: 10.1016/j.jchf.2023.04.016)

Peikert, A., Goyal, P., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Miao, Z. M., Vardeny, O., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status. JACC: Heart Failure, 11, pp. 1380-1393. (doi: 10.1016/j.jchf.2023.05.014)

Giommi, A., Gurgel, A. R. B., Smith, G. L., Workman, A. J. (2023) Does the small conductance Ca2+-activated K+ current ISK flow under physiological conditions in rabbit and human atrial isolated cardiomyocytes? Journal of Molecular and Cellular Cardiology, 183, pp. 70-80. (doi: 10.1016/j.yjmcc.2023.09.002)

Graham, F. J., Pellicori, P., Masini, G., Cuthbert, J. J., Clark, A. L., Cleland, J. G.F. (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Failure, 10, pp. 2826-2836. (doi: 10.1002/ehf2.14438)

Malik, M. E., Butt, J. H., Strange, J. E., Falkentoft, A. C., Jensen, J., Andersson, C., Zahir, D., Fosbøl, E., Petrie, M. C., Sattar, N., McMurray, J. J.V., Køber, L., Schou, M. (2023) Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study. Lancet Healthy Longevity, 4, pp. e552-e560. (doi: 10.1016/S2666-7568(23)00164-2)

Yang, M., Kondo, T., Adamson, C., Butt, J. H., Abraham, W. T., Desai, A. S., Jering, K. S., Køber, L., Kosiborod, M. N., Packer, M., Rouleau, J. L., Solomon, S. D., Vaduganathan, M., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 25, pp. 1831-1839. (doi: 10.1002/ejhf.2944)

Bozkurt, B., Savarese, G., Adamsson Eryd, S., Bodegård, J., Cleland, J. G.F., Khordoc, C., Kishi, T., Thuresson, M., Vardeny, O., Zhang, R., Lund, L. H. (2023) Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF. JACC: Heart Failure, 11, pp. 1320-1332. (doi: 10.1016/j.jchf.2023.04.017)

Nadarajah, R., Younsi, T., Romer, E., Raveendra, K., Nakao, Y., Nakao, K., Shuweidhi, F., Hogg, D., Arbel, R., Zahger, D., Iakobishvili, Z., Fonarow, G. C., Petrie, M. C., Wu, J., Gale, C. P. (2023) Prediction models for heart failure in the community: a systematic review and meta‐analysis. European Journal of Heart Failure, 25, pp. 1724-1738. (doi: 10.1002/ejhf.2970)

Lam, C. S.P., Docherty, K. F., Ho, J. E., McMurray, J. J.V., Myhre, P. L., Omland, T. (2023) Recent successes in heart failure treatment. Nature Medicine, 29, pp. 2424-2437. (doi: 10.1038/s41591-023-02567-2)

Gulliver, C., Baillie, G. S., Hoffmann, R. (2023) Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region. Future Science OA, 9, (doi: 10.2144/fsoa-2023-0064)

Parsons, E. C., Baillie, G. S., Hoffmann, R. (2023) Revisiting the roles of cAMP signalling in the progression of prostate cancer. Biochemical Journal, 480, pp. 1599-1614. (doi: 10.1042/BCJ20230297)

Cuthbert, J. J., Cleland, J. G.F. (2023) Should we resurrect acetazolamide as a diuretic for congestion due to heart failure? Cardiovascular Research, 119, pp. e149-e151. (doi: 10.1093/cvr/cvad148)

Brown, A. D., Vergunst, K. L., Branch, M., Blair, C. M., Dupré, D. J., Baillie, G. S., Langelaan, D. N. (2023) Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor. Biochimica et Biophysica Acta: Molecular Cell Research, 1870, (doi: 10.1016/j.bbamcr.2023.119520)

Al Ozairi, E., Alsaeed, D., Al Rhoudan, D., Jalali, M., Mashankar, A., Taliping, D., Abdulla, A., Gill, J. M.R., Sattar, N., Welsh, P., Gray, S. R. (2023) The effect of home-based resistance exercise training in people with type 2 diabetes: a randomized controlled trial. Diabetes/Metabolism Research and Reviews, 39, (doi: 10.1002/dmrr.3677)

Wei, L., Phillippo, D. M., Shah, A., Cleland, J. G.F., Lewsey, J., McAllister, D. A. (2023) Transportability of two heart failure trials to a disease registry using individual patient data. Journal of Clinical Epidemiology, 162, pp. 160-168. (doi: 10.1016/j.jclinepi.2023.08.019)

Logan, G., Somers, C., Baker, G., Connell, H., Gray, S., Kelly, P., McIntosh, E., Welsh, P., Gray, C., Gill, J. M. (2023) Benefits, risks, barriers, and facilitators to cycling: a narrative review. Frontiers in Sports and Active Living, 5, (doi: 10.3389/fspor.2023.1168357)

Perera, D. et al. (2023) Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: Prespecified analyses from the REVIVED-BCIS2 trial. Circulation: Heart Failure, 148, pp. 862-871. (doi: 10.1161/circulationaha.123.065300)

Burton, J. K., Drummond, M., Gallacher, K. I., Quinn, T. J. (2023) Listening and learning: a qualitative study of Scottish care home staff experiences of managing COVID-19 between March 2020-August 2022. BMC Geriatrics, 23, (doi: 10.1186/s12877-023-04251-z)

Lucas-Herald, A. K., Montezano, A. C., Alves-Lopes, R., Haddow, L., O'Toole, S., Flett, M., Lee, B., Amjad, S. B., Steven, M., McNeilly, J., Brooksbank, K., Touyz, R. M., Ahmed, S. F. (2023) Effects of sex hormones on vascular reactivity in boys with hypospadias. Journal of Clinical Endocrinology and Metabolism, (doi: 10.1210/clinem/dgad525)

Kondo, T., Wang, X., Yang, M., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Langkilde, A. M., Petersson, M., Zaozerska, N., Bachus, E., Solomon, S. D., McMurray, J. J. V. (2023) Efficacy of dapagliflozin according to geographic location of patients with heart failure. Journal of the American College of Cardiology, 82, pp. 1014-1026. (doi: 10.1016/j.jacc.2023.05.056)

Wang, X., Jering, K. S., Cikes, M., Tokmakova, M. P., Mehran, R., Han, Y., East, C., Mody, F. V., Wang, Y., Lewis, E. F., Claggett, B., McMurray, J. J. V., Granger, C. B., Pfeffer, M. A., Solomon, S. D. (2023) Sex differences in clinical characteristics and outcomes after myocardial infarction with low ejection fraction: insights from PARADISE‐MI. Journal of the American Heart Association, 12, (doi: 10.1161/JAHA.122.028942)

Matsumoto, S., Kondo, T., Jhund, P. S., Campbell, R. T., Swedberg, K., van Veldhuisen, D. J., Pocock, S. J., Pitt, B., Zannad, F., McMurray, J. J.V. (2023) Underutilization of mineralocorticoid antagonists in patients with heart failure with reduced ejection fraction. Journal of the American College of Cardiology, 82, pp. 1080-1091. (doi: 10.1016/j.jacc.2023.06.021)

Graham, F. J., Friday, J., Pellicori, P., Greenlaw, N., Cleland, J. G.F. (2023) Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart, 109, pp. 1294-1301. (doi: 10.1136/heartjnl-2022-322145)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Andersen, K. R., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2023) Baseline characteristics of patients enrolled in the EMPACT‐MI trial. European Journal of Heart Failure, 25, pp. 1708-1715. (doi: 10.1002/ejhf.2990)

Wright, T. A., Gemmell, A. O., Tejeda, G. S., Blair, C. M., Baillie, G. S. (2023) Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target. International Journal of Biochemistry and Cell Biology, 162, (doi: 10.1016/j.biocel.2023.106453)

Tromp, J., Ezekowitz, J. A., Ouwerkerk, W., Chandramouli, C., Yiu, K. H., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Cleland, J. G. F., Lam, C. S. P. (2023) Global variations according to sex in patients hospitalized for heart failure in the REPORT-HF registry. JACC: Heart Failure, 11, pp. 1262-1271. (doi: 10.1016/j.jchf.2023.06.028)

Yang, M., Kondo, T., Adamson, C., Butt, J. H., Abraham, W. T., Desai, A. S., Jering, K. S., Køber, L., Kosiborod, M. N., Packer, M., Rouleau, J. L., Solomon, S. D., Vaduganathan, M., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction. European Journal of Heart Failure, 25, pp. 1606-1618. (doi: 10.1002/ejhf.2962)

Pabon, M., Claggett, B. L., Wang, X., Miao, Z. M., Chatur, S., Bhatt, A. S., Vaduganathan, M., Fang, J. C., Desai, A. S., Jhund, P., Martinez, F., De Boer, R. A., Kosiborod, M. N., Lam, C. S., Shah, S. J., Hernandez, A. F., McMurray, J. J.V., Solomon, S. D., Vardeny, O. (2023) Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure, 25, pp. 1663-1670. (doi: 10.1002/ejhf.3001)

Brennan, A. C., Campbell, R. T., Lee, M. M.Y. (2023) Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure. European Journal of Heart Failure, 25, pp. 1693-1695. (doi: 10.1002/ejhf.2993)

Sykes, R., Doherty, D., Morrow, A., Mangion, K., Rushd, A., Berry, C. (2023) NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction. American Heart Journal Plus: Cardiology Research and Practice, 33, (doi: 10.1016/j.ahjo.2023.100311)

Watt, J. K., Dickie, D. A., Lyall, D., Ward, J., Ho, F., Dawson, J., Quinn, T. J. (2023) Normative values of the brain health index in UK biobank. Neuroimage: Reports, 3, (doi: 10.1016/j.ynirp.2023.100176)

Bhatt, A. S., Lindholm, D., Nilsson, A., Zaozerska, N., Claggett, B. L., Vaduganathan, M., Kosiborod, M. N., Lam, C. S.P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Desai, A., Jhund, P. S., Langkilde, A. M., Petersson, M., McMurray, J. J.V., Solomon, S. D. (2023) Operational challenges and mitigation measures during the COVID-19 pandemic – lessons from DELIVER. American Heart Journal, 263, pp. 133-140. (doi: 10.1016/j.ahj.2023.05.013)

Keast, T., McErlane, J., Kearns, R., McKinlay, S., Raju, I., Watson, M., Robertson, K. E., Berry, C., Greenlaw, N., Ackland, G., McCall, P., Shelley, B. (2023) Study protocol for IMPRoVE: a multicentre prospective observational cohort study of the incidence, impact and mechanisms of perioperative right ventricular dysfunction in non-cardiac surgery. BMJ Open, 13, (doi: 10.1136/bmjopen-2023-074687)

Ranasinghe, S., Merz, C. N. B., Khan, N., Wei, J., George, M., Berry, C., Chieffo, A., Camici, P. G., Crea, F., Kaski, J. C., Marzilli, M., Gulati, M. (2023) Sex differences in Quality of Life in Patients with Ischemia with No Obstructive Coronary Artery Disease (INOCA): A Patient Self-Report Retrospective Survey from INOCA International. Journal of Clinical Medicine, 12, (doi: 10.3390/jcm12175646)

Kondo, T., Dewan, P., Anand, I. S., Desai, A. S., Packer, M., Zile, M. R., Pfeffer, M. A., Solomon, S. D., Abraham, W. T., Shah, S. J., Lam, C. S.P., Jhund, P. S., McMurray, J. J.V. (2023) Clinical characteristics and outcomes in patients with heart failure: are there thresholds and inflection points in left ventricular ejection fraction and thresholds justifying a clinical classification? Circulation, 148, pp. 732-749. (doi: 10.1161/CIRCULATIONAHA.122.063642)

Borlaug, B. A. et al. (2023) Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature Medicine, 29, pp. 2358-2365. (doi: 10.1038/s41591-023-02526-x)

Ioannou, A. et al. (2023) Conventional heart failure therapy in cardiac ATTR amyloidosis. European Heart Journal, 44, pp. 2893-2907. (doi: 10.1093/eurheartj/ehad347)

Chatur, S., Vaduganathan, M., Claggett, B., Vardeny, O., Desai, A. S., Jhund, P. S., de Boer, R. A., Lam, C. S.P., Kosiborod, M. N., Shah, S. J., Martinez, F., Inzucchi, S. E., Hernandez, A. F., Haddad, T., Mitter, S. S., Miao, Z. M., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Heart Journal, 44, pp. 2930-2943. (doi: 10.1093/eurheartj/ehad283)

Yeoh, S. E., Osmanska, J., Petrie, M. C., Brooksbank, K. J.M., Clark, A. L., Docherty, K. F., Foley, P. W.X., Guha, K., Halliday, C. A., Jhund, P. S., Kalra, P. R., McKinley, G., Lang, N. N., Lee, M. M.Y., McConnachie, A., McDermott, J. J., Platz, E., Sartipy, P., Seed, A., Stanley, B., Weir, R. A.P., Welsh, P., McMurray, J. J.V., Campbell, R. T. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44, pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341)

Vaduganathan, M., Mentz, R. J., Claggett, B. L., Miao, Z. M., Kulac, I. J., Ward, J. H., Hernandez, A. F., Morrow, D. A., Starling, R. C., Velazquez, E. J., Williamson, K. M., Desai, A. S., Zieroth, S., Lefkowitz, M., McMurray, J. J.V., Braunwald, E., Solomon, S. D. (2023) Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. European Heart Journal, 44, pp. 2982-2993. (doi: 10.1093/eurheartj/ehad344)

Yang, M., Kondo, T., Butt, J. H., Abraham, W. T., Anand, I. S., Desai, A. S., Køber, L., Packer, M., Pfeffer, M. A., Rouleau, J. L., Sabatine, M. S., Solomon, S. D., Swedberg, K., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2023) Stroke in patients with heart failure and reduced or preserved ejection fraction. European Heart Journal, 44, pp. 2998-3013. (doi: 10.1093/eurheartj/ehad338)

Binmahfoz, A., Timraz, M., Quinn, T. J., Combet Aspray, E., Gray, S. R. (2023) The effect of long chain n-3 fatty acid supplementation on muscle strength in older adults: a systematic review and meta-analysis. Nutrients, 15, (doi: 10.3390/nu15163579)

Neves, J. S., Borges-Canha, M., Vasques-Nóvoa, F., Green, J. B., Leiter, L. A., Granger, C. B., Carvalho, D., Leite-Moreira, A., Hernandez, A. F., Del Prato, S., McMurray, J. J. V., Ferreira, J. P. (2023) GLP-1 receptor agonist therapy with and without SGLT2 inhibitors in patients with type 2 diabetes. Journal of the American College of Cardiology, 82, pp. 517-525. (doi: 10.1016/j.jacc.2023.05.048)

Mangion, K., Morrow, A. J., Sykes, R., Kamdar, A., Bagot, C., Bruce, G., Connelly, P., Delles, C., Gibson, V. B., Gillespie, L., Hall Barrientos, P., Lennie, V., Roditi, G., Sattar, N., Stobo, D., Allwood-Spiers, S., McConnachie, A., Berry, C., CISCO-19 investigators, , Hill, N. (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, (doi: 10.1186/s12872-023-03412-7)

Inciardi, R. M., Abanda, M., Shah, A. M., Cikes, M., Claggett, B., Skali, H., Vaduganathan, M., Prasad, N., Litwin, S., Merkely, B., Kosztin, A., Nagy, K. V., Shah, S. J., Mullens, W., Zile, M. R., Lam, C. S.P., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2023) Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction. Journal of the American College of Cardiology, 82, pp. 489-499. (doi: 10.1016/j.jacc.2023.05.010)

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13, (doi: 10.3390/diagnostics13152612)

Gargani, L., Girerd, N., Platz, E., Pellicori, P., Stankovic, I., Palazzuoli, A., Pivetta, E., Miglioranza, M. H., Soliman-Aboumarie, H., Agricola, E., Volpicelli, G., Price, S., Donal, E., Cosyns, B., Neskovic, A. N. (2023) Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) European Heart Journal, 24, pp. 1569-1582. (doi: 10.1093/ehjci/jead169)

Rigattieri, S., Barbato, E., Berry, C. (2023) Microvascular resistance reserve: a reference test of the coronary microcirculation? European Heart Journal, 44, pp. 2870-2872. (doi: 10.1093/eurheartj/ehad291)

Wood, K., Sardar, A., Eton, D. T., Mair, F. S., Kidd, L., Quinn, T. J., Gallacher, K. I. (2023) Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure. Disability and Rehabilitation, (doi: 10.1080/09638288.2023.2241360)

Henderson, A. D., Adesanya, E., Mulick, A., Matthewman, J., Vu, N., Davies, F., Smith, C. H., Hayes, J., Mansfield, K. E., M. Langan, S. (2023) Common mental health disorders in adults with inflammatory skin conditions: nationwide population-based matched cohort studies in the UK. BMC Medicine, 21, (doi: 10.1186/s12916-023-02948-x)

Foroutan, F., Rayner, D. G., Ross, H. J., Ehler, T., Srivastava, A., Shin, S., Malik, A., Benipal, H., Yu, C., Alexander Lau, T. H., Lee, J. G., Rocha, R., Austin, P. C., Levy, D., Ho, J. E., McMurray, J. J.V., Zannad, F., Tomlinson, G., Spertus, J. A., Lee, D. S. (2023) Global comparison of readmission rates for patients with heart failure. Journal of the American College of Cardiology, 82, pp. 430-444. (doi: 10.1016/j.jacc.2023.05.040)

Byrne, R. A., Fremes, S., Capodanno, D., Czerny, M., Doenst, T., Emberson, J. R., Falk, V., Gaudino, M., McMurray, J. J. V., Mehran, R., Milojevic, M., Uva, M. S. (2023) 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. European Journal of Cardio-Thoracic Surgery, 64, (doi: 10.1093/ejcts/ezad286)

Kobayashi, M., Huttin, O., Ferreira, J. P., Duarte, K., González, A., Heymans, S., Verdonschot, J. A.J., Brunner-La Rocca, H.-P., Pellicori, P., Clark, A. L., Petutschnigg, J., Edelmann, F., Cleland, J. G., Rossignol, P., Zannad, F., Girerd, N. (2023) A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. European Journal of Heart Failure, 25, pp. 1284-1289. (doi: 10.1002/ejhf.2859)

Jones, R. E. et al. (2023) Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease. Nature Cardiovascular Research, 2, pp. 733-745. (doi: 10.1038/s44161-023-00312-z)

Karusheva, Y., Petry, C. J., Yasara, N., Kottahachchi, D., Premawardhena, A., Barker, P., Burling, K., Sattar, N., Welsh, P., Mettananda, S., O'Rahilly, S. (2023) Association of GDF15 levels with body mass index and endocrine status in β-thalassaemia. Clinical Endocrinology, 99, pp. 182-189. (doi: 10.1111/cen.14897)

Myhre, P. L., Liu, Y., Kulac, I. J., Claggett, B. L., Prescott, M. F., Felker, G. M., Butler, J., Piña, I. L., Rouleau, J. L., Zile, M. R., McMurray, J. J.V., Ward, J. H., Solomon, S. D., Januzzi, J. L. (2023) Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan. European Journal of Heart Failure, 25, pp. 1396-1405. (doi: 10.1002/ejhf.2957)

Barat, A., Chen, C.‐W., Patel‐Murray, N., McMurray, J. J.V., Packer, M., Solomon, S. D., Desai, A. S., Rouleau, J. L., Zile, M. R., Attari, Z., Zhang, C., Xu, H., Hartman, N., Hon, C., Healey, M., Chutkow, W., O'Donnell, C. J., Jacob, J., Lefkowitz, M., Mendelson, M. M., Wandel, S., Yates, D., Gimpelewicz, C. (2023) Clinical characteristics of HFrEF patients with rare pathogenic variants in DCM-associated genes: a subgroup analysis of the PARADIGM-HF trial. European Journal of Heart Failure, 25, pp. 1256-1266. (doi: 10.1002/ejhf.2886)

Docherty, K. F., Jackson, A. M., Macartney, M., Campbell, R. T., Petrie, M. C., Pfeffer, M. A., McMurray, J. J.V., Jhund, P. S. (2023) Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016. European Journal of Heart Failure, 25, pp. 1213-1224. (doi: 10.1002/ejhf.2965)

Chatur, S., Kondo, T., Claggett, B. L., Docherty, K., Miao, Z. M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: insights from DELIVER and DAPA-HF. European Journal of Heart Failure, 25, pp. 1364-1371. (doi: 10.1002/ejhf.2912)

Zhou, Z., Parra-Soto, S., Boonpor, J., Petermann-Rocha, F., Welsh, P., Mark, P. B., Sattar, N., Pell, J. P., Celis-Morales, C., Ho, F. K. (2023) Exploring the underlying mechanisms linking adiposity and cardiovascular disease: a prospective cohort study of 404,332 UK Biobank participants. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2023.101715)

Butt, J. H. et al. (2023) Geographic differences in patients with acute myocardial infarction in the PARADISE‐MI trial. European Journal of Heart Failure, 25, pp. 1228-1242. (doi: 10.1002/ejhf.2851)

Docherty, K. F., Lam, C. S.P., Rakisheva, A., Coats, A. J.S., Greenhalgh, T., Metra, M., Petrie, M. C., Rosano, G. M.C. (2023) Heart failure diagnosis in the general community - who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 1185-1198. (doi: 10.1002/ejhf.2946)

Iaconelli, A., Pellicori, P., Caiazzo, E., Rezig, A. O. M., Bruzzese, D., Maffia, P., Cleland, J. G. F. (2023) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, 112, pp. 1007-1019. (doi: 10.1007/s00392-022-02104-0)

McDowell, K., Campbell, R., Simpson, J., Cunningham, J. W., Desai, A. S., Jhund, P. S., Lefkowitz, M. P., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Incremental prognostic value of biomarkers in PARADIGM-HF. European Journal of Heart Failure, 28, pp. 1406-1414-1406-1414. (doi: 10.1002/ejhf.2887)

Iaconelli, A., Cuthbert, J., Kazmi, S., Maffia, P., Clark, A. L., Cleland, J. G.F., Pellicori, P. (2023) Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity. Clinical Research in Cardiology, 112, pp. 1077-1086. (doi: 10.1007/s00392-023-02178-4)

Sykes, R., Ang, D. T. Y., Berry, C. (2023) Invasive coronary microvascular function assessment: pharmacological versus exercise testing. Heart, 109, pp. 1130-1131. (doi: 10.1136/heartjnl-2023-322512)

Jankowska, E. A., Andersson, T., Kaiser‐Albers, C., Bozkurt, B., Chioncel, O., Coats, A. J.S., Hill, L., Koehler, F., Lund, L. H., McDonagh, T., Metra, M., Mittmann, C., Mullens, W., Siebert, U., Solomon, S. D., Volterrani, M., McMurray, J. J.V. (2023) Optimizing outcomes in heart failure: 2022 and beyond. ESC Heart Failure, 10, pp. 2159-2169. (doi: 10.1002/ehf2.14363)

Zorn, A., Baillie, G. (2023) Phosphodiesterase 7 as a therapeutic target – Where are we now? Cellular Signalling, 108, (doi: 10.1016/j.cellsig.2023.110689)

Heidenreich, P. A., McMurray, J. J.V. (2023) Should beta-blockers be used in heart failure if the LVEF is not reduced? JACC: Heart Failure, 11, pp. 901-902. (doi: 10.1016/j.jchf.2023.05.023)

de Koning, M.-S. L.Y., Emmens, J. E., Romero-Hernández, E., Bourgonje, A. R., Assa, S., Figarska, S. M., Cleland, J. G.F., Samani, N. J., Ng, L. L., Lang, C. C., Metra, M., Filippatos, G. S., van Veldhuisen, D. J., Anker, S. D., Dickstein, K., Voors, A. A., Lipsic, E., van Goor, H., van der Harst, P. (2023) Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. Clinical Research in Cardiology, 112, pp. 1056-1066. (doi: 10.1007/s00392-023-02171-x)

Booth, D., Davis, J. A., McEwan, P., Solomon, S. D., McMurray, J. J.V., de Boer, R. A., Comin‐Colet, J., Bachus, E., Chen, J. (2023) The cost‐effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: a European health‐economic analysis of the DELIVER trial. European Journal of Heart Failure, 25, pp. 1386-1395. (doi: 10.1002/ejhf.2940)

Tromp, J., Jackson, A. M., Abdelhamid, M., Fouad, D., Youssef, G., Petrie, M. C., Bauersachs, J., Sliwa, K., van der Meer, P. (2023) Thrombo‐embolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. European Journal of Heart Failure, 25, pp. 1464-1466. (doi: 10.1002/ejhf.2871)

Monzo, L., Girerd, N., Duarte, K., Ferreira, J. P., McMurray, J. J.V., van Veldhuisen, D. J., Swedberg, K., Pocock, S. J., Pitt, B., Zannad, F. (2023) Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: a subgroups analysis from EMPHASIS-HF trial. European Journal of Heart Failure, 25, pp. 1444-1449. (doi: 10.1002/ejhf.2952)

Docherty, K. F., McDowell, K., Welsh, P., Osmanska, J., Anand, I., de Boer, R. A., Køber, L., Kosiborod, M. N., Martinez, F. A., O’Meara, E., Ponikowski, P., Schou, M., Berg, D. D., Sabatine, M. S., Morrow, D. A., Jarolim, P., Hammarstedt, A., Sjöstrand, M., Langkilde, A. M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82, pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011)

Bechman, K., Hayes, J. F., Mathewman, J., Henderson, A. D., Adesanya, E. I., Mansfield, K. E., Smith, C. H., Galloway, J., M. Langan, S. (2023) Electronic screening for mental illness in patients with psoriasis. British Journal of Dermatology, 189, pp. 246-246. (doi: 10.1093/bjd/ljad141)

Kelbling, E., Ferreira Prescott, D., Shearer, M., Quinn, T. J. (2023) An assessment of the content and properties of extended and instrumental activities of daily living scales: a systematic review. Disability and Rehabilitation, (doi: 10.1080/09638288.2023.2224082)

Peikert, A., Chandra, A., Kosiborod, M. N., Claggett, B. L., Desai, A. S., Jhund, P. S., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Janssens, S. P., Bělohlávek, J., Borleffs, C. J. W., Dobreanu, D., Langkilde, A. M., Bengtsson, O., Petersson, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Association of dapagliflozin vs placebo with individual Kansas City Cardiomyopathy Questionnaire components in patients with heart failure with mildly reduced or preserved ejection fraction. JAMA Cardiology, 8, pp. 684-690. (doi: 10.1001/jamacardio.2023.1342)

Lees, J. S., Dobbin, S. J.H., Elyan, B. M.P., Gilmour, D. F., Tomlinson, L. P., Lang, N. N., Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38, pp. 1666-1681. (doi: 10.1093/ndt/gfac305)

Paes, D., Schepers, M., Willems, E., Rombaut, B., Tiane, A., Solomina, Y., Tibbo, A., Blair, C., Kyurkchieva, E., Baillie, G. S., Ricciarelli, R., Brullo, C., Fedele, E., Bruno, O., van den Hove, D., Vanmierlo, T., Prickaerts, J. (2023) Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology. Cellular and Molecular Life Sciences, 80, (doi: 10.1007/s00018-023-04804-w)

Boonpor, J., Parra-Soto, S., Gore, J., Talebi, A., Lynskey, N., Raisi, A., Welsh, P., Sattar, N., Pell, J. P., Gill, J. M.R., Gray, S. R., Ho, F. K., Celis-Morales, C. A. (2023) Association between walking pace and incident type 2 diabetes by adiposity levels – a prospective cohort study from the UK Biobank. Diabetes, Obesity and Metabolism, 25, pp. 1900-1910. (doi: 10.1111/dom.15053)

Soltanisarvestani, M., Lynskey, N., Gray, S., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P., Ho, F. K., Celis-Morales, C., Petermann-Rocha, F. (2023) Associations of grip strength and walking pace with mortality in stroke survivors: a prospective study from UK Biobank. Scandinavian Journal of Medicine and Science in Sports, 33, pp. 1190-1200. (doi: 10.1111/sms.14352)

Dowsett, L., Duluc, L., Higgins, E., Alghamdi, F., Fast, W., Salt, I. P., Leiper, J. (2023) Asymmetric dimethylarginine positively modulates calcium-sensing receptor signalling to promote lipid accumulation. Cellular Signalling, 107, (doi: 10.1016/j.cellsig.2023.110676)

Iaconelli, A., Pellicori, P., Dolce, P., Busti, M., Ruggio, A., Aspromonte, N., D'Amario, D., Galli, M., Princi, G., Caiazzo, E., Rezig, A. O.M., Maffia, P., Pecorini, G., Crea, F., Cleland, J. G.F. (2023) Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials. European Journal of Heart Failure, 25, pp. 1170-1175. (doi: 10.1002/ejhf.2911)

Bhatt, A. S., Kosiborod, M. N., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Kulac, I. J., Lam, C. S.P., Hernandez, A. F., Martinez, F., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Effect of dapagliflozin on health status and quality-of-life across the spectrum of ejection fraction: participant-level pooled analysis from the DAPA-HF & DELIVER trials. European Journal of Heart Failure, 25, pp. 981-988. (doi: 10.1002/ejhf.2909)

Patel, T. R., Villines, T., Kramer, C. M., Kwong, R. Y., Raharjo, D. E., Kunadian, V., Berry, C. (2023) Great Debate: computed tomography coronary angiography should be the initial diagnostic test in suspected angina. European Heart Journal, 44, pp. 2366-2375. (doi: 10.1093/eurheartj/ehac597)

Jhund, P. S. (2023) Improving heart failure outcomes with SGLT-2 inhibitors in different patient groups. Diabetes, Obesity and Metabolism, 25, pp. 26-32. (doi: 10.1111/dom.15171)

Caiazzo, E., Sharma, M., Rezig, A. O., Morsy, M., Ialenti, A., Pellicori, P., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Inflammatory Cytokines and Risk of Developing Hypertension: A Systematic Review and Meta-Analysis. (doi: 10.1111/bph.16105)

Elyan, B. M.P., Rankin, S., Jones, R., Lang, N. N., Mark, P. B., Lees, J. S. (2023) Kidney disease patient representation in trials of combination therapy with VEGF-signaling pathway inhibitors and immune checkpoint inhibitors: a systematic review. Kidney Medicine, 5, (doi: 10.1016/j.xkme.2023.100672)

Desai, A. S., Deswal, A., McMurray, J. J.V., Pinney, S. P., Vaduganathan, M. (2023) Optimizing background therapy for heart failure in clinical trials. JACC: Heart Failure, 11, pp. 806-809. (doi: 10.1016/j.jchf.2023.05.012)

Talha, K. M., Butler, J., Greene, S. J., Aggarwal, R., Anker, S. D., Claggett, B. L., Docherty, K. F., Solomon, S. D., McMurray, J. J.V., Januzzi, J. L., Vaduganathan, M., Fonarow, G. C. (2023) Potential global impact of sodium‐glucose cotransporter‐2 inhibitors in heart failure. European Journal of Heart Failure, 25, pp. 999-1009. (doi: 10.1002/ejhf.2864)

Kondo, T., Jering, K. S., Jhund, P. S., Anand, I. S., Desai, A. S., Lam, C. S.P., Maggioni, A. P., Martinez, F. A., Packer, M., Petrie, M. C., Pfeffer, M. A., Redfield, M. M., Rouleau, J. L., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2023) Predicting stroke in heart failure and preserved ejection fraction without atrial fibrillation. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010377)

Hanlon, P., Burton, J. K., Quinn, T. J., Mair, F. S., McAllister, D., Lewsey, J., Gallacher, K. I. (2023) Prevalence, measurement and implications of frailty in stroke survivors: an analysis of three global aging cohorts. International Journal of Stroke, 18, pp. 720-727. (doi: 10.1177/17474930231151847)

Curtain, J. P., Adamson, C., Docherty, K. F., Jhund, P. S., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Prevalent and incident anemia in PARADIGM-HF and the effect of sacubitril/valsartan. JACC: Heart Failure, 11, pp. 749-759. (doi: 10.1016/j.jchf.2022.12.012)

Araki, T., Kondo, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Yang, M., Butt, J. H., Petrie, M. C., Murohara, T. (2023) Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support. American Heart Journal, 261, pp. 109-123. (doi: 10.1016/j.ahj.2023.03.017)

Chatur, S., Cunningham, J. W., Vaduganathan, M., Mc Causland, F. R., Claggett, B. L., Desai, A. S., Miao, Z. M., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: insights from the DELIVER trial. European Journal of Heart Failure, 25, pp. 1170-1175. (doi: 10.1002/ejhf.2915)

Kyurkchieva, E., Baillie, G. S. (2023) Short PDE4 isoforms as drug targets in disease. Frontiers in Bioscience: Landmark, 28, (doi: 10.31083/j.fbl2807133)

Pugliese, N. R., Pellicori, P., Filidei, F., Del Punta, L., De Biase, N., Balletti, A., Di Fiore, V., Mengozzi, A., Taddei, S., Gargani, L., Mullens, W., Cleland, J. G.F., Masi, S. (2023) The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure. European Heart Journal: Cardiovascular Imaging, 24, pp. 961-971. (doi: 10.1093/ehjci/jeac254)

Morrow, A. J., McFarlane, R., Berry, C. (2023) Novel therapy for ischaemia with no obstructive coronary arteries. European Heart Journal, (doi: 10.1093/eurheartj/ehad391)

Butt, J. H., Kondo, T., Yang, M., Jhund, P. S., Docherty, K. F., Vaduganathan, M., Claggett, B. L., Hernandez, A. F., Lam, C. S.P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Kosiborod, M. N., Desai, A. S., Køber, L., Ponikowski, P., Sabatine, M. S., Shah, S. J., Zaozerska, N., Wilderäng, U., Bengtsson, O., Solomon, S. D., McMurray, J. J.V. (2023) Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. European Heart Journal, 44, pp. 2170-2183. (doi: 10.1093/eurheartj/ehad276)

Tolomeo, P., Butt, J. H., Kondo, T., Campo, G., Desai, A. S., Jhund, P. S., Køber, L., Lefkowitz, M. P., Rouleau, J. L., Solomon, S. D., Swedberg, K., Vaduganathan, M., Zile, M. R., Packer, M., McMurray, J. J.V. (2023) Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. European Heart Journal, 44, pp. 2202-2212. (doi: 10.1093/eurheartj/ehad210)

Kondo, T., Adachi, T., Koba, K., Okumura, T., Izawa, H., Murohara, T., McMurray, J. J.V., Yamada, S. (2023) Physical frailty and use of guideline-recommended drugs in patients with heart failure and reduced ejection fraction. Journal of the American Heart Association, 12, (doi: 10.1161/JAHA.122.026844)

Sattar, N., McMurray, J., Boren, J., Rawshani, A., Omerovic, E., Berg, N., Holminen, J., Skoglund, K., Eliasson, B., Gerstein, H. C., McGuire, D. K., Bhatt, D., Rawshani, A. (2023) Years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study. Circulation, 147, pp. 1872-1886. (doi: 10.1161/CIRCULATIONAHA.122.063374)

Wightman, H., Quinn, T. J., Mair, F. S., Lewsey, J., McAllister, D. A., Hanlon, P. (2023) Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition. Alzheimer's Research and Therapy, 15, (doi: 10.1186/s13195-023-01260-3)

Cleland, J. G.F., Pellicori, P., Graham, F. J. (2023) Redefining both iron deficiency and anaemia in cardiovascular disease. European Heart Journal, 44, pp. 1992-1994. (doi: 10.1093/eurheartj/ehad154)

Campbell, R. T., Docherty, K. F. (2023) Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance? European Heart Journal, 44, pp. 2006-2008. (doi: 10.1093/eurheartj/ehad209)

Desai, A. S., Lam, C. S.P., McMurray, J. J.V., Redfield, M. M. (2023) How to manage heart failure with preserved ejection fraction: Practical guidance for clinicians. JACC: Heart Failure, 11, pp. 619-636. (doi: 10.1016/j.jchf.2023.03.011)

Conrad, N., Misra, S., Verbakel, J. Y., Verbeke, G., Molenberghs, G., Taylor, P. N., Mason, J., Sattar, N., McMurray, J. J.V., McInnes, I. B., Khunti, K., Cambridge, G. (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet, 401, pp. 1878-1890. (doi: 10.1016/S0140-6736(23)00457-9)

Gallacher, K. I., Taylor-Rowan, M., Eton, D. T., McLeod, H., Kidd, L., Wood, K., Sardar, A., Quinn, T. J., Mair, F. S. (2023) Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke. Health Open Research, 5, (doi: 10.12688/healthopenres.13334.1)

McMurray, J. J.V., Metra, M. (2023) Transcatheter repair of secondary mitral regurgitation. New England Journal of Medicine, 388, pp. 2097-2098. (doi: 10.1056/NEJMe2302924)

Henriksen, P. A., Rankin, S., Lang, N. N. (2023) Cardioprotection in patients at high risk of anthracycline-induced cardiotoxicity: JACC: CardioOncology Primer. JACC: CardioOncology, 5, pp. 292-297. (doi: 10.1016/j.jaccao.2023.05.004)

Markousis-Mavrogenis, G., Minich, W. B., Al-Mubarak, A. A., Anker, S. D., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Samani, N. J., Zannad, F., Metra, M., Seemann, P., Hoeg, A., Lopez, P., van Veldhuisen, D. J., de Boer, R. A., Voors, A. A., van der Meer, P., Schomburg, L., Bomer, N., The BIOSTAT-CHF Consortium, (2023) Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. Cardiovascular Research, 119, pp. 1690-1705. (doi: 10.1093/cvr/cvad042)

Smilowitz, N. R., Toleva, O., Chieffo, A., Perera, D., Berry, C. (2023) Coronary microvascular disease in contemporary clinical practice. Circulation: Cardiovascular Interventions, 16, pp. 386-395. (doi: 10.1161/CIRCINTERVENTIONS.122.012568)

Graham, F., Iaconelli, A., Sonecki, P., Campbell, R. T., Hunter, D., Cleland, J. G.F., Pellicori, P. (2023) Defining heart failure based on imaging the heart and beyond. Cardiac Failure Review, 9, (doi: 10.15420/cfr.2022.29)

Jhund, P. S., Claggett, B. L., Talebi, A., Butt, J. H., Gasparyan, S. B., Wei, L.-J., McCaw, Z. R., Wilderäng, U., Bengtsson, O., Desai, A. S., Petersson, M., Langkilde, A. M., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F. A., Shah, S. J., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction. A prespecified analysis of the DELIVER trial. JAMA Cardiology, 8, pp. 554-563. (doi: 10.1001/jamacardio.2023.0711)

Curtain, J. P., Lee, M. M.Y., McMurray, J. J.V., Gardner, R. S., Petrie, M. C., Jhund, P. S. (2023) Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis. Heart, 109, pp. 823-831. (doi: 10.1136/heartjnl-2022-321885)

Rabbani, A., Gao, H., Lazarus, A., Dalton, D., Ge, Y., Mangion, K., Berry, C., Husmeier, D. (2023) Image-based estimation of the left ventricular cavity volume using deep learning and Gaussian process with cardio-mechanical applications. Computerized Medical Imaging and Graphics, 106, (doi: 10.1016/j.compmedimag.2023.102203)

Misra, S., Quinn, T. J., Falcone, G. J., Sharma, V. K., de Havenon, A., Zhao, Y., Eldem, E., French, J. A., Yasuda, C. L., Dawson, J., Liebeskind, D. S., Kwan, P., Mishra, N. K. (2023) Impact of genetic polymorphisms on the risk of epilepsy amongst patients with acute brain injury: a systematic review. European Journal of Neurology, 30, pp. 1791-1800. (doi: 10.1111/ene.15777)

Farmakis, D., Tromp, J., Marinaki, S., Ouwerkerk, W., Angermann, C. E., Bistola, V., Dahlstrom, U., Dickstein, K., Ertl, G., Ghadanfar, M., Hassanein, M., Obergfell, A., Perrone, S. V., Polyzogopoulou, E., Schweizer, A., Boletis, I., Cleland, J. G.F., Collins, S. P., Lam, C. S.P., FIlippatos, G. (2023) Impact of left ventricular ejection fraction phenotypes on healthcare-resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. European Journal of Heart Failure, 25, pp. 818-828. (doi: 10.1002/ejhf.2833)

Gard, E. K., Beale, A. L., Telles, F., Silvestry, F. E., Hanff, T., Hummel, S. L., Litwin, S. E., Petrie, M. C., Shah, S. J., Borlaug, B. A., Burkhoff, D., Komtebedde, J., Kaye, D. M., Nanayakkara, S. (2023) Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction. European Journal of Heart Failure, 25, pp. 806-814. (doi: 10.1002/ejhf.2805)

Simitev, R. D., Al dawoud, A., Aziz, M. H.N., Myles, R., Smith, G. L. (2023) Phenomenological analysis of simple ion channel block in large populations of uncoupled cardiomyocytes. Mathematical Medicine and Biology, 40, pp. 175-198. (doi: 10.1093/imammb/dqad001)

Ball, E. L., Shah, M., Ross, E., Sutherland, R., Squires, C., Mead, G. E., Wardlaw, J., Quinn, T. J., Religa, D., Lundström, E., Cheyne, J., Shenkin, S. D. (2023) Predictors of post-stroke cognitive impairment using acute structural MRI neuroimaging: a systematic review and meta-analysis. International Journal of Stroke, 18, pp. 543-554. (doi: 10.1177/17474930221120349)

Biering-Sørensen, T., Lassen, M. C. H., Shah, A., Claggett, B., Zile, M., Pieske, B., Pieske-Kraigher, E., Voors, A., Shiramizu, V., Lefkowitz, M., Packer, M., McMurray, J. J.V., Solomon, S. D. (2023) The effect of sacubitril/valsartan on left ventricular myocardial deformation in heart failure with preserved ejection fraction (PARAMOUNT trial) Journal of Cardiac Failure, 29, pp. 968-973. (doi: 10.1016/j.cardfail.2023.03.019)

Butcher, C.J.T., Cantor, E., Sohaib, S.M.A., Shun-Shin, M., Haynes, R., Khan, H., Kyriacou, A., Shi, R., Chen, Z., Haldar, S., Cleland, J., Hussain, W., Markides, V., Jones, D., Lane, R.E., Mason, M.J., Whinnett, Z., Francis, D., Wong, T. (2023) Variation in optimal hemodynamic atrio-ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics. Journal of Cardiovascular Electrophysiology, 34, pp. 1431-1440. (doi: 10.1111/jce.15862)

Sykes, R. A., Neves, K. B., Alves-Lopes, R., Caputo, I., Jamieson, N. B., Kamdar, A., Legrini, A., Leslie, H., McIntosh, A., McConnachie, A., Morrow, A., McFarlane, R. W., Mangion, K., McAbney, J., Montezano, A. C., Touyz, R. M., Wood, C., Berry, C. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9, pp. 371-386. (doi: 10.1093/ehjcvp/pvad025)

Metra, M. et al. (2023) Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 776-791. (doi: 10.1002/ejhf.2874)

Yeoh, S. E., Docherty, K. F., Campbell, R. T., Jhund, P. S., Hammarstedt, A., Heerspink, H. J.L., Jarolim, P., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Solomon, S. D., Sjöstrand, M., Bengtsson, O., Greasley, P. J., Sattar, N., Welsh, P., Sabatine, M. S., Morrow, D. A., McMurray, J. J.V. (2023) Endothelin-1, outcomes in patients with heart failure and reduced ejection fraction, and effects of dapagliflozin: findings from DAPA-HF. Circulation, 147, pp. 1670-1683. (doi: 10.1161/CIRCULATIONAHA.122.063327)

Lam, C. S. P., Harding, E., Bains, M., Chin, A., Kanumilli, N., Petrie, M. C., Pohja-Hutchison, P., Yang, J., Butler, J. (2023) Identification of urgent gaps in public and policymaker knowledge of heart failure: results of a global survey. BMC Public Health, 23, (doi: 10.1186/s12889-023-15405-4)

Cerullo, E., Sutton, A. J., Jones, H. E., Wu, O., Quinn, T. J., Cooper, N. J. (2023) MetaBayesDTA: codeless Bayesian meta-analysis of test accuracy, with or without a gold standard. BMC Medical Research Methodology, 23, (doi: 10.1186/s12874-023-01910-y)

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Lynskey, N., Cabanas-Sánchez, V., Sattar, N., Gill, J. M.R., Welsh, P., Pell, J. P., Gray, S. R., Ho, F. K., Celis-Morales, C. (2023) Dose–response relationship between device-measured physical activity and incident type 2 diabetes: findings from the UK Biobank prospective cohort study. BMC Medicine, 21, (doi: 10.1186/s12916-023-02851-5)

Clephas, P.R.D., Radhoe, S.P., Boersma, E., Gregson, J., Jhund, P.S., Abraham, W.T., McMurray, J.J.V., de Boer, R.A., Brugts, J.J. (2023) Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials. European Heart Journal, (doi: 10.1093/eurheartj/ehad346)

Rasmussen, M. et al. (2023) Global variations in heart failure etiology, management, and outcomes. JAMA: Journal of the American Medical Association, 329, pp. 1650-1661. (doi: 10.1001/jama.2023.5942)

Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J.V., Rossing, P., Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J.L. (2023) Effects of dapagliflozin in chronic kidney disease, with and without other cardiovascular medications: DAPA-CKD trial. Journal of the American Heart Association, 12, (doi: 10.1161/JAHA.122.028739)

Jering, K. S., Claggett, B. L., Pfeffer, M. A., Granger, C. B., Køber, L., Lewis, E. F., Maggioni, A. P., Mann, D. L., McMurray, J. J.V., Prescott, M. F., Rouleau, J. L., Solomon, S. D., Steg, P. G., von Lewinski, D., Braunwald, E. (2023) Prognostic importance of NT-proBNP (N-terminal pro-B-type natriuretic peptide) following high-risk myocardial infarction in the PARADISE-MI trial. Circulation: Heart Failure, (doi: 10.1161/CIRCHEARTFAILURE.122.010259)

Khan, J., Graham, F. J., Masini, G., Iaconelli, A., Friday, J. M., Lang, C. C., Pellicori, P. (2023) Congestion and use of diuretics in heart failure and cardiomyopathies: a practical guide. Current Cardiology Reports, 25, pp. 411-420. (doi: 10.1007/s11886-023-01865-y)

McEwan, P., Boyce, R., Sanchez, J. J. G., Sjöström, C. D., Stefansson, B., Nolan, S., Correa-Rotter, R., Rossing, P., Chertow, G. M., McMurray, J. J.V., Wheeler, D. C., Heerspink, H. J. L. (2023) Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrology Dialysis Transplantation, 38, pp. 1260-1270. (doi: 10.1093/ndt/gfac280)

Dewan, P., Ferreira, J. P., Butt, J. H., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Stewart, S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2023) Impact of multimorbidity on mortality in HFrEF : which comorbidities matter most? – an analysis of PARADIGM‐HF and ATMOSPHERE. European Journal of Heart Failure, 25, pp. 687-697. (doi: 10.1002/ejhf.2856)

Watt, J., Quinn, T. J. (2023) May literature synopsis. Stroke, 54, pp. e215-e216. (doi: 10.1161/STROKEAHA.123.042506)

Lanfear, D. E., Njoroge, J. N., Adams, K. F., Anand, I., Fang, J. C., Ramires, F., Sliwa-Hahnle, K., Badat, A., Burgess, L., Gorodeski, E. Z., Williams, C., Diaz, R., Felker, G. M., McMurray, J. J.V., Metra, M., Solomon, S., Miao, Z. M., Claggett, B. L., Heitner, S. B., Kupfer, S., Malik, F. I., Teerlink, J. R. (2023) Omecamtiv mecarbil in Black patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF. JACC: Heart Failure, 11, pp. 569-579. (doi: 10.1016/j.jchf.2022.11.021)

Girerd, N. et al. (2023) Protein biomarkers of new-onset heart failure: insights from the Heart Omics and Ageing cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation: Heart Failure, 16, pp. 426-441. (doi: 10.1161/CIRCHEARTFAILURE.122.009694)

Lees, J. S., Elyan, B. M.P., Hermann, S. M., Lang, N. N., Jones, R. J., Mark, P. B. (2023) The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrology Dialysis Transplantation, 38, pp. 1071-1079. (doi: 10.1093/ndt/gfac011)

Fuller, W. (2023) zDHHC9 and the control of natriuretic peptide secretion by the heart. JACC: Basic to Translational Science, 8, pp. 543-545. (doi: 10.1016/j.jacbts.2023.02.013)

Field, R. J., Adamson, C., Jhund, P., Lewsey, J. (2023) Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality. BMC Medical Research Methodology, 23, (doi: 10.1186/s12874-023-01918-4)

Chatur, S., Claggett, B. L., McCausland, F. R., Rouleau, J., Zile, M. R., Packer, M., Pfeffer, M. A., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Variation in renal function following transition to sacubitril/valsartan in patients with heart failure. Journal of the American College of Cardiology, 81, pp. 1443-1455. (doi: 10.1016/j.jacc.2023.02.009)

Ferreira, J. P., Cleland, J. G., Girerd, N., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., González, A., Diez, J., Solomon, S. D., Claggett, B., Pfeffer, M. A., Pitt, B., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: pooled analysis of three randomized trials. International Journal of Cardiology, 377, pp. 86-88. (doi: 10.1016/j.ijcard.2023.01.088)

Lu, H. R., Van de Sande, D., Mohammadreza, G., Watters, T., Burton, F., Pham, L., Altrocchi, C., Gallacher, D. J., Smith, G. (2023) Are more mature hiPSC-cardiomyocytes better for the detection of drug-induced cardiotoxicity? Biomolecules, 13, (doi: 10.3390/biom13040676)

Butler, J., Petrie, M. C., Bains, M., Bawtinheimer, T., Code, J., Levitch, T., Malvolti, E., Monteleone, P., Stevens, P., Vafeiadou, J., Lam, C. S. P. (2023) Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period. Research Involvement and Engagement, 9, (doi: 10.1186/s40900-023-00412-x)

Congreve, S. D., Main, A., Butler, A. S., Gao, X., Brown, E., Du, C., Choisy, S. C., Cheng, H., Hancox, J. C., Fuller, W. (2023) Palmitoylation regulates the magnitude of HCN4-mediated currents in mammalian cells. Frontiers in Physiology, 14, (doi: 10.3389/fphys.2023.1163339)

Lee, M. M. Y., McMurray, J. J. V. (2023) Lack of benefit of renin-angiotensin system inhibitors in COVID-19. JAMA: Journal of the American Medical Association, 329, pp. 1155-1156. (doi: 10.1001/jama.2023.4405)

Biering-Sørensen, T., Cikes, M., Lassen, M. C.H., Claggett, B., Minamisawa, M., Santos, A. B.S., Pieske-Kraigher, E., Shah, A. M., Zile, M. R., McMurray, J. J.V., Solomon, S. D., Cheng, S. (2023) Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction. European Heart Journal: Cardiovascular Imaging, (doi: 10.1093/ehjci/jead062)

Kondo, T., Jering, K. S., Borleffs, C. J. W., de Boer, R. A., Claggett, B. L., Desai, A. S., Dobreanu, D., Inzucchi, S. E., Hernandez, A. F., Janssens, S. P., Jhund, P., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Vinh, P. N., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2023) Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial. Circulation, 147, pp. 1067-1078. (doi: 10.1161/CIRCULATIONAHA.122.062918)

Butt, J. H., Solomon, S. D., McMurray, J. J.V. (2023) Response by Butt et al to letter regarding article, “Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial” Circulation, 147, pp. 1119-1120. (doi: 10.1161/CIRCULATIONAHA.123.064052)

Butt, J. H., Petrie, M. C., Jhund, P. S., Sattar, N., Desai, A. S., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. European Heart Journal, 44, pp. 1136-1153. (doi: 10.1093/eurheartj/ehad083)

Bruhn, J., Malmborg, M., Garred, C. H., Ravn, P., Zahir, D., Andersson, C., Gislason, G., Torp-Pedersen, C., Kragholm, K., Fosbol, E., Butt, J. H., Lang, N. N., Petrie, M. C., McMurray, J., Kober, L., Schou, M. (2023) Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study. European Heart Journal, 44, pp. 1124-1132. (doi: 10.1093/eurheartj/ehac797)

Mooney, L., Jackson, C. E., Adamson, C., McConnachie, A., Welsh, P., Myles, R. C., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Lang, N. N. (2023) Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010051)

Collison, D., Copt, S., Mizukami, T., Collet, C., McLaren, R., Didagelos, M., Aetesam-ur-Rahman, M., McCartney, P., Ford, T. J., Lindsay, M., Shaukat, A., Rocchiccioli, P., Brogan, R., Watkins, S., McEntegart, M., Good, R., Robertson, K., O’Boyle, P., Davie, A., Khan, A., Hood, S., Eteiba, H., Berry, C., Oldroyd, K. G. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16, (doi: 10.1161/CIRCINTERVENTIONS.122.012511)

Cuthbert, J.J., Pellicori, P., Rigby, A.S., Abel, A.A.I., Kalvickbacka-Bennet, A., Shah, P., Kearsley, J.W., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2023) Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 281-292. (doi: 10.1093/ehjqcco/qcac035)

Butt, J. H., Docherty, K. F., Claggett, B. L., Desai, A. S., Petersson, M., Langkilde, A. M., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S. P., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Shah, S. J., Vaduganathan, M., Jhund, P. S., Solomon, S. D., McMurray, J. J.V. (2023) Association of dapagliflozin use with clinical outcomes and the introduction of uric acid–lowering therapy and colchicine in patients with heart failure with and without gout. JAMA Cardiology, 8, pp. 386-393. (doi: 10.1001/jamacardio.2022.5608)

Al-Sawaf, O. et al. (2023) Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29, pp. 846-858. (doi: 10.1038/s41591-023-02232-8)

Desai, A. S., Petrie, M. C. (2023) Centrally adjudicated heart failure outcomes are needed in clinical trials. JACC: Heart Failure, 11, pp. 418-421. (doi: 10.1016/j.jchf.2023.01.028)

Dobbin, S. J.H., Shen, L., Petrie, M. C., Packer, M., Solomon, S. D., McMurray, J. J.V., Lang, N. N., Jhund, P. S. (2023) Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials. European Journal of Heart Failure, 25, pp. 488-496. (doi: 10.1002/ejhf.2818)

Butt, J. H. et al. (2023) Dapagliflozin in Black and White patients with heart failure across the ejection fraction spectrum. JACC: Heart Failure, 11, pp. 375-388. (doi: 10.1016/j.jchf.2022.11.014)

Leo, V. C., Kazmi, S., Brownrigg, J., Araghi, M., Sarna, H. S., Pellicori, P., Cuthbert, J., Cleland, J. G.F., Clark, A. L. (2023) Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis. ESC Heart Failure, 10, pp. 1492-1496. (doi: 10.1002/ehf2.14315)

Faheem, W. et al. (2023) Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study. European Geriatric Medicine, 14, pp. 325-332. (doi: 10.1007/s41999-022-00737-y)

Graham, F. J., Pellicori, P., Kalra, P. R., Ford, I., Bruzzese, D., Cleland, J. G.F. (2023) Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. European Journal of Heart Failure, 25, pp. 528-537. (doi: 10.1002/ejhf.2810)

Conrad, N., McInnes, I. B., Mcmurray, J. J.V., Sattar, N. (2023) Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)'s recommendations for cardiovascular risk management? Annals of the Rheumatic Diseases, 82, pp. 457-459. (doi: 10.1136/ard-2022-223315)

Naeem, F., Reid, J., Bailey, M., Reid, A., Smyth, C., Taylor-Rowan, M., Newman, E. J., Quinn, T. (2023) Pharmacological interventions for sialorrhoea in people with Parkinson's disease: a systematic review and meta-analysis. Movement Disorders Clinical Practice, 10, pp. 558-568. (doi: 10.1002/mdc3.13688)

Tardif, J.‐C., Rouleau, J., Chertow, G. M., Al‐Shurbaji, A., Lisovskaja, V., Gustavson, S., Zhao, Y., Bouabdallaoui, N., Desai, A. S., Chernyavskiy, A., Evsina, M., Merkely, B., McMurray, J. J.V., Pfeffer, M. A. (2023) Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Failure, 10, pp. 1066-1076. (doi: 10.1002/ehf2.14268)

Carberry, J., Aubiniere-Robb, L., Kamdar, A., Lomholt-Welch, H., Berry, C. (2023) Reappraising ischemic heart disease in women. Reviews in Cardiovascular Medicine, 24, (doi: 10.31083/j.rcm2404118)

Bhandari, S., Parfrey, P., White, C., Anker, S. D., Farrington, K., Ford, I., Kalra, P. A., McMurray, J. J.V., Robertson, M., Tomson, C. R. V., Wheeler, D. C., Macdougall, I. C. (2023) Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes. Journal of Nephrology, (doi: 10.1007/s40620-023-01571-6)

Quinn, T. J., Muir, K. (2023) Do quality-of-life measures represent patient outcomes in stroke trials? Neurology, 100, pp. 597-598. (doi: 10.1212/WNL.0000000000206840)

Ferreira, J. P., Cleland, J. G.F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Retutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2023) Effect of spironolactone on QRS duration in patients at risk for heart failure (from the HOMAGE trial) American Journal of Cardiology, 191, pp. 39-42. (doi: 10.1016/j.amjcard.2022.12.016)

Friedman, D. J., Al-Khatib, S. M., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D. (2023) Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient-level meta-analysis of randomized controlled trials. Circulation, 147, pp. 812-823. (doi: 10.1161/CIRCULATIONAHA.122.062124)

Vaduganathan, M., Claggett, B. L., Jhund, P., Miao, Z. M., de Boer, R. A., Lam, C. S.P., Desai, A. S., Bengsston, O., McMurray, J. J.V., Solomon, S. D. (2023) Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology, 81, pp. 1004-1006. (doi: 10.1016/j.jacc.2022.12.026)

Cohen, J. B., Brown, N. J., Brown, S.-A., Dent, S., van Dorst, D. C.H., Herrmann, S. M., Lang, N. N., Oudit, G. Y., Touyz, R. M. (2023) Cancer therapy–related hypertension: a scientific statement from the American Heart Association. Hypertension, 80, pp. e46-e57. (doi: 10.1161/HYP.0000000000000224)

Packer, M., Cleland, J. G.F. (2023) Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events? Journal of Cardiac Failure, 29, pp. 403-406. (doi: 10.1016/j.cardfail.2022.12.007)

Nuzzi, V., Cannatà, A., Pellicori, P., Manca, P., Stolfo, D., Gregorio, C., Barbati, G., Bromage, D. I., McDonagh, T., Cleland, J. G.F., Merlo, M., Sinagra, G. (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clinical Research in Cardiology, 112, pp. 419-430. (doi: 10.1007/s00392-022-02126-8)

Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J.V., Langkilde, A. M., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J.L. (2023) Efficacy of dapagliflozin by baseline diabetes medications: a prespecified analysis from the DAPA-CKD study. Diabetes Care, 46, pp. 602-607. (doi: 10.2337/dc22-1514)

Adamson, C., Welsh, P., Docherty, K. F., de Boer, R. A., Diez, M., Drożdż, J., Dukát, A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ljungman, C. E.A., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Lindholm, D., Hammarstedt, A., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Solomon, S. D., Sattar, N., McMurray, J. J.V., Jhund, P. S. (2023) IGFBP-7 and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. JACC: Heart Failure, 11, pp. 291-304. (doi: 10.1016/j.jchf.2022.09.004)

Mayne, K. J., Lees, J. S., Rutherford, E., Thomson, P. C., Traynor, J. P., Dey, V., Lang, N. N., Mark, P. B. (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16, pp. 512-520. (doi: 10.1093/ckj/sfac248)

Kancheva, A., Quinn, T. J. (2023) Stroke literature synopsis (clinical) Stroke, 54, pp. e93-e94. (doi: 10.1161/STROKEAHA.122.042193)

Platz, E., Claggett, B., Jering, K. S., Kovacs, A., Cikes, M., Winzer, E. B., Rad, A., Lefkowitz, M. P., Gong, J., Køber, L., McMurray, J. J.V., Solomon, S. D., Pfeffer, M. A., Shah, A. (2023) Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI. European Heart Journal: Acute Cardiovascular Care, 12, pp. 155-164. (doi: 10.1093/ehjacc/zuad001)

Butt, J. H., Ibrahim, W., Dewan, P., Desai, A. S., Køber, L., Prescott, M. F., Lefkowitz, M. P., Rouleau, J. L., Solomon, S. D., Zile, M. R., Packer, M., Jhund, P. S., McMurray, J. J.V. (2023) Urinary cGMP (cyclic guanosine monophosphate)/BNP (B-type natriuretic peptide) ratio, sacubitril/valsartan, and outcomes in heart failure with reduced ejection fraction: an analysis of the PARADIGM-HF trial. Circulation: Heart Failure, 16, pp. 247-258. (doi: 10.1161/CIRCHEARTFAILURE.122.010111)

Dawson, J. et al. (2023) Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial. EClinicalMedicine, 57, (doi: 10.1016/j.eclinm.2023.101863)

Curtain, J. P., Adamson, C., Kondo, T., Butt, J., Desai, A. S., Zannad, F., Rouleau, J. L., Rohde, L. E., Kober, L., Anand, I. S., van Veldhuisen, D. J., Zile, M. R., Lefkowitz, M. P., Solomon, S. D., Packer, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2023) Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction. European Heart Journal, 44, pp. 668-677. (doi: 10.1093/eurheartj/ehac801)

Wang, X. et al. (2023) Sex differences in characteristics, outcomes and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA-HF and DELIVER. Circulation, 147, pp. 624-634. (doi: 10.1161/CIRCULATIONAHA.122.062832)

Maguire, M. L., McAndrew, D. J., Lake, H. A., Ostrowski, P. J., Zervou, S., Neubauer, S., Lygate, C. A., Schneider, J. E. (2023) Synergistic effect on cardiac energetics by targeting the creatine kinase system: in vivo application of high-resolution 31P-CMRS in the mouse. Journal of Cardiovascular Magnetic Resonance, 25, pp. 6. (doi: 10.1186/s12968-023-00911-6)

Kuo, C.-W. S., Dobi, S., Gök, C., Da Silva Costa, A., Main, A., Robertson-Gray, O., Baptista-Hon, D., Wypijewski, K. J., Costello, H., Hales, T. G., MacQuaide, N., Smith, G. L., Fuller, W. (2023) Palmitoylation of the pore-forming subunit of Ca(v)1.2 controls channel voltage sensitivity and calcium transients in cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America, 120, (doi: 10.1073/pnas.2207887120)

Gladysheva, I. P., Sullivan, R. D., Pellicori, P. (2023) Editorial: Edema in heart failure with reduced ejection fraction. Frontiers in Cardiovascular Medicine, 10, (doi: 10.3389/fcvm.2023.1141937)

Kosiborod, M. N., Bhatt, A. S., Claggett, B. L., Vaduganathan, M., Kulac, I. J., Lam, C. S.P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., de Boer, R. A., Jhund, P. S., Desai, A. S., Fang, J. C., Han, Y., Comin-Colet, J., Vardeny, O., Lindholm, D., Wilderäng, U., Bengtsson, O., McMurray, J. J.V., Solomon, S. D. (2023) Effect of dapagliflozin on health status in patients with preserved or mildly reduced ejection fraction. Journal of the American College of Cardiology, 81, pp. 460-473. (doi: 10.1016/j.jacc.2022.11.006)

Adesanya, E. I., Matthewman, J., Schonmann, Y., Hayes, J. F., Henderson, A., Mathur, R., Mulick, A. R., Smith, C. H., M. Langan, S., Mansfield, K. E. (2023) Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis. British Journal of Dermatology, 188, pp. 460-470. (doi: 10.1093/bjd/ljac132)

Docherty, K. F., Jhund, P. S. (2023) A welcome ‘failure’ of gliflozins: blood pressure reduction in heart failure. European Heart Journal, 44, pp. 408-410. (doi: 10.1093/eurheartj/ehac712)

Boorsma, E. M., ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R.T., Heerspink, H. J.L., Voors, A. A., Emmens, J. E. (2023) Albuminuria as a marker of systemic congestion in patients with heart failure. European Heart Journal, 44, pp. 368-380. (doi: 10.1093/eurheartj/ehac528)

Pathak, S., Lai, F. Y., Miksza, J., Petrie, M. C., Roman, M., Murray, S., Dearling, J., Perera, D., Murphy, G. J. (2023) Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial. European Heart Journal, 44, pp. 351-364. (doi: 10.1093/eurheartj/ehac670)

Johansen, N. D., Vaduganathan, M., Zahir, D., Fiuzat, M., DeFilippis, E. M., Januzzi, J. L., Butler, J., O’Connor, C. M., Abraham, W. T., Psotka, M. A., McMurray, J. J.V., Dewan, P., Claggett, B. L., Solomon, S. D., Modin, D., Butt, J. H., Jensen, J. U. S., Schou, M., Torp-Pedersen, C., Køber, L., Gislason, G. H., Biering-Sørensen, T. (2023) A composite score summarizing use and dosing of evidence-based medical therapies in heart failure: a nationwide cohort study. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.009729)

Chua, S. Y.L., Welsh, P., Sun, Z., Balaskas, K., Warwick, A., Steel, D., Sivaprasad, S., Channa, R., Ko, T., Sattar, N., Khawaja, A. P., Foster, P. J., Patel, P. J. (2023) Associations between HbA1c across the normal range, diagnosed, and undiagnosed diabetes and retinal layer thickness in UK Biobank cohort. Translational Vision Science and Technology, 12, (doi: 10.1167/tvst.12.2.25)

Rohde, L. E., Zimerman, A., Vaduganathan, M., Claggett, B. L., Packer, M., Desai, A. S., Zile, M., Rouleau, J., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2023) Associations between New York Heart Association classification, objective measures, and long-term prognosis in mild heart failure: a secondary analysis of the PARADIGM-HF trial. JAMA Cardiology, 8, pp. 150-158. (doi: 10.1001/jamacardio.2022.4427)

Malik, M. E., Andersson, C., Blanche, P., D’Souza, M., Madelaire, C., Zareini, B., Lamberts, M., Kristensen, S. L., Sattar, N., McMurray, J., Køber, L., Torp-Pedersen, C., Gislason, G., Schou, M. (2023) Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes. Clinical Research in Cardiology, 112, pp. 215-226. (doi: 10.1007/s00392-022-02016-z)

Wu, Y. et al. (2023) Comparison of the accuracy of the 7-item HADS Depression subscale and 14-item total HADS for screening for major depression: A systematic review and individual participant data meta-analysis. Psychological Assessment, 35, pp. 95-114. (doi: 10.1037/pas0001181)

Miller, R. J.H., Chew, D. S., Qin, L., Fine, N. M., Chen, J., McMurray, J. J.V., Howlett, J. G., McEwan, P. (2023) Cost‐effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure. European Journal of Heart Failure, 25, pp. 238-247. (doi: 10.1002/ejhf.2777)

Sattar, N., Welsh, P., Leslie, W. S., Thom, G., McCombie, L., Brosnahan, N., Richardson, J., Gill, J. M. R., Crawford, L., Lean, M. E. J. (2023) Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby) Lancet Regional Health – Southeast Asia, 9, (doi: 10.1016/j.lansea.2022.100111)

Whinnett, Z. I. et al. (2023) Effects of haemodynamically atrio‐ventricular optimized His‐pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomised, double‐blind, cross‐over trial. European Journal of Heart Failure, 25, pp. 274-283. (doi: 10.1002/ejhf.2736)

Docherty, K. F., McMurray, J. J.V., Claggett, B. L., Miao, Z. M., Adams, K. F., Arias‐Mendoza, A., Cleland, J. G.F., Diaz, R., Echeverría Correa, L. E., Felker, G. M., Fonseca, C., Li, J., Metra, M., Sliwa‐Hahnle, K., Solomon, S. D., Vandekerckhove, H. J., Vinereanu, D., Voors, A. A., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Teerlink, J. R. (2023) Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B ‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. European Journal of Heart Failure, 25, pp. 248-259. (doi: 10.1002/ejhf.2763)

Boden, W. E., Marzilli, M., Crea, F., Mancini, G.B. J., Weintraub, W. S., Taqueti, V. R., Pepine, C. J., Escaned, J., Al-Lamee, R., Gowdak, L. H. W., Berry, C., Kaski, J. C. (2023) Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week. Journal of the American College of Cardiology, 81, pp. 505-514. (doi: 10.1016/j.jacc.2022.08.814)

McAndrew, D. J., Lake, H. A., Zervou, S., Schwedhelm, E., Schneider, J. E., Neubauer, S., Lygate, C. A. (2023) Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure. ESC Heart Failure, 10, pp. 189-199. (doi: 10.1002/ehf2.14183)

Chu, W., Lynskey, N., Iain-Ross, J., Pell, J. P., Sattar, N., Ho, F. K., Welsh, P., Celis-Morales, C., Petermann-Rocha, F. (2023) Identifying the biomarker profile of pre-frail and frail people: a cross-sectional analysis from UK Biobank. International Journal of Environmental Research and Public Health, 20, (doi: 10.3390/ijerph20032421)

Alexander, C., Bishop, M. J., Gilchrist, R. J., Burton, F. L., Smith, G. L., Myles, R. C. (2023) Initiation of ventricular arrhythmia in the acquired long QT syndrome. Cardiovascular Research, 119, pp. 465-476. (doi: 10.1093/cvr/cvac103)

Leitch, S. L., Logan, M., Beishon, L., Quinn, T. J. (2023) International research priority setting exercises in stroke – systematic review. International Journal of Stroke, 18, pp. 133-143. (doi: 10.1177/17474930221096935)

Lim, M. W.S., Setjiadi, D., Dobbin, S. J.H., Lang, N. N., Delles, C., Connelly, P. J. (2023) Nailfold video-capillaroscopy in the study of cardiovascular disease: a systematic review. Blood Pressure Monitoring, 28, pp. 24-32. (doi: 10.1097/MBP.0000000000000624)

Sullivan, M. K., Jani, B. D., Rutherford, E., Welsh, P., McConnachie, A., Major, R. W., McAllister, D., Nitsch, D., Mair, F. S., Mark, P. B., Lees, J. S. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73, pp. e141-e147. (doi: 10.3399/BJGP.2022.0145)

Kondo, T., Araki, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Butt, J. H., Petrie, M. C., McMurray, J. J.V., Murohara, T. (2023) Prognosis in patients with cardiogenic shock who received temporary mechanical circulatory support. JACC: Asia, 3, pp. 122-134. (doi: 10.1016/j.jacasi.2022.10.004)

Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147, pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632)

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. (doi: 10.1136/heartjnl-2022-BSCMR.26)

Rawshani, A., McGuire, D. K., Omerovic, E., Sattar, N., McMurray, J. J.V., Smith, U., Redfors, B., Bergfeldt, L., Eliasson, B., Borén, J., Bhatt, D. L., Bergstrom, G., Rawshani, A. (2023) Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes. Scientific Reports, 13, (doi: 10.1038/s41598-023-27941-5)

Solomon, S.D., Vaduganathan, M., McMurray, J.J.V. (2023) Dapagliflozin in heart failure with preserved ejection fraction. New England Journal of Medicine, 388, pp. 286-288. (doi: 10.1056/NEJMc2213974)

Gulati, M., Khan, N., George, M., Berry, C., Chieffo, A., Camici, P. G., Crea, F., Kaski, J.-C., Marzilli, M., Merz, C. N. B. (2023) Ischemia with no obstructive coronary artery disease (INOCA): a patient self-report quality of life survey from INOCA international. International Journal of Cardiology, 371, pp. 28-39. (doi: 10.1016/j.ijcard.2022.09.047)

Conrad, N., McMurray, J. J.V. (2023) Cardiovascular risk in systemic autoimmune diseases – Authors' reply. Lancet, 401, pp. 22. (doi: 10.1016/S0140-6736(22)02426-6)

Savarese, G., von Haehling, S., Butler, J., Cleland, J. G.F., Ponikowski, P., Anker, S. D. (2023) Iron deficiency and cardiovascular disease. European Heart Journal, 44, pp. 14-27. (doi: 10.1093/eurheartj/ehac569)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10, (doi: 10.1136/openhrt-2022-002192)

Ouwerkerk, W., Tromp, J., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Filippatos, G., Collins, S. P., Lam, C. S. (2023) Association of time‐to‐IV ‐furosemide with mortality in acute heart failure: data from REPORT‐HF. European Journal of Heart Failure, 25, pp. 43-51. (doi: 10.1002/ejhf.2708)

Selvaraj, S., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Fang, J. C., Vardeny, O., Desai, A. S., Shah, S. J., Lam, C. S.P., Martinez, F. A., Inzucchi, S. E., de Boer, R. A., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2023) Blood pressure and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: DELIVER. JACC: Heart Failure, 11, pp. 76-89. (doi: 10.1016/j.jchf.2022.09.002)

Mc Causland, F. R., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P., de Boer, R. A., Docherty, K., Fang, J., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Saraiva, J. F. K., McGrath, M. M., Shah, S. J., Verma, S., Langkilde, A. M., Petersson, M., McMurray, J. J. V., Solomon, S. D. (2023) Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction. JAMA Cardiology, 8, pp. 56-65. (doi: 10.1001/jamacardio.2022.4210)

Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J.V., Correa-Rotter, R., Rossing, P., Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J.L. (2023) Effects of dapagliflozin on hospitalizations in patients with chronic kidney disease: a post hoc analysis of DAPA-CKD. Annals of Internal Medicine, 176, pp. 59-66. (doi: 10.7326/M22-2115)

Lee, M. M.Y., Campbell, R. T., Claggett, B. L., Lewis, E. F., Docherty, K. F., Lindner, M., Liu, J., Solomon, S. D., McMurray, J. J.V., Platz, E. (2023) Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion. European Journal of Heart Failure, 25, pp. 54-60. (doi: 10.1002/ejhf.2699)

Petrie, M. C., Jhund, P. S., Connolly, E., Mark, P. B., MacDonald, M. R., Robertson, M., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119, pp. 213-220. (doi: 10.1093/cvr/cvab317)

Inciardi, R., Pellicori, P., Chandra, A. (2023) Identification and quantification of congestion in heart failure: a work in progress. European Journal of Heart Failure, 25, pp. 61-62. (doi: 10.1002/ejhf.2751)

Taylor-Rowan, M., Nafisi, S., Owen, R., Duffy, R., Patel, A., Burton, J. K., Quinn, T. J. (2023) Informant-based screening tools for dementia: an overview of systematic reviews. Psychological Medicine, 53, pp. 580-589. (doi: 10.1017/S0033291721002002)

Perera, D., Berry, C., Hoole, S. P., Sinha, A., Rahman, H., Morris, P. D., Kharbanda, R. K., Petraco, R., Channon, K. (2023) Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart, 109, pp. 88-95. (doi: 10.1136/heartjnl-2021-320718)

Manla, Y., Kuan, W., Clark, A. L., Cleland, J. G. F., Pellicori, P. (2023) Ketone bodies in acute heart failure: fuel for thought. Journal of Cardiac Failure, 29, pp. 42-44. (doi: 10.1016/j.cardfail.2022.11.002)

Talha, K. M., Butler, J., Greene, S. J., Aggarwal, R., Anker, S. D., Claggett, B. L., Solomon, S. D., McMurray, J. J.V., Vaduganathan, M., Fonarow, G. C. (2023) Population-level implications of sodium-glucose cotransporter-2 inhibitors for heart failure with preserved ejection fraction in the US. JAMA Cardiology, 8, pp. 66-73. (doi: 10.1001/jamacardio.2022.4348)

Everett, C. C., Berry, C., McCann, G. P., Fernandez, C., Reynolds, C., Bucciarelli-Ducci, C., Dall’Armellina, E., Prasad, A., Foley, J. R., Mangion, K., Bijsterveld, P., Brown, J., Stocken, D., Walker, S., Sculpher, M., Plein, S., Greenwood, J. P. (2023) Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2. Open Heart, 10, (doi: 10.1136/openhrt-2022-002221)

Hlatky, M. A., Wilding, S., Stuart, B., Nicholas, Z., Shambrook, J., Eminton, Z., Fox, K., Connolly, D., O’Kane, P., Hobson, A., Chauhan, A., Uren, N., Mccann, G. P., Berry, C., Carter, J., Roobottom, C., Mamas, M., Rajani, R., Ford, I., Douglas, P. S., Curzen, N. (2023) Randomized comparison of chest pain evaluation with FFRCT or standard care: factors determining US costs. Journal of Cardiovascular Computed Tomography, 17, pp. 52-59. (doi: 10.1016/j.jcct.2022.09.005)

Chatur, S., Claggett, B. L., Vardeny, O., Jering, K., Desai, A. S., Pfeffer, M. A., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2023) Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial. European Journal of Heart Failure, 25, pp. 87-94. (doi: 10.1002/ejhf.2703)

Ferreira, J. P., Cleland, J. G., Girerd, N., Bozec, E., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., Solomon, S. D., Pitt, B., Pfeffer, M. A., Shah, A. M., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European Journal of Heart Failure, 25, pp. 108-113. (doi: 10.1002/ejhf.2726)

Gulliver, C., Huss, S., Semjonow, A., Baillie, G. S., Hoffmann, R. (2023) The CAPRA&PDE4D5/7/9 prognostic model is significantly associated to adverse post-surgical pathology outcomes. Cancers, 15, (doi: 10.3390/cancers15010262)

Netzer, S., Chocano-Bedoya, P., Feller, M., Janett-Pellegri, C., Wildisen, L., Büchi, A. E., Moutzouri, E., Rodriguez, E. G., Collet, T.-H., Poortvliet, R. K.E., Mc Carthy, V. J.C., Aeberli, D., Aujesky, D., Westendorp, R., Quinn, T. J., Gussekloo, J., Kearney, P. M., Mooijaart, S., Bauer, D. C., Rodondi, N. (2023) The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism—an ancillary study within two randomized placebo controlled trials. Age and Ageing, 52, (doi: 10.1093/ageing/afac326)

Welsh, P., Sattar, N. (2023) To apoB or not to apoB: new arguments, but basis for widespread implementation remains elusive. Clinical Chemistry, 69, pp. 3-5. (doi: 10.1093/clinchem/hvac183)

Sattar, N., McMurray, J. J. V., McInnes, I. B., Aroda, V. R., Lean, M. E. J. (2023) Treating chronic diseases without tackling excess adiposity promotes multimorbidity. Lancet Diabetes and Endocrinology, 11, pp. 58-62. (doi: 10.1016/S2213-8587(22)00317-5)

Mizani, M. A., Dashtban, A., Pasea, L., Lai, A. G., Thygesen, J., Tomlinson, C., Handy, A., Mamza, J. B., Morris, T., Khalid, S., Zaccardi, F., Macleod, M. J., Torabi, F., Canoy, D., Akbari, A., Berry, C., Bolton, T., Nolan, J., Khunti, K., Denaxas, S., Hemingway, H., Sudlow, C., Banerjee, A. (2023) Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19–a data-driven retrospective cohort study. Journal of the Royal Society of Medicine, 116, pp. 10-20. (doi: 10.1177/01410768221131897)

Tabish, T. A., Lygate, C. A. (2023) Mitochondria-targeted nanomedicines for cardiovascular applications. Nanomedicine, 18, pp. 2101-2104. (doi: 10.2217/nnm-2023-0321)

Perera, D., Ryan, M., Morgan, H. P., Greenwood, J. P., Petrie, M. C., Dodd, M., Weerackody, R., O'Kane, P. D., Masci, P. G., Nazir, M. S., Papachristidis, A., Chahal, N., Khattar, R., Ezad, S. M., Kapetanakis, S., Dixon, L. J., De Silva, K., McDiarmid, A. K., Marber, M. S., McDonagh, T., McCann, G. P., Clayton, T. C., Senior, R., Chiribiri, A. (2023) Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 Trial. JAMA Cardiology, 8, pp. 1154-1161. (doi: 10.1001/jamacardio.2023.3803)

Collet, C., Collison, D., Mizukami, T., McCartney, P., Sonck, J., Ford, T., Munhoz, D., Berry, C., De Bruyne, B., Oldroyd, K. (2022) Differential improvement in angina and health-related quality of life after PCI in focal and diffuse coronary artery disease. JACC: Cardiovascular Interventions, 15, pp. 2506-2518. (doi: 10.1016/j.jcin.2022.09.048)

Singh, A. K., Causland, F. R. M., Claggett, B. L., Wanner, C., Wiecek, A., Atkins, M. B., Carroll, K., Perkovic, V., McMurray, J. J.V., Wittes, J., Snapinn, S., Blackorby, A., Meadowcroft, A., Barker, T., DiMino, T., Mallett, S., Cobitz, A. R., Solomon, S. D. (2022) Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials. Nephrology Dialysis Transplantation, 38, pp. 1890-1897. (doi: 10.1093/ndt/gfac342)

Gerstein, H. C., Wolsk, E., Claggett, B., Diaz, R., Dickstein, K., Hess, S., Køber, L., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Tardif, J.-C., Pfeffer, M. A. (2022) Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: the ELIXA trial. Diabetes, Obesity and Metabolism, 25, pp. 1125-1129. (doi: 10.1111/dom.14954)

Metra, M., Pagnesi, M., Claggett, B. L., Díaz, R., Felker, G. M., McMurray, J. J. V., Solomon, S. D., Bonderman, D., Fang, J. C., Fonseca, C., Goncalvesova, E., Howlett, J. G., Li, J., O'Meara, E., Miao, Z. M., Abbasi, S. A., Heitner, S. B., Kupfer, S., Malik, F. I., Teerlink, J. R., on behalf of the GALACTIC-HF Investigators, (2022) Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial. European Heart Journal, 43, pp. 5006-5016. (doi: 10.1093/eurheartj/ehac293)

Lithgow, H., Johnston, L., Ho, F. K., Celis-Morales, C., Cobley, J., Raastad, T., Hunter, A. M., Lees, J. S., Mark, P. B., Quinn, T. J., Gray, S. R. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study. Trials, 23, (doi: 10.1186/s13063-022-06937-y)

Kalra, P. R., Cleland, J. G.F., Petrie, M. C., Thomson, E. A., Kalra, P. A., Squire, I. B., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Foley, P. W.X., Graham, F. J., Japp, A. G., Lane, R. E., Lang, N. N., Ludman, A. J., Macdougall, I. C., Pellicori, P., Ray, R., Robertson, M., Seed, A., Ford, I. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400, pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9)

Bowman, L. et al. (2022) Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation. Circulation, 147, pp. 925-929. (doi: 10.1161/CIRCULATIONAHA.122.063378)

Bowman, L. et al. (2022) Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation. European Heart Journal, 44, pp. 931-934. (doi: 10.1093/eurheartj/ehac633)

McGettrick, M., Dormand, H., Brewis, M., Johnson, M. K., Lang, N. N., Church, A. C. (2022) Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease. Frontiers in Cardiovascular Medicine, 9, (doi: 10.3389/fcvm.2022.1004169)

Taylor-Rowan, M., Alharthi, A. A., Noel-Storr, A. H., Myint, P. K., Stewart, C., McCleery, J., Quinn, T. J. (2022) Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment. Cochrane Database of Systematic Reviews, 2022, (doi: 10.1002/14651858.cd015405)

Mehran, R., Steg, P. G., Pfeffer, M. A., Jering, K., Claggett, B., Lewis, E. F., Granger, C., Køber, L., Maggioni, A., Mann, D. L., McMurray, J. J.V., Rouleau, J.-L., Solomon, S. D., Ducrocq, G., Berwanger, O., De Pasquale, C. G., Landmesser, U., Petrie, M., Leng, D. S. K., van der Meer, P., Lefkowitz, M., Zhou, Y., Braunwald, E. (2022) The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial. Circulation, 146, pp. 1749-1757. (doi: 10.1161/CIRCULATIONAHA.122.060841)

Bhandari, S., Mehta, S., Khwaja, A., Cleland, J. G.F., Ives, N., Brettell, E., Chadburn, M., Cockwell, P. (2022) Renin-angiotensin system inhibition in advanced chronic kidney disease. New England Journal of Medicine, 387, pp. 2021-2032. (doi: 10.1056/NEJMoa2210639)

Saxena, P., Myles, R. C., Smith, G. L., Workman, A. J. (2022) Adrenoceptor sub-type involvement in Ca2+ current stimulation by noradrenaline in human and rabbit atrial myocytes. Pflügers Archiv European Journal of Physiology, 474, pp. 1311-1321. (doi: 10.1007/s00424-022-02746-z)

Logan, M., Leitch, S., Bosakh, Z., Beishon, L., Quinn, T. J. (2022) Comparing international dementia research priorities—systematic review. International Journal of Geriatric Psychiatry, 37, (doi: 10.1002/gps.5836)

McEwan, P., Darlington, O., Miller, R., McMurray, J. J.V., Wheeler, D. C., Heerspink, H. J.L., Briggs, A., Bergenheim, K., Garcia Sanchez, J. J. (2022) Cost-effectiveness of dapagliflozin as a treatment for chronic kidney disease: a health-economic analysis of DAPA-CKD. Clinical Journal of the American Society of Nephrology, 17, pp. 1730-1741. (doi: 10.2215/CJN.03790322)

Vardeny, O., Fang, J. C., Desai, A. S., Jhund, P. S., Claggett, B., Vaduganathan, M., de Boer, R. A., Hernandez, A. F., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., Kosiborod, M. N., DeMets, D., O’Meara, E., Zieroth, S., Comin-Colet, J., Drozdz, J., Chiang, C.-E., Kitakaze, M., Petersson, M., Lindholm, D., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature Medicine, 28, pp. 2504-2511. (doi: 10.1038/s41591-022-02102-9)

Yang, M., Butt, J. H., Kondo, T., Jering, K. S., Docherty, K. F., Jhund, P. S., de Boer, R. A., Claggett, B. L., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Martinez, F. A., Petersson, M., Shah, S. J., Vaduganathan, M., Wilderäng, U., Solomon, S. D., McMurray, J. J.V. (2022) Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan. European Journal of Heart Failure, 24, pp. 2307-2319. (doi: 10.1002/ejhf.2722)

Gregers, M. C. T., Schou, M., Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, T., Goetze, J. P., Rossing, P., Jørgensen, P. G. (2022) Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes. Scandinavian Cardiovascular Journal, 56, pp. 256-263. (doi: 10.1080/14017431.2022.2095435)

Monzo, L., Ferreira, J. P., Cleland, J. G.F., Pellicori, P., Mariottoni, B., Hazebroek, M. R., Collier, T. J., Cuthbert, J. J., Pieske, B., Petutschnigg, J., Ahmed, F. Z., Girerd, N., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial. ESC Heart Failure, 9, pp. 4352-4357. (doi: 10.1002/ehf2.14086)

Inzucchi, S. E., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Shah, S. J., Verma, S., Han, Y., Kerr Saraiva, J. F., Bengtsson, O., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes and Endocrinology, 10, pp. 869-881. (doi: 10.1016/S2213-8587(22)00308-4)

Chandra, A., Polanczyk, C. A., Claggett, B. L., Vaduganathan, M., Packer, M., Lefkowitz, M. P., Rouleau, J. L., Liu, J., Shi, V. C., Schwende, H., Zile, M. R., Desai, A. S., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D., Lewis, E. F. (2022) Health‐related quality of life outcomes in PARAGON‐HF. European Journal of Heart Failure, 24, pp. 2264-2274. (doi: 10.1002/ejhf.2738)

Pugliese, N. R., Pellicori, P., Filidei, F., De Biase, N., Maffia, P., Guzik, T. J., Masi, S., Taddei, S., Cleland, J. G.F. (2022) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovascular Research, 118, pp. 3536-3555. (doi: 10.1093/cvr/cvac133)

Myhre, P. L., Vaduganathan, M., Claggett, B. L., Miao, Z. M., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Influence of NT-proBNP on efficacy of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC: Heart Failure, 10, pp. 902-913. (doi: 10.1016/j.jchf.2022.08.007)

Monga, S., Valkovič, L., Tyler, D., Lygate, C. A., Rider, O., Myerson, S. G., Neubauer, S., Mahmod, M. (2022) Insights into the metabolic aspects of aortic stenosis with the use of magnetic resonance imaging. JACC: Cardiovascular Imaging, 15, pp. 2112-2126. (doi: 10.1016/j.jcmg.2022.04.025)

Bracun, V., van Essen, B., Voors, A. A., van Veldhuisen, D. J., Dickstein, K., Zannad, F., Metra, M., Anker, S., Samani, N. J., Ponikowski, P., Filippatos, G., Cleland, J. G.F., Lang, C. C., Ng, L. L., Shi, C., de Wit, S., About Msallem, J. P., Meijers, W. C., Klip, I. T., van der Meer, P., de Boer, R. A. (2022) Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Failure, 9, pp. 4167-4176. (doi: 10.1002/ehf2.14120)

Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., Patel, R. K. (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clinical Kidney Journal, 15, pp. 2186-2199. (doi: 10.1093/ckj/sfac146)

de Wit, S., Glen, C., de Boer, R. A., Lang, N. N. (2022) Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies. Cardiovascular Research, 118, pp. 3451-3466. (doi: 10.1093/cvr/cvac132)

Suda, A., Takahashi, J., Schwidder, M., Ong, P., Ang, D., Berry, C., Camici, P. G., Crea, F., Carlos Kaski, J., Pepine, C., Rimoldi, O., Sechtem, U., Yasuda, S., Beltrame, J. F., Noel Bairey Merz, C., Shimokawa, H., Coronary Vasomotor Disorders International Study COVADIS Group, . (2022) Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS- International Journal of Cardiology: Heart and Vasculature, 43, (doi: 10.1016/j.ijcha.2022.101139)

Kalra, P. R., Cleland, J. G. F., Petrie, M. C., Ahmed, F. Z., Foley, P. W. X., Kalra, P. A., Lang, N. N., Lane, R. E., Macdougall, I. C., Pellicori, P., Pope, M. T. B., Robertson, M., Squire, I. B., Thomson, E. A., Ford, I. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108, pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304)

Bradley, C., Berry, C. (2022) Retinal microvascular function: a tractable biomarker of cardiovascular risk? Cardiovascular Research, 118, pp. 3169-3170. (doi: 10.1093/cvr/cvac170)

Lyko, C. et al. (2022) Thyroid antibodies and levothyroxine effects in subclinical hypothyroidism: a pooled analysis of two randomized controlled trials. Journal of Internal Medicine, 292, pp. 892-903. (doi: 10.1111/joim.13544)

Burton, J. K., Ciminata, G., Lynch, E., Shenkin, S. D., Geue, C., Quinn, T. J. (2022) Understanding Pathways into Care homes using Data (UnPiCD study): a retrospective cohort study using national linked health and social care data. Age and Ageing, 51, (doi: 10.1093/ageing/afac304)

Kilpi, F., Soares, A. G., Clayton, G. L., Fraser, A., Welsh, P., Sattar, N., Nelson, S. M., Tilling, K., Lawlor, D. A. (2022) Changes in women’s physical function in mid-life by reproductive age and hormones: a longitudinal study. BMC Women's Health, 22, (doi: 10.1186/s12905-022-02070-9)

Cervilla-Martínez, J. F., Rodríguez-Gotor, J. J., Wypijewski, K. J., Fontán-Lozano, Á., Wang, T., Santamaría, E., Fuller, W., Mejías, R. (2022) Altered cortical palmitoylation induces widespread molecular disturbances in Parkinson's disease. International Journal of Molecular Sciences, 23, (doi: 10.3390/ijms232214018)

McErlane, J., McCall, P., Willder, J., Berry, C., Shelley, B. (2022) Right ventricular free wall longitudinal strain is independently associated with mortality in mechanically ventilated patients with COVID-19. Annals of Intensive Care, 12, (doi: 10.1186/s13613-022-01077-7)

Tromp, J., Bauer, D., Claggett, B. L., Frost, M., Iversen, M. B., Prasad, N., Petrie, M. C., Larson, M. G., Ezekowitz, J. A., Solomon, S. D. (2022) A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram. Nature Communications, 13, (doi: 10.1038/s41467-022-34245-1)

Vaduganathan, M., Claggett, B. L., Jhund, P., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Estimated event-free survival benefits with dapagliflozin in HF with mildly reduced or preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1775-1784. (doi: 10.1016/j.jacc.2022.08.745)

Paterson, C., Hinterberg, M. A., Morrow, A. J., Sykes, R., Mangion, K., Welsh, P., McConnachie, A., Sattar, N., Berry, C., Williams, S. A. (2022) Utility of a Proteomic Surrogate for Cardiovascular Outcomes to Predict and Monitor COVID-19 Induced Myocarditis. (doi: 10.1161/circ.146.suppl_1.12132)

Kondo, T., Abdul-Rahim, A. H., Talebi, A., Abraham, W. T., Desai, A. S., Dickstein, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Packer, M., Petrie, M., Ponikowski, P., Rouleau, J. L., Sabatine, M. S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. European Heart Journal, 43, pp. 4469-4479. (doi: 10.1093/eurheartj/ehac487)

Zhang, L. et al. (2022) Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction. Circulation, 146, pp. 1411-1414. (doi: 10.1161/CIRCULATIONAHA.122.061481)

Adamson, C. et al. (2022) Dapagliflozin for heart failure according to body mass index: the DELIVER trial. European Heart Journal, 43, pp. 4406-4417. (doi: 10.1093/eurheartj/ehac481)

Butt, J. H., Kondo, T., Jhund, P. S., Comin-Colet, J., de Boer, R. A., Desai, A. S., Hernandez, A. F., Inzucchi, S. E., Janssens, S. P., Kosiborod, M. N., Lam, C. S.P., Langkilde, A. M., Lindholm, D., Martinez, F., Petersson, M., Shah, S. J., Thierer, J., Vaduganathan, M., Verma, S., Wilderäng, U., Claggett, B. C., Solomon, S. D., McMurray, J. J.V. (2022) Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER. Journal of the American College of Cardiology, 80, pp. 1705-1717. (doi: 10.1016/j.jacc.2022.08.718)

Butler, J. et al. (2022) Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European Heart Journal, 43, pp. 4362-4373. (doi: 10.1093/eurheartj/ehac401)

Pellicori, P., Kalra, P. R., Clark, A. L., Friday, J., Cleland, J. G. F. (2022) Chronic kidney disease (CKD) and CKD-ism in heart failure – what a mess! European Journal of Heart Failure, 24, pp. 2196-2198. (doi: 10.1002/ejhf.2696)

Yang, Y., Gao, H., Berry, C., Carrick, D., Radjenovic, A., Husmeier, D. (2022) Classification of myocardial blood flow based on dynamic contrast-enhanced magnetic resonance imaging using hierarchical Bayesian models. Journal of the Royal Statistical Society: Series C (Applied Statistics), 71, pp. 1085-1115. (doi: 10.1111/rssc.12568)

Inciardi, R. M., Pagnesi, M., Lombardi, C. M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Pellicori, P., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Solomon, S. D., Voors, A. A., Metra, M. (2022) Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. European Journal of Heart Failure, 24, pp. 2131-2139. (doi: 10.1002/ejhf.2593)

Karusheva, Y., Ratcliff, M., Mörseburg, A., Barker, P., Melvin, A., Sattar, N., Burling, K., Backmark, A., Roth, R., Jermutus, L., Guiu-Jurado, E., Blueher, M., Welsh, P., Hyvönen, M., O’Rahilly, S. (2022) Common H202D variant in GDF-15 does not affect its bioactivity but can significantly interfere with measurement of its circulating levels. Journal of Applied Laboratory Medicine, 7, pp. 1388-1400. (doi: 10.1093/jalm/jfac055)

Fischer, F., Levis, B., Falk, C., Sun, Y., Ioannidis, J. P. A., Cuijpers, P., Shrier, I., Benedetti, A., Thombs, B. D., , , , (2022) Comparison of different scoring methods based on latent variable models of the PHQ-9: an individual participant data meta-analysis. Psychological Medicine, 52, pp. 3472-3483. (doi: 10.1017/S0033291721000131)

Morris, P. D., Al-Lamee, R. K., Berry, C., on behalf of the BCIS Research and Development Committee, (2022) Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives. Heart, 108, pp. 1737-1746. (doi: 10.1136/heartjnl-2020-318743)

Jongs, N., Chertow, G. M., Greene, T., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Kashihara, N., Rossing, P., Sjöström, C. D., Stefánsson, B., Toto, R., Wheeler, D., Heerspink, H., for the DAPA-CKD Trial Committees and Investigators, (2022) Correlates and consequences of an acute change in eGFR in response to the SGLT2 inhibitor dapagliflozin in patients with CKD. Journal of the American Society of Nephrology, 33, pp. 2094-2107. (doi: 10.1681/ASN.2022030306)

Lachaud, Q., Aziz, M. H. N., Burton, F. L., Macquaide, N., Myles, R. C., Simitev, R. D., Smith, G. L. (2022) Electrophysiological heterogeneity in large populations of rabbit ventricular cardiomyocytes. Cardiovascular Research, 118, pp. 3112-3125. (doi: 10.1093/cvr/cvab375)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Vedin, O., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2022) Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. American Heart Journal, 253, pp. 86-98. (doi: 10.1016/j.ahj.2022.05.010)

Sun, G., Yafasova, A., Andersson, C., McMurray, J. J.V., Jhund, P. S., Docherty, K. F., Faurschou, M., Nielsen, C. T., Schou, M., Gislason, G. H., Torp-Pedersen, C., Fosbøl, E. L., Køber, L., Butt, J. H. (2022) Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis. Rheumatology, 61, pp. 4374-4383. (doi: 10.1093/rheumatology/keac072)

Jhund, P. S. (2022) Implementing the evidence – the true summit of evidence based care and the false peak of guidelines. European Journal of Heart Failure, 24, pp. 2090-2092. (doi: 10.1002/ejhf.2712)

Arulmurugananthavadivel, A., Holt, A., Parveen, S., Lamberts, M., Gislason, G. H., Torp-Pedersen, C., Madelaire, C., Andersson, C., Zahir, D., Butt, J. H., Petrie, M. C., McMurray, J., Fosbol, E. L., Kober, L., Schou, M. (2022) Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark 1997–2017. European Heart Journal: Quality of Care and Clinical Outcomes, 8, pp. 750-760. (doi: 10.1093/ehjqcco/qcab073)

Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J.V., Bakris, G. L., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, P., Tobe, S., Parving, H.-H., de Zeeuw, D., Heerspink, H. J.L. (2022) Organic anion transporter gene variants associated with plasma exposure and long-term response to atrasentan in patients with diabetic kidney disease. Clinical Pharmacology and Therapeutics, 112, pp. 1098-1107. (doi: 10.1002/cpt.2721)

Khunti, K., Aroda, V. R., Bhatt, D. L., Bozkurt, B., Buse, J. B., Heerspink, H. L., Inzucchi, S. E., Lam, C. S.P., Marx, N., McMurray, J. J.V., Solomon, S. D., Kosiborod, M. N. (2022) Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: a perspective based on the updated evidence. Diabetes, Obesity and Metabolism, 24, pp. 2071-2080. (doi: 10.1111/dom.14805)

Adamson, C., Jhund, P. S., McMurray, J. J.V. (2022) Reply to 'the 50 shades of bilirubin'. Letter regarding the article 'liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF' European Journal of Heart Failure, 24, pp. 2206-2207. (doi: 10.1002/ejhf.2683)

McMahon, D., Micallef, C., Quinn, T. J. (2022) Review of clinical practice guidelines relating to cognitive assessment in stroke. Disability and Rehabilitation, 44, pp. 7632-7640. (doi: 10.1080/09638288.2021.1980122)

Ferreira, J. P., Pitt, B., McMurray, J. J.V., Pocock, S. J., Solomon, S. D., Pfeffer, M. A., Zannad, F., Rossignol, P. (2022) Steroidal MRA across the spectrum of renal function: a pooled analysis of RCTs. JACC: Heart Failure, 10, pp. 842-850. (doi: 10.1016/j.jchf.2022.06.010)

Perkovic, V., Blackorby, A., Cizman, B., Carroll, K., Cobitz, A. R., Davies, R., DiMino, T. L., Jha, V., Johansen, K. L., Lopes, R. D., Kler, L., Macdougall, I. C., McMurray, J. J.V., Meadowcroft, A. M., Obrador, G. T., Solomon, S., Taft, L., Wanner, C., Waikar, S. S., Wheeler, D. C., Wiecek, A., Singh, A. K. (2022) The ASCEND-ND trial: study design and participant characteristics. Nephrology Dialysis Transplantation, 37, pp. 2157-2170. (doi: 10.1093/ndt/gfab318)

Salah, H. M., Goldberg, L. R., Molinger, J., Felker, G. M., Applefeld, W., Rassaf, T., Tedford, R. J., Mirro, M., Cleland, J. G.F., Fudim, M. (2022) Diaphragmatic function in cardiovascular disease: JACC review topic of the week. Journal of the American College of Cardiology, 80, pp. 1647-1659. (doi: 10.1016/j.jacc.2022.08.760)

Butt, J. H. et al. (2022) Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial. Circulation, 146, pp. 1210-1224. (doi: 10.1161/CIRCULATIONAHA.122.061754)

Tardif, J. C., Pfeffer, M. A., Kouz, S., Koenig, W., Maggioni, A. P., McMurray, J. J. V., Mooser, V., Waters, D. D., Grégoire, J. C., L’Allier, P. L., Jukema, W. J., White, H. D., Heinonen, T., Black, D. M., Laghrissi-Thode, F., Levesque, S., Guertin, M. C., Dubé, M. P. (2022) Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. European Heart Journal, 43, pp. 3947-3956. (doi: 10.1093/eurheartj/ehac374)

Bruegmann, T., Smith, G. L., Lehnart, S. E. (2022) Editorial: Cardiac optogenetics: Using light to observe and excite the heart. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.1031062)

Lota, A. S. et al. (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation, 146, pp. 1123-1134. (doi: 10.1161/CIRCULATIONAHA.121.058457)

Main, A., Bogusalvskyii, A., Howie, J., Kuo, C.-W., Rankin, A., Burton, F. L., Smith, G. L., Hajjar, R., Baillie, G. S., Campbell, K. S., Shattock, M. J., Fuller, W. (2022) Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.1023237)

Garred, C. H., Zahir, D., Butt, J. H., Ravn, P. B., Bruhn, J., Gislason, G. H., Fosbøl, E. L., Torp‐Pedersen, C., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2022) Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.122.026187)

Ford, T. J., Adamson, C., Morrow, A. J., Rocchiccioli, P., Collison, D., McCartney, P. J., Shaukat, A., Lindsay, M., Good, R., Watkins, S., Eteiba, H., Robertson, K., Berry, C., Oldroyd, K. G., McEntegart, M. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.121.024492)

Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Desai, A. S., Jhund, P. S., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., McGrath, M. M., O’Meara, E., Wilderäng, U., Lindholm, D., Petersson, M., Langkilde, A. M., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1302-1310. (doi: 10.1016/j.jacc.2022.07.021)

Shah, A. M., Claggett, B., Prasad, N., Li, G., Volquez, M., Jering, K., Cikes, M., Kovacs, A., Mullens, W., Nicolau, J. C., Køber, L., van der Meer, P., Jhund, P. S., Ibram, G., Lefkowitz, M., Zhou, Y., Solomon, S. D., Pfeffer, M. A. (2022) Impact of sacubitril/valsartan compared to ramipril on cardiac structure and function following acute myocardial infarction: The PARADISE-MI echocardiographic sub-study. Circulation, 146, pp. 1067-1081. (doi: 10.1161/CIRCULATIONAHA.122.059210)

Desai, A. S., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Miao, Z. M., Kondo, T., Barkoudah, E., Brahimi, A., Connolly, E., Finn, P., Lang, N. N., Mc Causland, F. R., McGrath, M., Petrie, M. C., McMurray, J. J.V., Solomon, S. D. (2022) Effect of dapagliflozin on cause-specific mortality in patients with heart failure across the spectrum of ejection fraction. JAMA Cardiology, 7, pp. 1227-1234. (doi: 10.1001/jamacardio.2022.3736)

Baumhove, L., Tromp, J., Figarska, S., van Essen, B. J., Anker, S. D., Dickstein, K., Cleland, J. G., Lang, C. C., Filippatos, G., Ng, L. L., Samani, N. J., Metra, M., van Veldhuisen, D. J., Lam, C. S.P., Voors, A. A., van der Meer, P. (2022) Heart failure with normal LVEF in BIOSTAT-CHF. International Journal of Cardiology, 364, pp. 85-90. (doi: 10.1016/j.ijcard.2022.05.054)

Bayes‐Genis, A. et al. (2022) Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 24, pp. 1767-1777. (doi: 10.1002/ejhf.2675)

Pocock, S. J., Ferreira, J. P., Packer, M., Zannad, F., Filippatos, G., Kondo, T., McMurray, J. J.V., Solomon, S. D., Januzzi, J. L., Iwata, T., Salsali, A., Butler, J., Anker, S. D. (2022) Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial. European Journal of Heart Failure, 24, pp. 1869-1878. (doi: 10.1002/ejhf.2607)

Jhund, P. S. (2022) Cardiopulmonary functional capacity: another piece of the puzzle of SGLT2 inhibition in heart failure? European Journal of Heart Failure, 24, pp. 1827-1828. (doi: 10.1002/ejhf.2672)

Verduri, A. et al. (2022) Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study. European Journal of Public Health, 32, pp. 807-812. (doi: 10.1093/eurpub/ckac108)

Núñez, J. et al. (2022) Congestion in heart failure: a circulating biomarker‐based perspective. European Journal of Heart Failure, 24, pp. 1751-1766. (doi: 10.1002/ejhf.2664)

Ostrominski, J. W., Vaduganathan, M., Claggett, B. L., de Boer, R. A., Desai, A. S., Dobreanu, D., Hernandez, A. F., Inzucchi, S. E., Jhund, P. S., Kosiborod, M., Lam, C. S.P., Langkilde, A. M., Lindholm, D., Martinez, F. A., O'Meara, E., Petersson, M., Shah, S. J., Thierer, J., McMurray, J. J.V., Solomon, S. D. (2022) Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. European Journal of Heart Failure, 24, pp. 1892-1901. (doi: 10.1002/ejhf.2652)

Kazmi, S., Kambhampati, C., Cleland, J. G.F., Cuthbert, J., Kazmi, K. S., Pellicori, P., Rigby, A. S., Clark, A. L. (2022) Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure. ESC Heart Failure, 9, pp. 3009-3018. (doi: 10.1002/ehf2.14028)

Peikert, A., Martinez, F. A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Desai, A. S., Jhund, P. S., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Shah, S. J., Katova, T., Merkely, B., Vardeny, O., Wilderäng, U., Lindholm, D., Petersson, M., Langkilde, A.-M., McMurray, J. J.V., Solomon, S. D. (2022) Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial. Circulation: Heart Failure, 15, pp. 934-943. (doi: 10.1161/CIRCHEARTFAILURE.122.010080)

Harrington, J., Petrie, M. C., Anker, S. D., Bhatt, D. L., Jones, S. W., Udell, J. A., Hernandez, A. F., Butler, J. (2022) Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction. JAMA Cardiology, 7, pp. 1067-1075. (doi: 10.1001/jamacardio.2022.2847)

McMurray, J. J. V., Sattar, N. (2022) Heart failure: now centre-stage in diabetes. Lancet Diabetes and Endocrinology, 10, pp. 689-691. (doi: 10.1016/S2213-8587(22)00249-2)

Adamson, C., Cowan, L. M., de Boer, R. A., Diez, M., Drożdż, J., Dukát, A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ljungman, C. E.A., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Lindholm, D., Bengtsson, O., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V., Jhund, P. S. (2022) Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. European Journal of Heart Failure, 24, pp. 1856-1868. (doi: 10.1002/ejhf.2649)

Chatur, S., Vaduganathan, M., Peikert, A., Claggett, B. L., McCausland, F. R., Skali, H., Pfeffer, M. A., Beldhuis, I. E., Kober, L., Seferovic, P., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D. (2022) Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with HFpEF in the PARAGON‐HF trial. European Journal of Heart Failure, 24, pp. 1906-1914. (doi: 10.1002/ejhf.2638)

Bilan, J., Aggrey, K., Quinn, T. J., Lumsden, J., Colquhoun, K. (2022) Occurrence and outcomes of possible superadded infections in older adults with COVID-19—cohort study. European Geriatric Medicine, 13, pp. 1161-1167. (doi: 10.1007/s41999-022-00675-9)

Dubé, M.‐P., Chazara, O., Lemaçon, A., Asselin, G., Provost, S., Barhdadi, A., Lemieux Perreault, L.‐P., Mongrain, I., Wang, Q., Carss, K., Paul, D. S., Cunningham, J. W., Rouleau, J., Solomon, S. D., McMurray, J. J.V., Yusuf, S., Granger, C. B., Haefliger, C., de Denus, S., Tardif, J.‐C. (2022) Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. ESC Heart Failure, 9, pp. 2997-3008. (doi: 10.1002/ehf2.14026)

Claggett, B. L., McCaw, Z. R., Tian, L., McMurray, J. J.V., Jhund, P. S., Uno, H., Pfeffer, M. A., Solomon, S. D., Wei, L.-J. (2022) Quantifying treatment effects in trials with multiple event-time outcomes. NEJM Evidence, 1, (doi: 10.1056/EVIDoa2200047)

Welsh, P., Campbell, R. T., Mooney, L., Kimenai, D. M., Hayward, C., Campbell, A., Porteous, D., Mills, N., Lang, N. N., Petrie, M. C., Januzzi, J. L., McMurray, J. J.V., Sattar, N. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15, pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427)

Cooper, T. J., Pellicori, P., Ushakov, A., Dickstein, K. (2022) Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease' European Journal of Heart Failure, 24, pp. 1990-1992. (doi: 10.1002/ejhf.2690)

McDowell, K., Jhund, P. S., McMurray, J. J.V. (2022) Reply to 'sodium-glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction - lessons from clinical trials' European Journal of Heart Failure, 24, pp. 1994. (doi: 10.1002/ejhf.2686)

Jhund, P. S. (2022) SGLT2 inhibitors and heart failure with preserved ejection fraction. Heart Failure Clinics, 18, pp. 579-586. (doi: 10.1016/j.hfc.2022.03.010)

Fertig, B., Ling, J., Nollet, E. E., Dobi, S., Busiau, T., Ishikawa, K., Yamada, K., Lee, A., Kho, C., Wills, L., Tibbo, A. J., Scott, M., Grant, K., Campbell, K. S., Birks, E. J., MacQuaide, N., Hajjar, R., Smith, G. L., van der Velden, J., Baillie, G. (2022) SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca2+ FEBS Journal, 289, pp. 6267-6285. (doi: 10.1111/febs.16537)

Berwanger, O., Pfeffer, M., Claggett, B., Jering, K. S., Maggioni, A. P., Steg, P. G., Mehran, R., Lewis, E. F., Zhou, Y., van der Meer, P., De Pasquale, C., Merkely, B., Filippatos, G., McMurray, J. J.V., Granger, C. B., Solomon, S. D., Braunwald, E. (2022) Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial. European Journal of Heart Failure, 24, pp. 1918-1927. (doi: 10.1002/ejhf.2663)

Carter, B., Keevil, V. L., Anand, A., Osuafor, C. N., Goudie, R. J.B., Preller, J., Lowry, M., Clunie, S., Shenkin, S. D., McCarthy, K., Hewitt, J., Quinn, T. J. (2022) The prognostic and discriminatory utility of the Clinical Frailty Scale and modified Frailty Index compared to age. Geriatrics, 7, (doi: 10.3390/geriatrics7050087)

Bedrouni, W., Sharma, A., Pitt, B., Lam, C. S.P., Ni, J., Ferreira, J. P., McMurray, J., Giannetti, N., Girerd, N., Rossignol, P., Solomon, S. D., Claggett, B., Pocock, S., Huynh, T., Zannad, F. (2022) Timing of statistical benefit of mineralocorticoid receptor antagonists among patients with heart failure and post-myocardial infarction. Circulation: Heart Failure, 15, pp. 988-990. (doi: 10.1161/CIRCHEARTFAILURE.121.009295)

Berry, C., Morrow, A. J., Marzilli, M., Pepine, C. J. (2022) What is the role of assessing ischemia to optimize therapy and outcomes for patients with stable angina and non-obstructed coronary arteries? Cardiovascular Drugs and Therapy, 36, pp. 1027-1038. (doi: 10.1007/s10557-021-07179-x)

Ferreira, J. P., Claggett, B. L., Docherty, K. F., Jhund, P. S., Zannad, F., Solomon, S. D., McMurray, J. J.V. (2022) Within trial comparison of survival time projections from short-term follow-up with long-term follow-up findings. ESC Heart Failure, 9, pp. 3655-3658. (doi: 10.1002/ehf2.13731)

Nitz, K. et al. (2022) The amino acid homoarginine inhibits atherogenesis by modulating T-cell function. Circulation Research, 131, pp. 701-712. (doi: 10.1161/CIRCRESAHA.122.321094)

Docherty, K. F., Welsh, P., Verma, S., De Boer, R. A., O'Meara, E., Bengtsson, O., Køber, L., Kosiborod, M. N., Hammarstedt, A., Langkilde, A. M., Lindholm, D., Little, D. J., Sjöstrand, M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Schou, M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2022) Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF. Circulation, 146, pp. 980-994. (doi: 10.1161/CIRCULATIONAHA.122.060511)

Solomon, S. D. et al. (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. New England Journal of Medicine, 387, pp. 1089-1098. (doi: 10.1056/NEJMoa2206286)

Ho, F. K., Zhou, Z., Petermann-Rocha, F., Parra-Soto, S., Boonpor, J., Welsh, P., Gill, J. M.R., Gray, S. R., Sattar, N., Pell, J. P., Celis-Morales, C. (2022) Association between device-measured physical activity and incident heart failure: a prospective cohort study of 94 739 UK Biobank participants. Circulation, 146, pp. 883-891. (doi: 10.1161/CIRCULATIONAHA.122.059663)

Butt, J. H., Dewan, P., Jhund, P. S., Anand, I. S., Atar, D., Ge, J., Desai, A. S., Echeverria, L. E., Køber, L., Lam, C. S.P., Maggioni, A. P., Martinez, F., Packer, M., Rouleau, J. L., Sim, D., Van Veldhuisen, D. J., Vrtovec, B., Zannad, F., Zile, M. R., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Solomon, S. D., McMurray, J. J.V. (2022) Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction. Journal of the American College of Cardiology, 80, pp. 1130-1143. (doi: 10.1016/j.jacc.2022.06.037)

Conrad, N., Verbeke, G., Molenberghs, G., Goetschalckx, L., Callender, T., Cambridge, G., Mason, J. C., Rahimi, K., McMurray, J. J.V., Verbakel, J. Y. (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet, 400, pp. 733-743. (doi: 10.1016/S0140-6736(22)01349-6)

Vaduganathan, M., Docherty, K. F., Claggett, B. L., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S.P., Martinez, F., Shah, S. J., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2022) SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet, 400, pp. 757-767. (doi: 10.1016/S0140-6736(22)01429-5)

Mc Causland, F. R., Lefkowitz, M. P., Claggett, B., Packer, M., Senni, M., Gori, M., Jhund, P. S., McGrath, M. M., Rouleau, J. L., Shi, V., Swedberg, K., Vaduganathan, M., Zannad, F., Pfeffer, M. A., Zile, M., McMurray, J. J.V., Solomon, S. D. (2022) Angiotensin‐neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure. European Journal of Heart Failure, 24, pp. 1591-1598. (doi: 10.1002/ejhf.2421)

Aulin, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J., Lopes, R. D., McMurray, J. J.V., Oldgren, J., Siegbahn, A., Wallentin, L. (2022) Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multistate model. American Heart Journal, 251, pp. 13-24. (doi: 10.1016/j.ahj.2022.03.009)

Jhund, P. S., Kondo, T., Butt, J. H., Docherty, K. F., Claggett, B. L., Desai, A. S., Vaduganathan, M., Gasparyan, S. B., Bengtsson, O., Lindholm, D., Petersson, M., Langkilde, A. M., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Køber, L., Lam, C. S. P., Martinez, F. A., Sabatine, M. S., Shah, S. J., Solomon, S. D., McMurray, J. J. V. (2022) Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nature Medicine, 28, pp. 1956-1964. (doi: 10.1038/s41591-022-01971-4)

Ravera, A., Santema, B. T., de Boer, R. A., Anker, S. D., Samani, N. J., Lang, C. C., Ng, L., Cleland, J. G.F., Dickstein, K., Lam, C. S.P., Van Spall, H., Filippatos, G., van Veldhuisen, D. J., Metra, M., Voors, A. A., Sama, I. E. (2022) Distinct pathophysiological pathways in women and men with heart failure. European Journal of Heart Failure, 24, pp. 1532-1544. (doi: 10.1002/ejhf.2534)

Vaduganathan, M., Ferreira, J. P., Rossignol, P., Neuen, B., Claggett, B. L., Pfeffer, M. A., McMurray, J. J.V., Pitt, B., Zannad, F., Solomon, S. D. (2022) Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure. European Journal of Heart Failure, 24, pp. 1586-1590. (doi: 10.1002/ejhf.2635)

Johansson, I., Balasubramanian, K., Bangdiwala, S., Mielniczuk, L., Hage, C., Sharma, S. K., Branch, K., Zhu, J., Kragholm, K., Sliwa, K., Alla, F., Yonga, G., Roy, A., Orlandini, A., Grinvalds, A., McCready, T., Pogosova, N., Störk, S., McMurray, J. J.V., Conen, D., Yusuf, S. (2022) Factors associated with health‐related quality of life in heart failure in 23,000 patients from 40 countries: results of the G‐CHF Research Program. European Journal of Heart Failure, 24, pp. 1478-1490. (doi: 10.1002/ejhf.2535)

Cerullo, E., Jones, H. E., Carter, O., Quinn, T. J., Cooper, N. J., Sutton, A. J. (2022) Meta‐analysis of dichotomous and ordinal tests with an imperfect gold standard. Research Synthesis Methods, 13, pp. 595-611. (doi: 10.1002/jrsm.1567)

Gao, X., Kuo, C.-W., Main, A., Brown, E., Rios, F. J., De Lucca Camargo, L., Mary, S., Wypijewski, K., Gök, C., Touyz, R. M., Fuller, W. (2022) Palmitoylation regulates cellular distribution of and transmembrane Ca flux through TrpM7. Cell Calcium, 106, (doi: 10.1016/j.ceca.2022.102639)

Gerstein, H. C., Hess, S., Claggett, B., Dickstein, K., Kober, L., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Tardif, J.-C., Pfeffer, M. A. (2022) Protein biomarkers and cardiovascular outcomes in people with type 2 diabetes and acute coronary syndrome: the ELIXA biomarker study. Diabetes Care, 45, pp. 2152-2155. (doi: 10.2337/dc22-0453)

Wheeler, D. C., Jongs, N., Stefansson, B. V., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J.V., Rossing, P., Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjöström, C. D., Toto, R. D., Heerspink, H. J. L. (2022) Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the DAPA-CKD trial. Nephrology Dialysis Transplantation, 37, pp. 1647-1656. (doi: 10.1093/ndt/gfab335)

Quinn, T. J., Kelbling, E. (2022) September Literature Synopsis. Stroke, 53, pp. e429-e430. (doi: 10.1161/strokeaha.122.040206)

Kobayashi, M., Girerd, N., Ferreira, J. P., Kevin, D., Huttin, O., González, A., Bozec, E., Clark, A. L., Cosmi, F., Cuthbert, J., Diez, J., Edelmann, F., Hazebroek, M., Heymans, S., Mariottoni, B., Pellicori, P., Petutschnigg, J., Pieske, B., Staessen, J. A., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F. (2022) The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 1559-1568. (doi: 10.1002/ejhf.2579)

Butt, J. H., McMurray, J. J.V. (2022) Vericiguat, sacubitril/valsartan and more evidence that we are failing our patients. European Journal of Heart Failure, 24, pp. 1623-1624. (doi: 10.1002/ejhf.2647)

Stables, R. H. et al. (2022) Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: the RIPCORD 2 trial. Circulation, 146, pp. 687-698. (doi: 10.1161/CIRCULATIONAHA.121.057793)

Taylor-Rowan, M., Kraia, O., Kolliopoulou, C., Noel-Storr, A. H., Alharthi, A. A., Cross, A. J., Stewart, C., Myint, P. K., McCleery, J., Quinn, T. J. (2022) Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. Cochrane Database of Systematic Reviews, 2022, (doi: 10.1002/14651858.cd015196.pub2)

Clayton, G. L., Soares, A. G., Kilpi, F., Fraser, A., Welsh, P., Sattar, N., Nelson, S. M., Tilling, K., Lawlor, D. A. (2022) Cardiovascular health in the menopause transition: a longitudinal study of up to 3892 women with up to four repeated measures of risk factors. BMC Medicine, 20, (doi: 10.1186/s12916-022-02454-6)

Lygate, C. A., Lake, H. A., McAndrew, D. J., Neubauer, S., Zervou, S. (2022) Influence of homoarginine on creatine accumulation and biosynthesis in the mouse. Frontiers in Nutrition, 9, (doi: 10.3389/fnut.2022.969702)

Adamson, C., Docherty, K. F., Heerspink, H. J.L., de Boer, R. A., Damman, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Solomon, S. D., Verma, S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2022) Initial decline ("dip") in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF. Circulation, 146, pp. 438-449. (doi: 10.1161/CIRCULATIONAHA.121.058910)

Mangion, K., Berry, C. (2022) Multisystem involvement in COVID-19: what have we learnt? British Journal of Hospital Medicine, 83, pp. 1-5. (doi: 10.12968/hmed.2022.0290)

Thomson, P. C., Mark, P. B., Robertson, M., White, C., Anker, S. D., Bhandari, S., Farrington, K., Jardine, A. G., Kalra, P. A., McMurray, J., Reddan, D., Wheeler, D. C., Winearls, C. G., Ford, I., Macdougall, I. C. (2022) An analysis of vascular access thrombosis events from the Proactive IV Iron Therapy in Hemodialysis Patients (PIVOTAL) trial. Kidney International Reports, 7, pp. 1793-1801. (doi: 10.1016/j.ekir.2022.05.008)

Savarese, G., Uijl, A., Ouwerkerk, W., Tromp, J., Anker, S. D., Dickstein, K., Hage, C., Lam, C. S.P., Lang, C. C., Metra, M., Ng, L. L., Orsini, N., Samani, N. J., van Veldhuisen, D. J., Cleland, J. G.F., Voors, A. A., Lund, L. H. (2022) Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2107-2118. (doi: 10.1002/ehf2.13917)

Büchi, A. E., Feller, M., Netzer, S., Blum, M. R., Rodriguez, E. G., Collet, T.-H., Del Giovane, C., van Heemst, D., Quinn, T., Kearney, P. M., Westendorp, R. G. J., Gussekloo, J., Mooijaart, S., Hans, D., Bauer, D. C., Rodondi, N., Aeberli, D. (2022) Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: a nested study within a randomized placebo controlled trial. Bone, 161, (doi: 10.1016/j.bone.2022.116404)

Stathopoulou, K., Schnittger, J., Raabe, J., Fleischer, F., Mangels, N., Piasecki, A., Findlay, J., Hartmann, K., Krasemann, S., Schlossarek, S., Uebeler, J., Wixler, V., Blake, D. J., Baillie, G., Carrier, L., Ehler, E., Cuello, F. (2022) CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes. FEBS Journal, 289, pp. 4622-4645. (doi: 10.1111/febs.16402)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G. S., Inciardi, R. M., Lang, C. C., Lombardi, C. M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2022) Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clinical Research in Cardiology, 111, pp. 912-923. (doi: 10.1007/s00392-022-01991-7)

Bradley, C., Berry, C. (2022) Definition and epidemiology of coronary microvascular disease. Journal of Nuclear Cardiology, 29, pp. 1763-1775. (doi: 10.1007/s12350-022-02974-x)

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., McMurray, J. J.V. (2022) Effects of dapagliflozin according to the heart failure collaboratory medical therapy score insights from DAPA-HF. JACC: Heart Failure, 10, pp. 543-555. (doi: 10.1016/j.jchf.2022.03.009)

Segar, M. W., Hall, J. L., Jhund, P. S., Powell-Wiley, T. M., Morris, A. A., Kao, D., Fonarow, G. C., Hernandez, R., Ibrahim, N. E., Rutan, C., Navar, A. M., Stevens, L. S., Pandey, A. (2022) Machine learning–based models incorporating social determinants of health vs traditional models for predicting in-hospital mortality in patients with heart failure. JAMA Cardiology, 7, pp. 844-854. (doi: 10.1001/jamacardio.2022.1900)

Hoes, M. F., Arany, Z., Bauersachs, J., Hilfiker-Kleiner, D., Petrie, M. C., Sliwa, K., van der Meer, P. (2022) Pathophysiology and risk factors of peripartum cardiomyopathy. Nature Reviews Cardiology, 19, pp. 555-565. (doi: 10.1038/s41569-021-00664-8)

Rossignol, P., Silva-Cardoso, J., Kosiborod, M.N., Brandenburg, V., Cleland, J.G., Hadimeri, H., Hullin, R., Makela, S., Mörtl, D., Paoletti, E., Pollock, C., Vogt, L., Jadoul, M., Butler, J. (2022) Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease. Pharmacological Research, 182, (doi: 10.1016/j.phrs.2022.106277)

Ryan, M., Perera, D., Petrie, M. C. (2022) Revascularisation and HFpEF – time for randomised trials. European Journal of Heart Failure, 24, pp. 1439-1440. (doi: 10.1002/ejhf.2583)

Deo, S. V., Reddy, Y. N.V., Zakeri, R., Karnib, M., Selvaganesan, P., Elgudin, Y., Kilic, A., Rubelowsky, J., Altarabsheh, S. E., Osman, M. N., Josephson, R. A., Mohan, S. K. M., Cmolik, B., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Sundaram, V. (2022) Revascularization in ischemic heart failure with preserved ejection fraction: a nationwide cohort study. European Journal of Heart Failure, 24, pp. 1427-1438. (doi: 10.1002/ejhf.2446)

Jorbendaze, A., Young, R., Shaburishvili, T., Demyanchuk, V., Buriak, R., Todurov, B., Rudenko, K., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Mirro, M., Fudim, M., Goldberg, L. R., Cleland, J. G.F. (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first‐in‐patient study. ESC Heart Failure, 9, pp. 2207-2214. (doi: 10.1002/ehf2.13984)

Broomfield, N. M., West, R., Barber, M., Quinn, T. J., Gillespie, D., Walters, M., House, A. (2022) TEARS: a longitudinal investigation of the prevalence, psychological associations and trajectory of poststroke emotionalism. Journal of Neurology, Neurosurgery and Psychiatry, 93, pp. 886-894. (doi: 10.1136/jnnp-2022-329042)

Girerd, N., Von Hunolstein, J.-J., Pellicori, P., Bayés-Genís, A., Jaarsma, T., Lund, L. H., Bilbault, P., Boivin, J.-M., Chouihed, T., Costa, J., Eicher, J.-C., Fall, E., Kenizou, D., Maillier, B., Nazeyrollas, P., Roul, G., Zannad, N., Rossignol, P., Seronde, M.-F. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2063-2069. (doi: 10.1002/ehf2.13929)

Lip, S., Dempster, G., Jain, S., Brooksbank, K., Ghouri, N., McCallum, L., Padmanabhan, S. (2022) Underrepresentation of ethnic minorities in hypertension research—a survey of enablers and barriers among South Asian and African communities in Glasgow. Trials, 23, (doi: 10.1186/s13063-022-06542-z)

Yang, Y., Gao, H., Berry, C., Radjenovic, A., Husmeier, D. (2022) Myocardial Perfusion Classification Using A Markov Random Field Constrained Gaussian Mixture Model. (doi: 10.11159/icsta22.146)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 146, pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851)

Lewis, G. D., Voors, A. A., Cohen-Solal, A., Metra, M., Whellan, D. J., Ezekowitz, J. A., Böhm, M., Teerlink, J. R., Docherty, K. F., Lopes, R. D., Divanji, P. H., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Wohltman, A., Felker, G. M. (2022) Effect of omecamtiv mecarbil on exercise capacity in chronic heart failure with reduced ejection fraction. JAMA: Journal of the American Medical Association, 328, pp. 259-269. (doi: 10.1001/jama.2022.11016)

Kimenai, D. M., Pirondini, L., Gregson, J., Prieto, D., Pocock, S. J., Perel, P., Hamilton, T., Welsh, P., Campbell, A., Porteous, D. J., Hayward, C., Sattar, N., Mills, N. L., Shah, A. S.V. (2022) Socioeconomic deprivation: an important, largely unrecognized risk factor in primary prevention of cardiovascular disease. Circulation, 146, pp. 240-248. (doi: 10.1161/CIRCULATIONAHA.122.060042)

Lewinter, C., Nielsen, T. H., Edfors, L. R., Linde, C., Bland, J. M., LeWinter, M., Cleland, J. G.F., Køber, L., Braunschweig, F., Mansson-Broberg, A. (2022) A systematic review and meta-analysis of beta-blockers and inhibitors of the renin-angiotensin system for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European Heart Journal, 43, pp. 2562-2569. (doi: 10.1093/eurheartj/ehab843)

Shen, L., Jhund, P. S., Docherty, K. F., Vaduganathan, M., Petrie, M. C., Desai, A. S., Køber, L., Schou, M., Packer, M., Solomon, S. D., Zhang, X., McMurray, J. J. V. (2022) Accelerated and personalized therapy for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2573-2587. (doi: 10.1093/eurheartj/ehac210)

Cowie, M., Cleland, J. G.F. (2022) The COVID-19 pandemic and heart failure: lessons from GUIDE-HF. European Heart Journal, 43, pp. 2619-2621. (doi: 10.1093/eurheartj/ehac226)

Ferreira, V. M., Berry, C. (2022) The health economics of ischemia with nonobstructive coronary arteries. JACC: Cardiovascular Imaging, 14, pp. 1380-1383. (doi: 10.1016/j.jcmg.2021.03.017)

Cester, L., Starshynov, I., Jones, Y., Pellicori, P., Cleland, J. G.F., Faccio, D. (2022) Remote laser-speckle sensing of heart sounds for health assessment and biometric identification. Biomedical Optics Express, 13, pp. 3743-3750. (doi: 10.1364/BOE.451416)

Rao, S., Li, Y., Ramakrishnan, R., Hassaine, A., Canoy, D., Cleland, J. G., Lukasiewicz, T., Salimi-Khorshidi, G., Rahimi, K. (2022) An explainable transformer-based deep learning model for the prediction of incident heart failure. IEEE Journal of Biomedical and Health Informatics, 26, pp. 3362-3372. (doi: 10.1109/JBHI.2022.3148820)

Kwan, J., Hafdi, M., Chiang, L. L. W., Myint, P. K., Wong, L. S., Quinn, T. J. (2022) Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia. Cochrane Database of Systematic Reviews, 2022, (doi: 10.1002/14651858.CD012269.pub2)

Bularga, A. et al. (2022) Assessment of oxygen supply-demand imbalance and outcomes among patients with type 2 myocardial infarction: a secondary analysis of the High-STEACS cluster randomized clinical trial. JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2022.20162)

Colaço, K., Lee, K.‐A., Akhtari, S., Winer, R., Welsh, P., Sattar, N., McInnes, I. B., Chandran, V., Harvey, P., Cook, R. J., Gladman, D. D., Piguet, V., Eder, L. (2022) Association of cardiac biomarkers with cardiovascular outcomes in patients with psoriatic arthritis and psoriasis: a longitudinal cohort study. Arthritis and Rheumatology, 74, pp. 1184-1192. (doi: 10.1002/art.42079)

Drummond, M., Johnston, B., Quinn, T. J. (2022) Cutting through the intersections to care for caregivers: secondary data analysis of a carers support service in Glasgow, Scotland. Health and Social Care in the Community, 30, pp. 1334-1343. (doi: 10.1111/hsc.13463)

Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J.V., Rossing, P., Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. (2022) Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia, 65, pp. 1085-1097. (doi: 10.1007/s00125-022-05694-6)

Cooper, T. J., Cleland, J. G.F., Guazzi, M., Pellicori, P., Ben Gal, T., Amir, O., Al‐Mohammad, A., Clark, A. L., McConnachie, A., Steine, K., Dickstein, K. (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomised placebo‐controlled multicentre trial. European Journal of Heart Failure, 24, pp. 1239-1248. (doi: 10.1002/ejhf.2527)

Thorvaldsen, T., Ferrannini, G., Mellbin, L., Benson, L., Cosentino, F., McMurray, J. J.V., Dahlström, U., Lund, L. H., Savarese, G. (2022) Eligibility for dapagliflozin and empagliflozin in a real-world heart failure population. Journal of Cardiac Failure, 28, pp. 1050-1062. (doi: 10.1016/j.cardfail.2022.04.011)

Ang, D., Berry, C. (2022) FAVOR III China: quantitative flow ratio-guided coronary intervention in practice. Cardiovascular Research, 118, pp. e78-e80. (doi: 10.1093/cvr/cvac109)

Gallacher, P. J. et al. (2022) High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with renal impairment. Kidney International, 102, pp. 149-159. (doi: 10.1016/j.kint.2022.02.019)

Smeijer, J. D., Koomen, J., Kohan, D. E., McMurray, J. J.V., Bakris, G. L., Correa-Rotter, R., Hou, F.-F., Januzzi, J. L., Kitzman, D. W., Kolansky, D. M., Makino, H., Perkovic, V., Tobe, S., Parving, H.-H., de Zeeuw, D., Heerspink, H. J.L. (2022) Increase in BNP in response to endothelin-receptor antagonist atrasentan is associated with incident heart failure. JACC: Heart Failure, 10, pp. 498-507. (doi: 10.1016/j.jchf.2022.03.004)

Houchen-Wolloff, L. et al. (2022) Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19. Thorax, 77, pp. 717-720. (doi: 10.1136/thoraxjnl-2021-218582)

Santema, B. T., Artola Arita, V., Sama, I. E., Kloosterman, M., van den Berg, M. P., Nienhuis, H. L.A., Van Gelder, I. C., van der Meer, P., Zannad, F., Metra, M., Ter Maaten, J. M., Cleland, J. G., Ng, L. L., Anker, S. D., Lang, C. C., Samani, N. J., Dickstein, K., Filippatos, G., van Veldhuisen, D. J., Lam, C. S.P., Rienstra, M., Voors, A. A. (2022) Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovascular Research, 118, pp. 2478-2487. (doi: 10.1093/cvr/cvab331)

Ball, E. L., Sutherland, R., Squires, C., Mead, G. E., Religa, D., Lundström, E., Cheyne, J., Wardlaw, J. M., Quinn, T. J., Shenkin, S. D. (2022) Predicting post-stroke cognitive impairment using acute CT neuroimaging: a systematic review and meta-analysis. International Journal of Stroke, 17, pp. 618-627. (doi: 10.1177/17474930211045836)

Henriksen, P. A., Hall, P., Oikonomidou, O., MacPherson, I. R., Maclean, M., Lewis, S., McVicars, H., Broom, A., Scott, F., McKay, P., Borley, A., Rowntree, C., Lord, S., Collins, G., Radford, J., Guppy, A., Payne, J. R., Newby, D. E., Mills, N. L., Lang, N. N. (2022) Rationale and design of the Cardiac CARE trial: A randomized trial of troponin-guided neurohormonal blockade for the prevention of anthracycline cardiotoxicity. Circulation: Heart Failure, 15, (doi: 10.1161/CIRCHEARTFAILURE.121.009445)

Cohen, D. J., Magnuson, E., Stone, G. W., Cleland, J. G.F. (2022) Response to: correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock. Heart, 108, (doi: 10.1136/heartjnl-2022-321180)

McCall, P.J., Willder, J.M., Stanley, B.L., Messow, C.-M., Allan, J., Gemmell, L., Puxty, A., Strachan, D., Berry, C., Shelley, B.G. (2022) Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia, 77, pp. 772-784. (doi: 10.1111/anae.15745)

McDowell, K., Docherty, K. F. (2022) Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 8, pp. 371-373. (doi: 10.1093/ehjqcco/qcab088)

Lip, S., McCallum, L., Delles, C., McClure, J. D., Guzik, T., Berry, C., Touyz, R., Padmanabhan, S. (2022) Rationale and design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR) Open Heart, 9, (doi: 10.1136/openhrt-2022-002057)

Vaduganathan, M., Claggett, B. L., McMurray, J. J.V., Solomon, S. D. (2022) Health status trajectories before and after hospitalization for heart failure. Circulation, 145, pp. 1872-1874. (doi: 10.1161/CIRCULATIONAHA.122.059282)

Wijkman, M. O., Claggett, B., Vaduganathan, M., Cunningham, J. W., Rørth, R., Jackson, A., Packer, M., Zile, M., Rouleau, J., Swedberg, K., Lefkowitz, M., Shah, S. J., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2022) Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials. Cardiovascular Diabetology, 21, (doi: 10.1186/s12933-022-01545-1)

Aktaa, S., Batra, G., Cleland, J. G.F., Coats, A., Lund, L. H., McDonagh, T., Rosano, G., Seferovic, P., Vasko, P., Wallentin, L., Maggioni, A. P., Casadei, B., Gale, C. P. (2022) Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) European Heart Journal, 43, pp. 2185-2195. (doi: 10.1093/eurheartj/ehac151)

Tromp, J., Ouwerkerk, W., Teng, T.-H. K., Cleland, J. G.F., Bamadhaj, S., Angermann, C. E., Dahlstrom, U., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P., Filippatos, G., Lam, C. S.P. (2022) Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2224-2234. (doi: 10.1093/eurheartj/ehac103)

Lee, K. K. et al. (2022) Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study. British Medical Journal, 377, (doi: 10.1136/bmj-2021-068424)

Tayal, U. et al. (2022) Precision phenotyping of dilated cardiomyopathy using multidimensional data. Journal of the American College of Cardiology, 79, pp. 2219-2232. (doi: 10.1016/j.jacc.2022.03.375)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28, pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9)

Schwartze, J. T., Havenga, M., Bakker, W. A. M., Bradshaw, A. C., Nicklin, S. A. (2022) Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. Journal of Molecular Medicine, 100, pp. 875-901. (doi: 10.1007/s00109-022-02208-0)

Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S., Petrie, M. C., Dahlström, U., McMurray, J. J.V., Lund, L. H. (2022) Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. JACC: Heart Failure, 10, pp. 380-392. (doi: 10.1016/j.jchf.2022.04.006)

Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., Gray, S. R., Forrest, E., Alazawi, W., Gill, J. M.R., Katikireddi, S. V., Cleland, J. G.F., Welsh, P., Pell, J. P., Sattar, N. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, (doi: 10.1016/j.eclinm.2022.101435)

Gulliver, C., Hoffmann, R., Baillie, G. S. (2022) Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer. International Journal of Biochemistry and Cell Biology, 147, (doi: 10.1016/j.biocel.2022.106230)

Boyalla, V., Harling, L., Snell, A., Kralj-Hans, I., Barradas-Pires, A., Haldar, S., Khan, H. R., Cleland, J. G.F., Athanasiou, T., Harding, S. E., Wong, T. (2022) Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis. Clinical Research in Cardiology, 111, pp. 680-691. (doi: 10.1007/s00392-021-01978-w)

Aimo, A. et al. (2022) Cardiac remodelling part 2: clinical, imaging and laboratory findings: a review from the Biomarkers Working Group of the Heart Failure Association of the ESC. European Journal of Heart Failure, 24, pp. 944-958. (doi: 10.1002/ejhf.2522)

González, A. et al. (2022) Cardiac remodelling – part 1: from cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 24, pp. 927-943. (doi: 10.1002/ejhf.2493)

Halliday, B. P., Owen, R., Gregson, J., Vazir, A., Wassall, R., Khalique, Z., Lota, A. S., Tayal, U., Hammersley, D. J., Jones, R. E., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2022) Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy. ESC Heart Failure, 9, pp. 1616-1624. (doi: 10.1002/ehf2.13872)

Streng, K. W., Hillege, H. L., Maaten, J. M., Veldhuisen, D. J., Dickstein, K., Ng, L. L., Samani, N. J., Metra, M., Ponikowski, P., Cleland, J. G., Anker, S. D., Romaine, S. P.R., Damman, K., Meer, P., Lang, C. C., Voors, A. A. (2022) Clinical implications of low estimated protein intake in patients with heart failure. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1762-1770. (doi: 10.1002/jcsm.12973)

Curtain, J. P., Campbell, R. T., Petrie, M. C., Jackson, A. M., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Clinical outcomes related to background diuretic use and new diuretic initiation in patients with HFrEF. JACC: Heart Failure, 10, pp. 415-427. (doi: 10.1016/j.jchf.2022.01.020)

Rastogi, T., Ho, F. K., Rossignol, P., Merkling, T., Butler, J., Clark, A., Collier, T., Delles, C., Jukema, J. W., Heymans, S., Latini, R., Mebazaa, A., Pellicori, P., Sever, P., Staessen, J. A., Thijs, L., Cleland, J. G., Sattar, N., Zannad, F., Girerd, N. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, 24, pp. 976-984. (doi: 10.1002/ejhf.2495)

McDowell, K., Welsh, P., Docherty, K. F., Morrow, D. A., Jhund, P. S., De Boer, R. A., O’Meara, E., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Hammarstedt, A., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Solomon, S. D., Sattar, N., Sabatine, M. S., McMurray, J. J.V. (2022) Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF. European Journal of Heart Failure, 24, pp. 1066-1076. (doi: 10.1002/ejhf.2433)

Butt, J. H., Dewan, P., Merkely, B., Belohlávek, J., Drożdż, J., Kitakaze, M., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Tereshchenko, S., Ponikowski, P., Bengtsson, O., Lindholm, D., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., Chiang, C.-E., Docherty, K. F., Jhund, P. S., Køber, L., McMurray, J. J.V. (2022) Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction. Annals of Internal Medicine, 175, pp. 820-830. (doi: 10.7326/m21-4776)

Singh, A. K., Cizman, B., Carroll, K., McMurray, J. J.V., Perkovic, V., Jha, V., Johansen, K. L., Lopes, R. D., Macdougall, I. C., Obrador, G. T., Waikar, S. S., Wanner, C., Wheeler, D. C., Wiecek, A., Stankus, N., Strutz, F., Blackorby, A., Cobitz, A. R., Meadowcroft, A. M., Paul, G., Ranganathan, P., Sedani, S., Solomon, S. (2022) Efficacy and safety of daprodustat for treatment of anemia of chronic kidney disease in incident dialysis patients. JAMA Internal Medicine, 182, pp. 592-602. (doi: 10.1001/jamainternmed.2022.0605)

Esteban-Cornejo, I., Ho, F., Petermann-Rocha, F., Lyall, D. M., Martinez-Gomez, D., Cabanas-Sanchez, V., Ortega, F. B., Hillman, C. H., Gill, J. M.R., Quinn, T. J., Sattar, N., Pell, J. P., Gray, S. R., Celis-Morales, C. (2022) Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1514-1525. (doi: 10.1002/jcsm.12857)

Pellicori, P., Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, 24, pp. 1063-1065. (doi: 10.1002/ejhf.2517)

McMurray, J. J.V., Docherty, K. F. (2022) Insights into foundational therapies for heart failure with reduced ejection fraction. Clinical Cardiology, 45, pp. S26-S30. (doi: 10.1002/clc.23847)

Gok, C., Robertson, A. D., Fuller, W. (2022) Insulin-induced palmitoylation regulates the Cardiac Na+/Ca2+ Exchanger NCX1. Cell Calcium, 104, (doi: 10.1016/j.ceca.2022.102567)

Bomer, N., Pavez-Giani, M. G., Grote Beverborg, N., Cleland, J. G.F., van Veldhuisen, D. J., van der Meer, P. (2022) Micronutrient deficiencies in heart failure: mitochondrial dysfunction as a common pathophysiological mechanism? Journal of Internal Medicine, 291, pp. 713-731. (doi: 10.1111/joim.13456)

Berry, C., Sykes, R. (2022) Microvascular dysfunction in heart failure with preserved ejection fraction: a modifiable therapeutic target? JACC: Cardiovascular Imaging, 15, pp. 1012-1014. (doi: 10.1016/j.jcmg.2022.04.008)

Du Puy, R. S., Poortvliet, R. K. E., Mooijaart, S. P., Stott, D. J., Quinn, T., Sattar, N., Westendorp, R. G. J., Kearney, P. M., McCarthy, V. J. C., Byrne, S., Rodondi, N., Baretella, O., Collet, T.-H., van Heemst, D., Dekkers, O. M., Jukema, J. W., Smit, J. W. A., Gussekloo, J., den Elzen, W. P. J. (2022) No effect of levothyroxine on hemoglobin in older adults with subclinical hypothyroidism: pooled results from 2 randomized controlled trials. Journal of Clinical Endocrinology and Metabolism, 107, pp. e2339-e2347. (doi: 10.1210/clinem/dgac106)

McNaughton, C. D., McConnachie, A., Cleland, J. G., Spertus, J. A., Angermann, C. E., Duklas, P., Tromp, J., Lam, C. S.P., Filippatos, G., Dahlstrom, U., Dickstein, K., Schweizer, A., Perrone, S. V., Hassanein, M., Ertl, G., Obergfell, A., Ghadanfar, M., Collins, S. P. (2022) Quality of life assessed six months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) European Journal of Heart Failure, 24, pp. 1020-1029. (doi: 10.1002/ejhf.2508)

Israr, M. Z., Zhan, H., Salzano, A., Voors, A. A., Cleland, J. G.F., Anker, S. D., Metra, M., van Veldhuisen, D. J., Lang, C. C., Zannad, F., Samani, N. J., Ng, L. L., Suzuki, T. (2022) Surrogate markers of gut dysfunction are related to heart failure severity and outcome - from the BIOSTAT-CHF consortium. American Heart Journal, 248, pp. 108-119. (doi: 10.1016/j.ahj.2022.03.002)

Goldberg, L. R., Jorbenadze, A., Shaburishvilli, T., Mirro, M. J., Fudim, M., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Cleland, J. G. (2022) Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure. ESC Heart Failure, 9, pp. 1677-1681. (doi: 10.1002/ehf2.13882)

Fullerton, J. L., Thomas, J. M., Gonzalez-Trueba, L., Trivett, C., Van Kralingen, J. C., Allan, S. M., Quinn, T. J., Work, L. M. (2022) Systematic review: association between circulating microRNA expression & stroke. Journal of Cerebral Blood Flow and Metabolism, 42, pp. 935-951. (doi: 10.1177/0271678X221085090)

Crea, F., Badimon, L., Berry, C., De Caterina, R., Elliott, P. M., Hatala, R., Libby, P., Linde, C., Tybjaerg-Hansen on behalf of the EHJ Editorial Board, A. (2022) The European Heart Journal: fulfilling the mission. European Heart Journal, 43, pp. 2181-2184. (doi: 10.1093/eurheartj/ehac171)

Cleland, J. G.F., Bristow, M. R., Freemantle, N., Olshansk, B., Gras, D., Saxon, L., Tavazzi, L., Boehmer, J., Ghio, S., Feldman, A. M., Daubert, J.-C., deMets, D. (2022) The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual-patient-data meta-analysis of COMPANION and CARE-HF. European Journal of Heart Failure, 24, pp. 1080-1090. (doi: 10.1002/ejhf.2524)

Alkhedhairi, S. A.A., Aba Alkhayl, F. F., Ismail, A. D., Rozendaal, A., German, M., MacLean, B., Johnston, L., Miller, A.A., Hunter, A.M., Macgregor, L.J., Combet, E., Quinn, T.J., Gray, S.R. (2022) The effect of krill oil supplementation on skeletal muscle function and size in older adults: a randomised controlled trial. Clinical Nutrition, 41, pp. 1228-1235. (doi: 10.1016/j.clnu.2022.04.007)

Nath, M., Romaine, S. P.R., Koekemoer, A., Hamby, S., Webb, T. R., Nelson, C. P., Castellanos-Uribe, M., Papakonstantinou, M., Anker, S. D., Lang, C. C., Metra, M., Zannad, F., Filippatos, G., van Veldhuisen, D. J., Cleland, J. G., Ng, L. L., May, S. T., Marelli-Berg, F., Voors, A. A., Timmons, J. A., Samani, N. J. (2022) Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure. European Journal of Heart Failure, 24, pp. 1009-1019. (doi: 10.1002/ejhf.2540)

Malagueta-Vieira, L., Fernández-Ruocco, J., Hortigon, M., Zamora, V., Zayas-Arrabal, J., Echeazarra, L., Smith, G. L., Vila Petroff, M., Medei, E., Casis, Ó., Gallego, M. (2022) Metformin reduces potassium currents and prolongs repolarization in non-diabetic heart. International Journal of Molecular Sciences, 23, (doi: 10.3390/ijms23116021)

Borlaug, B. A. et al. (2022) Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation, 145, pp. 1592-1604. (doi: 10.1161/CIRCULATIONAHA.122.059486)

Udell, J. A., Jones, W. S., Petrie, M. C., Harrington, J., Anker, S. D., Bhatt, D. L., Hernandez, A. F., Butler, J. (2022) Sodium glucose cotransporter-2 inhibition for acute myocardial infarction: JACC Review Topic of the Week. Journal of the American College of Cardiology, 79, pp. 2058-2068. (doi: 10.1016/j.jacc.2022.03.353)

Girerd, N., Cleland, J., Anker, S. D., Byra, W., Lam, C. S.P., Lapolice, D., Mehra, M. R., van Veldhuisen, D. J., Bresso, E., Lamiral, Z., Greenberg, B., Zannad, F. (2022) Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Scientific Reports, 12, (doi: 10.1038/s41598-022-12385-0)

Fairbairn, T. et al. (2022) Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA: Journal of the American Medical Association, 327, pp. 1875-1887. (doi: 10.1001/jama.2022.5776)

Lucas-Herald, A. K., Montezano, A. C., Alves-Lopes, R., Haddow, L., Alimussina, M., O’Toole, S., Flett, M., Lee, B., Amjad, S. B., Steven, M., Brooksbank, K., McCallum, L., Delles, C., Padmanabhan, S., Ahmed, S. F., Touyz, R. M. (2022) Vascular dysfunction and increased cardiovascular risk in hypospadias. European Heart Journal, 43, pp. 1832-1845. (doi: 10.1093/eurheartj/ehac112)

Sattar, N., Welsh, P. (2022) Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatments. European Heart Journal, 43, pp. 1728-1730. (doi: 10.1093/eurheartj/ehac125)

Jhund, P. S., Docherty, K. F., McMurray, J. J.V. (2022) Age-adjusted survival extrapolations—results may differ from those generated by the Weibull model—reply. JAMA Cardiology, 7, pp. 570. (doi: 10.1001/jamacardio.2021.6032)

Petermann-Rocha, F., Gray, S. R., Forrest, E., Welsh, P., Sattar, N., Celis-Morales, C., Ho, F. K., Pell, J. P. (2022) Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants. Journal of Hepatology, 76, pp. 1021-1029. (doi: 10.1016/j.jhep.2022.01.010)

Cikes, M., Planinc, I., Claggett, B., Cunningham, J., Milicic, D., Sweitzer, N., Senni, M., Gori, M., Linssen, G., Shah, S. J., Packer, M., Pfeffer, M., Zile, M. R., Anand, I., Chiang, L.-M., Lam, C. S.P., Redfield, M., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2022) Atrial fibrillation in heart failure with preserved ejection fraction: the PARAGON-HF trial. JACC: Heart Failure, 10, pp. 336-346. (doi: 10.1016/j.jchf.2022.01.018)

Cohen, D. J., Wang, K., Magnuson, E. A., Smith, R. D., Petrie, M. C., Buch, M. H., Abraham, W. T., Lindenfeld, J., Mack, M. J., Stone, G. W., Cleland, J. G. F. (2022) Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation. Heart, 108, pp. 717-724. (doi: 10.1136/heartjnl-2021-320005)

Lewis, G. D., Docherty, K. F., Voors, A. A., Cohen-Solal, A., Metra, M., Whellan, D. J., Ezekowitz, J. A., Ponikowski, P., Böhm, M., Teerlink, J. R., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Felker, G. M. (2022) Developments in exercise capacity assessment in heart failure clinical trials and the rationale for the design of METEORIC-HF. Circulation: Heart Failure, 15, (doi: 10.1161/CIRCHEARTFAILURE.121.008970)

van Rijssel, A. E., Stins, B. C., Beishon, L. C., Sanders, M. L., Quinn, T. J., Claassen, J. A.H.R., de Heus, R. A.A. (2022) Effect of antihypertensive treatment on cerebral blood flow in older adults: a systematic review and meta-analysis. Hypertension, 79, pp. 1067-1078. (doi: 10.1161/HYPERTENSIONAHA.121.18255)

Peikert, A., Vaduganathan, M., McCausland, F., Claggett, B. L., Chatur, S., Packer, M., Pfeffer, M. A., Zannad, F., Lefkowitz, M. P., Pieske, B., Düngen, H.‐D., McMurray, J. J.V., Solomon, S. D. (2022) Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF. European Journal of Heart Failure, 24, pp. 794-803. (doi: 10.1002/ejhf.2450)

Butt, J. H., Adamson, C., Docherty, K. F., Vaduganathan, M., Solomon, S. D., Anand, I. S., Zannad, F., Køber, L., Jhund, P. S., McMurray, J. J.V. (2022) Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new CKD-EPI creatinine equation for estimating glomerular filtration rate. European Journal of Heart Failure, 24, pp. 861-866. (doi: 10.1002/ejhf.2460)

De Caterina, R., Patti, G., Westerbergh, J., Horowitz, J., Ezekowitz, J. A., Lewis, B. S., Lopes, R. D., McMurray, J. J.V., Atar, D., Bahit, M. C., Keltai, M., López-Sendón, J. L., Ruzyllo, W., Granger, C. B., Alexander, J. H., Wallentin, L. (2022) Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 227-235. (doi: 10.1093/ehjcvp/pvaa140)

Ferreira, J. P., Verdonschot, J. A.J., Girerd, N., Bozec, E., Pellicori, P., Collier, T., Mariottoni, B., Cosmi, F., Hazebroek, M., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelman, F., Clark, A. L., Díez, J., González, A., Rossignol, P., Cleland, J. G., Zannad, F. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 771-778. (doi: 10.1002/ejhf.2455)

He, W. et al. (2022) Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size. Cardiovascular Research, 118, pp. 1535-1547. (doi: 10.1093/cvr/cvab204)

Cleland, J. G.F. (2022) Maintaining public trust in medical advice—could less be more? JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2022.11113)

Halliday, B. P., Cleland, J. G. F. (2022) Maintaining success for patients with dilated cardiomyopathy and remission of heart failure. JACC: Basic to Translational Science, 7, pp. 500-503. (doi: 10.1016/j.jacbts.2022.03.008)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Fereirra, J. P., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., Lang, C.C., Metra, M., Samani, N.J., de Boer, R.A., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovascular Research, 118, pp. 1964-1977. (doi: 10.1093/cvr/cvab235)

Graham, F. J., Masini, G., Pellicori, P., Cleland, J. G.F., Greenlaw, N., Friday, J., Kazmi, S., Clark, A. L. (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, 24, pp. 807-817. (doi: 10.1002/ejhf.2251)

Girerd, N., Newton, N., Tartière, J.-M., Guijarro, D., Jourdain, P., Damy, T., Lamblin, N., Bayes-Génis, A., Pellicori, P., Januzzi, J., Rossignol, P., Roubille, F. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, 24, pp. 750-761. (doi: 10.1002/ejhf.2503)

Pellicori, P., McConnachie, A., Carlin, C., Wales, A., Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, (doi: 10.1016/j.phrs.2022.106199)

Rastogi, T., Bozec, E., Pellicori, P., Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A., Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15, pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024)

Yeoh, S. E., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2022) Relationship of dapagliflozin with serum sodium: findings from the DAPA-HF trial. JACC: Heart Failure, 10, pp. 306-318. (doi: 10.1016/j.jchf.2022.01.019)

Lee, M. M.Y., Docherty, K. F., Jhund, P. S. (2022) Sodium–glucose co-transporter-2 inhibitors. Oxford University Press

Singh, A. K., Blackorby, A., Cizman, B., Carroll, K., Cobitz, A. R., Davies, R., Jha, V., Johansen, K. L., Lopes, R. D., Kler, L., Macdougall, I. C., McMurray, J. J.V., Meadowcroft, A. M., Obrador, G. T., Perkovic, V., Solomon, S., Wanner, C., Waikar, S. S., Wheeler, D. C., Wiecek, A. (2022) Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial. Nephrology Dialysis Transplantation, 37, pp. 960-972. (doi: 10.1093/ndt/gfab065)

Al-Lamee, R., Aubiniere-Robb, L., Berry, C. (2022) The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond. Heart, 108, pp. 800-806. (doi: 10.1136/heartjnl-2021-320150)

Verdonschot, J. A.J., Ferreira, J. P., Pizard, A., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Waring, O. J., Henkens, M. H.T.M., Mariottoni, B., Petutschnigg, J., Rossignol, P., Hazebroek, M. R., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28, pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005)

Kite, T. A., Banning, A. S., Ladwiniec, A., Gale, C. P., Greenwood, J. P., Dalby, M., Hobson, R., Barber, S., Parker, E., Berry, C., Flather, M. D., Curzen, N., Banning, A. P., McCann, G. P., Gershlick, A. H. (2022) Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial. BMJ Open, 12, (doi: 10.1136/bmjopen-2021-055878)

Maurovich-Horvat, P. et al. (2022) CT or invasive coronary angiography in stable chest pain. New England Journal of Medicine, 386, pp. 1591-1602. (doi: 10.1056/NEJMoa2200963)

Ho, F., Gray, S. R., Welsh, P., Gill, J. M.R., Sattar, N., Pell, J. P., Celis-Morales, C. (2022) Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors. BMC Medicine, 20, (doi: 10.1186/s12916-022-02337-w)

Said, S., Pazoki, R., Karhunen, V., Võsa, U., Ligthart, S., Bodinier, B., Koskeridis, F., Welsh, P., Alizadeh, B. Z., Chasman, D. I., Sattar, N., Chadeau-Hyam, M., Evangelou, E., Jarvelin, M.-R., Elliott, P., Tzoulaki, I., Dehghan, A. (2022) Genetic analysis of over half a million people characterises C-reactive protein loci. Nature Communications, 13, (doi: 10.1038/s41467-022-29650-5)

Berry, C., Ang, D. T.Y. (2022) Picture perfect? Performance of quantitative coronary angiography-based vessel FFR versus pressure wire-based FFR. EuroIntervention, 17, pp. 1463-1465. (doi: 10.4244/EIJ-E-22-00005)

Wolsk, E., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L., Lewis, E. F., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Solomon, S. D., Tardif, J.‐C., Pfeffer, M. A. (2022) Risk estimates of imminent cardiovascular death and heart failure hospitalization are improved using serial natriuretic peptide measurements in patients with coronary artery disease and type 2 diabetes. Journal of the American Heart Association, 11, (doi: 10.1161/jaha.121.021327)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS) Trials, 23, (doi: 10.1186/s13063-022-06226-8)

Beishon, L. C., Elliott, E., Hietamies, T. M., Mc Ardle, R., O'Mahony, A., Elliott, A. R., Quinn, T. J. (2022) Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia. Cochrane Database of Systematic Reviews, 2022, (doi: 10.1002/14651858.cd013724.pub2)

Aune, E., McMurray, J., Lundgren, P., Sattar, N., Israelsson, J., Nordberg, P., Herlitz, J., Rawshani, A. (2022) Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest. Scientific Reports, 12, (doi: 10.1038/s41598-022-09510-4)

Mileva, N., Nagumo, S., Mizukami, T., Sonck, J., Berry, C., Gallinoro, E., Monizzi, G., Candreva, A., Munhoz, D., Vassilev, D., Penicka, M., Barbato, E., De Bruyne, B., Collet, C. (2022) Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta‐analysis. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.121.023207)

Ho, F. K., Celis-Morales, C., Gray, S. R., Demou, E., Mackay, D., Welsh, P., Katikireddi, S. V., Sattar, N., Pell, J. P. (2022) Association and pathways between shift work and cardiovascular disease: a prospective cohort study of 238 661 participants from UK Biobank. International Journal of Epidemiology, 51, pp. 579-590. (doi: 10.1093/ije/dyab144)

Taylor-Rowan, M., McGuire, L., Hafdi, M., Evans, J., Stott, D. J., Wetherall, K., Elliott, E., Drozdowska, B., Quinn, T. J. (2022) Comparative validity of informant tools for assessing pre-stroke cognitive impairment. International Journal of Geriatric Psychiatry, 37, pp. 1-10. (doi: 10.1002/gps.5700)

Docherty, K. F., Anand, I. S., Chiang, C.-E., Chopra, V. K., Desai, A. S., Kitakaze, M., Verma, S., Vinh, P. N., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Langkilde, A. M., Jhund, P. S., McMurray, J. J.V. (2022) Effects of dapagliflozin in Asian patients with heart failure and reduced ejection fraction in DAPA-HF. JACC: Asia, 2, pp. 139-153. (doi: 10.1016/j.jacasi.2022.02.004)

Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, P., Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C., Heerspink, H. J. L. (2022) Efficacy and safety of dapagliflozin in patients with CKD across major geographic regions. Kidney International Reports, 7, pp. 699-707. (doi: 10.1016/j.ekir.2022.01.1060)

Täger, T., Frankenstein, L., Atar, D., Agewall, S., Frey, N., Grundtvig, M., Clark, A. L., Cleland, J. G.F., Fröhlich, H. (2022) Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology, 111, pp. 428-439. (doi: 10.1007/s00392-021-01913-z)

Abraham, G. R., Morrow, A. J., Oliveira, J., Weir-McCall, J. R., Davenport, E. E., Berry, C., Davenport, A. P., Hoole, S. P. (2022) Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study. International Journal of Cardiology: Heart and Vasculature, 39, (doi: 10.1016/j.ijcha.2022.100980)

Tayal, U., Gregson, J., Buchan, R., Whiffin, N., Halliday, B. P., Lota, A., Roberts, A. M., Baksi, A. J., Voges, I., Jarman, J. W.E., Baruah, R., Frenneaux, M., Cleland, J. G., Barton, P. J., Pennell, D. J., Ware, J. S., Cook, S. A., Prasad, S. K. (2022) Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy. Heart, 108, pp. 619-625. (doi: 10.1136/heartjnl-2021-319418)

Pabón, M. A., Cunningham, J. W., Claggett, B. L., Packer, M., Zile, M., Pfeffer, M. A., Lefkowitz, M., Shi, V., Rizkala, A., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2022) Natriuretic peptide‐based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON‐HF. European Journal of Heart Failure, 24, pp. 672-677. (doi: 10.1002/ejhf.2439)

Cleland, J. G.F., Butler, J., Januzzi, J. L., Pellicori, P., McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24, pp. 678-680. (doi: 10.1002/ejhf.2488)

Tibbo, A. J., Mika, D., Dobi, S., Ling, J., McFall, A., Tejeda, G. S., Blair, C., MacLeod, R., MacQuaide, N., Gök, C., Fuller, W., Smith, B. O., Smith, G. L., Vandecasteele, G., Brand, T., Baillie, G. S. (2022) Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins. Journal of Molecular and Cellular Cardiology, 165, pp. 86-102. (doi: 10.1016/j.yjmcc.2022.01.001)

Tromp, J., Beusekamp, J. C., Ouwerkerk, W., Meer, P., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Dickstein, K., Collins, S. P., Lam, C. S.P. (2022) Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry. European Journal of Heart Failure, 24, pp. 645-652. (doi: 10.1002/ejhf.2431)

Ritchie, C. W., Waymont, J. M. J., Pennington, C., Draper, K., Borthwick, A., Fullerton, N., Chantler, M., Porteous, M. E., Danso, S. O., Green, A., McWhirter, L., Muniz Terrera, G., Simpson, S., Thompson, G., Trépel, D., Quinn, T.J., Kilgour, A. (2022) The Scottish Brain Health Service Model: rationale and scientific basis for a national care pathway of brain health services in Scotland. Journal of Prevention of Alzheimer's Disease, 9, pp. 348-358. (doi: 10.14283/jpad.2021.63)

Solomon, S. D., Claggett, B. L., Miao, Z. M., Diaz, R., Felker, G. M., McMurray, J. J.V., Metra, M., Corbalan, R., Filippatos, G., Goudev, A. R., Mareev, V., Serpytis, P., Suter, T., Yilmaz, M. B., Zannad, F., Kupfer, S., Heitner, S. B., Malik, F. I., Teerlink, J. R. (2022) Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. European Heart Journal, (doi: 10.1093/eurheartj/ehac144)

Dietrichs, E. S., Smith, G. L. (2022) Prediction of ventricular arrhythmias by QRS/QTc - ratio in Citalopram or Escitalopram intoxication. Frontiers in Medicine, 9, (doi: 10.3389/fmed.2022.866454)

Ang, D. T.Y., Sidik, N. P., Morrow, A. J., Sykes, R., McEntegart, M. B., Berry, C. (2022) Interventional diagnostic procedure: A practical guide for the assessment of coronary vascular function. Journal of Visualized Experiments, 181, (doi: 10.3791/62265)

Coats, A. J. S. et al. (2022) Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. European Heart Journal, 43, pp. 863-867. (doi: 10.1093/eurheartj/ehab834)

Divorty, N., Jenkins, L., Ganguly, A., Butcher, A. J., Hudson, B. D., Schulz, S., Tobin, A. B., Nicklin, S. A., Milligan, G. (2022) Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. Journal of Biological Chemistry, 298, (doi: 10.1016/j.jbc.2022.101655)

Cleland, J. G.F. (2022) Aspirin for primary and secondary prevention of cardiovascular disease: time to stop? Thrombosis and Haemostasis, 122, pp. 311-314. (doi: 10.1055/s-0041-1740639)

Solomon, S. D. et al. (2022) Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial. JACC: Heart Failure, 10, pp. 184-197. (doi: 10.1016/j.jchf.2021.11.006)

Pellicori, P., Vaduganathan, M., Ferreira, J. P., Zannad, F., Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48, (doi: 10.1016/j.diabet.2021.101281)

Butt, J. H., Docherty, K. F., Jhund, P. S., De Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Nicolau, J. C., Petrie, M. C., Ponikowski, P., Bengtsson, O., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., McMurray, J. J.V., Køber, L. (2022) Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF. European Journal of Heart Failure, 24, pp. 513-525. (doi: 10.1002/ejhf.2381)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24, pp. 497-509. (doi: 10.1002/ejhf.2403)

Kondo, T., Jhund, P. S., McMurray, J. J.V. (2022) Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose? European Journal of Heart Failure, 24, pp. 421-430. (doi: 10.1002/ejhf.2447)

Curtain, J. P., Jackson, A., Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Castagno, D., Desai, A. S., Rohde, L. E., Lefkowitz, M. P., Rouleau, J.-L., Zile, M. R., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V. (2022) Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. European Journal of Heart Failure, 24, pp. 551-561. (doi: 10.1002/ejhf.2419)

Ferguson, L. D., Cathcart, S., Rimmer, D., Semple, G., Brooksbank, K., Paterson, C., Brown, R., Harvie, J., Gao, X., Radjenovic, A., Welsh, P., McInnes, I. B., Sattar, N., Siebert, S. (2022) Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease – results of the Immune Metabolic Associations in Psoriatic Arthritis study. Rheumatology, 61, pp. 1026-1034. (doi: 10.1093/rheumatology/keab474)

Yeoh, S. E., Dewan, P., Serenelli, M., Ferreira, J. P., Pitt, B., Swedberg, K., Veldhuisen, D. J., Zannad, F., Jhund, P. S., McMurray, J. J.V. (2022) Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES. European Journal of Heart Failure, 24, pp. 529-538. (doi: 10.1002/ejhf.2350)

Sundaram, V., Nagai, T., Chiang, C.-E., Reddy, Y. N.V., Chao, T.-F., Zakeri, R., Bloom, C., Nakai, M., Nishimura, K., Hung, C.-L., Miyamoto, Y., Yasuda, S., Banerjee, A., Anzai, T., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Quint, J. K. (2022) Hospitalization for heart failure in the USA, UK, Taiwan and Japan: an international comparison of administrative health records on 417,385 individual patients. Journal of Cardiac Failure, 28, pp. 353-366. (doi: 10.1016/j.cardfail.2021.08.024)

Dobbin, S. J.H., Herrmann, S. M.S., Lang, N. N., Herrmann, J., Touyz, R. M. (2022) Hypertension and renal disease before anti-cancer therapies. Elsevier

Herrmann, S. M.S., Dobbin, S. J.H., Herrmann, J., Touyz, R. M., Lang, N. N. (2022) Hypertension and renal disease during anti-cancer therapies. Elsevier

Lang, N. N., Dobbin, S. J.H., Herrmann, S. M.S., Herrmann, J., Touyz, R. M. (2022) Hypertension and renal failure prevention and management after cancer therapy. Elsevier

Glen, C., Tan, Y. Y., Waterston, A., Evans, T. R. J., Jones, R. J., Petrie, M. C., Lang, N. N. (2022) Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. JACC: CardioOncology, 4, pp. 1-18. (doi: 10.1016/j.jaccao.2022.01.096)

Martin, T. P., MacDonald, E. A., Elbassioni, A. A., Zaeri, A. A. I., O'Toole, D., Nicklin, S. A., Gray, G. A., Loughrey, C. M. (2022) Pre-clinical models of myocardial infarction: from mechanism to translation. British Journal of Pharmacology, 179, pp. 770-791. (doi: 10.1111/bph.15595)

Burton, J. K., Stewart, J., Blair, M., Oxley, S., Wass, A., Taylor-Rowan, M., Quinn, T. J. (2022) Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age and Ageing, 51, (doi: 10.1093/ageing/afac064)

Lee, M. M.Y., Docherty, K. F., Sattar, N., Mehta, N., Kalra, A., Nowacki, A. S., Solomon, S. D., Vaduganathan, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2022) Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 165-178. (doi: 10.1093/ehjcvp/pvaa138)

Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H.-P. B.-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., Verdonschot, J., Rossignol, P., Girerd, N., Cleland, J. G., Zannad, F. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 149-156. (doi: 10.1093/ehjcvp/pvab031)

Zahir, D., Bonde, A., Madelaire, C., Malmborg, M., Butt, J. H., Fosbol, E., Gislason, G., Torp‐Pedersen, C., Andersson, C., Rossignol, P., McMurray, J. J.V., Kober, L., Schou, M. (2022) Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003–2017. European Journal of Heart Failure, 24, pp. 539-547. (doi: 10.1002/ejhf.2418)

Stoyek, M. R., MacDonald, E., Mantifel, M., Baillie, J. S., Selig, B. M., Croll, R. P., Smith, F. M., Quinn, T. A. (2022) Drivers of sinoatrial node automaticity in zebrafish: comparison with mechanisms of mammalian pacemaker function. Frontiers in Physiology, 13, (doi: 10.3389/fphys.2022.818122)

Reynolds, H. R., Bairey Merz, C. N., Berry, C., Samuel, R., Saw, J., Smilowitz, N. R., de Souza, A. C. d. A.H., Sykes, R., Taqueti, V. R., Wei, J. (2022) Coronary arterial function and disease in women with no obstructive coronary arteries. Circulation Research, 130, pp. 529-551. (doi: 10.1161/CIRCRESAHA.121.319892)

Aba Alkhayl, F. F., Ismail, A. D., Celis-Morales, C., Wilson, J., Radjenovic, A., Johnston, L., Welsh, P., Sattar, N., Gill, J. M.R., Preston, T., Gray, S. (2022) Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men. Scientific Reports, 12, (doi: 10.1038/s41598-022-06446-7)

Carter, B. et al. (2022) Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study. BMC Geriatrics, 22, (doi: 10.1186/s12877-022-02782-5)

Adamson, C., Jhund, P. S. (2022) Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic kidney disease due to type 2 diabetes. European Heart Journal, 43, pp. 485-487. (doi: 10.1093/eurheartj/ehab827)

Huethorst, E., Mortensen, P., Simitev, R. D., Gao, H., Pohjolainen, L., Talman, V., Ruskoaho, H., Burton, F. L., Gadegaard, N., Smith, G. L. (2022) Conventional rigid 2D substrates cause complex contractile signals in monolayers of human induced pluripotent stem cell derived cardiomyocytes. Journal of Physiology, 600, pp. 483-507. (doi: 10.1113/JP282228)

Masini, G., Graham, F. J., Pellicori, P., Cleland, J. G.F., Cuthbert, J. J., Kazmi, S., Inciardi, R. M., Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79, pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039)

Kondo, T., McMurray, J. J.V. (2022) Re-emergence of heart failure with a normal ejection fraction? European Heart Journal, 43, pp. 427-429. (doi: 10.1093/eurheartj/ehab828)

Mujaj, B., ZHang, Z.-Y., Yang, W.-Y., Thijs, L., Wei, F.-F., Verhamme, P., Delles, C., Butler, J., Sever, P., Latini, R., Cleland, J. G. F., Zannad, F., Staessen, J. A. (2022) Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Failure, 9, pp. 685-694. (doi: 10.1002/ehf2.13688)

Ravassa, S., López, B., Ferreira, J. P., Girerd, N., Bozec, E., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A.J., Cuthbert, J., Petutschnigg, J., Moreno, M. U., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Cleland, J. G.F., Zannad, F., Díez, J., González, A. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24, pp. 321-331. (doi: 10.1002/ejhf.2394)

Joyce, N., Atkinson, T., Mc Guire, K., Wiggam, M. I., Gordon, P. L., Kerr, E. L., Patterson, C. E., McILmoyle, J., Roberts, G. E., Flynn, P. A., Burns, P., Rennie, I. R., Taylor-Rowan, M., Quinn, T. J., Fearon, P. (2022) Frailty and stroke thrombectomy outcomes—an observational cohort study. Age and Ageing, 51, (doi: 10.1093/ageing/afab260)

Gök, Ç., Devecioğlu, İ., Güçlü, B. (2022) Mechanical impedance of rat glabrous skin and its relation with skin morphometry. Journal of Biomechanical Engineering, 144, (doi: 10.1115/1.4052225)

Fiuzat, M., Hamo, C. E., Butler, J., Abraham, W. T., DeFilippis, E. M., Fonarow, G. C., Lindenfeld, J., Mentz, R. J., Psotka, M. A., Solomon, S. D., Teerlink, J. R., Vaduganathan, M., Vardeny, O., McMurray, J. J.V., O’Connor, C. M. (2022) Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week. Journal of the American College of Cardiology, 79, pp. 504-510. (doi: 10.1016/j.jacc.2021.11.033)

Craig, L., Hoo, Z. L., Yan, T. Z., Wardlaw, J., Quinn, T. J. (2022) Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry, 93, pp. 180-187. (doi: 10.1136/jnnp-2020-325796)

Weir, R. A.P., Clements, S., Steedman, T., Dargie, H. J., McMurray, J. J.V. (2022) Prognostic value of cardiac magnetic resonance parameters and biomarkers following myocardial infarction; 10 year follow‐up of the Eplerenone Remodeling in Myocardial Infarction without Heart Failure trial. European Journal of Heart Failure, 24, pp. 393-395. (doi: 10.1002/ejhf.2402)

Main, A., Fuller, W. (2022) Protein S‐palmitoylation: advances and challenges in studying a therapeutically important lipid modification. FEBS Journal, 289, pp. 861-882. (doi: 10.1111/febs.15781)

Deis, T., Wolsk, E., Mujkanovic, J., Komtebedde, J., Burkhoff, D., Kaye, D., Hasenfuß, G., Hayward, C., Van der Heyden, J., Petrie, M.C., Shah, S.J., Borlaug, B.A., Kahwash, R., Litwin, S., Hoendermis, E., Hummel, S., Gustafsson, F. (2022) Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction. ESC Heart Failure, 9, pp. 186-195. (doi: 10.1002/ehf2.13697)

Docherty, K. F., Petrie, M. C. (2022) Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure. Heart, 108, pp. 312-320. (doi: 10.1136/heartjnl-2020-318658)

Caiazzo, E., Rezig, A. O.M., Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F., Guzik, T. J., Maffia, P., Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, (doi: 10.1016/j.phrs.2021.106053)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Figarska, S. M., Sama, I. E., Cotter, G., Cleland, J. G.F., Davison, B. A., Felker, G. M., Givertz, M. M., Greenberg, B., Pang, P. S., Severin, T., Gimpelewicz, C., Metra, M., Voors, A. A., Teerlink, J. R. (2022) Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure, 24, pp. 365-374. (doi: 10.1002/ejhf.2384)

Mesin, L., Albani, S., Policastro, P., Pasquero, P., Porta, M., Melchiorri, C., Leonardi, G., Albera, C., Scacciatella, P., Pellicori, P., Stolfo, D., Grillo, A., Fabris, B., Bini, R., Giannoni, A., Pepe, A., Ermini, L., Seddone, S., Sinagra, G., Antonini-Canterin, F., Roatta, S. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, (doi: 10.3389/fcvm.2021.775635)

Herrmann, J. et al. (2022) Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European Heart Journal, 43, pp. 280-299. (doi: 10.1093/eurheartj/ehab674)

Berg, D. D., Docherty, K. F., Sattar, N., Jarolim, P., Welsh, P., Jhund, P. S., Anand, I. S., Chopra, V., de Boer, R. A., Kosiborod, M. N., Nicolau, J. C., O'Meara, E., Schou, M., Hammarstedt, A., Langkilde, A.-M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V., Sabatine, M. S., Morrow, D. A. (2022) Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial. Circulation, 145, pp. 158-169. (doi: 10.1161/CIRCULATIONAHA.121.057852)

Gabriel, J. L., Tinti, M., Fuller, W., Ashford, M. L.J. (2022) Identifying the beta-site amyloid precursor protein cleaving enzyme 1 interactome through the proximity-dependent biotin identification assay. Neuroscience Letters, 767, (doi: 10.1016/j.neulet.2021.136302)

Ryan, M., Morgan, H., Chiribiri, A., Nagel, E., Cleland, J., Perera, D. (2022) Myocardial viability testing: all STICHed up, or about to be REVIVED? European Heart Journal, 43, pp. 118-126. (doi: 10.1093/eurheartj/ehab729)

Januzzi, J. L., Garasic, J. M., Kasner, S. E., McDonald, V., Petrie, M. C., Seltzer, J., Mauro, M., Croce, K., Berman, E., Deininger, M., Hochhaus, A., Pinilla-Ibarz, J., Nicolini, F., Kim, D.-W., DeAngelo, D. J., Kantarjian, H., Xu, J., Hall, T., Srivastava, S., Naranjo, D., Cortes, J. (2022) Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. Journal of Hematology and Oncology, 15, (doi: 10.1186/s13045-021-01221-z)

Pfeffer, M. A. et al. (2022) Impact of sacubitril/valsartan versus ramipril on total heart failure events in the PARADISE-MI trial. Circulation, 145, pp. 87-89. (doi: 10.1161/CIRCULATIONAHA.121.057429)

Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J.V., Correa‐Rotter, R., Rossing, P., Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. (2022) Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease. Diabetes, Obesity and Metabolism, 24, pp. 827-837. (doi: 10.1111/dom.14641)

Faulkner-Jones, A., Zamora, V., Hortigon-Vinagre, M. P., Wang, W., Ardron, M., Smith, G. L., Shu, W. (2022) A bioprinted heart-on-a-chip with human pluripotent stem cell-derived cardiomyocytes for drug evaluation. Bioengineering, 9, (doi: 10.3390/bioengineering9010032)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Chandramouli, C., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Lam, C. S. (2022) A global perspective of racial differences and outcomes in patients presenting with acute heart failure. American Heart Journal, 243, pp. 11-14. (doi: 10.1016/j.ahj.2021.09.001)

Heerspink, H. J.L., Cherney, D., Postmus, D., Stefánsson, B. V., Chertow, G. M., Dwyer, J. P., Greene, T., Kosiborod, M., Langkilde, A. M., McMurray, J. J.V., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Toto, R. D., Wheeler, D. C. (2022) A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney International, 101, pp. 174-184. (doi: 10.1016/j.kint.2021.09.005)

Alnuwaysir, R. I.S., Grote Beverborg, N., Hoes, M. F., Markousis‐Mavrogenis, G., Gomez, K. A., van der Wal, H. H., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Ponikowski, P., Anker, S. D., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 24, pp. 192-204. (doi: 10.1002/ejhf.2393)

Felker, G. M., Solomon, S. D., Claggett, B., Diaz, R., McMurray, J. J.V., Metra, M., Anand, I., Crespo-Leiro, M. G., Dahlström, U., Goncalvesova, E., Howlett, J. G., MacDonald, P., Parkhomenko, A., Tomcsányi, J., Abbasi, S. A., Heitner, S. B., Hucko, T., Kupfer, S., Malik, F. I., Teerlink, J. R. (2022) Assessment of omecamtiv mecarbil for the treatment of patients with severe heart failure. JAMA Cardiology, 7, pp. 26-34. (doi: 10.1001/jamacardio.2021.4027)

McMurray, J. J.V. (2022) Can an implanted minipump deliver for diabetes patients? Nature Medicine, 28, pp. 27-28. (doi: 10.1038/s41591-021-01628-8)

Lee, M. M.Y., Kristensen, S. L., Gerstein, H. C., McMurray, J. J.V., Sattar, N. (2022) Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 16, (doi: 10.1016/j.dsx.2021.102382)

Rossing, P. et al. (2022) Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes and Endocrinology, 10, pp. 24-34. (doi: 10.1016/S2213-8587(21)00295-3)

Cuthbert, J.J., Brown, O.I., Urbinati, A., Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S.C., Riistama, J.M., Cleland, J.G.F., Clark, A.L. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11, pp. 43-52. (doi: 10.1093/ehjacc/zuab097)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., LaPolice, D. A., Greenberg, B., Zannad, F. (2022) New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical Research in Cardiology, 111, pp. 50-59. (doi: 10.1007/s00392-021-01891-2)

Rodríguez-Gómez, I., Gray, S. R., Ho, F. K., Petermann-Rocha, F., Welsh, P., Cleland, J., Iliodromiti, S., Ara, I., Pell, J., Sattar, N., Ferguson, L. D., Celis-Morales, C. (2022) Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank prospective cohort study. Mayo Clinic Proceedings, 97, pp. 110-121. (doi: 10.1016/j.mayocp.2021.07.019)

Lam, P. H., Keramida, K., Filippatos, G. S., Gupta, N., Faselis, C., Deedwania, P., George, B., Iskandrian, A., Cleland, J. G.F., Choudhary, G., Wu, W.-C., Morgan, C. J., Fonarow, G. C., Ahmed, A. (2022) Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction: Beta-blocker and outcomes in HFrEF by RVEF. Journal of Cardiac Failure, 28, pp. 65-70. (doi: 10.1016/j.cardfail.2021.07.026)

Kidd, L., Duncan Millar, J., Mason, H., Quinn, T., Gallacher, K. I., Jones, F., Fisher, R. J., Lebedis, T., Barber, M., Brennan, K., Smith, M. (2022) Supported self-management in community stroke rehabilitation: what is it and how does it work? A protocol for a realist evaluation study. BMJ Open, 12, (doi: 10.1136/bmjopen-2021-055491)

Romaine, S. P. R., Denniff, M., Codd, V., Nath, M., Koekemoer, A., Anker, S. D., Cleland, J. G., Filippatos, G., Levin, D., Metra, M., Mordi, I. R., Ouwerkerk, W., ter Maaten, J. M., van Veldhuisen, D. J., Zannad, F., Ng, L. L., van der Harst, P., Lang, C. C., Voors, A. A., Nelson, C. P., Samani, N. J. (2022) Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart, 108, pp. 124-129. (doi: 10.1136/heartjnl-2020-318654)

Chan, Y., Seckin, M., Johnston, B., Petrie, M., Stewart, S. (2022) Characteristics of symptom change in men and women with different heart failure subtypes. Heart, Lung and Circulation, 31, (doi: 10.1016/j.hlc.2022.06.074)

Baillie, G., Kyurkchieva, E., Sin, Y. Y., Ahmed, F., Rajapakse, N., Schoolmeesters, A., Richard, N., Erdman, P., Hecht, D., Chourasia, A. H., Mercurio, F., Fung, L., Chan, K., Stirling, D. (2022) Evaluating the Utility of Bi-functional Degrader Molecules for Selective Inhibition of PDE4 In Acrodysostosis Type2.

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2022) Optimal management of heart failure and chronic obstructive pulmonary disease: clinical challenges. International Journal of General Medicine, 15, pp. 7961-7975. (doi: 10.2147/IJGM.S295467)

Morrow, A., Gray, S. R., Bayes, H. K., Sykes, R., McGarry, E., Anderson, D., Boiskin, D., Burke, C., Cleland, J. G. F., Goodyear, C., Ibbotson, T., Lang, C. C., McConnachie, A., Mair, F., Mangion, K., Patel, M., Sattar, N., Taggart, D., Taylor, R., Dawkes, S., Berry, C. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, (doi: 10.1186/s13063-022-06632-y)

Lyall, D. M., Quinn, T., Lyall, L. M., Ward, J., Anderson, J. J., Smith, D. J., Stewart, W., Strawbridge, R. J., Bailey, M. E.S., Cullen, B. (2022) Quantifying bias in psychological and physical health in the UK Biobank imaging sub-sample. Brain Communications, 4, (doi: 10.1093/braincomms/fcac119)

Welsh, P., Kimenai, D. M., Marioni, R. E., Hayward, C., Campbell, A., Porteous, D., Mills, N. L., O’Rahilly, S., Sattar, N. (2022) Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort. Clinical Chemistry and Laboratory Medicine, 60, pp. 1820-1829. (doi: 10.1515/cclm-2022-0135)

Quinn, T. J., Taylor-Rowan, M., Elliott, E., Drozdowska, B., McMahon, D., Broomfield, N. M., Barber, M., MacLeod, M. J., Cvoro, V., Byrne, A., Ross, S., Crow, J., Slade, P., Dawson, J., Langhorne, P. (2022) Research protocol – Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: a prospective cohort study in stroke. Cerebral Circulation - Cognition and Behavior, 3, (doi: 10.1016/j.cccb.2022.100042)

Singh, A. K., Carroll, K., McMurray, J. J.V., Solomon, S., Jha, V., Johansen, K. L., Lopes, R. D., Macdougall, I. C., Obrador, G. T., Waikar, S. S., Wanner, C., Wheeler, D. C., Więcek, A., Blackorby, A., Cizman, B., Cobitz, A. R., Davies, R., DiMino, T. L., Kler, L., Meadowcroft, A. M., Taft, L., Perkovic, V. (2021) Daprodustat for the treatment of anemia in patients not undergoing dialysis. New England Journal of Medicine, 385, pp. 2313-2324. (doi: 10.1056/NEJMoa2113380)

Singh, A. K., Carroll, K., Perkovic, V., Solomon, S., Jha, V., Johansen, K. L., Lopes, R. D., Macdougall, I. C., Obrador, G. T., Waikar, S. S., Wanner, C., Wheeler, D. C., Więcek, A., Blackorby, A., Cizman, B., Cobitz, A. R., Davies, R., Dole, J., Kler, L., Meadowcroft, A. M., Zhu, X., McMurray, J. J.V. (2021) Daprodustat for the treatment of anemia in patients undergoing dialysis. New England Journal of Medicine, 385, pp. 2325-2335. (doi: 10.1056/NEJMoa2113379)

Mooney, L., Hawkins, N. M., Jhund, P. S., Redfield, M. M., Muthiah Vaduganathan, M., Desai, A. S., Rouleau, J. L., Minamisawa, M., Shah, A. M., Lefkowitz, M. P., Zile, M. R., Van Veldhuisen, D. J., Pfeffer, M. A., Anand, I. S., Maggioni, A. P., Senni, M., Claggett, B. L., Solomon, S. D., McMurray, J. J. V. (2021) Impact of chronic obstructive pulmonary disease in patients with heart failure with preserved ejection fraction: insights from PARAGON‐HF. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.121.021494)

Petermann-Rocha, F., Lyall, D. M., Gray, S. R., Gill, J. M.R., Sattar, N., Welsh, P., Quinn, T. J., Stewart, W., Pell, J. P., Ho, F. K., Celis-Morales, C. (2021) Dose-response association between device-measured physical activity and incident dementia: a prospective study from UK Biobank. BMC Medicine, 19, (doi: 10.1186/s12916-021-02172-5)

Crowe, K., Quinn, T. J., Mark, P. B., Findlay, M. D. (2021) “Is it removed during dialysis?”—cognitive dysfunction in advanced kidney failure—a review article. Frontiers in Neurology, 12, (doi: 10.3389/fneur.2021.787370)

Chung, Y. J., Park, K. C., Tokar, S., Eykyn, T. R., Fuller, W., Pavlovic, D., Swietach, P., Shattock, M. J. (2021) Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart. Cardiovascular Research, 117, pp. 2794-2806. (doi: 10.1093/cvr/cvaa323)

Collison, D., Didagelos, M., Aetesam-Ur-Rahman, M., Copt, S., McDade, R., McCartney, P., Ford, T. J., McClure, J., Lindsay, M., Shaukat, A., Rocchiccioli, P., Brogan, R., Watkins, S., McEntegart, M., Good, R., Robertson, K., O’Boyle, P., Davie, A., Khan, A., Hood, S., Eteiba, H., Berry, C., Oldroyd, K. G. (2021) Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR) European Heart Journal, 42, pp. 4656-4668. (doi: 10.1093/eurheartj/ehab449)

Chung, Y. J., Park, K. C., Tokar, S., Eykyn, T. R., Fuller, W., Pavlovic, D., Swietach, P., Shattock, M. J. (2021) SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens. Cardiovascular Research, 117, pp. 2702-2704. (doi: 10.1093/cvr/cvab184)

Farzi, M., Mcclymont, D., Whittington, H., Zdora, M.-C., Khazin, L., Lygate, C. A., Rau, C., Dall'Armellina, E., Teh, I., Schneider, J. E. (2021) Assessing myocardial microstructure with biophysical models of diffusion MRI. IEEE Transactions on Medical Imaging, 40, pp. 3775-3786. (doi: 10.1109/TMI.2021.3097907)

Macpherson, J. M., Gray, S. R., Ip, P., McCallum, M., Hanlon, P., Welsh, P., Chan, K. L., Mair, F. S., Celis-Morales, C., Minnis, H., Pell, J. P., Ho, F. K. (2021) Child maltreatment and incident mental disorders in middle and older ages: a retrospective UK Biobank cohort study. Lancet Regional Health - Europe, 11, (doi: 10.1016/j.lanepe.2021.100224)

Butt, J. H., Adamson, C., Docherty, K. F., de Boer, R. A., Petrie, M. C., Inzucchi, S. E., Kosiborod, M. N., Maria Langkilde, A., Lindholm, D., Martinez, F. A., Bengtsson, O., Schou, M., O’Meara, E., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide: insights from the DAPA-HF trial. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008837)

Codina, P., Lupón, J., Borrellas, A., Spitaleri, G., Cediel, G., Domingo, M., Simpson, J., Levy, W. C., Santiago‐Vacas, E., Zamora, E., Buchaca, D., Subirana, I., Santesmases, J., Diez‐Quevedo, C., Troya, M. I., Boldo, M., Altmir, S., Alonso, N., González, B., Rivas, C., Nuñez, J., McMurray, J., Bayes‐Genis, A. (2021) Head‐to‐head comparison of contemporary heart failure risk scores. European Journal of Heart Failure, 23, pp. 2035-2044. (doi: 10.1002/ejhf.2352)

Diamant, M. J., Andrade, J. G., Virani, S. A., Jhund, P. S., Petrie, M. C., Hawkins, N. M. (2021) Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Failure, 8, pp. 4484-4496. (doi: 10.1002/ehf2.13526)

Jackson, A. M. et al. (2021) Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. European Journal of Heart Failure, 23, pp. 2058-2069. (doi: 10.1002/ejhf.2264)

Suzuki, K., Claggett, B., Minamisawa, M., Packer, M., Zile, M. R., Pfeffer, M. A., Chiang, L.‐M., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., Desai, A. S. (2021) Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure, 23, pp. 2085-2090. (doi: 10.1002/ejhf.2262)

Welsh, P., Welsh, C., Celis-Morales, C. A., Brown, R., Ho, F. K., Ferguson, L. D., Mark, P. B., Lewsey, J., Gray, S. R., Lyall, D. M., Gill, J. M.R., Pell, J. P., de Lemos, J. A., Willeit, P., Sattar, N. (2021) Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions. European Journal of Preventive Cardiology, 28, pp. 1991-2000. (doi: 10.1093/eurjpc/zwaa063)

Lang, N. N., Touyz, R. M. (2021) Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity. Clinical Science, 135, pp. 2661-2663. (doi: 10.1042/CS20210986)

Desai, A. S., Vaduganathan, M., Cleland, J. G., Claggett, B. L., Barkoudah, E., Finn, P., McCausland, F. R., Yilmaz, M. B., Lefkowitz, M., Shi, V., Pfeffer, M. A., McMurray, J. J.V., Soloman, S. D. (2021) Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008597)

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P., Cleland, J. G., Rossignol, P., Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114, pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003)

Vaduganathan, M., Claggett, B. L., Greene, S. J., Aggarwal, R., Bhatt, A. S., McMurray, J. J.V., Fonarow, G. C., Solomon, S. D. (2021) Potential implications of expanded US Food and Drug Administration labeling for sacubitril/valsartan in the US. JAMA Cardiology, 6, pp. 1415-1423. (doi: 10.1001/jamacardio.2021.3651)

Lota, A. S., Tsao, A., Owen, R., Halliday, B. P., Auger, D., Vassiliou, V. S., Tayal, U., Almogheer, B., Vilches, S., Al-Balah, A., Patel, A., Mouy, F., Buchan, R., Newsome, S., Gregson, J., Ware, J. S., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Prognostic significance of nonischaemic myocardial fibrosis in patients with normal left ventricular volumes and ejection-fraction. JACC: Cardiovascular Imaging, 14, pp. 2353-2365. (doi: 10.1016/j.jcmg.2021.05.016)

Kulkarni, S., Welsh, P., Ali, M., Petrie, J. R. (2021) Quality of life in people with type 2 diabetes; a study in a multi-ethnic clinical trial population. British Journal of Diabetes, 21, pp. 210-215. (doi: 10.15277/bjd.2021.315)

Keenan, N. G., Captur, G., McCann, G. P., Berry, C., Myerson, S. G., Fairbairn, T., Hudsmith, L., O'Regan, D. P., Westwood, M., Greenwood, J. P. (2021) Regional variation in cardiovascular magnetic resonance service delivery across the UK. Heart, 107, pp. 1974-1979. (doi: 10.1136/heartjnl-2020-318667)

Waijer, S. W., Gansevoort, R. T., Bakris, G. L., Correa-Rotter, R., Hou, F.-F., Kohan, D. E., Kitzman, D. W., Makino, H., McMurray, J. J.V., Perkovic, V., Tobe, S., Parving, H.-H., de Zeeuw, D., Heerspink, H. J.L. (2021) The effect of atrasentan on kidney and heart failure outcomes by baseline albuminuria and kidney function: a post hoc analysis of the SONAR randomized trial. Clinical Journal of the American Society of Nephrology, 16, pp. 1824-1832. (doi: 10.2215/CJN.07340521)

Lumbers, R. T. et al. (2021) The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Failure, 8, pp. 5531-5541. (doi: 10.1002/ehf2.13517)

Wannamethee, S. G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P. (2021) Vitamin D deficiency, impaired lung function and total and respiratory mortality in a cohort of older men: cross-sectional and prospective findings from the British Regional Heart Study. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-051560)

Mark, P. B., Jhund, P. S., Walters, M. R., Petrie, M. C., Power, A., White, C., Robertson, M., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., McMurray, J. J.V., Macdougall, I. C., Ford, I. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2, pp. 1761-1769. (doi: 10.34067/KID.0004272021)

Taylor-Rowan, M., Kraia, O., Kolliopoulou, C., Cross, A. J., Stewart, C., Myint, P. K., McCleery, J., Quinn, T. J. (2021) Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia (Protocol) Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.cd015196)

Müllenbroich, M. C., Kelly, A., Acker, C., Bub, G., Bruegmann, T., Di Bona, A., Entcheva, E., Ferrantini, C., Kohl, P., Lehnart, S. E., Mongillo, M., Parmeggiani, C., Richter, C., Sasse, P., Zaglia, T., Sacconi, L., Smith, G. L. (2021) Novel optics-based approaches for cardiac electrophysiology: a review. Frontiers in Physiology, 12, (doi: 10.3389/fphys.2021.769586)

Mahindra, A., Tejeda, G., Rossi, M., Janha, O., Herbert, I., Morris, C., Morgan, D. C., Beattie, W., Montezano, A. C., Hudson, B., Tobin, A. B., Bhella, D., Touyz, R. M., Jamieson, A. G., Baillie, G. S., Blair, C. M. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16, (doi: 10.1371/journal.pone.0260283)

Rankin, A. J., Mangion, K., Lees, J. S., Rutherford, E., Gillis, K. A., Edy, E., Dymock, L., Treibel, T. A., Radjenovic, A., Patel, R. K., Berry, C., Roditi, G., Mark, P. B. (2021) Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. Journal of Cardiovascular Magnetic Resonance, 23, (doi: 10.1186/s12968-021-00822-4)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print] Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Sveberg Dietrichs, E., Myles, R., Smith, G. (2021) Is hypothermia more neuroprotective than avoiding fever after cardiac arrest? Cardiovascular Research, 117, pp. e159-e161. (doi: 10.1093/cvr/cvab297)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. (doi: 10.1136/heartjnl-2021-BSCMR.3)

McCleery, J., Quinn, T. J. (2021) Aducanumab and the certainty of evidence. Age And Ageing, 50, pp. 1899-1900. (doi: 10.1093/ageing/afab167)

Täger, T., Atar, D., Agewall, S., Katus, H. A., Grundtvig, M., Cleland, J. G.F., Clark, A. L., Fröhlich, H., Frankenstein, L. (2021) Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews, 26, pp. 1421-1435. (doi: 10.1007/s10741-020-09954-8)

Heerspink, H. J.L., Xie, D., Bakris, G., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J.V., Perkovic, V., Rossing, P., Parving, H.-H., de Zeeuw, D. (2021) Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: a prespecified analysis from the SONAR trial. Journal of the American Society of Nephrology, 32, pp. 2900-2911. (doi: 10.1681/ASN.2021030391)

Docherty, K. F., Jhund, P. S., Claggett, B., Ferreira, J. P., Bengtsson, O., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2021) Extrapolating long-term event-free and overall survival with dapagliflozin in patients with heart failure and reduced ejection fraction: an exploratory analysis of a phase 3 randomized clinical trial. JAMA Cardiology, 6, pp. 1298-1305. (doi: 10.1001/jamacardio.2021.2632)

Sullivan, M. K., Jani, B. D., Lees, J. S., Welsh, C. E., McConnachie, A., Stanley, B., Welsh, P., Nicholl, B. I., Lyall, D. M., Carrero, J.-J., Nitsch, D., Sattar, N., Mair, F. S., Mark, P. B. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14, pp. 2409-2419. (doi: 10.1093/ckj/sfab079)

Burton, J. K., Craig, L., Yong, S. Q., Siddiqi, N., Teale, E. A., Woodhouse, R., Barugh, A. J., Shepherd, A. M., Brunton, A., Freeman, S. C., Sutton, A. J., Quinn, T. J. (2021) Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013307.pub3)

Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Sokoreli, I., Urbinati, A., Brown, O., Sze, S., Rigby Cstat, A. R., Kazmi, S., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110, pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9)

Colaco, K., Lee, K.-A., Akhtari, S., Winer, R., Welsh, P., Sattar, N., McInnes, I. B., Chandran, V., Harvey, P., Cook, R. J., Gladman, D. D., Piguet, V., Eder, L. (2021) Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases, 80, pp. 1429-1435. (doi: 10.1136/annrheumdis-2021-220168)

Cuthbert, J. J., Pellicori, P., Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F., Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23, pp. 1831-1840. (doi: 10.1002/ejhf.2353)

He, T. et al. (2021) Urinary peptides in heart failure: a link to molecular pathophysiology. European Journal of Heart Failure, 23, pp. 1875-1887. (doi: 10.1002/ejhf.2195)

Shoaib, A., Rashid, M., Berry, C., Curzen, N., Kontopantelis, E., Timmis, A., Ahmad, A., Kinnaird, T., Mamas, M. A. (2021) Clinical characteristics, management strategies, and outcomes of non–ST‐segment–elevation myocardial infarction patients with and without prior coronary artery bypass grafting. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.018823)

Lee, M., Campbell, R. T., Claggett, B.L., Lewis, E.F., Groarke, J.D., Docherty, K. F., Lindner, M., Liu, J., Soloman, S.D., McMurray, J. J.V., Platz, E. (2021) Lung Ultrasound in Acute Heart Failure: Association Between Quality of Life, Symptoms and B-Lines. (doi: 10.1093/eurheartj/ehab724.1043)

Curzen, N. et al. (2021) Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. European Heart Journal, 42, pp. 3844-3852. (doi: 10.1093/eurheartj/ehab444)

Marshall-McKenna, R., Campbell, E., Ho, F., Banger, M., Ireland, J., Rowe, P., McAlpine, C., McArthur, K., Quinn, T. J., Gray, S. R. (2021) Resistance exercise training at different loads in frail and healthy older adults: a randomised feasibility trial. Experimental Gerontology, 153, (doi: 10.1016/j.exger.2021.111496)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P., Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F., Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8, pp. 3929-3934. (doi: 10.1002/ehf2.13402)

Papageorgiou, V., Jones, K., Halliday, B. P., Mindham, R., Bruton, J., Wassall, R., Cleland, J. G.F., Prasad, S. K., Ward, H. (2021) A qualitative exploration of participant and investigator perspectives from the TRED-HF trial. ESC Heart Failure, 8, pp. 3760-3768. (doi: 10.1002/ehf2.13524)

Touyz, R. M., Boyd, M. O.E., Guzik, T., Padmanabhan, S., McCallum, L., Delles, C., Mark, P. B., Petrie, J. R., Rios, F., Montezano, A. C., Sykes, R., Berry, C. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3, pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020)

Sattar, N., Lee, M. M.Y., Kristensen, S. L., Branch, K. R.H., Del Prato, S., Khurmi, N. S., Lam, C. S.P., Lopes, R. D., McMurray, J. J.V., Pratley, R. E., Rosenstock, J., Gerstein, H. C. (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes and Endocrinology, 9, pp. 653-662. (doi: 10.1016/S2213-8587(21)00203-5)

Meijers, W. C., Bayes‐Genis, A., Mebazaa, A., Bauersachs, J., Cleland, J. J.G., Coats, A. J.S., Januzzi, J. L., Maisel, A. S., McDonald, K., Mueller, T., Richards, A. M., Seferovic, P., Mueller, C., de Boer, R. A. (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) European Journal of Heart Failure, 23, pp. 1610-1632. (doi: 10.1002/ejhf.2346)

Dalal, H., Taylor, R. S., Cleland, J. G. (2021) Correspondence to European Heart Journal—Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. e7. (doi: 10.1093/ehjqcco/qcab033)

Adamson, C., Jhund, P. S., Docherty, K. F., Bělohlávek, J., Chiang, C.‐E., Diez, M., Drożdż, J., Dukát, A., Howlett, J., Ljungman, C. E.A., Petrie, M. C., Schou, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Langkilde, A. M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V. (2021) Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. European Journal of Heart Failure, 23, pp. 1662-1672. (doi: 10.1002/ejhf.2308)

Jani, B. D., Nicholl, B. I., Hanlon, P., Mair, F. S., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A., Ho, F. K., Lyall, D. M., Anderson, J. J., Hastie, C. E., Bailey, M. E.S., Foster, H., Pell, J. P., Welsh, P., Sattar, N. (2021) Family history of diabetes and risk of SARS-COV-2 in UK Biobank: a prospective cohort study. Endocrinology, Diabetes and Metabolism, 4, (doi: 10.1002/edm2.283)

Rankin, A. J., Zhu, L., Mangion, K., Rutherford, E., Gillis, K. A., Lees, J. S., Woodward, R., Patel, R. K., Berry, C., Roditi, G., Mark, P. B. (2021) Global longitudinal strain by feature tracking cardiovascular MRI predicts mortality in patients with end stage kidney disease. Clinical Kidney Journal, 14, pp. 2187-2196. (doi: 10.1093/ckj/sfab020)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Pitt, B., Greenberg, B., Zannad, F. (2021) Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical Research in Cardiology, 110, pp. 1554-1563. (doi: 10.1007/s00392-021-01830-1)

Raafs, A. et al. (2021) Identification of sex‐specific biomarkers predicting new‐onset heart failure. ESC Heart Failure, 8, pp. 3512-3520. (doi: 10.1002/ehf2.13476)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Ponikowski, P., Ravera, A., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2021) Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 1750-1758. (doi: 10.1002/ejhf.2276)

Rush, C. J., Berry, C., Oldroyd, K. G., Rocchiccioli, J. P., Lindsay, M. M., Touyz, R. M., Murphy, C. L., Ford, T. J., Sidik, N., McEntegart, M. B., Lang, N. N., Jhund, P. S., Campbell, R. T., McMurray, J. J.V., Petrie, M. C. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6, pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825)

Anderson, J. J., Ho, F. K., Niedzwiedz, C. L., Katikireddi, V., Celis-Morales, C., Iliodromiti, S., Welsh, P., Pellicori, P., Demou, E., Hastie, C. E., Lyall, D. M., Gray, S. R., Forbes, J. F., Gill, J. M.R., Mackay, D. F., Berry, C., Cleland, J. G.F., Sattar, N., Pell, J. P. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19, pp. 2533-2538. (doi: 10.1111/jth.15452)

Graham, F. J., Pellicori, P., Cleland, J. G.F., Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure' European Journal of Heart Failure, 23, pp. 1800-1801. (doi: 10.1002/ejhf.2304)

Al-Ozairi, E., Brown, R., Hamdan, Y., Alabdullah, L., Voase, N., Al Kandari, J., Alsaeed, D., Al Ozairi, A., Hasan, A., Al-Mulla, F., Katikireddi, S. V., Gray, S. R., Gill, J. M.R., Celis-Morales, C. A., Sattar, N., Welsh, P. (2021) Risk of mortality among inpatients with COVID-19 and type 2 diabetes: national data from Kuwait. Endocrinology, Diabetes and Metabolism, 4, (doi: 10.1002/edm2.287)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C., Wong, I. C.K., Berry, C., Sattar, N., Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96, pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002)

Camafort, M., Jhund, P. S., Formiga, F., Castro- Salomó, A., Arévalo-Lorido, J. C., Sobrino-Martínez, J., Manzano, L., Diez-Manglano, J., Aramburu, O., Pérez-Barquero, M. M. (2021) Utilidad pronóstica de las cifras ambulatorias de presión arterial en pacientes de edad avanzada con insuficiencia cardíaca. Resultados del estudio DICUMAP = Prognostic value of ambulatory blood pressure values in elderly patients with heart failure. Results of the DICUMAP study. Revista Clínica Española, 221, pp. 433-440. (doi: 10.1016/j.rce.2020.11.010)

MacDonald, E. A., Quinn, T. A. (2021) What keeps us ticking? Sinoatrial node mechano-sensitivity: the grandfather clock of cardiac rhythm. Biophysical Reviews, 13, pp. 707-716. (doi: 10.1007/s12551-021-00831-8)

Brown, R., Lewsey, J., Wild, S., Logue, J., Welsh, P. (2021) Associations of statin adherence and lipid targets with adverse outcomes in myocardial infarction survivors: a retrospective cohort study. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-054893)

Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H.-D., Lam, C. S.P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., Rouleau, J. L., Saraiva, J. F.K., Senni, M., Vardeny, O., Wijkman, M. O., Yilmarz, M. B., Saito, Y., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2021) Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal, 42, pp. 3741-3752. (doi: 10.1093/eurheartj/ehab499)

Stoumpos, S., Rankin, A., Hall Barrientos, P., Mangion, K., McGregor, E., Thomson, P. C., Stevenson, K., Welsh, P., Kasthuri, R., Kingsmore, D., Roditi, G., Mark, P. B. (2021) Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Scientific Reports, 11, (doi: 10.1038/s41598-021-97625-5)

Cleland, J. G.F., Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398, pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0)

Selvaraj, S., Claggett, B. L., Packer, M., Zannad, F., Anand, I. S., Pieske, B., Zhao, Z., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2021) Effects of sacubitril/valsartan on serum lipids in heart failure with preserved ejection fraction. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.121.022069)

Ferreira, J. P., Ouwerkerk, W., Santema, B. T., van Veldhuisen, D. J., Lang, C. C., Ng, L. L., Anker, S. D., Dickstein, K., Metra, M., Cleland, J. G.F., Nilesh, S. J., Filippatos, G., Aboumsallem, J.-P., de Boer, R. A., Figarska, S., Sama, I. E., Voors, A. A., Zannad, F. (2021) Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovascular Research, 117, pp. 2228-2236. (doi: 10.1093/cvr/cvaa279)

Zhou, Z., Macpherson, J., Gray, S. R., Gill, J. M.R., Welsh, P., Celis-Morales, C., Sattar, N., Pell, J. P., Ho, F. K. (2021) Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia, 64, pp. 1963-1972. (doi: 10.1007/s00125-021-05484-6)

Ferreira, J. P., Konstam, M. A., McMurray, J. J.V., Butler, J., Girerd, N., Rossignol, P., Sharma, A., Voors, A. A., Lam, C. S.P., Packer, M., Zannad, F. (2021) Dosing of losartan in men vs. women with HFrEF: the HEAAL trial. European Journal of Heart Failure, 23, pp. 1477-1484. (doi: 10.1002/ejhf.2255)

Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Liu, J., Packer, M., Desai, A. S., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Zile, M. R., Swedberg, K., Vardeny, O., McMurray, J. J.V., Solomon, S. D. (2021) Effect of sacubitril/valsartan versus enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial. European Journal of Heart Failure, 23, pp. 1518-1524. (doi: 10.1002/ejhf.2259)

Chertow, G. M., Vart, P., Jongs, N., Toto, R. D., Gorriz, J. L., Hou, F. F., McMurray, J. J.V., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Stefánsson, B. V., Langkilde, A. M., Wheeler, D. C., Heerspink, H. J.L. (2021) Effects of dapagliflozin in stage 4 chronic kidney disease. Journal of the American Society of Nephrology, 32, pp. 2352-2361. (doi: 10.1681/ASN.2021020167)

Quinn, T. J., Richard, E., Teuschl, Y., Gattringer, T., Hafdi, M., O’Brien, J. T., Merriman, N., Gillebert, C., Huyglier, H., Verdelho, A., Schmidt, R., Ghaziani, E., Forchammer, H., Pendlebury, S. T., Bruffaerts, R., Mijajlovic, M., Drozdowska, B. A., Ball, E., Markus, H. S. (2021) European Stroke Organisation (ESO) and European Academy Neurology (EAN) joint guidelines on post stroke cognitive impairment. European Stroke Journal, 6, pp. I-XXXVIII. (doi: 10.1177/23969873211042192)

Buist, H. K., Luchowska-Stańska, U., van Basten, B., Valli, J., Smith, B. O., Baillie, G. S., Rickman, C., Ricketts, B., Davidson, A., Hannam, R., Sunderland, J., Yarwood, S. J. (2021) Identification and characterization of an affimer affinity reagent for the detection of the cAMP sensor, EPAC1. Cells, 10, (doi: 10.3390/cells10092307)

Sigfrid, L. et al. (2021) Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health - Europe, 8, (doi: 10.1016/j.lanepe.2021.100186)

Romaszko, L., Borowska, A., Lazarus, A., Dalton, D., Berry, C., Luo, X., Husmeier, D., Gao, H. (2021) Neural network-based left ventricle geometry prediction from CMR images with application in biomechanics. Artificial Intelligence In Medicine, 119, (doi: 10.1016/j.artmed.2021.102140)

Pellicori, P., Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28, pp. 921-923. (doi: 10.1177/2047487320937135)

Bayes‐Genis, A., Januzzi, J. L., Richards, A. M., Arfsten, H., de Boer, R. A., Emdin, M., González, A., Jaarsma, T., Jhund, P. S., Mueller, C., Núñez, J., Rossignol, P., Milinkovic, I., Rosano, G. M.C., Coats, A., Seferovic, P. (2021) The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe. European Journal of Heart Failure, 23, pp. 1432-1436. (doi: 10.1002/ejhf.2293)

Bhatt, A. S., Claggett, B. L., Packer, M., Lefkowitz, M. P., Zile, M. R., McMurray, J. J.V., Solomon, S. D., Vaduganathan, M. (2021) Treatment effects of sacubitril/valsartan compared with valsartan in patients with recent hospitalization. Journal of Cardiac Failure, 27, pp. 1027-1030. (doi: 10.1016/j.cardfail.2021.05.020)

McDonagh, T. A. et al. (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42, pp. 3599-3726. (doi: 10.1093/eurheartj/ehab368)

Welsh, P., Welsh, C. E., Jhund, P. S., Woodward, M., Brown, R., Lewsey, J., Celis-Morales, C. A., Ho, F. K., MacKay, D. F., Gill, J. M.R., Gray, S. R., Katikireddi, S. V., Pell, J. P., Forbes, J., Sattar, N. (2021) Derivation and validation of a 10-year risk score for symptomatic abdominal aortic aneurysm: cohort study of nearly 500 000 individuals. Circulation, 144, pp. 604-614. (doi: 10.1161/CIRCULATIONAHA.120.053022)

Quin, T. J., Burton, J. K., Carter, B., Cooper, N., Dwan, K., Field, R., Freeman, S. C., Gue, C., Hsieh, P.-H., McGill, K., Nevill, C. R., Rana, D., Sutton, A., Taylor-Rowan, M., Xin, Y. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, (doi: 10.1186/s12916-021-02073-7)

Heggie, R., Briggs, A., Stanley, B., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., YII, E., Collison, D., Oldroyd, K., Ford, T. J., Berry, C. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016)

Zakeri, R., Morgan, A. D., Sundaram, V., Bloom, C., Cleland, J. G.F., Quint, J. K. (2021) Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Medicine, 19, (doi: 10.1186/s12916-021-02048-8)

Jabbour, R. J. et al. (2021) In vivo grafting of large engineered heart tissue patches for cardiac repair. JCI Insight, 6, (doi: 10.1172/jci.insight.144068)

Verdonschot, J. A.J., Ferreira, J. P., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Mariottoni, B., Petutschnigg, J., Rossignol, P., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, (doi: 10.1186/s12933-021-01357-9)

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Ferrari, G., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M. R., Ho, F. K., Gray, S. R., Celis-Morales, C. (2021) Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank Prospective Cohort Study. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2020-001865)

Rørth, R., Clausen, M. F., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2021) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer. PLoS ONE, 16, (doi: 10.1371/journal.pone.0255364)

Ambrosy, A. P., von Haehling, S., Kalra, P. R., Court, E., Bhandari, S., McDonagh, T., Cleland, J. G.F. (2021) Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency anemia in patients with chronic kidney disease with and without heart failure. American Journal of Cardiology, 152, pp. 138-145. (doi: 10.1016/j.amjcard.2021.04.042)

Cleland, J. G.F., Pellicori, P., González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27, pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9)

Kobayashi, M., Gargani, L., Palazzuoli, A., Ambrosio, G., Bayés-Genis, A., Lupon, J., Pellicori, P., Pugliese, N. R., Reddy, Y. N.V., Ruocco, G., Duarte, K., Huttin, O., Rossignol, P., Coiro, S., Girerd, N. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110, pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8)

Shen, L., Jhund, P. S., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Køber, L., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. (2021) Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction. Clinical Research in Cardiology, 110, pp. 1234-1248. (doi: 10.1007/s00392-020-01786-8)

Shen, L., Claggett, B. L., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Gong, J., Køber, L. V., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2021) Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clinical Research in Cardiology, 110, pp. 1334-1349. (doi: 10.1007/s00392-021-01888-x)

Kerr, M., Dennis, K.M.J.H., Carr, C.A., Fuller, W., Berridge, G., Rohling, S., Aitken, C.L., Lopez, C., Fischer, R., Miller, J.J., Clarke, K., Tyler, D.J., Heather, L.C. (2021) Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischaemia. FASEB Journal, 35, (doi: 10.1096/fj.202100394R)

Rohde, L. E., Vaduganathan, M., Claggett, B. L., Polanczyk, C. A., Dorbala, P., Packer, M., Desai, A. S., Zile, M., Rouleau, J., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2021) Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysis. European Journal of Heart Failure, 23, pp. 1346-1356. (doi: 10.1002/ejhf.2120)

Jorbenadze, A., Fudim, M., Mahfoud, F., Adamson, P. B., Bekfani, T., Wachter, R., Sievert, H., Ponikowski, P. P., Cleland, J. G.F., Anker, S. D. (2021) Extra-cardiac targets in the management of cardiometabolic disease: device-based therapies. ESC Heart Failure, 8, pp. 3327-3338. (doi: 10.1002/ehf2.13361)

Bates, E. A., Counsell, J. R., Alizert, S., Baker, A. T., Suff, N., Boyle, A., Bradshaw, A. C., Waddington, S. N., Nicklin, S. A., Baker, A. H., Parker, A. L. (2021) In vitro and in vivo evaluation of human adenovirus type 49 as a vector for therapeutic applications. Viruses, 13, (doi: 10.3390/v13081483)

Wamil, M., Coleman, R. L., Adler, A. I., McMurray, J. J.V., Holman, R. R. (2021) Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89. Diabetes Care, 44, pp. 1877-1884. (doi: 10.2337/dc21-0429)

Graham, F. J., Pellicori, P., Ford, I., Petrie, M. C., Kalra, P. R., Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110, pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8)

Lees, J. S., Ho, F., Parra -Soto, S., Celis-Morales, C., Welsh, P., Sullivan, M. K., Jani, B. D., Sattar, N., Lang, N. N., Pell, J. P., Webster, A. C., Mark, P. B. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, (doi: 10.1016/j.eclinm.2021.101030)

Thom, G., Messow, C.-M., Leslie, W.S., Barnes, A.C., Brosnahan, N., McCombie, L., Al-Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., Taylor, R., Lean, M.E.J. (2021) Predictors of type 2 diabetes in the Diabetes Remission Clinical Trial (DiRECT) Diabetic Medicine, 38, (doi: 10.1111/dme.14395)

Petrie, M. C., Lee, M. M.Y., Docherty, K. F. (2021) Sodium–glucose co-transporter 2 inhibitors—the first successful treatment for heart failure with preserved ejection fraction? European Journal of Heart Failure, 23, pp. 1256-1259. (doi: 10.1002/ejhf.2108)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J., Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14, pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012)

Curtain, J. P., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. European Heart Journal, 42, pp. 3727-3738. (doi: 10.1093/eurheartj/ehab560)

Lee, M. M.Y., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Sattar, N. (2021) Response by Lee et al to letter regarding article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)" Circulation, 144, pp. e40. (doi: 10.1161/CIRCULATIONAHA.121.055067)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Dreisbach, J. G., Forsyth, P., Godeseth, R., Hopkins, T., Jackson, A. M., Lee, M. M.Y., McConnachie, A., Roditi, G., Squire, I. B., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M., McMurray, J. J.V. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144, pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892)

Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J.V., Metra, M., Solomon, S. D., Biering-Sørensen, T., Böhm, M., Bonderman, D., Fang, J. C., Lanfear, D. E., Lund, M., Momomura, S.-I., O'Meara, E., Ponikowski, P., Spinar, J., Flores-Arredondo, J. H., Claggett, B. L., Heitner, S. B., Kupfer, S., Abbasi, S. A., Malik, F. I. (2021) Effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in GALACTIC-HF. Journal of the American College of Cardiology, 78, pp. 97-108. (doi: 10.1016/j.jacc.2021.04.065)

Simpson, J., Jackson, C. E., Haig, C., Jhund, P. S., Tomaszewski, M., Gardner, R. S., Tsorlalis, Y., Petrie, M. C., McMurray, J. J.V., Squire, I. B., Gupta, P. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7, pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071)

Bistola, V., Simitsis, P., Parissis, J., Ouwerkerk, W., van Veldhuisen, D. J., Cleland, J. G., Anker, S. D., Samani, N. J., Metra, M., Zannad, F., Polyzogopoulou, E., Keramida, K., Farmakis, D., Voors, A. A., Filippatos, G. (2021) Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum. European Journal of Heart Failure, 23, pp. 1170-1181. (doi: 10.1002/ejhf.2219)

Solomon, S. D., Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Shah, S. J., Lindholm, D., Wilderäng, U., Öhrn, F., Claggett, B., Langkilde, A. M., Petersson, M., McMurray, J. J.V. (2021) Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. European Journal of Heart Failure, 23, pp. 1217-1225. (doi: 10.1002/ejhf.2249)

Noh, R. M., Graveling, A. J., Lang, N. N., White, A. C., Lee, K. K., Mills, N. L., Newby, D. E., Lang, C. C., Frier, B. M. (2021) Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: a prospective, randomised, open-label, blinded endpoint, cross-over study. Endocrinology, Diabetes and Metabolism, 4, (doi: 10.1002/edm2.258)

Lang, N. N., Ahmad, F. A., Cleland, J. G., O'Connor, C. M., Teerlink, J. R., Voors, A. A., Taubel, J., Hodes, A. R., Anwar, M., Karra, R., Sakata, Y., Ishihara, S., Senior, R., Khemka, A., Prasad, N. G., DeSouza, M. M., Seiffert, D., Ye, J. Y., Kessler, P. D., Borentain, M., Solomon, S. D., Felker, G. M., McMurray, J. J.V. (2021) Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. European Journal of Heart Failure, 23, pp. 1147-1155. (doi: 10.1002/ejhf.2138)

Jhund, P. S., Petrie, M. C., Robertson, M., Mark, P. B., MacDonald, M. R., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9, pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005)

Halliday, B. P., Vazir, A., Owen, R., Gregson, J., Wassall, R., Lota, A. S., Khalique, Z., Tayal, U., Jones, R. E., Hammersley, D., Pantazis, A., Baksi, A. J., Rosen, S., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2021) Heart rate as a marker of relapse during withdrawal of therapy in recovered dilated cardiomyopathy. JACC: Heart Failure, 9, pp. 509-517. (doi: 10.1016/j.jchf.2021.03.010)

Burton, J. K., Reid, M., Gribben, C., Caldwell, D., Clark, D.N., Hanlon, P., Quinn, T. J., Fischbacher, C., Knight, P., Guthrie, B., McAllister, D. (2021) Impact of COVID-19 on care-home mortality and life expectancy in Scotland. Age and Ageing, 50, pp. 1029-1037. (doi: 10.1093/ageing/afab080)

Gök, C., Main, A., Gao, X., Kerekes, Z., Plain, F., Kuo, C.-W., Robertson, A. D., Fraser, N. J., Fuller, W. (2021) Insights into the molecular basis of the palmitoylation and depalmitoylation of NCX1. Cell Calcium, 97, (doi: 10.1016/j.ceca.2021.102408)

Gupta, P., Voors, A. A., Patel, P., Lane, D., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., Lang, C.C., Veldhuisen, D. J., Metra, M., Zannad, F., Samani, N. J., Jones, D. J.L., Squire, I. B., Ng, L. L. (2021) Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study) European Journal of Heart Failure, 23, pp. 1182-1190. (doi: 10.1002/ejhf.2160)

Burton, J. K., Craig, L. E., Yong, S. Q., Siddiqi, N., Teale, E. A., Woodhouse, R., Barugh, A. J., Sheperd, A. M., Brunton, A., Freeman, S. C., Sutton, A. J., Quinn, T. J. (2021) Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013307.pub2)

Morgan, D. C., Morris, C., Mahindra, A., Blair, C. M., Tejeda, G., Herbert, I., Turnbull, M. L., Lieber, G., Willett, B. J., Logan, N., Smith, B., Tobin, A. B., Bhella, D., Baillie, G. S., Jamieson, A. G. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113, (doi: 10.1002/pep2.24217)

Diaz-Navarro, R., Urrútia, G., Cleland, J. G.F., Poloni, D., Villagran, F., Acosta-Dighero, R., Bangdiwala, S. I., Rada, G., Madrid, E. (2021) Stem cell therapy for dilated cardiomyopathy. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.cd013433.pub2)

Markousis-Mavrogenis, G., Tromp, J., Mentz, R. J., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. Journal of Cardiac Failure, 27, pp. 808-811. (doi: 10.1016/j.cardfail.2021.01.008)

Holmes, A. P., Saxena, P., Kabir, S. N., O'Shea, C., Kuhlmann, S. M., Gupta, S., Fobian, D., Apicella, C., O'Reilly, M., Syeda, F., Reyat, J. S., Smith, G. L., Workman, A. J., Pavlovic, D., Fabritz, L., Kirchhof, P. (2021) The atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone. Heart Rhythm, 18, pp. 1212-1220. (doi: 10.1016/j.hrthm.2021.03.016)

Rush, C. J., Cleland, J. G.F., Veldtman, G. (2021) The emerging burden of heart failure in adults with congenital heart disease. International Journal of Cardiology Congenital Heart Disease, 4, (doi: 10.1016/j.ijcchd.2021.100171)

Pellicori, P., Fitchett, D., Kosiborod, M. N., Ofstad, A. P., Seman, L., Zinman, B., Zwiener, I., Wanner, C., George, J., Inzucchi, S. E., Testani, J. M., Cleland, J. G.F. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23, pp. 1085-1093. (doi: 10.1002/ejhf.2220)

Cleland, J. G.F., Pfeffer, M. A., Clark, A. L., Januzzi, J. L., McMurray, J. J.V., Mueller, C., Pellicori, P., Richards, M., Teerlink, J. R., Zannad, F., Bauersachs, J. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42, pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082)

Gorecka, M. et al. (2021) Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study. Journal of Cardiovascular Magnetic Resonance, 23, (doi: 10.1186/s12968-021-00752-1)

Anand, A., Lee, K. K., Chapman, A. R., Ferry, A. V., Adamson, P. D., Strachan, F. E., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Collinson, P. O., Apple, F. S., McAllister, D., Maguire, D., Fox, K. A.A., Newby, D. E., Tuck, C., Harkess, R., Keerie, C., Weir, C. J., Parker, R. A., Gray, A., Shah, A. S.V., Mills, N. (2021) High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial. Circulation, 143, pp. 2214-2224. (doi: 10.1161/CIRCULATIONAHA.120.052380)

Butt, J. H., Docherty, K. F., Petrie, M. C., Schou, M., Kosiborod, M. N., O’Meara, E., Katova, T., Ljungman, C. E.A., Diez, M., Ogunniyi, M. O., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Bengtsson, O., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in men and women with heart failure with reduced ejection fraction: results from the DAPA-HF trial. JAMA Cardiology, 6, pp. 678-689. (doi: 10.1001/jamacardio.2021.0379)

Sierpinski, R., Josiak, K., Suchocki, T., Wojtas‐Polc, K., Mazur, G., Butrym, A., Rozentryt, P., Meer, P., Comin‐Colet, J., Haehling, S., Kosmala, W., Przewlocka‐Kosmala, M., Banasiak, W., Nowak, J., Voors, A. A., Anker, S. D., Cleland, J. G.F., Ponikowski, P., Jankowska, E. A. (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. European Journal of Heart Failure, 23, pp. 919-932. (doi: 10.1002/ejhf.2036)

Jering, K. S. et al. (2021) Prospective ARNI versus ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics. European Journal of Heart Failure, 23, pp. 1040-1048. (doi: 10.1002/ejhf.2191)

Packer, M., McMurray, J. J.V. (2021) Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction. European Journal of Heart Failure, 23, pp. 882-894. (doi: 10.1002/ejhf.2149)

Espersen, C., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Lindner, M., Biering‐Sørensen, T., Solomon, S. D., McMurray, J. J.V., Platz, E. (2021) Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Failure, 8, pp. 1784-1795. (doi: 10.1002/ehf2.13300)

Sørensen, T. B., Minamisawa, M., Liu, J., Claggett, B., Papolos, A. I., Felker, G. M., McMurray, J. J.V., Legg, J. C., Malik, F. I., Honarpour, N., Kurtz, C. E., Teerlink, J. R., Solomon, S. D. (2021) The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF) European Journal of Heart Failure, 23, pp. 1052-1056. (doi: 10.1002/ejhf.2181)

Pandhi, P., Streng, K. W., Anker, S. D., Cleland, J. G., Damman, K., Dickstein, K., Pellicori, P., Lang, C. C., Ng, L., Samani, N. J., Metra, M., Rossignol, P., Filippatos, G., van Veldhuisen, D. J., Voors, A. A., ter Maaten, J. M. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12, pp. 555-567. (doi: 10.1002/jcsm.12690)

Maznyczka, A. M., Carrick, D., Oldroyd, K. G., James-Rae, G., McCartney, P., Greenwood, J. P., Good, R., McEntegart, M., Eteiba, H., Lindsay, M., Cotton, J. M., Petrie, M. C., Berry, C. (2021) Thermodilution-derived temperature recovery time, a novel predictor of microvascular reperfusion and prognosis after myocardial infarction. EuroIntervention, 17, pp. 220-228. (doi: 10.4244/EIJ-D-19-00904)

Bowman, P. R.T., Smith, G. L., Gould, G. W. (2021) Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease? PeerJ, 9, (doi: 10.7717/peerj.11485)

Beggs, S. A.S., Jhund, P. S., McMurray, J. J.V. (2021) Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA. European Heart Journal, 42, pp. e5-e7. (doi: 10.1093/eurheartj/ehy609)

Jhund, P. S., Ponikowski, P., Docherty, K. F., Gasparyan, S. B., Böhm, M., Chang, C.-E., Desai, A. S., Howlett, J., Kitakaze, M., Petrie, M. C., Verma, S., Bengtsson, O., Langkilde, A.-M., Sjöstrand, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2021) Dapagliflozin and recurrent heart failure hospitalizations in heart failure with reduced ejection fraction: an analysis of DAPA-HF. Circulation, 143, pp. 1962-1972. (doi: 10.1161/CIRCULATIONAHA.121.053659)

Lygate, C. A. (2021) The pitfalls of in vivo cardiac physiology in genetically modified mice – lessons learnt the hard way in the creatine kinase system. Frontiers in Physiology, 12, (doi: 10.3389/fphys.2021.685064)

Wang, L., Myles, R. C., Lee, I.-J., Bers, D. M., Ripplinger, C. M. (2021) Role of reduced sarco-endoplasmic reticulum Ca2+-ATPase function on sarcoplasmic reticulum Ca2+ alternans in the intact rabbit heart. Frontiers in Physiology, 12, (doi: 10.3389/fphys.2021.656516)

Emmens, J. E., Jia, C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Anker, S. D., Lang, C. C., Filippatos, G., Cleland, J. G.F., Metra, M., Voors, A. A., de Boer, R. A., Tietge, U. J.F. (2021) Impaired high-density lipoprotein function in patients with heart failure. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019123)

Rossitto, G., Maiolino, G., Lerco, S., Ceolotto, G., Blackburn, G., Mary, S., Antonelli, G., Berton, C., Bisogni, V., Cesari, M., Seccia, T. M., Lenzini, L., Pinato, A., Montezano, A., Touyz, R. M., Petrie, M. C., Daly, R., Welsh, P., Plebani, M., Rossi, G. P., Delles, C. (2021) High sodium intake, glomerular hyperfiltration and protein catabolism in patients with essential hypertension. Cardiovascular Research, 117, pp. 1372-1381. (doi: 10.1093/cvr/cvaa205)

Heath Richardson, S. I., Gao, H., Cox, J., Janiczek, R., Griffith, B. E., Berry, C., Luo, X. (2021) A poroelastic immersed finite element framework for modeling cardiac perfusion and fluid-structure interaction. International Journal for Numerical Methods in Biomedical Engineering, 37, (doi: 10.1002/cnm.3446)

Geriatric Medicine Research Collaborative, et al. (2021) Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age and Ageing, 50, pp. 617-630. (doi: 10.1093/ageing/afab026)

Taylor-Rowan, M., Edwards, S., Noel-Storr, A. H., McCleery, J., Myint, P. K., Soiza, R., Stewart, C., Loke, Y. K., Quinn, T. J. (2021) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013540.pub2)

Wolsk, E., Kaye, D. M., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Cleland, J. G., Hasenfuß, G., Hassager, C., Møller, J. E., Gustafsson, F. (2021) Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 23, pp. 754-764. (doi: 10.1002/ejhf.2146)

Abzhandadze, T., Lundström, E., Buvarp, D., Eriksson, M., Quinn, T. J., Sunnerhagen, K. S. (2021) Development of a short-form Swedish version of the Montreal Cognitive Assessment (s-MoCA-SWE): protocol for a cross-sectional study. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-049035)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Teng, K. T.-H., Bamadhaj, S., Ertl, G., Hassanein, M., Perrone, S. V., Ghandanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Collins, S. P., Lam, C. S.P., Dickstein, K. (2021) Global differences in burden and treatment of ischemic heart disease in acute heart failure: REPORT-HF. JACC: Heart Failure, 9, pp. 349-359. (doi: 10.1016/j.jchf.2020.12.015)

Mutambudzi, M., Niedzwiedz, C. L., Macdonald, E. B., Leyland, A. H., Mair, F. S., Anderson, J. J., Celis-Morales, C. A., Cleland, J. G., Forbes, J., Gill, J. M.R., Hastie, C. E., Ho, F. K., Jani, B. D., Mackay, D. F., Nicholl, B. I., O'Donnell, C. A., Sattar, N., Welsh, P., Pell, J. P., Katikireddi, S. V., Demou, E. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78, pp. 307-314. (doi: 10.1136/oemed-2020-106731)

Ferreira, J. P., Claggett, B. L., Liu, J., Desai, A. S., Pfeffer, M. A., Anand, I. S., Van Veldhuisen, D. J., Kober, L., Cleland, J. G.F., Rouleau, J. L., Packer, M., Zile, M. R., Shi, V. C., Lefkowitz, M. P., Shah, S. J., Vardeny, O., Zanannd, F., Solomon, S. D., McMurray, J. J.V. (2021) Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial. European Journal of Heart Failure, 23, pp. 776-784. (doi: 10.1002/ejhf.2134)

Zhang, J., Pellicori, P., Schutte, R., Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289, pp. 747-748. (doi: 10.1111/joim.13226)

Campbell, E., Petermann-Rocha, F., Welsh, P., Celis-Morales, C., Pell, J. P., Ho, F. K., Gray, S. R. (2021) The effect of exercise on quality of life and activities of daily life in frail older adults: a systematic review of randomised control trials. Experimental Gerontology, 147, (doi: 10.1016/j.exger.2021.111287)

Berg, D. D., Jhund, P. S., Docherty, K. F., Murphy, S. A., Verma, S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V., Sabatine, M. S. (2021) Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction. JAMA Cardiology, 6, pp. 499-507. (doi: 10.1001/jamacardio.2020.7585)

Pellicori, P., Platz, E., Dauw, J., ter Maaten, J. M., Martens, P., Pivetta, E., Cleland, J. G.F., McMurray, J. J.V., Mullens, W., Solomon, S. D., Zannad, F., Gargani, L., Girerd, N. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23, pp. 703-712. (doi: 10.1002/ejhf.2032)

Shen, L., Jhund, P. S., Anand, I. S., Bhatt, A. S., Desai, A. S., Maggioni, A. P., Martinez, F. A., Pfeffer, M. A., Rizkala, A. R., Rouleau, J. L., Swedberg, K., Vaduganathan, M., Vardeny, O., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Packer, M., Solomon, S. D., McMurray, J. J.V. (2021) Incidence and outcomes of pneumonia in patients with heart failure. Journal of the American College of Cardiology, 77, pp. 1961-1973. (doi: 10.1016/j.jacc.2021.03.001)

McMurray, J. J.V., Solomon, S. D., Docherty, K. F., Jhund, P. S. (2021) The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context. European Heart Journal, 42, pp. 1199-1202. (doi: 10.1093/eurheartj/ehz916)

Coats, A. J. et al. (2021) The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European Heart Journal, 42, pp. 1254-1269. (doi: 10.1093/eurheartj/ehab086)

Mooney, L., Goodyear, C. S., Chandra, T., Kirschner, K., Copland, M., Petrie, M. C., Lang, N. N. (2021) Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure. Clinical Science, 135, pp. 991-1007. (doi: 10.1042/CS20200306)

Docherty, K. F., Curtain, J. P., Anand, I. S., Bengtsson, O., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2021) Effect of dapagliflozin on anaemia in DAPA-HF. European Journal of Heart Failure, 23, pp. 617-628. (doi: 10.1002/ejhf.2132)

Dewan, P., Docherty, K. F., Bengtsson, O., de Boer, R. A., Desai, A. S., Drozdz, J., Hawkins, N. M., Inzucchi, S. E., Kitakaze, M., Køber, L., Kosiborod, M. N., Langkilde, A. M., Lindholm, D., Martinez, F. A., Merkely, B., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Sjöstrand, M., Solomon, S. D., Verma, S., Jhund, P. S., McMurray, J. J.V. (2021) Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF. European Journal of Heart Failure, 23, pp. 632-643. (doi: 10.1002/ejhf.2083)

Butt, J. H., Nicolau, J. C., Verma, S., Docherty, K. F., Petrie, M. C., Inzucchi, S. E., Schou, M., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Bengtsson, O., Jhund, P. S., McMurray, J., Køber, L. (2021) Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial. European Journal of Heart Failure, 23, pp. 601-613. (doi: 10.1002/ejhf.2124)

Mbakwem, A. C., Bauersachs, J., Viljoen, C., Hoevelmann, J., Meer, P., Petrie, M. C., Mebazaa, A., Goland, S., Karaye, K., Laroche, C., Sliwa, K. (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Failure, 8, pp. 879-889. (doi: 10.1002/ehf2.13172)

van Dorst, D. C.H., Dobbin, S. J.H., Neves, K. B., Herrmann, J., Herrmann, S. M., Versmissen, J., Mathijssen, R. H.J., Danser, A.H. J., Lang, N. N. (2021) Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circulation Research, 128, pp. 1040-1061. (doi: 10.1161/CIRCRESAHA.121.318051)

Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., Matthews, A. A., Bidulka, P., Gayle, A., Forbes, H., Cook, S., Wong, A. Y.S., Strongman, H., Wing, K., Warren-Gash, C., Cadogan, S. L., Smeeth, L., Hayes, J. F., Quint, J. K., McKee, M., Langan, S. M. (2021) Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digital Health, 3, pp. e217-e230. (doi: 10.1016/s2589-7500(21)00017-0)

Ferreira, J. P., Lam, C. S. P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Cleland, J. G.F., Greenberg, B., Zannad, F. (2021) Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial. European Journal of Heart Failure, 23, pp. 648-656. (doi: 10.1002/ejhf.2003)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9, pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010)

Sliwa, K. et al. (2021) Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 23, pp. 527-540. (doi: 10.1002/ejhf.2133)

Zervou, S., McAndrew, D. J., Whittington, H. J., Lake, H. A., Park, K. C., Cha, K. M., Ostrowski, P. J., Eykyn, T. R., Schneider, J. E., Neubauer, S., Lygate, C. A. (2021) Subtle role for adenylate kinase 1 in maintaining normal basal contractile function and metabolism in the murine heart. Frontiers in Physiology, 12, (doi: 10.3389/fphys.2021.623969)

Scott, M., Blondel-Tepaz, E., Leverve, M., Sokrat, B., Paradis, J., Kosic, M., Saha, K., Auffray, C., Lima-Fernandes, E., Zamborlini, A., Poupon, A., Gaboury, L., Findlay, J., Baillie, G., Enslen, H., Bouvier, M., Angers, S., Marullo, S. (2021) The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signalling axis. Oncogene, 40, pp. 2243-2257. (doi: 10.1038/s41388-021-01704-w)

Petermann-Rocha, F., Parra-Soto, S., Gray, S., Anderson, J., Welsh, P., Gill, J., Sattar, N., Ho, F. K., Celis-Morales, C., Pell, J. P. (2021) Vegetarians, fish, poultry and meat-eaters: who has higher risk of CVD incidence and mortality? A prospective study from UK Biobank. European Heart Journal, 42, pp. 1136-1143. (doi: 10.1093/eurheartj/ehaa939)

Henderson, A. D., Kama, M., Aubry, M., Hue, S., Teissier, A., Naivalu, T., Bechu, V. D., Kailawadoko, J., Rabukawaqa, I., Sahukhan, A., Hibberd, M. L., Nilles, E. J., Funk, S., Whitworth, J., Watson, C. H., Lau, C. L., John Edmunds, W., Cao-Lormeau, V.-M., Kucharski, A. J. (2021) Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji. Nature Communications, 12, (doi: 10.1038/s41467-021-21788-y)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-043887)

Carnicer, R., Duglan, D., Ziberna, K., Recalde, A., Reilly, S., Simon, J. N., Mafrici, S., Arya, R., Roselló-Lletí, E., Chuaiphichai, S., Tyler, D., Lygate, C. A., Channon, K. M., Casadei, B. (2021) BH4 increases nNOS activity and preserves left ventricular function in diabetes. Circulation Research, 128, pp. 585-601. (doi: 10.1161/CIRCRESAHA.120.316656)

Uijl, A., Vaartjes, I., Denaxas, S., Hemingway, H., Shah, A. D., Cleland, J., Grobbee, D. E., Hoes, A. W., Asselbergs, F. W., Koudstaal, S. (2021) Temporal trends in heart failure medication prescription in a population-based cohort study. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-043290)

Mortensen, P., Gao, H., Smith, G., Simitev, R. D. (2021) Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling. Mathematical Medicine and Biology, 38, pp. 106-131. (doi: 10.1093/imammb/dqaa014)

Pellicori, P., Doolub, G., Wong, C. M., Lee, K. S., Mangion, K., Ahmad, M., Berry, C., Squire, I., Lambiase, P., Lyon, A. R., McConnachie, A., Taylor, R. S., Cleland, J. G.F. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013879)

Perry, R. J., Smith, C. J., Roffe, C., Simister, R. J., Narayanamoorthi, S., Marigold, R., Willmot, M., Dixit, A., Hassan, A., Quinn, T., Ankolekar, S., Zhang, L., Banerjee, S., Ahmed, U., Padmanabhan, N., Ferdinand, P., McGrane, F., Banaras, A., Marks, I. H., Werring, D. J., SETICOS collaborators, . (2021) Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study. Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 242-248. (doi: 10.1136/jnnp-2020-324927)

Briscoe, M., Sykes, R., Krystofiak, T., Peck, O., Mangion, K., Berry, C. (2021) Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury. Clinical Cardiology, 44, pp. 332-339. (doi: 10.1002/clc.23530)

Smart, N. A., Pearson, M. J., Taylor, R. S., Cleland, J. (2021) Exercise training for heart failure with preserved ejection fraction (ExTraMATCH III): protocol for an individual patient data meta-analysis. Journal of Clinical Exercise Physiology, 10, pp. 3-11. (doi: 10.31189/2165-7629-10.1.3)

Mordi, I. R., Ouwerkerk, W., Anker, S. D., Cleland, J. G., Dickstein, K., Metra, M., Ng, L. L., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A. A., Lang, C. C. (2021) Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 436-444. (doi: 10.1002/ejhf.1799)

Ferreira, J. P., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D., Byra, W. M., La Police, D. A., Anker, S. D., Mehra, M. R., Leroy, C., Eschwege, V., Toussaint-Hacquard, M., Rossignol, P., Greenberg, B., Zannad, F. (2021) Impact of geographic region on the COMMANDER-HF Trial. JACC: Heart Failure, 9, pp. 201-211. (doi: 10.1016/j.jchf.2020.11.007)

Sykes, R. A., Mohamed, M. O., Kwok, C. S., Mamas, M. A., Berry, C. (2021) Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (nationwide readmissions database) Clinical Cardiology, 44, pp. 291-306. (doi: 10.1002/clc.23543)

Doherty, D. J., Sykes, R., Mangion, K., Berry, C. (2021) Predictors of microvascular reperfusion after myocardial infarction. Current Cardiology Reports, 23, (doi: 10.1007/s11886-021-01442-1)

Drozdowska, B. A., McGill, K., McKay, M., Bartlam, R., Langhorne, P., Quinn, T. J. (2021) Prognostic rules for predicting cognitive syndromes following stroke: a systematic review. European Stroke Journal, 6, pp. 18-27. (doi: 10.1177/2396987321997045)

Wardlaw, J. M., Doubal, F., Brown, R., Backhouse, E., Woodhouse, L., Bath, P., Quinn, T. J., Robinson, T., Markus, H. S., McManus, R., O’Brien, J. T., Werring, D. J., Sprigg, N., Parry-Jones, A., Touyz, R. M., Williams, S., Mah, Y.-H., Emsley, H. (2021) Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: protocol. European Stroke Journal, 6, pp. 89-101. (doi: 10.1177/2396987320953312)

Tomasoni, D., Petrie, M. C., Adamo, M., Metra, M. (2021) Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. European Journal of Heart Failure, 23, pp. 486-488. (doi: 10.1002/ejhf.2098)

Cameron, A. C., Neves, K. B., White, J., Touyz, R. M., Lang, N. N. (2021) Reply: Cisplatin-associated aortic thrombosis: a review of cases reported to the FDA adverse event reporting system. JACC: CardioOncology, 3, pp. 166. (doi: 10.1016/j.jaccao.2021.01.005)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113, pp. 695-705. (doi: 10.1093/ajcn/nqaa311)

Hortigon-Vinagre, M.P., Zamora, V., Burton, F. L., Smith, G. L. (2021) The use of voltage sensitive dye di-4-ANEPPS and video-based contractility measurements to assess drug effects on excitation-contraction coupling in human induced pluripotent stem cell-derived cardiomyocytes. Journal of Cardiovascular Pharmacology, 77, pp. 280-290. (doi: 10.1097/FJC.0000000000000937)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8, (doi: 10.1136/openhrt-2020-001453)

Quinn, T. J., Burton, J. K., Carter, B., Cooper, N., Dwan, K., Field, R., Freeman, S. C., Geue, C., Hsieh, P.-H., McGill, K., Nevill, C. R., Rana, D., Sutton, A., Taylor Rowan, M., Xin, Y. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, (doi: 10.1186/s12916-021-01920-x)

Irvine, L., Burton, J. K., Ali, M., Quinn, T. J., Goodman, C. (2021) Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (The Virtual International Care Homes Trials Archive (VICHTA)) Trials, 22, (doi: 10.1186/s13063-021-05107-w)

Battle, C. E., Abdul-Rahim, A., Shenkin, S. D., Hewitt, J., Quinn, T. (2021) Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis. Cochrane Database of Systematic Reviews, 2, (doi: 10.1002/14651858.CD013306.pub2)

Ehteshami-Afshar, S., Mooney, L., Dewan, P., Desai, A. S., Lang, N. N., Lefkowitz, M. P., Petrie, M. C., Rizkala, A. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Shi, V. C., Zile, M. R., Packer, M., McMurray, J. J.V., Jhund, P. S., Hawkins, N. M. (2021) Clinical characteristics and outcomes of patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: insights from PARADIGM-HF. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019238)

Thom, G., McIntosh, A., Messow, C.-M., Leslie, W. S., Barnes, A. C., Brosnahan, N., McCombie, L., Malkova, D., Al-Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., Taylor, R., Lean, M. E.J. (2021) Weight loss induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial. Diabetes, Obesity and Metabolism, 23, pp. 711-719. (doi: 10.1111/dom.14274)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 143, pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186)

Petrie, M. C., Lee, M. M., Lang, N. N. (2021) EMPEROR-REDUCED reigns while EMPERIAL whimpers. European Heart Journal, 42, pp. 711-714. (doi: 10.1093/eurheartj/ehaa965)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42, pp. 684-696. (doi: 10.1093/eurheartj/ehaa758)

Laasmaa, M., Branovets, J., Barsunova, K., Karro, N., Lygate, C. A., Birkedal, R., Vendelin, M. (2021) Altered calcium handling in cardiomyocytes from arginine-glycine amidinotransferase-knockout mice is rescued by creatine. American Journal of Physiology: Heart and Circulatory Physiology, 320, pp. H805-H825. (doi: 10.1152/AJPHEART.00300.2020)

Branovets, J., Karro, N., Barsunova, K., Laasmaa, M., Lygate, C. A., Vendelin, M., Birkedal, R. (2021) Cardiac expression and location of hexokinase changes in a mouse model of pure creatine deficiency. American Journal of Physiology: Heart and Circulatory Physiology, 320, pp. H613-H629. (doi: 10.1152/AJPHEART.00188.2020)

Li, W., Gao, H., Mangion, K., Berry, C., Luo, X. (2021) Apparent growth tensor of left ventricular post myocardial infarction – in human first natural history study. Computers in Biology and Medicine, 129, (doi: 10.1016/j.compbiomed.2020.104168)

Inzucchi, S. E., Docherty, K. F., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Verma, S., Bělohlávek, J., Böhm, M., Chiang, C.-E., de Boer, R. A., Diez, M., Dukát, A., Ljungman, C. E.A., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Jhund, P. S., McMurray, J. J.V. (2021) Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF. Diabetes Care, 44, pp. 586-594. (doi: 10.2337/dc20-1675)

Maznyczka, A. M., McCartney, P., Duklas, P., McEntegart, M., Oldroyd, K., Greenwood, J., Muir, D., Chowdhary, S., Gershlick, A. H., Eteiba, H., Cotton, J., Wragg, A., Curzen, N., Tait, R., Macfarlane, P., Welsh, P., Sattar, N., Petrie, M., Ford, I., Fox, K., McConnachie, A., Berry, C. (2021) Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial. Heart, 107, pp. 299-312. (doi: 10.1136/heartjnl-2020-317828)

Felker, G. M. et al. (2021) Effects of a novel nitroxyl donor in acute heart failure: the STAND-UP AHF Study. JACC: Heart Failure, 9, pp. 146-157. (doi: 10.1016/j.jchf.2020.10.012)

Donin, A. S., Nightingale, C. M., Perkin, M. R., Ussher, M., Jebb, S. A., Landberg, R., Welsh, P., Sattar, N., Adab, P., Owen, C. G., Rudnicka, A. R., Cook, D. G., Whincup, P. H. (2021) Evaluating an intervention to increase cereal fiber intake in children: a randomized controlled feasibility trial. Journal of Nutrition, 151, pp. 379-386. (doi: 10.1093/jn/nxaa347)

Koomen, J. V., Stevens, J., Bakris, G., Correa‐Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., Parving, H.‐H., Perkovic, V., Tobe, S. W., de Zeeuw, D., Heerspink, H. J.L. (2021) Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: a post hoc analysis of the SONAR trial. Diabetes, Obesity and Metabolism, 23, pp. 561-568. (doi: 10.1111/dom.14252)

Halliday, B. P., Owen, R., Gregson, J., Vassiliou, V., Chen, X., Wage, R., Lota, A. S., Khalique, Z., Tayal, U., Hammersley, D. J., Jones, R. E., Baksi, A. J., Cowie, M. R., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy – insights from TRED‐HF. European Journal of Heart Failure, 23, pp. 293-301. (doi: 10.1002/ejhf.2063)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Godeseth, R. L., Forsyth, P., McConnachie, A., Roditi, G., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8, pp. 129-138. (doi: 10.1002/ehf2.13137)

Maznyczka, A. M., McCartney, P. J., Oldroyd, K. G., Lindsay, M., McEntegart, M., Eteiba, H., Rocchiccioli, J. P., Good, R., Shaukat, A., Robertson, K., Malkin, C. J., Greenwood, J. P., Cotton, J. M., Hood, S., Watkins, S., Collison, D., Gillespie, L., Ford, T. J., Weir, R. A.P., McConnachie, A., Berry, C. (2021) Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circulation: Cardiovascular Interventions, 14, (doi: 10.1161/CIRCINTERVENTIONS.120.009529)

Platz, E., Jhund, P. S. (2021) Risk stratification in patients presenting with acute heart failure. European Heart Journal: Acute Cardiovascular Care, 10, pp. 113-115. (doi: 10.1093/ehjacc/zuab005)

Al Ozairi, E., Alroudhan, D., Alsaeed, D., Voase, N., Hasan, A., Gill, J. M.R., Sattar, N., Welsh, P., Gray, C. M., Boonpor, J., Celis-Morales, C., Gray, S. R. (2021) Skeletal muscle and metabolic health – how do we increase muscle mass and function in people with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 106, pp. 309-317. (doi: 10.1210/clinem/dgaa835)

Baillie, G. S., Gulliver, C., Hoffmann, R. (2021) The enigmatic helicase DHX9 and its association with the hallmarks of cancer. Future Science OA, 7, (doi: 10.2144/fsoa-2020-0140)

Robertson-Gray, O., Fuller, W. (2021) The role of protein S-acylation in cardiac function. Clinical Laboratory International, Feb, pp. 10-13.

Gill, D., Cameron, A. C., Burgess, S., Liu, X., Doherty, D. J., Karhunen, V., Abdul-Rahim, A., Taylor-Rowan, M., Zuber, V., Tsao, P. S., Klarin, D., VA Million Veteran Program, , Evangelou, E., Elliott, P., Damrauer, S. M., Quinn, T. J., Dehghan, A., Theodoratou, E., Dawson, J., Tzoulaki, I. (2021) Urate, blood pressure, and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials. Hypertension, 77, pp. 383-392. (doi: 10.1161/HYPERTENSIONAHA.120.16547)

Jhund, P. S. et al. (2021) Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF. Circulation, 143, pp. 289-309. (doi: 10.1161/CIRCULATIONAHA.120.050391)

Samuel, N. A., Cuthbert, J. J., Brown, O. I., Kazmi, S., Cleland, J. G.F., Rigby, A. S., Clark, A. L. (2021) Relation between thyroid function and mortality in patients with chronic heart failure. American Journal of Cardiology, 139, pp. 57-63. (doi: 10.1016/j.amjcard.2020.10.034)

Teerlink, J. R. et al. (2021) Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. New England Journal of Medicine, 384, pp. 105-116. (doi: 10.1056/NEJMoa2025797)

Main, A., Robertson-Gray, O., Fuller, W. (2021) Cyclophilin D palmitoylation and permeability transition: a new twist in the tale of myocardial ischaemia-reperfusion injury. Cardiovascular Research, 117, pp. 15-17. (doi: 10.1093/cvr/cvaa149)

Corcoran, D., Radjenovic, A., Mordi, I., Nazir, S. A., Wilson, S. J., Hinder, M., Yates, D. P., Machineni, S., Alcantara, J., Prescott, M. F., Gugliotta, B., Pang, Y., Tzemos, N., Semple, S. I., Newby, D. E., McCann, G. P., Squire, I., Berry, C. (2021) Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial. Cardiovascular Research, 117, pp. 320-329. (doi: 10.1093/cvr/cvz345)

Bekfani, T., Fudim, M., Cleland, J. G.F., Jorbenadze, A., Haehling, S., Lorber, A., Rothman, A. M.‐K., Stein, K., Abraham, W. T., Sievert, H., Anker, S. D. (2021) A current and future outlook on upcoming technologies in the remote monitoring of patients with heart failure. European Journal of Heart Failure, 23, pp. 175-185. (doi: 10.1002/ejhf.2033)

Stewart, C., Yrjana, K., Kishor, M., Soiza, R. L., Taylor-Rowan, M., Quinn, T. J., Loke, Y. K., Myint, P. K. (2021) Anticholinergic burden measures predict older people's physical function and quality of life: a systematic review. Journal of the American Medical Directors Association, 22, pp. 56-64. (doi: 10.1016/j.jamda.2020.05.065)

Dobbin, S. J.H., Petrie, M. C., Myles, R. C., Touyz, R. M., Lang, N. N. (2021) Cardiotoxic effects of angiogenesis inhibitors. Clinical Science, 135, pp. 71-100. (doi: 10.1042/CS20200305)

Davison, B. A., Senger, S., Sama, I. E., Koch, G. G., Mebazaa, A., Dickstein, K., Samani, N. J., Metra, M., Anker, S. D., Cleland, J. G., Ng, L. L., Mordi, I. R., Zannad, F., Filippatos, G. S., Hillege, H. L., Ponikowski, P., Veldhuisen, D. J., Lang, C. C., Meer, P., Núñez, J., Bayés‐Genís, A., Edwards, C., Voors, A. A., Cotter, G. (2021) Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF. European Journal of Heart Failure, 23, pp. 43-57. (doi: 10.1002/ejhf.2077)

Docherty, K. F., Vaduganathan, M. (2021) OUTSTEP‐HF: re‐evaluating the role of physical activity measures in drug and device development in heart failure. European Journal of Heart Failure, 23, pp. 136-139. (doi: 10.1002/ejhf.2106)

McCallum, L., Brooksbank, K., McConnachie, A., Aman, A., Lip, S., Dawson, J., MacIntyre, I. M., MacDonald, T. M., Webb, D. J., Padmanabhan, S. (2021) Rationale and design of the genotype-blinded trial of torasemide for the treatment of hypertension (BHF UMOD) American Journal of Hypertension, 34, pp. 92-99. (doi: 10.1093/ajh/hpaa166)

McMurray, J. J.V., Docherty, K. F. (2021) SOLOIST-WHF: Sodium-glucose cotransporter 2 (SGLT2) inhibitors should be initiated in patients hospitalised with worsening heart failure. European Journal of Heart Failure, 23, pp. 27-30. (doi: 10.1002/ejhf.2075)

He, T., Melgarejo, J. D., Clark, A. L., Yu, Y.‐L., Thijs, L., Díez, J., López, B., González, A., Cleland, J. G., Schanstra, J. P., Vlahou, A., Latosinska, A., Mischak, H., Staessen, J. A., Zhang, Z.‐Y., Jankowski, V. (2021) Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure. Clinical and Translational Medicine, 11, (doi: 10.1002/ctm2.267)

Willder, J. M., McCall, P., Messow, C.-M., Gillies, M., Berry, C., Shelley, B. (2021) Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-042098)

Burton, R. F., Burton, F. L. (2021) When is sitting height a better measure of adult body size than total height, and why? The contrasting examples of body mass, waist circumference and lung volume. American Journal of Human Biology, 33, (doi: 10.1002/ajhb.23433)

Mortensen, P., Gao, H., Smith, G., Simitev, R. D. (2021) Addendum: Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling. Mathematical Medicine and Biology, 38, pp. 292-298. (doi: 10.1093/imammb/dqab005)

Stewart, C., Taylor-Rowan, M., Soiza, R. L., Quinn, T. J., Loke, Y. K., Myint, P. K. (2021) Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review. Therapeutic Advances in Drug Safety, 12, pp. 20420986211016645. (doi: 10.1177/20420986211016645)

Jacobs, M., Benovoy, M., Chang, L.-C., Corcoran, D., Berry, C., Arai, A. E., Hsu, L.-Y. (2021) Automated segmental analysis of fully quantitative myocardial blood flow maps by first-pass perfusion cardiovascular magnetic resonance. IEEE Access, 9, pp. 52796-52811. (doi: 10.1109/ACCESS.2021.3070320)

Kamdar, A., Sykes, R., Morrow, A., Mangion, K., Berry, C. (2021) Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis. Reviews in Cardiovascular Medicine, 22, pp. 1479-1490. (doi: 10.31083/j.rcm2204152)

Da Silva Costa, A., Mortensen, P., Hortigon-Vinagre, M. P., van der Heyden, M. A. G., Burton, F. L., Gao, H., Simitev, R. D., Smith, G. L. (2021) Electrophysiology of hiPSC-cardiomyocytes co-cultured with HEK cells expressing the inward rectifier channel. International Journal of Molecular Sciences, 22, (doi: 10.3390/ijms22126621)

Anderson, J. J., Welsh, P., Ho, F. K., Ferguson, L. D., Welsh, C. E., Pellicori, P., Cleland, J. G.F., Forbes, J., Iliodromiti, S., Boyle, J., Lindsay, R., Celis-Morales, C., Gray, S. R., Katikireddi, S. V., Gill, J. M. R., Pell, J. P., Sattar, N. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2021-002176)

Boguslavskyi, A., Tokar, S., Prysyazhna, O., Rudyk, O., Sanchez-Tatay, D., Lemmey, H. A.L., Dora, K. A., Garland, C. J., Warren, H. R., Doney, A., Palmer, C. N.A., Caulfield, M. J., Vlachaki Walker, J., Howie, J., Fuller, W., Shattock, M. J. (2021) Phospholemman phosphorylation regulates vascular tone, blood pressure and hypertension in mice and man. Circulation, 143, pp. 1123-1138. (doi: 10.1161/CIRCULATIONAHA.119.040557)

McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N., Johnson, M.K., Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-050281)

Wijkman, M. O., Malachias, M. V.B., Claggett, B. L., Cheng, S., Matsushita, K., Shah, A. M., Jhund, P. S., Coresh, J., Solomon, S. D., Vardeny, O. (2021) Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study. Journal of Clinical Hypertension, 23, pp. 1887-1896. (doi: 10.1111/jch.14269)

Shoaib, A., Van Spall, H. G.C., Wu, J., Cleland, J. G.F., McDonagh, T. A., Rashid, M., Mohamed, M. O., Ahmed, F. Z., Deanfield, J., de Belder, M., Gale, C. P., Mamas, M. A. (2021) Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. 378-387. (doi: 10.1093/ehjqcco/qcab040)

Shah, P., Pellicori, P., Hanning, I., Zhang, J., Clark, A. L., Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22, (doi: 10.1186/s12882-021-02562-0)

Sykes, R., Briscoe, M., Krystofiak, T., Peck, O., Mangion, K., Berry, C. (2021) Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to de-risk clinical trials. Open Heart, 8, (doi: 10.1136/openhrt-2021-001633)

Ang, D. T. Y., Berry, C. (2021) What an interventionalist needs to know about INOCA. Interventional Cardiology Review, 16, (doi: 10.15420/icr.2021.16)

Sykes, R., Doherty, D., Mangion, K., Morrow, A., Berry, C. (2021) What an interventionalist needs to know about MI with non-obstructive coronary arteries. Interventional Cardiology Review, 16, (doi: 10.15420/icr.2021.10)

Brown, R., Welsh, P., Logue, J. (2020) Systematic review of clinical guidelines for lipid-lowering in the secondary prevention of cardiovascular disease events. Open Heart, 7, (doi: 10.1136/openhrt-2020-001396)

Rossitto, G., Mary, S., McAllister, C., Neves, K. B., Haddow, L., Rocchiccioli, J. P., Lang, N. N., Murphy, C. L., Touyz, R. M., Petrie, M. C., Delles, C. (2020) Reduced lymphatic reserve in heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 76, pp. 2817-2829. (doi: 10.1016/j.jacc.2020.10.022)

Goncalves Soares, A., Kilpi, F., Fraser, A., Nelson, S. M., Sattar, N., Welsh, P. I., Tilling, K., Lawlor, D. A. (2020) Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC) Scientific Reports, 10, (doi: 10.1038/s41598-020-77871-9)

Purcell, C., Daw, P., Kerr, C., Cleland, J., Cowie, A., Dalal, H., Ibbotson, T., Murphy, C., Taylor, R. (2020) Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF) BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040771)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116, pp. 2185-2196. (doi: 10.1093/cvr/cvaa209)

Ferguson, A. C., Tank, R., Lyall, L. M., Ward, J., Welsh, P., Celis-Morales, C., McQueenie, R., Strawbridge, R. J., Mackay, D. F., Pell, J. P., Smith, D. J., Sattar, N., Cavanagh, J., Lyall, D. M. (2020) Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank. Journal of Hypertension, 38, pp. 2482-2489. (doi: 10.1097/HJH.0000000000002579)

Mangion, K., Loughrey, C., Auger, D. A., McComb, C., Lee, M. M., Corcoran, D., McEntegart, M., Davie, A., Good, R., Lindsay, M., Eteiba, H., Rocchiccioli, J. P., Watkins, S., Hood, S., Shaukat, A., Haig, C., Epstein, F. H., Berry, C. (2020) Displacement encoding with stimulated echoes enables the identification of infarct transmurality early postmyocardial infarction. Journal of Magnetic Resonance Imaging, 52, pp. 1722-1731. (doi: 10.1002/jmri.27295)

Pellicori, P., Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M., Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7, pp. 3401-3407. (doi: 10.1002/ehf2.12891)

Felker, G. M., Solomon, S. D., McMurray, J. J.V., Cleland, J. G.F., Abbasi, S. A., Malik, F. I., Zhang, H., Globe, G., Teerlink, J. R. (2020) Effects of omecamtiv mecarbil on symptoms and health-related quality of life in patients with chronic heart failure: results from the COSMIC-HF study. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.120.007814)

Ferreira, J. P., Docherty, K. F., Stienen, S., Jhund, P. S., Claggett, B. L., Solomon, S. D., Petrie, M. C., Gregsone, J., Pocock, S. L., Zannad, F., McMurray, J. (2020) Estimating the lifetime benefits of treatments for heart failure. JACC: Heart Failure, 8, pp. 984-995. (doi: 10.1016/j.jchf.2020.08.004)

Main, A., Fuller, W., Baillie, G. S. (2020) Post-translational regulation of cardiac myosin binding protein-C: a graphical review. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109788)

Wamil, M., McMurray, J. J.V., Scott, C. A.B., Coleman, R. L., Sun, Y., Standl, E., Rydén, L., Holman, R. R. (2020) Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial. Diabetes Research and Clinical Practice, 170, (doi: 10.1016/j.diabres.2020.108488)

Kristensen, S. L., Castagno, D., Shen, L., Jhund, P., Docherty, K., Rørth, R., Abraham, W. T., Desai, A., Dickstein, K., Rouleau, J. L., Zile, M. R., Swedberg, K., Packer, M., Solomon, S. D., Køber, L., McMurray, J. J.V. (2020) Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM‐HF and ATMOSPHERE. European Journal of Heart Failure, 22, pp. 2370-2379. (doi: 10.1002/ejhf.1972)

Brown, O., Costanzo, P., Clark, A. L., Condorelli, G., Cleland, J. G.F., Sathyapalan, T., Hepburn, D., Kilpatrick, E. S., Atkin, S. L. (2020) Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus. Cardiovascular Endocrinology and Metabolism, 9, pp. 177-182. (doi: 10.1097/XCE.0000000000000202)

Yeoh, S. E., Dewan, P., Desai, A. S., Solomon, S. D., Rouleau, J. L., Lefkowitz, M., Rizkala, A., Swedberg, K., Zile, M. R., Jhund, P. S., Packer, M., McMurray, J. J.V. (2020) Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF. ESC Heart Failure, 7, pp. 3355-3364. (doi: 10.1002/ehf2.12972)

O'Toole, D., Zaeri, A. A. I., Nicklin, S. A., French, A. T., Loughrey, C. M., Martin, T. P. (2020) Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109770)

McFall, A., Nicklin, S. A., Work, L. M. (2020) The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: insight from preclinical stroke studies and therapeutic potential. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109809)

Pashova, A., Work, L.M., Nicklin, S.A. (2020) The role of extracellular vesicles in neointima formation post vascular injury. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109783)

Gök, C., Fuller, W. (2020) Topical review: shedding light on molecular and cellular consequences of NCX1 palmitoylation. Cellular Signalling, 76, (doi: 10.1016/j.cellsig.2020.109791)

Mackenzie, I. S. et al. (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet, 396, pp. 1745-1757. (doi: 10.1016/S0140-6736(20)32234-0)

Taylor-Rowan, M., Nafisi, S., Burton, J. K., Quinn, T. J. (2020) Informant-based screening tools for diagnosis of dementia, an overview of systematic reviews of test accuracy studies protocol. Systematic Reviews, 9, (doi: 10.1186/s13643-020-01530-3)

Ho, F. K., Celis-Morales, C. A., Gray, S. R., Katikireddi, S. V., Niedzwiedz, C. L., Hastie, C., Ferguson, L. D., Berry, C., Mackay, D. F., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2020) Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040402)

Briscoe, M., Sykes, R. A., Krysztofiak, T., Peck, O. H., Mangion, K., Berry, C. (2020) Clinical Significance of Coronavirus Disease 2019 in Hospitalized Patients With Myocardial Injury. (doi: 10.1161/circ.142.suppl_3.15932)

Briscoe, M., Sykes, R. A., Krysztofiak, T., Mangion, K., Peck, O. H., Berry, C. (2020) Clinical Significance of Troponin Elevation in a Contemporary Hospitalized Population: Endotypes, Morbidity and In-hospital Mortality. (doi: 10.1161/circ.142.suppl_3.14870)

Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76, pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544)

Petermann-Rocha, F., Hanlon, P., Gray, S. R., Welsh, P., Gill, J. M.R., Foster, H., Katikireddi, S. V., Lyall, D., Mackay, D. F., O'Donnell, C., Sattar, N., Nicholl, B. I., Pell, J. P., Jani, B. D., Ho, F. K., Mair, F. S., Celis-Morales, C. (2020) Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Medicine, 18, (doi: 10.1186/s12916-020-01822-4)

Ho, F. K., Petermann-Rocha, F., Gray, S. R., Jani, B. D., Katikireddi, S. V., Niedzwiedz, C. L., Foster, H., Hastie, C. E., Mackay, D. F., Gill, J. M.R., O'Donnell, C., Welsh, P., Mair, F., Sattar, N., Celis-Morales, C. A., Pell, J. P. (2020) Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE, 15, (doi: 10.1371/journal.pone.0241824)

Dietrichs, E. S., McGlynn, K., Allan, A., Connolly, A., Bishop, M., Burton, F., Kettlewell, S., Myles, R., Tveita, T., Smith, G. L. (2020) Moderate but not severe hypothermia causes pro-arrhythmic changes in cardiac electrophysiology. Cardiovascular Research, 116, pp. 2081-2090. (doi: 10.1093/cvr/cvz309)

McEwan, P., Darlington, O., McMurray, J. J.V., Jhund, P. S., Docherty, K. F., Böhm, M., Petrie, M. C., Bergenheim, K., Qin, L. (2020) Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF. European Journal of Heart Failure, 22, pp. 2147-2156. (doi: 10.1002/ejhf.1978)

Ferreira, J. P., Dewan, P., Jhund, P., Lorenzo-Almorós, A., Duarte, K., Petrie, M., Carson, P. E., McKelvie, R., Komajda, M., Zile, M., Zannad, F., McMurray, J. J.V. (2020) Covariate adjusted reanalysis of the I-Preserve trial. Clinical Research in Cardiology, 109, pp. 1358-1365. (doi: 10.1007/s00392-020-01632-x)

McMurray, J. J.V. (2020) EMPEROR‐Reduced: confirming sodium–glucose co‐transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction. European Journal of Heart Failure, 22, pp. 1987-1990. (doi: 10.1002/ejhf.2006)

Docherty, K., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Kober, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2020) Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy. Diabetes Care, 43, pp. 2878-2881. (doi: 10.2337/dc20-1402)

Charla, E., Mercer, J., Maffia, P., Nicklin, S. (2020) Extracellular vesicle signalling in atherosclerosis. Cellular Signalling, 75, (doi: 10.1016/j.cellsig.2020.109751)

Seferović, P. M. et al. (2020) Heart Failure Association of the European Society of Cardiology update on sodium glucose co‐transporter‐2 inhibitors in heart failure (an update on the Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology) European Journal of Heart Failure, 22, pp. 1984-1986. (doi: 10.1002/ejhf.2026)

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7, (doi: 10.3310/eme07050)

Teerlink, J. R. et al. (2020) Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials. European Journal of Heart Failure, 22, pp. 2160-2171. (doi: 10.1002/ejhf.2015)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007)

Richardson, S. J., Carroll, C. B., Close, J., Gordon, A. L., O'Brien, J., Quinn, T. J., Rochester, L., Sayer, A. A., Shenkin, S. D., van der Velde, N., Woo, J., Witham, M. D. (2020) Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities. Age and Ageing, 49, pp. 901-906. (doi: 10.1093/ageing/afaa149)

Ferreira, J. P., Mogensen, U. M., Jhund, P. S., Desai, A. S., Zile, M. R., Rossignol, P., Zannad, F., Packer, M., Solomon, S. D., McMurray, J. J.V. (2020) Serum potassium in the PARADIGM-HF trial. European Journal of Heart Failure, 22, pp. 2056-2064. (doi: 10.1002/ejhf.1987)

Selvaraj, S., Claggett, B. L., Pfeffer, M. A., Desai, A. S., McCausland, F. R., McGrath, M. M., Anand, I. S., van van Veldhuisen, D. J., Kober, L., Janssens, S., Cleland, J. G.F., Pieske, B., Rouleau, J. L., Zile, M. R., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2020) Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. European Journal of Heart Failure, 22, pp. 2093-2101. (doi: 10.1002/ejhf.1984)

Dewan, P., Jackson, A., Jhund, P. S., Shen, L., Ferreira, J. P., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure, 22, pp. 2123-2133. (doi: 10.1002/ejhf.1832)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R., Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109, pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9)

Foster, H. M.E., Ho, F. K., Sattar, N., Welsh, P., Pell, J. P., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A. (2020) Understanding how much TV is too much: a non-linear analysis of the association between television viewing time and adverse health outcomes. Mayo Clinic Proceedings, 95, pp. 2429-2441. (doi: 10.1016/j.mayocp.2020.04.035)

Docherty, K. F. et al. (2020) Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction: a prespecified analysis of DAPA-HF. Circulation, 142, pp. 1623-1632. (doi: 10.1161/CIRCULATIONAHA.120.047480)

Heerspink, H. J.L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F.E., McMurray, J. J.V., Lindberg, M., Rossing, P., Sjöström, C. D., Toto, R. D., Langkilde, A.-M., Wheeler, D. C. (2020) Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 383, pp. 1436-1446. (doi: 10.1056/NEJMoa2024816)

Kunadian, V., Chieffo, A., Camici, P. G., Berry, C., Escaned, J., Maas, A. H. E. M., Prescott, E., Karam, N., Appelman, Y., Fraccaro, C., Louise Buchanan, G., Manzo-Silberman, S., Al-Lamee, R., Regar, E., Lansky, A., Abbott, J. D., Badimon, L., Duncker, D. J., Mehran, R., Capodanno, D., Baumbach, A. (2020) An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. European Heart Journal, 41, pp. 3504-3520. (doi: 10.1093/eurheartj/ehaa503)

Wheeler, D. C. et al. (2020) The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrology Dialysis Transplantation, 35, pp. 1700-1711. (doi: 10.1093/ndt/gfaa234)

Lang, N. N., Dobbin, S. J.H., Petrie, M. C. (2020) Vericiguat in worsening heart failure – agonising over, or celebrating, agonism. Cardiovascular Research, 116, pp. e152-e155. (doi: 10.1093/cvr/cvaa247)

Solomon, S. D., Jhund, P. S., Claggett, B. L., Dewan, P., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Inzucchi, S. E., Desai, A. S., Bengtsson, O., Lindholm, D., Sjostrand, M., Langkilde, A. M., McMurray, J. J.V. (2020) Effect of dapagliflozin in patients with HFrEF treated with sacubitril/valsartan: the DAPA-HF trial. JACC: Heart Failure, 8, pp. 811-818. (doi: 10.1016/j.jchf.2020.04.008)

Rahimi, K., Nazarzadeh, M., Pinho-Gomes, A.-C., Woodward, M., Salimi-Khorshidi, G., Ohkuma, T., Fitzpatrick, R., Tarassenko, L., Denis, M., Cleland, J. (2020) Home monitoring with technology-supported management in chronic heart failure: a randomised trial. Heart, 106, pp. 1573-1578. (doi: 10.1136/heartjnl-2020-316773)

von Haehling, S., Garfias Macedo, T., Valentova, M., Anker, M. S., Ebner, N., Bekfani, T., Haarmann, H., Schefold, J. C., Lainscak, M., Cleland, J. G.F., Doehner, W., Hasenfuss, G., Anker, S. D. (2020) Muscle wasting as an independent predictor of survival in patients with chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle, 11, pp. 1242-1249. (doi: 10.1002/jcsm.12603)

Malachias, M. V.B., Jhund, P., Claggett, B. L., Wijkman, M. O., Bentley-Lewis, R., Chaturvedi, N., Desai, A. S., Haffner, S. M., Parving, H.-H., Prescott, M. F., Solomon, S. D., De Zeeuw, D., McMurray, J. J.V., Pfeffer, M. A. (2020) N-terminal pro-B-type natriuretic peptide by itself predicts death and cardiovascular events in high-risk patients with type 2 diabetes. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.120.017462)

Carter, B., Collins, J.T., Barlow-Pay, F., Rickard, F., Bruce, E., Verduri, A., Quinn, T.J., Mitchell, E., Price, A., Vilches-Moraga, A., Stechman, M.J., Short, R., Einarsson, A., Braude, P., Moug, S., Myint, P.K., Hewitt, J., Pearce, L., McCarthy, K., , , on behalf of the COPE Study Collaborators, (2020) Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial study (COVID in Older PEople) Journal of Hospital Infection, 106, pp. 376-384. (doi: 10.1016/j.jhin.2020.07.013)

Butt, J. H., Fosbøl, E. L., Gerds, T. A., Andersson, C., McMurray, J. J.V., Petrie, M. C., Gustafsson, F., Madelaire, C., Kristensen, S. L., Gislason, G. H., Torp-Pedersen, C., Køber, L., Schou, M. (2020) Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort. European Journal of Heart Failure, 22, pp. 1777-1785. (doi: 10.1002/ejhf.1800)

Docherty, K. F., Vaduganathan, M., Solomon, S. D., McMurray, J. J.V. (2020) Sacubitril/valsartan: neprilysin inhibition 5 Years after PARADIGM-HF. JACC: Heart Failure, 8, pp. 800-810. (doi: 10.1016/j.jchf.2020.06.020)

Dewan, P., Jhund, P. S., McMurray, J. J.V. (2020) VICTORIA in context. European Journal of Heart Failure, 22, pp. 1747-1751. (doi: 10.1002/ejhf.1833)

Mc Causland, F. R., Lekowitz, M. P., Claggett, B., Anavekar, N. S., Senni, M., Gori, M., Jhund, P. S., McGrath, M. M., Packer, M., Shi, V., Van Veldhuisen, D. J., Zannad, F., Comin-Colet, J., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2020) Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction. Circulation, 142, pp. 1236-1245. (doi: 10.1161/CIRCULATIONAHA.120.047643)

Burton, J.K., Goodman, C., Guthrie, B., Gordon, A.L., Hanratty, B., Quinn, T.J. (2020) Closing the UK care home data gap - methodological challenges and solutions. International Journal of Population Data Sciences, 5, (doi: 10.23889/ijpds.v5i4.1391)

Serenelli, M. et al. (2020) Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) European Heart Journal, 41, pp. 3402-3418. (doi: 10.1093/eurheartj/ehaa496)

Dowsett, L., Higgins, E., Alanazi, S., Alshuwayer, N. A., Leiper, F. C., Leiper, J. (2020) ADMA: A key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. Journal of Clinical Medicine, 9, (doi: 10.3390/jcm9093026)

Jackson, A. M. et al. (2020) Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF. Circulation, 142, pp. 1040-1054. (doi: 10.1161/CIRCULATIONAHA.120.047077)

Ganesh, A., Taylor-Rowan, M., Quinn, T. J. (2020) Reader response: Outcomes of patients with stroke treated with thrombolysis according to prestroke Rankin Scale scores. Neurology, 95, pp. 506-507. (doi: 10.1212/WNL.0000000000010516)

Ford, T. J., Corcoran, D., Padmanabhan, S., Aman, A., Rocchiccioli, P., Good, R., McEntegart, M., Maguire, J. J., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., Sattar, N., Hsu, L.-Y., Arai, A. E., Oldroyd, K. G., Touyz, R. M., Davenport, A. P., Berry, C. (2020) Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. European Heart Journal, 41, pp. 3239-3252. (doi: 10.1093/eurheartj/ehz915)

Vaduganathan, M., McMurray, J. J.V., Solomon, S. D. (2020) Angiotensin receptor–neprilysin inhibition in heart failure with preserved ejection fraction: lessons from PARAGON‐HF. European Journal of Heart Failure, 22, pp. 1525-1530. (doi: 10.1002/ejhf.1976)

Sattar, N., Ho, F. K., Gill, J. M.R., Ghouri, N., Gray, S. R., Celis-Morales, C. A., Katikireddi, S. V., Berry, C., Pell, J. P., McMurray, J. J.V., Welsh, P. (2020) BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, pp. 1149-1151. (doi: 10.1016/j.dsx.2020.06.060)

Cameron, A. C., McMahon, K., Hall, M., Neves, K. B., Rios, F. J., Montezano, A. C., Welsh, P., Waterston, A., White, J., Mark, P. B., Touyz, R. M., Lang, N. N. (2020) Comprehensive characterisation of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer. JACC: CardioOncology, 2, pp. 443-455. (doi: 10.1016/j.jaccao.2020.06.004)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22, pp. 1649-1658. (doi: 10.1002/ejhf.1933)

Pellicori, P., Ferreira, J. P., Mariottoni, B., Brunner-La Rocca, H.-P., Ahmed, F. Z., Job, V., Collier, T., Cuthbert, J. J., Petutschnigg, J., Mujaj, B., Girerd, N., González, A., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Latini, R., Rossignol, P., Zannand, F., Cleland, J. G.F. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22, pp. 1711-1723. (doi: 10.1002/ejhf.1716)

Suzuki, K., Claggett, B., Minamisawa, M., Packer, M., Zile, M. R., Rouleau, J., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Zucker, S. D., Solomon, S. D. (2020) Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction. European Journal of Heart Failure, 22, pp. 1662-1671. (doi: 10.1002/ejhf.1853)

Todd, O. M., Burton, J. K., Dodds, R. M., Hollinghurst, J., Lyons, R. A., Quinn, T. J., Schneider, A., Walesby, K. E., Wilkinson, C., Conroy, S., Gale, C. P., Hall, M., Walters, K., Clegg, A. P. (2020) New horizons in the use of routine data for ageing research. Age and Ageing, 49, pp. 716-722. (doi: 10.1093/ageing/afaa018)

Seferović, P. M. et al. (2020) Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 22, pp. 1495-1503. (doi: 10.1002/ejhf.1954)

Collins, J. T., Short, R., Carter, B., Verduri, A., Myint, P. K., Quinn, T. J., Vilches-Moraga, A., Stechman, M. J., Moug, S., McCarthy, K., Hewitt, J. (2020) The clinical frailty scale: estimating the prevalence of frailty in older patients hospitalised with COVID-19. The COPE study. Geriatrics, 5, (doi: 10.3390/geriatrics5030058)

Aksentijević, D., Karlstaedt, A., Basalay, M. V., O’Brien, B. A., Sanchez-Tatay, D., Eminaga, S., Thakker, A., Tennant, D. A., Fuller, W., Eykyn, T. R., Taegtmeyer, H., Shattock, M. J. (2020) Intracellular sodium elevation reprograms cardiac metabolism. Nature Communications, 11, (doi: 10.1038/s41467-020-18160-x)

Ford, T. J., Ong, P., Sechtem, U., Beltrame, J., Camici, P. G., Crea, F., Kaski, J.-C., Bairey Merz, C. N., Pepine, C. J., Shimokawa, H., Berry, C. (2020) Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how and when. JACC: Cardiovascular Interventions, 13, pp. 1847-1864. (doi: 10.1016/j.jcin.2020.05.052)

Rossitto, G., Mary, S., Chen, J. Y., Bodder, P., Chew, K. S., Neves, K. B., Alves, R. L., Montezano, A. C., Welsh, P., Petrie, M. C., Graham, D., Touyz, R. M., Delles, C. (2020) Tissue sodium excess is not hypertonic and reflects extracellular volume expansion. Nature Communications, 11, (doi: 10.1038/s41467-020-17820-2)

Ferguson, A. C., Tank, R., Lyall, L. M., Strawbridge, R., Ward, J., Celis-Morales, C., Ho, F., Whelan, C. D., Gill, J., Welsh, P., Anderson, J. J., Mark, P. B., Smith, D. J., Pell, J. P., Cavanagh, J., Sattar, N., Lyall, D. M. (2020) Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769) Journal of Alzheimer's Disease, 76, pp. 1541-1551. (doi: 10.3233/JAD-200338)

McClure, J. D., Ramsay, J. C., Berry, C. (2020) Pooled analysis of bleeding and major adverse cardiovascular events in clinical trials of time-constrained dual-antiplatelet therapy after percutaneous coronary intervention. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.120.017109)

Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewksi, M., Maffia, P., D'Acquisto, F., Nicklin, S. A., Marian, A. J., Nosalski, R., Murray, E. C., Guzik, B., Berry, C., Touyz, R. M., Kreutz, R., Wang, D. W., Bhella, D., Sagliocco, O., Crea, F., Thomson, E. C., McInnes, I. B. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116, pp. 1666-1687. (doi: 10.1093/cvr/cvaa106)

Wright, A. K., Welsh, P., Gill, J. M.R., Kontopantelis, E., Emsley, R., Buchan, I., Ashcroft, D. M., Rutter, M. K., Sattar, N. (2020) Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia, 63, pp. 1542-1553. (doi: 10.1007/s00125-020-05169-6)

Rossignol, P., Duarte, K., Girerd, N., Karoui, M., McMurray, J. J.V., Swedberg, K., van Veldhuisen, D. J., Pocock, S., Dickstein, K., Zannad, F., Pitt, B. (2020) Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction. European Journal of Heart Failure, 22, pp. 1402-1411. (doi: 10.1002/ejhf.1724)

Berglund, E., Wallentin, L., Oldgren, J., Renlund, H., Alexander, J. H., Granger, C. B., Hohnloser, S. H., Hylek, E. M., Lopes, R. D., McMurray, J. J.V., Lytsy, P. (2020) Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial. European Journal of Preventive Cardiology, 27, pp. 1311-1319. (doi: 10.1177/2047487319886959)

Ouwerkerk, W., Teng, T.-H. K., Tromp, J., Ting Tay, W., Cleland, J. G., van Veldhuisen, D. J., Dickstein, K., Ng, L. L., Lang, C. C., Anker, S. D., Zannad, F., Hung, C.-L., Sawhney, J.P.S., Naik, A., Shimizu, W., Hagiwara, N., Singh Wander, G., Anand, I., Richards, A. M., Voors, A. A., Lam, C. S.P. (2020) Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. European Journal of Heart Failure, 22, pp. 1472-1482. (doi: 10.1002/ejhf.1869)

Zou, Z.-G., Rios, F. J., Neves, K. B., Alves-Lopes, R., Ling, J., Baillie, G. S., Gao, X., Fuller, W., Camargo, L. L., Gudermann, T., Chubanov, V., Montezano, A. C., Touyz, R. M. (2020) Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function. Clinical Science, 134, pp. 2019-2035. (doi: 10.1042/CS20200827)

Lombardi, C. M., Ferreira, J. P., Carubelli, V., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A., Metra, M. (2020) Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clinical Research in Cardiology, 109, pp. 967-977. (doi: 10.1007/s00392-019-01588-7)

ter Maaten, J. M., Martens, P., Damman, K., Dickstein, K., Ponikowski, P., Lang, C. C., Ng, L. L., Anker, S. D., Samani, N. J., Filippatos, G., Cleland, J. G., Zannad, F., Hillege, H. L., van Veldhuisen, D. J., Metra, M., Voors, A. A., Mullens, W. (2020) Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clinical Research in Cardiology, 109, pp. 1048-1059. (doi: 10.1007/s00392-020-01598-w)

Petermann-Rocha, F., Ho, F. K., Welsh, P., Mackay, D., Brown, R., Gill, J. M.R., Sattar, N., Gray, S. R., Pell, J. P., Celis-Morales, C. A. (2020) Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: a prospective study from UK Biobank. Maturitas, 138, pp. 69-75. (doi: 10.1016/j.maturitas.2020.04.017)

Harris, K., Oshima, M., Sattar, N., Würtz, P., Jun, M., Welsh, P., Hamet, P., Harrap, S., Poulter, N., Chalmers, J., Woodward, M. (2020) Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study. Diabetologia, 63, pp. 1637-1647. (doi: 10.1007/s00125-020-05162-z)

Bomer, N., Grote Beverborg, N., Hoes, M. F., Streng, K. W., Vermeer, M., Dokter, M. M., IJmker, J., Anker, S. D., Cleland, J. G.F., Hillege, H. L., Lang, C. C., Ng, L. L., Samani, N. J., Tromp, J., Veldhuisen, D. J., Touw, D. J., Voors, A. A., Meer, P. (2020) Selenium and outcome in heart failure. European Journal of Heart Failure, 22, pp. 1415-1423. (doi: 10.1002/ejhf.1644)

Hewitt, J., Carter, B., Vilches-Moraga, A., Quinn, T. J., Braude, P., Verduri, A., Pearce, L., Stechman, M., Short, R., Price, A., Collins, J. T., Bruce, E., Einarsson, A., Rickard, F., Mitchell, E., Holloway, M., Hesford, J., Barlow-Pay, F., Clini, E., Myint, P. K., Moug, S. J., McCarthy, K., on behalf of the COPE Study Collaborators, . (2020) The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health, 5, pp. e444-e451. (doi: 10.1016/S2468-2667(20)30146-8)

Campbell, R. T., Jasilek, A., Mischak, H., Nkuipou-Kenfack, E., Latosinska, A., Welsh, P. I., Jackson, C. E., Cannon, J., McConnachie, A., Delles, C., McMurray, J. J.V. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7, pp. 1595-1604. (doi: 10.1002/ehf2.12708)

Shi, C., van der Wal, H. H., Silljé, H. H.W., Dokter, M. M., van den Berg, F., Huizinga, L., Vriesema, M., Post, J., Anker, S. D., Cleland, J. G., Ng, L. L., Samani, N. J., Dickstein, K., Zannad, F., Lang, C. C., van Haelst, P. L., Gietema, J. A., Metra, M., Ameri, P., Canepa, M., van Veldhuisen, D. J., Voors, A. A., de Boer, R. A. (2020) Tumor biomarkers: association with heart failure outcomes. Journal of Internal Medicine, 288, pp. 207-218. (doi: 10.1111/joim.13053)

Salerno, S., Solvang-Garten, K., Smith, G. L., Stølen, T., Kelly, A. (2020) Two-photon excitation of FluoVolt allows improved interrogation of transmural electrophysiological function in the intact mouse heart. Progress in Biophysics and Molecular Biology, 154, pp. 11-20. (doi: 10.1016/j.pbiomolbio.2019.08.007)

Dobbie, L. J., Mackin, S. T., Hogarth, K., Lonergan, F., Kannenkeril, D., Brooksbank, K., Delles, C. (2020) Validation of semi-automated flow mediated dilation measurement in healthy volunteers. Blood Pressure Monitoring, 25, pp. 216-223. (doi: 10.1097/MBP.0000000000000448)

Plain, F., Howie, J., Kennedy, J., Brown, E., Shattock, M. J., Fraser, N. J., Fuller, W. (2020) Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase. Communications Biology, 3, (doi: 10.1038/s42003-020-01145-3)

MacDonald, E. A., Madl, J., Greiner, J., Ramadan, A. F., Wells, S. M., Torrente, A. G., Kohl, P., Rog-Zielinska, E. A., Quinn, T. A. (2020) Sinoatrial node structure, mechanics, electrophysiology and the chronotropic response to stretch in rabbit and mouse. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00809)

Fong, L. C. W., Ford, T. J., da Costa, B. R., Jüni, P., Berry, C. (2020) Bias and loss to follow-up in cardiovascular randomized trials: a systematic review. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.119.015361)

Bulluck, H., Carberry, J., Carrick, D., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Mahrous, A., Ford, I., Oldroyd, K. G., Berry, C. (2020) Redefining adverse and reverse left ventricular remodeling by cardiovascular magnetic resonance following ST-segment elevation myocardial infarction and their implications on long-term prognosis. Circulation: Cardiovascular Imaging, 13, (doi: 10.1161/CIRCIMAGING.119.009937)

Sattar, N., Welsh, P. (2020) The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence? European Heart Journal, 41, pp. 2678-2680. (doi: 10.1093/eurheartj/ehaa398)

Lees, J. S., Mangion, K., Rutherford, E., Witham, M. D., Woodward, R., Roditi, G., Hopkins, T., Brooksbank, K., Jardine, A., Mark, P. B. (2020) Vitamin K for kidney transplant organ recipients: investigating vEssel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart, 7, (doi: 10.1136/openhrt-2019-001070)

Vaduganathan, M., Claggett, B. L., Jhund, P., Cunningham, J. W., Ferreira, J. P., Zannad, F., Packer, M., Fonarow, G. C., McMurray, J., Solomon, S. D. (2020) Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet, 396, pp. 121-128. (doi: 10.1016/S0140-6736(20)30748-0)

Vaduganathan, M., Jhund, P. S., Claggett, B. L., Packer, M., Widimský, J., Seferovic, P., Rizkala, A., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2020) A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction. European Heart Journal, 41, pp. 2356-2362. (doi: 10.1093/eurheartj/ehaa184)

Lam, C. S.P., Voors, A. A., Piotr, P., McMurray, J. J.V., Solomon, S. D. (2020) Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. European Heart Journal, 41, pp. 2353-2355. (doi: 10.1093/eurheartj/ehaa158)

McFall, A. et al. (2020) UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings. Journal of Cerebral Blood Flow and Metabolism, 40, pp. 1402-1414. (doi: 10.1177/0271678X20910552)

Cleland, J. G.F., Li, C., Jones, Y. (2020) Artificial intelligence needs clinical intelligence to succeed. JACC: Heart Failure, 8, pp. 588-591. (doi: 10.1016/j.jchf.2020.06.002)

Dobbin, S. J.H., Mangion, K., Berry, C., Roditi, G., Basak, S., Sourbron, S., White, J., Venugopal, B., Touyz, R. M., Jones, R. J., Petrie, M. C., Lang, N. N. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22, pp. 1276-1277. (doi: 10.1002/ejhf.1847)

Pan, D., Pellicori, P., Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J., Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26, pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002)

Docherty, K. F., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Desai, A. S., Diez, M., Howlett, J. G., Katova, T., Ljungman, C. E. A., O’Meara, E., Petrie, M. C., Schou, M., Verma, S., Vinh, P. N., Solomon, S. D., McMurray, J. J.V. (2020) Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. European Heart Journal, 41, pp. 2379-2392. (doi: 10.1093/eurheartj/ehaa183)

Dewan, P., Solomon, S. D., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Anand, I. S., Bělohlávek, J., Chopra, V. K., Dukát, A., Kitakaze, M., Merkely, B., O'Meara, E., Schou, M., Vinh, P. N., McMurray, J. J.V. (2020) Efficacy and safety of sodium–glucose co‐transporter 2 inhibition according to left ventricular ejection fraction in DAPA‐HF. European Journal of Heart Failure, 22, pp. 1247-1258. (doi: 10.1002/ejhf.1867)

Shin, S.-H., Claggett, B., Pfeffer, M. A., Skali, H., Liu, J., Aguilar, D., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Lewis, E. F., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Tardif, J.-C., Solomon, S. D., for the ELIXA Investigators, . (2020) Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. European Journal of Heart Failure, 22, pp. 1133-1143. (doi: 10.1002/ejhf.1790)

Sattar, N., McInnes, I. B., McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142, pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659)

Taya, U., Wage, R., Newsome, S., Manivarmane, R., Izgi, C., Muthumala, A., Dungu, J. N., Assomull, R., Hatipoglu, S., Halliday, B. P., Lota, A. S., Ware, J. S., Gregson, J., Frenneaux, M., Cook, S. A., Pennell, D. J., Scott, A. D., Cleland, J. G.F., Prasad, S. K. (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. European Journal of Heart Failure, 22, pp. 1160-1170. (doi: 10.1002/ejhf.1734)

Riddell, A., McBride, M., Braun, T., Nicklin, S. A., Cameron, E., Loughrey, C. M., Martin, T. P. (2020) RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovascular Research, 116, pp. 1410-1423. (doi: 10.1093/cvr/cvaa034)

Hastie, C. E., Mackay, D. F., Ho, F., Celis-Morales, C. A., Katikireddi, S. V., Niedzwiedz, C. L., Jani, B. D., Welsh, P., Mair, F. S., Gray, S. R., O'Donnell, C. A., Gill, J. M.R., Sattar, N., Pell, J. P. (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, pp. 561-565. (doi: 10.1016/j.dsx.2020.04.050)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology 2019: heart failure. Romanian Journal of Cardiology, 30, pp. 185-204. (doi: 10.47803/rjc.2020.30.2.185)

Al Ozairi, E., Alsaeed, D., Taliping, D., Jalali, M., El Samad, A., Mashankar, A., Taghadom, E., Guess, N., Gill, J. M.R., Sattar, N., Gray, C., Welsh, P., Gray, S. R. (2020) Protocol for a randomised controlled trial to investigate the effect of home and gym-based resistance exercise training on glycaemic control, body composition and muscle strength. Trials, 21, (doi: 10.1186/s13063-020-04480-2)

Williams, J. J.L., Baillie, G. S., Palmer, T. M. (2020) Investigation of Novel Cavin-1/Suppressor of Cytokine Signaling 3 (SOCS3) Interactions by Coimmunoprecipitation, Peptide Pull-Down, and Peptide Array Overlay Approaches. Springer

Al-Hussaini, A., Abdelaty, A. M.S.E.K., Gulsin, G. S., Arnold, J. R., Garcia-Guimaraes, M., Premawardhana, D., Budgeon, C., Wood, A., Natarajan, N., Mangion, K., Rakhit, R., Hoole, S. P., Johnson, T. W., Berry, C., Hudson, I., Gershlick, A. H., Ladwiniec, A., Kovac, J., Squire, I., Samani, N. J., Plein, S., McCann, G. P., Adlam, D. (2020) Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management. European Heart Journal, 41, pp. 2197-2205. (doi: 10.1093/eurheartj/ehz895)

Gök, C., Plain, F., Robertson, A., Howie, J., Baillie, G. S., Fraser, N. J., Fuller, W. (2020) Dynamic palmitoylation of the sodium-calcium exchanger modulates its structure, affinity for lipid ordered domains, and inhibition by XIP. Cell Reports, 31, (doi: 10.1016/j.celrep.2020.107697)

Anker, S. D. et al. (2020) Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) European Heart Journal, 41, pp. 2109-2117. (doi: 10.1093/eurheartj/ehaa461)

Katus, H. A., Cleland, J. G.F., Jaffe, A. S. (2020) Myocardial injury in severe COVID-19 infection. European Heart Journal, 41, pp. 2080-2082. (doi: 10.1093/eurheartj/ehaa447)

de Montmollin, M., Feller, M., Beglinger, S., McConnachie, A., Aujesky, D., Collet, T.-H., Ford, I., Gussekloo, J., Kearney, P. M., McCarthy, V. J.C., Mooijaart, S., Poortvliet, R. K.E., Quinn, T., Stott, D. J., Watt, T., Westendorp, R., Rodondi, N., Bauer, D. C. (2020) L-thyroxine therapy for older adults with subclinical hypothyroidism and hypothyroid symptoms: secondary analysis of a randomized trial. Annals of Internal Medicine, 172, pp. 709-716. (doi: 10.7326/M19-3193)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4, (doi: 10.1093/cdn/nzaa071)

Brainin, P., Claggett, B., Lewis, E. F., Dwyer, K. H., Merz, A. A., Silverman, M. B., Swamy, V., Biering-Sørensen, T., Rivero, J., Cheng, S., McMurray, J. J.V., Solomon, S. D., Platz, E. (2020) Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure. ESC Heart Failure, 7, pp. 1201-1209. (doi: 10.1002/ehf2.12640)

Cleland, J. G.F., Clark, R. A., Pellicori, P., Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22, pp. 995-998. (doi: 10.1002/ejhf.1864)

Sidik, N., McDermott, M., McEntegart, M. B., Berry, C. (2020) Chest pain without obstructive coronary artery disease: a case series report. European Heart Journal: Case Reports, 4, pp. 1-6. (doi: 10.1093/ehjcr/ytaa060)

Levis, B. et al. (2020) Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. Journal of Clinical Epidemiology, 122, pp. 115-128.e1. (doi: 10.1016/j.jclinepi.2020.02.002)

Mentel, A., Quinn, T. J., Cameron, A. C., Lees, K. R., Abdul-Rahim, A. H. (2020) The impact of atrial fibrillation type on the risks of thromboembolic recurrence, mortality and major haemorrhage in patients with previous stroke: a systematic review and meta-analysis of observational studies. European Stroke Journal, 5, pp. 155-168. (doi: 10.1177/2396987319896674)

Niedzwiedz, C. L., O'Donnell, C. A., Jani, B. D., Demou, E., Ho, F. K., Celis-Morales, C., Nicholl, B. I., Mair, F. S., Welsh, P., Sattar, N., Pell, J. P., Katikireddi, S. V. (2020) Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Medicine, 18, (doi: 10.1186/s12916-020-01640-8)

Sama, I. E., Woolley, R. J., Nauta, J. F., Romaine, S. P.R., Tromp, J., ter Maaten, J. M., van der Meer, P., Lam, C. S.P., Samani, N. J., Ng, L. L., Metra, M., Dickstein, K., Anker, S. D., Zannad, F., Lang, C. C., Cleland, J. G.F., van Veldhuisen, D. J., Hillege, H. L., oors, A. A.V. (2020) A network analysis to identify pathophysiological pathways distinguishing ischemic from non-ischemic heart failure. European Journal of Heart Failure, 22, pp. 821-833. (doi: 10.1002/ejhf.1811)

Błyszczuk, P., Zuppinger, C., Costa, A., Nurzynska, D., Di Meglio, F., Stellato, M., Agarkova, I., Smith, G., Distler, O., Kania, G. (2020) Activated cardiac fibroblasts control contraction of human fibrotic cardiac microtissues by a β-adrenoreceptor-dependent mechanism. Cells, 9, (doi: 10.3390/cells9051270)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41, pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415)

Voors, A. A., van Veldhuisen, D. J., Metra, M., Ponikowski, P., Anker, S. D., Filippatos, G., Lang, C. C., Dickstein, K., Ng, L. L., Samani, N. J., Friedrich, A. W., Rienstra, M., Cleland, J. G.F., ter Maaten, J. M., van Goor, H., Santema, B. T., Ravera, A., Sama, I. E. (2020) Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41, pp. 1810-1817. (doi: 10.1093/eurheartj/ehaa373)

Welsh, C. E., Celis-Morales, C. A., Ho, F. K., Brown, R., Mackay, D. F., Lyall, D. M., Anderson, J. J., Pell, J. P., Gill, J. M.R., Sattar, N., Welsh, P., Gray, S. R. (2020) Grip strength and walking pace and cardiovascular disease risk prediction in 406,834 UK Biobank participants. Mayo Clinic Proceedings, 95, pp. 879-888. (doi: 10.1016/j.mayocp.2019.12.032)

Collison, D., McClure, J. D., Berry, C., Oldroyd, K. G. (2020) A randomized controlled trial of a physiology‐guided percutaneous coronary intervention optimization strategy: rationale and design of the TARGET FFR study. Clinical Cardiology, 43, pp. 414-422. (doi: 10.1002/clc.23342)

Hayes, S., Forbes, J. F., Celis-Morales, C., Anderson, J., Ferguson, L., Gill, J. M.R., Gray, S., Hastie, C., Iliodromoti, S., Lyall, D., Pellicori, P., Sattar, N., Welsh, C. E., Pell, J. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51, pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064)

Peterzan, M. A., Clarke, W. T., Lygate, C. A., Lake, H. A., Lau, J. Y.C., Miller, J. J., Johnson, E., Rayner, J. J., Hundertmark, M. J., Sayeed, R., Petrou, M., Krasopoulos, G., Srivastava, V., Neubauer, S., Rodgers, C. T., Rider, O. J. (2020) Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction. Circulation, 141, pp. 1971-1985. (doi: 10.1161/circulationaha.119.043450)

Sattar, N., McMurray, J. J.V., Cheng, A. (2020) Cardiorenal risk reduction guidance in diabetes: can we reach consensus? Lancet Diabetes and Endocrinology, 8, pp. 357-360. (doi: 10.1016/S2213-8587(20)30062-0)

Maznyczka, A. M., Oldroyd, K. G., Greenwood, J. P., McCartney, P. J., Cotton, J., Lindsay, M., McEntegart, M., Rocchiccioli, J. P., Good, R., Robertson, K., Eteiba, H., Watkins, S., Shaukat, A., Petrie, C. J., Murphy, A., Petrie, M. C., Berry, C. (2020) Comparative significance of invasive measures of microvascular injury in acute myocardial infarction. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008505)

Tzolos, E., Adamson, P.D., Hall, P.S., MacPherson, I.R., Oikonomidou, O., MacLean, M., Lewis, S.C., McVicars, H., Newby, D.E., Mills, N.L., Lang, N.N., Henriksen, P.A. (2020) Dynamic changes in high-sensitivity cardiac troponin I in response to anthracycline-based chemotherapy. Clinical Oncology, 32, pp. 292-297. (doi: 10.1016/j.clon.2019.11.008)

Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Zile, M. R., Anand, I. S., Packer, M., Zannad, F., Lam, C. S.P., Janssens, S., Jhund, P. S., Kober, L., Rouleau, J., Shah, S. J., Chopra, V. K., Shi, V. C., Lefkowitz, M. P., Prescott, M. F., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2020) Effects of sacubitril/valsartan on N-terminal pro-B-type natriuretic peptide in heart failure with preserved ejection fraction. JACC: Heart Failure, 8, pp. 372-381. (doi: 10.1016/j.jchf.2020.03.002)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G., Pellicori, P., Girerd, N., Rossignol, P., Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22, pp. 901-903. (doi: 10.1002/ejhf.1812)

Fudim, M., Dalgaard, F., Al-Khatib, S. M., J. Friedman, D., Lallinger, K., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Schaber, D. E., Tang, A., Ali-Ahmed, F., Goldstein, S. A., Kaufman, B., Fortman, R., Davis, J. K., Inoue, L. Y.T., Sanders, G. D. (2020) Future research prioritization in cardiac resynchronization therapy. American Heart Journal, 223, pp. 48-58. (doi: 10.1016/j.ahj.2020.02.011)

Hawkins, N. M., Osmanska, J., Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22, pp. 868-870. (doi: 10.1002/ejhf.1803)

Dewan, P., Jackson, A., Lam, C. S.P., Pfeffer, M. A., Zannad, F., Pitt, B., Solomon, S. D., McMurray, J. J.V. (2020) Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure. European Journal of Heart Failure, 22, pp. 898-901. (doi: 10.1002/ejhf.1776)

Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G.F., Gheorghiade, M., Lam, C. S.P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2020) Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF. JACC: Heart Failure, 8, pp. 359-368. (doi: 10.1016/j.jchf.2019.12.009)

Jorsal, A., Pryds, K., McMurray, J. J.V., Wiggers, H., Sommer, A., Nielsen, J. C., Nielsen, R. R. (2020) Optimizing heart failure treatment following cardiac resynchronization therapy. Clinical Research in Cardiology, 109, pp. 638-645. (doi: 10.1007/s00392-019-01553-4)

Hennigan, B., Berry, C., Collison, D., Corcoran, D., Eteiba, H., Good, R., McEntegart, M., Watkins, S., McClure, J., Mangion, K., Ford, T., Petrie, M. C., Hood, S., Rocchiccioli, P., Shaukat, A., Lindsay, M., Oldroyd, K. G. (2020) Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart, 106, pp. 714-715. (doi: 10.1136/heartjnl-2019-316075)

Docherty, K. F., Ferreira, J. P., Sharma, A., Girerd, N., Gregson, J., Duarte, K., Petrie, M. C., Jhund, P. S., Dickstein, K., Pfeffer, M. A., Pitt, B., Rossignol, P., Zannad, F., McMurray, J. J.V. (2020) Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. European Journal of Heart Failure, 22, pp. 848-855. (doi: 10.1002/ejhf.1694)

Malik, M. E., Madelaire, C., D'Souza, M., Blanche, P., Kristensen, S. L., Kistorp, C., Gustafsson, F., Køber, L., Rørth, R., McMurray, J., Sattar, N., Gislason, G., Torp-Pedersen, C., Schou, M. (2020) Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease. European Journal of Heart Failure, 22, pp. 813-820. (doi: 10.1002/ejhf.1819)

Rossello, X., Ferreira, J. P., Pocock, S. J., McMurray, J. J.V., Solomon, S. D., Lam, C. S.P., Girerd, N., Pitt, B., Rossignol, P., Zannad, F. (2020) Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials. European Journal of Heart Failure, 22, pp. 834-844. (doi: 10.1002/ejhf.1740)

Quint, J. K., Rajagopalan, S., Cleland, J. G.F., Simon, D. I., Banerjee, A., Briere, J.-B., Bowrin, K., Cohen, A., Halcox, J., Zakeri, R., Bloom, C., Sundaram, V. (2020) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal, 41, pp. 1636-1649. (doi: 10.1093/eurheartj/ehz880)

Li, W., Lazarus, A., Gao, H., Martinez De Azcona Naharro, A., Fontana, M., Hawkins, P., Biswas, S., Janiczek, R., Cox, J., Berry, C., Husmeier, D., Luo, X. (2020) Analysis of cardiac amyloidosis progression using model-based markers. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00324)

Graves-Morris, K., Stewart, C., Soiza, R. L., Taylor-Rowan, M., Quinn, T. J., Loke, Y. K., Myint, P. K. (2020) The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: a systematic review and meta-analysis. Frontiers in Pharmacology, 11, (doi: 10.3389/fphar.2020.00570)

Anderson, J. J., Gray, S. R., Welsh, P., Mackay, D. F., Celis-Morales, C. A., Lyall, D. M., Forbes, J., Sattar, N., Gill, J. M.R., Pell, J. P. (2020) The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study. BMC Medicine, 18, (doi: 10.1186/s12916-020-01554-5)

Siedlinski, M., Jozefczuk, E., Xu, X., Teumer, A., Evangelou, E., Schnabel, R. B., Welsh, P., Maffia, P., Erdmann, J., Tomaszewski, M., Caulfield, M. J., Sattar, N., Holmes, M. V., Guzik, T. J. (2020) White blood cells and blood pressure: a Mendelian randomization study. Circulation, 141, pp. 1307-1317. (doi: 10.1161/CIRCULATIONAHA.119.045102)

Ling, J., Blair, C. M., Baillie, G. S. (2020) Fibrin Breakdown Assay. Bio-Protocol, 10, (doi: 10.21769/BioProtoc.3585)

Petrie, M. C., et al. (2020) Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes. JAMA: Journal of the American Medical Association, 323, pp. 1353-1368. (doi: 10.1001/jama.2020.1906)

Selvaraj, S., Claggett, B. L., Böhm, M., Anker, S. D., Vaduganathan, M., Zannad, F., Pieske, B., Lam, C. S.P., Anand, I. S., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2020) Systolic blood pressure in heart failure with preserved ejection fraction treated with sacubitril/valsartan. Journal of the American College of Cardiology, 75, pp. 1644-1656. (doi: 10.1016/j.jacc.2020.02.009)

Dietrichs, E. S., Tveita, T., Myles, R., Smith, G. (2020) A novel ECG-biomarker for cardiac arrest during hypothermia. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 28, (doi: 10.1186/s13049-020-00721-0)

Blair, C. M., Ling, J., Baillie, G. S. (2020) Measuring cAMP specific phosphodiesterase activity: a two-step radioassay. Bio-Protocol, 10, (doi: 10.21769/BioProtoc.3581)

White, S. L., Begum, S., Vieira, M. C., Seed, P., Lawlor, D. L., Sattar, N., Nelson, S. M., Welsh, P., Pasupathy, D., Poston, L., on behalf of UPBEAT Consortium, (2020) Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study. PLoS ONE, 15, (doi: 10.1371/journal.pone.0230658)

Pandhi, P., Maaten, J. M., Emmens, J. E., Struck, J., Bergmann, A., Cleland, J. G., Givertz, M. M., Metra, M., O'Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Veldhuisen, D. J., Voors, A. A. (2020) Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. European Journal of Heart Failure, 22, pp. 683-691. (doi: 10.1002/ejhf.1693)

Jackson, A. M., Zhang, R., Findlay, I., Robertson, K., Lindsay, M., Morris, T., Forbes, B., Papworth, R., McConnachie, A., Mangion, K., Jhund, P. S., McCowan, C., Berry, C. (2020) Healthcare disparities for women hospitalised with myocardial infarction and angina. European Heart Journal: Quality of Care and Clinical Outcomes, 6, pp. 156-165. (doi: 10.1093/ehjqcco/qcz040)

Macdougall, I. C., Bhandari, S., White, C., Anker, S. D., Farrington, K., Kalra, P. A., Mark, P. B., McMurray, J. J.V., Reid, C., Robertson, M., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., Ford, I. (2020) Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial. Journal of the American Society of Nephrology, 31, (doi: 10.1681/ASN.2019090972)

Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J.V., Metra, M., Solomon, S. D., Legg, J. C., Büchele, G., Varin, C., Kurtz, C. E., Malik, F. I., Honarpour, N. (2020) Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: rationale and design of GALACTIC-HF. JACC: Heart Failure, 8, pp. 329-340. (doi: 10.1016/j.jchf.2019.12.001)

Simpson, J., Jhund, P. S., Lund, L. H., Padmanabhan, S., Clagget, B. L., Shen, L., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Kober, L., Paker, M., Rouleau, J. L., Mueller-Velten, G., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiology, 5, pp. 432-441. (doi: 10.1001/jamacardio.2019.5850)

Mangion, K., Adamson, P. D., Williams, M. C., Hunter, A., Pawade, T., Shah, A. S.V., Lewis, S., Boon, N. A., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D., McAllister, D., Berry, C. (2020) Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain. European Heart Journal, 41, pp. 1337-1345. (doi: 10.1093/eurheartj/ehz903)

Tardif, J.-C., Dubé, M.-P., Pfeffer, M. A., Waters, D. D., Koenig, W., Maggioni, A. P., McMurray, J. J.V., Mooser, V., White, H. D., Heinonen, T., Black, D. M., Guertin, M.-C. (2020) Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib. American Heart Journal, 222, pp. 157-165. (doi: 10.1016/j.ahj.2020.01.007)

Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J.V., Pfeffer, M. A., Solomon, S. D. (2020) Renin–Angiotensin–Aldosterone System inhibitors in patients with Covid-19. New England Journal of Medicine, 382, pp. 1653-1659. (doi: 10.1056/nejmsr2005760)

Wehner, G. J., Jing, L., Haggerty, C. M., Suever, J. D., Leader, J. B., Hartzel, D. N., Kirchner, H. L., Manus, J. N.A., James, N., Ayar, Z., Gladding, P., Good, C. W., Cleland, J. G.F., Fornwalt, B. K. (2020) Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? European Heart Journal, 41, pp. 1249-1257. (doi: 10.1093/eurheartj/ehz550)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology: heart failure. European Heart Journal, 41, pp. 1232-1248. (doi: 10.1093/eurheartj/ehz949)

Berry, C., Duncker, D. J. (2020) Coronary microvascular disease: the next frontier for Cardiovascular Research. Cardiovascular Research, 116, pp. 737-740. (doi: 10.1093/cvr/cvaa035)

Welsh, C., Celis-Morales, C. A., Ho, F., Lyall, D. M., Mackay, D., Ferguson, L., Sattar, N., Gray, S. R., Gill, J. M.R., Pell, J. P., Welsh, P. (2020) Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study. British Medical Journal, 368, (doi: 10.1136/bmj.m336)

Sharma, A., Pagidipati, N. J., Califf, R. M., McGuire, D. K., Green, J. B., Demets, D., George, J. T., Gerstein, H. C., Hobbs, T., Holman, R. R., Lawson, F. C., Leiter, L. A., Pfeffer, M. A., Reusch, J., Riesmeyer, J. S., Roe, M. T., Rosenberg, Y., Temple, R., Wiviott, S., McMurray, J., Granger, C. (2020) Impact of regulatory guidance on evaluating cardiovascular risk of new glucose-lowering therapies to treat type 2 diabetes mellitus. Circulation, 141, pp. 843-862. (doi: 10.1161/circulationaha.119.041022)

MacDonald, E. A., Rose, R. A., Quinn, T. A. (2020) Neurohumoral control of sinoatrial node activity and heart rate: insight from experimental models and findings from humans. Frontiers in Physiology, 11, (doi: 10.3389/fphys.2020.00170)

Hanlon, P., Quinn, T. J., Gallacher, K. I., Myint, P. K., Jani, B. D., Nicholl, B. I., Lowrie, R., Soiza, R. L., Neal, S. R., Lee, D., Mair, F. S. (2020) Assessing risks of polypharmacy involving medications with anticholinergic properties. Annals of Family Medicine, 18, pp. 148-155. (doi: 10.1370/afm.2501)

Ford, T. J., Berry, C. (2020) Angina: contemporary diagnosis and management. Heart, 106, pp. 387-398. (doi: 10.1136/heartjnl-2018-314661)

Ho, F. K., Gray, S. R., Welsh, P., Petermann-Rocha, F., Foster, H., Waddell, H., Anderson, J., Lyall, D., Sattar, N., Gill, J. M.R., Mathers, J. C., Pell, J. P., Celis-Morales, C. (2020) Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants. British Medical Journal, 368, (doi: 10.1136/bmj.m688)

Kristensen, S. L., McMurray, J. J.V. (2020) Diagnosing heart failure with preserved ejection fraction – what's the score? European Journal of Heart Failure, 22, pp. 425-427. (doi: 10.1002/ejhf.1764)

Shen, L., Jhund, P., McMurray, J. (2020) Dyslipidaemia, a factor worthy of adjustment: reply. European Journal of Heart Failure, 22, pp. 564-565. (doi: 10.1002/ejhf.1718)

Lee, M. M.Y., Petrie, M. C., McMurray, J. J.V., Sattar, N. (2020) How do SGLT2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists reduce cardiovascular outcomes? Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 506-522. (doi: 10.1161/atvbaha.119.311904)

Tromp, J., Bamadhaj, S., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ouwerkerk, W., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Hu, D., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Lam, C. S.P., Filippatos, G., Collins, S. P. (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Global Health, 8, pp. e411-e422. (doi: 10.1016/S2214-109X(20)30004-8)

Sidik, N. P., McEntegart, M., Roditi, G., Ford, T. J., McDermott, M., Morrow, A., Byrne, J., Adams, J., Hargreaves, A., Oldroyd, K. G., Stobo, D., Wu, O., Messow, C.-M., McConnachie, A., Berry, C. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015)

Fuller, W., Gök, C. (2020) Regulation of NCX1 by palmitoylation. Cell Calcium, 86, (doi: 10.1016/j.ceca.2019.102158)

Docherty, K. F., Shen, L., Castagno, D., Petrie, M. C., Abraham, W. T., Böhm, M., Desai, A. S., Dickstein, K., Køber, L. V., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Vazir, A., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2020) Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. European Journal of Heart Failure, 22, pp. 528-538. (doi: 10.1002/ejhf.1682)

Lochhead, M. R., Brown, A. D., Kirlin, A. C., Chitayat, S., Munro, K., Findlay, J. E., Baillie, G. S., LeBrun, D. P., Langelaan, D. N., Smith, S. P. (2020) Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A. Journal of Biological Chemistry, 27, pp. 4303-4315. (doi: 10.1074/jbc.RA119.011078)

Santema, B. T., Chan, M. M.Y., Tromp, J., Dokter, M., van der Wal, H. H., Emmens, J. E., Takens, J., Samani, N. J., Ng, L. L., Lang, C. C., van der Meer, P., ter Maaten, J. M., Damman, K., Dickstein, K., Cleland, J. G., Zannad, F., Anker, S. D., Metra, M., van der Harst, P., de Boer, R. A., van Veldhuisen, D. J., Rienstra, M., Lam, C. S.P., Voors, A. A. (2020) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology, 109, pp. 331-338. (doi: 10.1007/s00392-019-01513-y)

Monzo, L., Ferreira, J. P., Abreu, P., Szumski, A., Böhm, M., McMurray, J. J.V., Pitt, B., Swedberg, K., van Veldhuisen, D. J., Girerd, N., Vincent, J., Zannad, F., Rossignol, P. (2020) Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial. Journal of Hypertension, 38, pp. 420-425. (doi: 10.1097/HJH.0000000000002275)

Serenelli, M., Jackson, A., Dewan, P., Jhund, P. S., Petrie, M. C., Rossignol, P., Campo, G., Pitt, B., Zannad, F., Ferreira, J. P., McMurray, J. J.V. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8, pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011)

Quinn, T. J., Myint, P. K., McCleery, J., Taylor-Rowan, M., Stewart, C. (2020) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews, 2020, (doi: 10.1002/14651858.cd013540)

Rorth, R., Jhund, P. S., Yilmaz, M. B., Kristensen, S. L., Welsh, P., Desai, A. S., Køber, L., Prescott, M. F., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2020) Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.119.006541)

Huethorst, E., Cutiongco, M. F.A., Campbell, F. A., Saeed, A., Love, R., Reynolds, P. M., Dalby, M. J., Gadegaard, N. (2020) Customizable, engineered substrates for rapid screening of cellular cues. Biofabrication, 12, (doi: 10.1088/1758-5090/ab5d3f)

McMurray, J. J.V. et al. (2020) Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF. Circulation, 141, pp. 338-351. (doi: 10.1161/CIRCULATIONAHA.119.044491)

Maznyczka, A. M., McCartney, P. J., Oldroyd, K. G., Lindsay, M., McEntegart, M., Eteiba, H., Rocchiccioli, P., Good, R., Shaukat, A., Robertson, K., Kodoth, V., Greenwood, J. P., Cotton, J. M., Hood, S., Watkins, S., Macfarlane, P. W., Kennedy, J., Tait, C., Welsh, P., Sattar, N., Collison, D., Gillespie, L., McConnachie, A., Berry, C. (2020) Effects of intracoronary alteplase on microvascular function in acute myocardial infarction. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.119.014066)

Solomon, S. D. et al. (2020) Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation, 141, pp. 352-361. (doi: 10.1161/circulationaha.119.044586)

Morrow, A., Sidik, N., Berry, C. (2020) ISCHEMIA: new questions from a landmark trial. Cardiovascular Research, 116, pp. e23-e25. (doi: 10.1093/cvr/cvz343)

Cameron, A. C., Welsh, P., Neves, K. B., Newby, D., Touyz, R. M., Lang, N. (2020) Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation. Journal of Hypertension, 38, pp. 257-265. (doi: 10.1097/HJH.0000000000002230)

Seferović, P. M. et al. (2020) European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure. European Journal of Heart Failure, 22, pp. 196-213. (doi: 10.1002/ejhf.1673)

Baylan, S., Haig, C., MacDonald, M., Stiles, C., Easto, J., Thomson, M., Cullen, B., Quinn, T. J., Stott, D. J., Mercer, S. W., Broomfield, N. M., Murray, H., Evans, J. J. (2020) Measuring the Effects of Listening for Leisure on Outcome after stroke (MELLO): a pilot randomised controlled trial of mindful music listening. International Journal of Stroke, 15, pp. 149-158. (doi: 10.1177/1747493019841250)

Bégué, C., Mörner, S., Brito, D., Hengstenberg, C., Cleland, J. G.F., Arbustini, E., Galve, E., Wichter, T., Richter, A., Golmard, J.-L., Bernard, M., Dubourg, O., Komajda, M., Charron, P., Isnard, R. (2020) Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy. Heart, 106, pp. 196-202. (doi: 10.1136/heartjnl-2019-314826)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008855)

Ford, T. J., Khan, A., Docherty, K. F., Jackson, A., Morrow, A., Sidik, N., Rocchiccioli, P., Good, R., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Petrie, M., Berry, C., Oldroyd, K., McEntegart, M. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95, pp. 232-241. (doi: 10.1002/ccd.28373)

Jhund, P. S. (2020) The recurring problem of heart failure hospitalisations. European Journal of Heart Failure, 22, pp. 249-250. (doi: 10.1002/ejhf.1721)

Fraser, N. J., Howie, J., Wypijewski, K. J., Fuller, W. (2020) Therapeutic targeting of protein S-acylation for the treatment of disease. Biochemical Society Transactions, 48, pp. 281-290. (doi: 10.1042/BST20190707)

Vaduganathan, M., Claggett, B. L., Desai, A. S., Anker, S. D., Perrone, S. V., Janssens, S., Milicic, D., Arango, J. L., Packer, M., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2020) Prior heart failure hospitalization, clinical outcomes, and response to sacubitril/valsartan compared with valsartan in HFpEF. Journal of the American College of Cardiology, 75, pp. 245-254. (doi: 10.1016/j.jacc.2019.11.003)

Henderson, A. D., Aubry, M., Kama, M., Vanhomwegen, J., Teissier, A., Mariteragi-Helle, T., Paoaafaite, T., Teissier, Y., Manuguerra, J.-C., Edmunds, J., Whitworth, J., Watson, C. H., Lau, C. L., Cao-Lormeau, V.-M., Kucharski, A. J. (2020) Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji. eLife, 9, (doi: 10.7554/eLife.48460)

Aksentijević, D., Zervou, S., Eykyn, T. R., McAndrew, D. J., Wallis, J., Schneider, J. E., Neubauer, S., Lygate, C. A. (2020) Age-dependent decline in cardiac function in Guanidinoacetate-N-methyltransferase knockout mice. Frontiers in Physiology, 10, (doi: 10.3389/fphys.2019.01535)

Welsh, C., Welsh, P., Celis Morales, C. A., Mark, P., Mackay, D., Ghouri, N., Ho, F., Ferguson, L. D., Brown, R., Lewsey, J., Cleland, J. G., Gray, S. R., Lyall, D. M., Anderson, J., Jhund, P. S., Pell, J., McGuire, D. K., Gill, J. M.R., Sattar, N. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43, pp. 440-445. (doi: 10.2337/dc19-1683)

Kosiborod, M. N., Jhund, P., Docherty, K. F., Diez, M., Petrie, M. C., Verma, S., Nicolau, J. C., Merkely, B., Kitakaze, M., DeMets, D. L., Inzucchi, S. E., Køeber, L., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Lindholm, D., Niklasson, A., Sjöstrand, M., Langkilde, A. M., McMurray, J. J.V. (2020) Effects of dapagliflozin on symptoms, function and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial. Circulation, 141, pp. 90-99. (doi: 10.1161/CIRCULATIONAHA.119.044138)

Martinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ponikowski, P., Sabatine, M. S., DeMets, D. L., Dutkiewicz-Piasecka, M., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Jhund, P., McMurray, J. J.V. (2020) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF. Circulation, 141, pp. 100-111. (doi: 10.1161/CIRCULATIONAHA.119.044133)

Ford, T. J., Stanley, B., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., McCartney, P., Corcoran, D., Collison, D., Rush, C., Sattar, N., McConnachie, A., Touyz, R. M., Oldroyd, K. G., Berry, C. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA) JACC: Cardiovascular Interventions, 13, pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001)

Cao, F., Maguire, M. L., McAndrew, D. J., Lake, H. A., Neubauer, S., Zervou, S., Schneider, J. E., Lygate, C. A. (2020) Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure. Basic Research in Cardiology, 115, (doi: 10.1007/s00395-020-0777-3)

Shah, S. et al. (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nature Communications, 11, (doi: 10.1038/s41467-019-13690-5)

Filippatos, G., Angermann, C. E., Cleland, J. G.F., Lam, C. S.P., Dahlström, U., Dickstein, K., Ertl, G., Hassanein, M., Hart, K. W., Lindsell, C. J., Perrone, S. V., Guerin, T., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P. (2020) Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiology, 5, pp. 401-410. (doi: 10.1001/jamacardio.2019.5108)

Tejeda, G. S., Whiteley, E. L., Deeb, T. Z., Bürli, R. W., Moss, S. J., Sheridan, E., Brandon, N. J., Baillie, G. S. (2020) Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme. Proceedings of the National Academy of Sciences of the United States of America, 117, pp. 677-688. (doi: 10.1073/pnas.1916398117)

Ferreira, J. P., Ouwerkerk, W., Tromp, J., Ng, L., Dickstein, K., Anker, S., Filippatos, G., Cleland, J. G., Metra, M., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2020) Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 22, pp. 81-89. (doi: 10.1002/ejhf.1654)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16, pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003)

Nikolaidou, T., Samuel, N. A., Marincowitz, C., Fox, D. J., Cleland, J. G.F., Clark, A. L. (2020) Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: a systematic review and meta‐analysis. Annals of Noninvasive Electrocardiology, 25, (doi: 10.1111/anec.12710)

Li, Z. et al. (2020) General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico Strategy. Clinical Pharmacology and Therapeutics, 107, pp. 102-111. (doi: 10.1002/cpt.1647)

Kobayashi, M., Voors, A. A., Girerd, N., Billotte, M., Anker, S. D., Cleland, J. G., Lang, C. C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Metra, M., Duarte, K., Rossignol, P., Zannad, F., Ferreira, J. P. (2020) Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. European Journal of Internal Medicine, 71, pp. 62-69. (doi: 10.1016/j.ejim.2019.10.017)

Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L., Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116, pp. 91-100. (doi: 10.1093/cvr/cvz198)

Chapman, A. R., Adamson, P. D., Shah, A. S.V., Anand, A., Strachan, F. E., Ferry, A. V., Lee, K. K., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Gray, A., Collinson, P. O., Apple, F., McAllister, D., McAllister, D. A., Maguire, D., Fox, K. A.A., Vallejos, C. A., Keerie, C., Weir, C. J., Newby, D. E., Mills, N. L. (2020) High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation, 141, pp. 161-171. (doi: 10.1161/CIRCULATIONAHA.119.042960)

Sidik, N., Morrow, A., Berry, C. (2020) Human microcirculation in ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 11-13. (doi: 10.1161/ATVBAHA.119.313579)

Pellicori, P., Khan, M. J. I., Graham, F. J., Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7)

Cao, T. H., Jones, D. J.L., Voors, A. A., Quinn, P. A., Sandhu, J. K., Chan, D. C.S., Parry, H. M., Mohan, M., Mordi, I. R., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Lang, C. C., Ng, L. L. (2020) Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure, 22, pp. 70-80. (doi: 10.1002/ejhf.1608)

McArthur, L., Riddell, A., Chilton, L., Smith, G. L., Nicklin, S. A. (2020) Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model. Heliyon, 6, (doi: 10.1016/j.heliyon.2019.e03031)

Kao, D., Purohit, S., Jhund, P. (2020) Therapeutic futility and phenotypic heterogeneity in heart failure with preserved ejection fraction: what is the role of bionic learning? European Journal of Heart Failure, 22, pp. 159-161. (doi: 10.1002/ejhf.1658)

de Korte, T., Katili, P. A., Mohd Yusof, N. A.N., van Meer, B. J., Saleem, U., Burton, F. L., Smith, G. L., Clements, P., Mummery, C. L., Eschenhagen, T., Hansen, A., Denning, C. (2020) Unlocking personalized biomedicine and drug discovery with human induced pluripotent stem cell–derived cardiomyocytes: fit for purpose or forever elusive? Annual Review of Pharmacology and Toxicology, 60, pp. 529-551. (doi: 10.1146/annurev-pharmtox-010919-023309)

Anker, M. S., Hülsmann, M., Cleland, J. G. (2020) What do patients with heart failure die from? A single assassin or a conspiracy? European Journal of Heart Failure, 22, pp. 26-28. (doi: 10.1002/ejhf.1689)

Heggie, R., Wu, O., Boyd, K., Lee, M. M.Y., Petrie, M. C., McEntegart, M., Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes.

Marshall-Mckenna, R., Campbell, E., Ho, F., Banger, M., Rowe, P., McAlpine, C., McArthur, K., Quinn, T. J., Gray, S. R. (2020) Feasibility of resistance exercise to failure at different loads in frail and healthy older adults?

Coll, A. P. et al. (2020) GDF15 mediates the effects of metformin on body weight and energy balance. Nature, 578, pp. 444-448. (doi: 10.1038/s41586-019-1911-y)

Israr, M. Z. et al. (2020) Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF. European Journal of Heart Failure, 22, pp. 1486-1490. (doi: 10.1002/ejhf.1951)

McCartney, P. J., Maznyczka, A. M., Eteiba, H., McEntegart, M., Oldroyd, K. G., Greenwood, J. P., Mareida, N., Schmitt, M., McCann, G. P., Fairbairn, T., McAlindon, E., Tait, C., Welsh, P., Sattar, N., Orchard, V., Corcoran, D., Ford, T. J., Radjenovic, A., Ford, I., McConnachie, A., Berry, C. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75, pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041)

Baillie, G., Tibbo, A. (2020) Phosphodiesterase 4B: master regulator of brain signaling. Cells, 9, (doi: 10.3390/cells9051254)

Tardif, J.-C. et al. (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. New England Journal of Medicine, 381, pp. 2497-2505. (doi: 10.1056/NEJMoa1912388)

Gould, G., Bowman, P., Smith, G. (2019) Cardiac SNARE expression in health and disease. Frontiers in Endocrinology, 10, (doi: 10.3389/fendo.2019.00881)

Geriatric Medicine Research Collaborative, ., , , , , , , , (2019) Delirium is prevalent in older hospital inpatients and associated with adverse outcomes: results of a prospective multi-centre study on World Delirium Awareness Day. BMC Medicine, 17, (doi: 10.1186/s12916-019-1458-7)

Shah, A. M., Cikes, M., Prasad, N., Li, G., Getchevski, S., Claggett, B., Rizkala, A., Lukashevich, I., O’Meara, E., Ryan, J. J., Shah, S. J., Mullens, W., Zile, M. R., Lam, C. S.P., McMurray, J. J.V., Solomon, S. D. (2019) Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction. Journal of the American College of Cardiology, 74, pp. 2858-2873. (doi: 10.1016/j.jacc.2019.09.063)

Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J.V., Wikstrand, J., Anker, S. D., van Veldhuisen, D. J., Manzano, L., von Lueder, T. G., Rigby, A. S., Andersson, B., Kjekshus, J., Wedel, H., Ruschitzka, F., Cleland, J. G.F., Damman, K., Redon, J., Coats, A. J.S. (2019) Impact of renal impairment on beta-blocker efficacy in patients with heart failure. Journal of the American College of Cardiology, 74, pp. 2893-2904. (doi: 10.1016/j.jacc.2019.09.059)

Dewan, P., Rorth, R., Raparelli, V., Campbell, R. T., Shen, L., Jhund, P. S., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Køber, L., Komajda, M., McKelvie, R. S., O'Meara, E., Pfeffer, M. A., Pitt, B., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Sex-related differences in heart failure with preserved ejection fraction. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.006539)

Nagel, E., Berry, C. (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. Reply. New England Journal of Medicine, 381, pp. 2277-2278. (doi: 10.1056/NEJMc1913968)

Ferguson, L. D., Brown, R., Celis-Morales, C., Welsh, P., Lyall, D. M., Pell, J. P., McInnes, I. B., Siebert, S., Sattar, N. (2019) Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank. Rheumatology, 58, pp. 2137-2142. (doi: 10.1093/rheumatology/kez192)

Eastwood, S. V., Chaturvedi, N., Sattar, N., Welsh, P. I., Hughes, A. D., Tillin, T. (2019) Impact of kidney function on cardiovascular risk and mortality: a comparison of South Asian and European cohorts. American Journal of Nephrology, 50, pp. 425-433. (doi: 10.1159/000503873)

Ford, T. J., Yii, E., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., McCartney, P., Corcoran, D., Collison, D., Rush, C., Stanley, B., McConnachie, A., Sattar, N., Touyz, R. M., Oldroyd, K. G., Berry, C. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.008126)

Platz, E., Solomon, S. D., McMurray, J. J.V. (2019) Lung ultrasound: monitoring congestion in patients with heart failure. European Journal of Heart Failure, 21, pp. 1614-1615. (doi: 10.1002/ejhf.1636)

Ferreira, J. P., Rossello, X., Eschalier, R., McMurray, J. J.V., Pocock, S., Girerd, N., Rossignol, P., Pitt, B., Zannad, F. (2019) MRAs in Elderly HF Patients Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT. JACC: Heart Failure, 7, pp. 1012-1021. (doi: 10.1016/j.jchf.2019.08.017)

Drummond, M., Johnston, B., Quinn, T. J. (2019) Measuring the success of interventions for caregivers: a focussed systematic review. Current Opinion in Supportive and Palliative Care, 13, pp. 351-359. (doi: 10.1097/SPC.0000000000000461)

Johnson, M. J., Cockayne, S., Currow, D. C., Bell, K., Hicks, K., Fairhurst, C., Gabe, R., Torgerson, D., Jefferson, L., Oxberry, S., Ghosh, J., Hogg, K. J., Murphy, J., Allgar, V., Cleland, J. G.F., Clark, A. L. (2019) Oral modified release morphine for breathlessness in chronic heart failure: a randomised placebo-controlled trial. ESC Heart Failure, 6, pp. 1149-1160. (doi: 10.1002/ehf2.12498)

Avtaar Singh, S. S., Das De, S., Rushton, S., Berry, C., Al-Attar, N. (2019) PREDICTA: a model to predict primary graft dysfunction after adult heart transplantation in the United Kingdom. Journal of Cardiac Failure, 25, pp. 971-977. (doi: 10.1016/j.cardfail.2019.07.009)

Adamson, C., Rocchiccioli, P., Brogan, R., Berry, C., Ford, T. J. (2019) Post-operative myocardial infarction following aortic root surgery with coronary reimplantation: a case series treated with percutaneous coronary intervention. European Heart Journal: Case Reports, 3, pp. 1-6. (doi: 10.1093/ehjcr/ytz181)

Cameron, A. C., Lang, N. N., Dominiczak, A. F., Jennings, G. L.R., Batlle, D., Bursztyn, M., Chugh, A. R., Floras, J. S., Taler, S. J., Touyz, R. M., Delles, C. (2019) Progressive hypertension and severe left ventricular outflow tract obstruction. Hypertension, 74, pp. 1216-1225. (doi: 10.1161/hypertensionaha.119.13343)

Jackson, A. M., Jhund, P. S. (2019) The price of a failing heart. European Journal of Heart Failure, 21, pp. 1532-1533. (doi: 10.1002/ejhf.1605)

Mehra, M. R., Vaduganathan, M., Fu, M., Ferreira, J. P., Anker, S. A., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D. J., Byra, W. M., Spiro, T., Deng, H., Zannad, F., Greenberg, B. (2019) A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Heart Journal, 40, pp. 3593-3602. (doi: 10.1093/eurheartj/ehz427)

McMurray, J. J.V. et al. (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381, pp. 1995-2008. (doi: 10.1056/NEJMoa1911303)

Ferreira, J. P., Rossignol, P., Dewan, P., Lamiral, Z., White, W. B., Pitt, B., McMurray, J. J.V., Zannad, F. (2019) Income level and inequality as complement to geographical differences in cardiovascular trials. American Heart Journal, 218, pp. 66-74. (doi: 10.1016/j.ahj.2019.08.019)

Bularga, A., Lee, K. K., Stewart, S., Ferry, A. V., Chapman, A. R., Marshall, L., Strachan, F. E., Cruickshank, A., Maguire, D., Berry, C., Findlay, I., Shah, A. S.V., Newby, D. E., Mills, N. L., Anand, A. (2019) High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome. Circulation, 140, pp. 1557-1568. (doi: 10.1161/CIRCULATIONAHA.119.042866)

Tillin, T., Tuson, C., Sowa, B., Chattopadhyay, K., Sattar, N., Welsh, P., Roberts, I., Ebrahim, S., Kinra, S., Hughes, A., Chaturvedi, N. (2019) Yoga and Cardiovascular Health Trial (YACHT): a UK-based randomised mechanistic study of a yoga intervention plus usual care versus usual care alone following an acute coronary event. BMJ Open, 9, (doi: 10.1136/bmjopen-2019-030119)

Docherty, K. F., McMurray, J. J.V. (2019) PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction. Cardiovascular Research, 115, pp. e136-e139. (doi: 10.1093/cvr/cvz223)

Sillars, A., Celis-Morales, C. A., Ho, F., Petermann, F., Welsh, P., Iliodromiti, S., Ferguson, L. D., Lyall, D. M., Anderson, J., Mackay, D., Pellicori, P., Cleland, J., Pell, J. P., Gill, J. M.R., Gray, S. R., Sattar, N. (2019) Association of fitness and grip-strength with heart failure: findings from the UK Biobank population-based study. Mayo Clinic Proceedings, 94, pp. 2230-2240. (doi: 10.1016/j.mayocp.2019.04.041)

McDonald, M. W., Black, S. E., Copland, D. A., Corbett, D., Dijkhuizen, R. M., Farr, T. D., Jeffers, M. S., Kalaria, R. N., Karayanidis, F., Leff, A. P., Nithianantharajah, J., Pendlebury, S., Quinn, T. J., Clarkson, A. N., O’Sullivan, M. J. (2019) Cognition in stroke rehabilitation and recovery research: consensus-based core recommendations from the second Stroke Recovery and Rehabilitation Roundtable. Neurorehabilitation and Neural Repair, 33, pp. 943-950. (doi: 10.1177/1545968319886444)

Shaw, R., Drozdowska, B., Taylor-Rowan, M., Elliott, E., Cuthbertson, G., Stott, D. J., Quinn, T. J. (2019) Delirium in an acute stroke setting, occurrence, and risk factors. Stroke, 50, pp. 3265-3268. (doi: 10.1161/strokeaha.119.025993)

Steell, L., Ho, F. K., Sillars, A., Petermann, F., Li, H., Lyall, D. M., Iliodromiti, S., Welsh, P., Anderson, J., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A. (2019) Dose-response associations of cardiorespiratory fitness with all-cause mortality and incidence and mortality of cancer and cardiovascular and respiratory diseases: the UK Biobank cohort study. British Journal of Sports Medicine, 53, pp. 1371-1378. (doi: 10.1136/bjsports-2018-099093)

Ferguson, L., Welsh, P., Brown, R., Tindell, A., Kerrigan, S., Sattar, N., McInnes, I., Siebert, S. (2019) Effect of Phosphodiesterase 4 Inhibition with Apremilast on Cardiometabolic Outcomes in Psoriatic Arthritis – Initial Results from the Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) Study.

Davies, V., Noè, U., Lazarus, A., Gao, H., Macdonald, B., Berry, C., Luo, X., Husmeier, D. (2019) Fast parameter inference in a biomechanical model of the left ventricle by using statistical emulation. Journal of the Royal Statistical Society: Series C (Applied Statistics), 68, pp. 1555-1576. (doi: 10.1111/rssc.12374)

Lees, J. S., Welsh, C. E., Celis-Morales, C. A., Mackay, D., Lewsey, J., Gray, S. R., Lyall, D. M., Cleland, J. G., Gill, J. M.R., Jhund, P. S., Pell, J., Sattar, N., Welsh, P., Mark, P. B. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8)

Beusekamp, J. C., Tromp, J., Cleland, J. G.F., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Ouwerkerk, W., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality. JACC: Heart Failure, 7, pp. 970-979. (doi: 10.1016/j.jchf.2019.07.010)

Shaw, R. C., Walker, G., Elliott, E., Quinn, T. J. (2019) Occurrence rate of delirium in acute stroke settings. Stroke, 50, pp. 3028-3036. (doi: 10.1161/strokeaha.119.025015)

Pellicori, P., Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F., Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124, pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018)

Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A. C., Millett, E. R.C., Salimi-Khorshidi, G., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiology, 4, pp. 1102-1111. (doi: 10.1001/jamacardio.2019.3593)

McMurray, J. J.V., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Bengtsson, O., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D. (2019) The Dapagliflozin and Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics. European Journal of Heart Failure, 21, pp. 1402-1411. (doi: 10.1002/ejhf.1548)

Beldhuis, I. E., Streng, K. W., van der Meer, P., Ter Maaten, J. M., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Cotter, G., Cleland, J. G.F., Davison, B. A., Givertz, M. M., Teerlink, J. R., Bloomfield, D. M., Voors, A. A., Damman, K. (2019) Trajectories of changes in renal function in patients with acute heart failure. Journal of Cardiac Failure, 25, pp. 866-874. (doi: 10.1016/j.cardfail.2019.07.004)

Solomon, S. D. et al. (2019) Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction. New England Journal of Medicine, 381, pp. 1609-1620. (doi: 10.1056/NEJMoa1908655)

Selvaraj, S., Claggett, B., Pozzi, A., McMurray, J. J.V., Jhund, P. S., Packer, M., Desai, A. S., Lewis, E. F., Vaduganathan, M., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Zile, M. R., Swedberg, K., Solomon, S. D. (2019) Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF. Circulation, 140, pp. 1369-1379. (doi: 10.1161/CIRCULATIONAHA.119.039920)

Santema, B. T. et al. (2019) Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet, 394, (doi: 10.1016/S0140-6736(19)31792-1)

Stirrat, C. G., Alam, S., MacGillivray, T. J., Gray, C., Dweck, M. R., Jones, V., Wallace, W., Payne, J. R., Prasad, S. K., Gardner, R. S., Petrie, M. C., Mirsadraee, S., Henriksen, P., Newby, D. E., Semple, S. (2019) Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation. Open Heart, 6, (doi: 10.1136/openhrt-2019-001115)

McDicken, J. A., Elliott, E., Blayney, G., Makin, S., Ali, M., Larner, A. J., Quinn, T. J. (2019) Accuracy of the short-form Montreal Cognitive Assessment: systematic review and validation. International Journal of Geriatric Psychiatry, 34, pp. 1515-1525. (doi: 10.1002/gps.5162)

Coiro, S., Girerd, N., Sharma, A., Rossignol, P., Tritto, I., Pitt, B., Pfeffer, M. A., McMurray, J. J.V., Ambrosio, G., Dickstein, K., Moss, A., Zannad, F. (2019) Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.1541)

Howlett, J. G., Stebbins, A., Petrie, M. C., Jhund, P. S., Castelvecchio, S., Cherniavsky, A., Sueta, C. A., Roy, A., Piña, I. L., Wurm, R., Drazner, M. H., Andersson, B., Batlle, C., Senni, M., Chrzanowski, L., Merkely, B., Carson, P., Desvigne-Nickens, P. M., Lee, K. L., Velazquez, E. J., Al-Khalidi, H. R. (2019) CABG improves outcomes in patients with ischemic cardiomyopathy 10-year follow-up of the STICH trial. JACC: Heart Failure, 7, pp. 878-887. (doi: 10.1016/j.jchf.2019.04.018)

Seferovic, P. M. et al. (2019) Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 1169-1186. (doi: 10.1002/ejhf.1531)

McDonald, M. W., Black, S. E., Copland, D. A., Corbett, D., Dijkhuizen, R. M., Farr, T. D., Jeffers, M. S., Kalaria, R. N., Karayanidis, F., Leff, A. P., Nithianantharajah, J., Pendlebury, S., Quinn, T. J., Clarkson, A. N., O’Sullivan, M. J. (2019) Cognition in stroke rehabilitation and recovery research: Consensus-based core recommendations from the second Stroke Recovery and Rehabilitation Roundtable. International Journal of Stroke, 14, pp. 774-782. (doi: 10.1177/1747493019873600)

Muilwijk, M., Ho, F., Waddell, H., Sillars, A., Welsh, P., Iliodromiti, S., Brown, R., Ferguson, L., Stronks, K., van Valkengoed, I., Pell, J. P., Gray, S. R., Gill, J. M. R., Sattar, N., Celis-Morales, C. (2019) Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study. BMJ Open Diabetes Research and Care, 7, (doi: 10.1136/bmjdrc-2019-000765)

Rahman, H., Corcoran, D., Aetesam-Ur-Rahman, M., Hoole, S. P., Berry, C., Perera, D. (2019) Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart, 105, pp. 1536-1542. (doi: 10.1136/heartjnl-2019-315042)

Hausenloy, D. J. et al. (2019) Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet, 394, pp. 1415-1424. (doi: 10.1016/S0140-6736(19)32039-2)

Packer, M. et al. (2019) Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial. European Journal of Heart Failure, 21, pp. 1270-1278. (doi: 10.1002/ejhf.1536)

Anker, S. D. et al. (2019) Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial. European Journal of Heart Failure, 21, pp. 1279-1287. (doi: 10.1002/ejhf.1596)

Yazaki, Y., Salzano, A., Nelson, C. P., Voors, A. A., Anker, S. D., Cleland, J. G., Lang, C. C., Metra, M., Samani, N. J., Ng, L. L., Suzuki, T. (2019) Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis. European Journal of Heart Failure, 21, pp. 1291-1294. (doi: 10.1002/ejhf.1550)

Adamson, P. D., Williams, M. C., Dweck, M. R., Mills, N. L., Boon, N. A., Daghem, M., Bing, R., Moss, A. J., Mangion, K., Flather, M., Forbes, J., Hunter, A., Norrie, J., Shah, A. S.V., Timmis, A. D., van Beek, E. J.R., Ahmadi, A. A., Leipsic, J., Narula, J., Newby, D. E., Roditi, G., McAllister, D. A., Berry, C. (2019) Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. Journal of the American College of Cardiology, 74, pp. 2058-2070. (doi: 10.1016/j.jacc.2019.07.085)

Platz, E., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Merz, A. A., Silverman, M., Swamy, V., Lindner, M., Rivero, J., Solomon, S. D., McMurray, J. J.V. (2019) Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short- and long-term outcomes. JACC: Heart Failure, 7, pp. 849-858. (doi: 10.1016/j.jchf.2019.07.008)

Blair, C. M., Baillie, G. S. (2019) Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes. Biochemical Society Transactions, 47, pp. 1405-1414. (doi: 10.1042/BST20190252)

Lee, K. K., Ferry, A. V., Anand, A., Strachan, F. E., Chapman, A. R., Kimenai, D. M., Meex, S. J.R., Berry, C., Findlay, I., Reid, A., Cruickshank, A., Gray, A., Collinson, P. O., Apple, F. S., McAllister, D. A., Maguire, D., Fox, K. A.A., Newby, D. E., Tuck, C., Keerie, C., Weir, C. J., Shah, A. S.V., Mills, N. L. (2019) Sex-specific thresholds of high-sensitivity troponin in patients with suspected acute coronary syndrome. Journal of the American College of Cardiology, 74, pp. 2032-2043. (doi: 10.1016/j.jacc.2019.07.082)

Lee, M. M.Y., Sattar, N., McMurray, J. J.V., Packard, C. J. (2019) Statins in the prevention and treatment of heart failure: a review of the evidence. Current Atherosclerosis Reports, 21, (doi: 10.1007/s11883-019-0800-z)

Baillie, G. S., Tejeda, G. S., Kelly, M. P. (2019) Therapeutic targeting of 3’,5’-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nature Reviews Drug Discovery, 18, pp. 770-796. (doi: 10.1038/s41573-019-0033-4)

Tibbo, A. J., Tejeda, G. S., Baillie, G. S. (2019) Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches. Biochemical Society Transactions, 47, pp. 1557-1565. (doi: 10.1042/BST20190763)

Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., Wang, W., Lefkowitz, M. P., Shi, V. C., Anand, I. S., Ge, J., Lam, C. S.P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., McMurray, J. J.V., Solomon, S. D. (2019) Health-related quality of life in heart failure with preserved ejection fraction the PARAGON-HF trial. JACC: Heart Failure, 7, pp. 862-874. (doi: 10.1016/j.jchf.2019.05.015)

Becker, C. E., Quinn, T. J., Williams, A. (2019) Association between endothelial cell stabilizing medication and small vessel disease stroke: a case-control study. Frontiers in Neurology, 10, (doi: 10.3389/fneur.2019.01029)

Gallacher, K., Quinn, T., Kidd, L., Eton, D., Elliot, J., Johnston, N., Erwin, P. J., Mair, F. (2019) Systematic review of patient-reported measures of treatment burden in stroke. BMJ Open, 9, (doi: 10.1136/bmjopen-2019-029258)

Nicolau, J. C., Stevens, S. R., Al-Khalidi, H. R., Jatene, F. B., Furtado, R. H.M., Dallan, L. A.O., Lisboa, L. A.F., Desvigne-Nickens, P., Haddad, H., Jolicoeur, E. M., Petrie, M. C., Doenst, T., Michler, R. E., Ohman, E. M., Maddury, J., Ali, I., Deja, M. A., Rouleau, J. L., Velazquez, E. J., Hill, J. A. (2019) Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International Journal of Cardiology, 291, pp. 36-41. (doi: 10.1016/j.ijcard.2019.03.029)

Chan, C. C.H., Fage, B. A., Burton, J. K., Smailagic, N., Gill, S. S., Herrmann, N., Nikolaou, V., Quinn, T. J., Noel-Storr, A. H., Seitz, D. P. (2019) Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting. Cochrane Database of Systematic Reviews, 9, (doi: 10.1002/14651858.CD011414.pub2)

Yap, J., Tay, W. T., Teng, T.‐H. K., Anand, I., Richards, A. M., Ling, L. H., MacDonald, M. R., Chandramouli, C., Tromp, J., Siswanto, B. B., Zile, M., McMurray, J., Lam, C. S. P. (2019) Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. Journal of the American Heart Association, 8, (doi: 10.1161/jaha.119.013114)

Efstathiadou, A., Gill, D., McGrane, F., Quinn, T., Dawson, J. (2019) Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a Mendelian randomization study of outcomes investigated in randomized trials. Journal of the American Heart Association, 8, (doi: 10.1161/JAHA.119.012738)

Beggs, S. A.S., Rørth, R., Gardner, R. S., McMurray, J. J.V. (2019) Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis. Heart, 105, pp. 1325-1334. (doi: 10.1136/heartjnl-2018-314381)

Kristensen, S. L., Rorth, R., Jhund, P. S., Docherty, K., Sattar, N., Preiss, D., Kober, L., Petrie, M. C., McMurray, J. J.V. (2019) Cardiovascular, mortality and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes and Endocrinology, 7, pp. 776-785. (doi: 10.1016/S2213-8587(19)30249-9)

Touyz, R. M., Lang, N. N. (2019) Hypertension and antiangiogenesis: the Janus face of VEGF inhibitors. JACC: CardioOncology, 1, pp. 37-40. (doi: 10.1016/j.jaccao.2019.08.010)

Tromp, J., Lim, S. L., Tay, W. T., Teng, T.-H. K., Chandramouli, C., Ouwerkerk, W., Wander, G. S., Sawhney, J. P.S., Yap, J., MacDonald, M. R., Ling, L. H., Sattar, N., McMurray, J. J.V., Richards, A. M., Anand, I., Lam, C. S.P. (2019) Microvascular disease in patients with diabetes with heart failure and reduced ejection versus preserved ejection fraction. Diabetes Care, 42, pp. 1792-1799. (doi: 10.2337/dc18-2515)

Dérimay, F., Johnson, N. P., Zimmermann, F. M., Adjedj, J., Witt, N., Hennigan, B., Koo, B.‐K., Barbato, E., Esposito, G., Trimarco, B., Rioufol, G., Park, S.‐J., Baptista, S. B., Chrysant, G. S., Leone, A. M., Jeremias, A., Berry, C., De Bruyne, B., Oldroyd, K. G., Pijls, N. H.J., Fearon, W. F. (2019) Predictive factors of discordance between the instantaneous wave‐free ratio and fractional flow reserve. Catheterization and Cardiovascular Interventions, 94, pp. 356-363. (doi: 10.1002/ccd.28116)

Avtaar Singh, S. S., Dalzell, J. R., Berry, C., Al-Attar, N. (2019) Primary graft dysfunction after heart transplantation: a thorn amongst the roses. Heart Failure Reviews, 24, pp. 805-820. (doi: 10.1007/s10741-019-09794-1)

Grodin, J. L., Liebo, M. J., Butler, J., Metra, M., Felker, G. M., Hernandez, A. F., Voors, A., McMurray, J. J., Armstrong, P. W., O'Connor, C., Starling, R. C., Troughton, R. C., Tang, W.H. W. (2019) Prognostic implications of changes in amino-terminal pro–B-type natriuretic peptide in acute decompensated heart failure: insights from ASCEND-HF. Journal of Cardiac Failure, 25, pp. 703-711. (doi: 10.1016/j.cardfail.2019.04.002)

Pickford, C. G., Findlow, A. H., Kerr, A., Banger, M., Clarke-Cornwell, A. M., Hollands, K. L., Quinn, T., Granat, M. H. (2019) Quantifying sit-to-stand and stand-to-sit transitions in free-living environments using the activPAL thigh-worn activity monitor. Gait and Posture, 73, pp. 140-146. (doi: 10.1016/j.gaitpost.2019.07.126)

Ho, F. K.W., Celis-Morales, C. A., Petermann, F., Sillars, A., Welsh, P., Welsh, C., Anderson, J., Lyall, D. M., Mackay, D. F., Sattar, N., Gill, J. M.R., Pell, J. P., Gray, S. R. (2019) The association between handgrip strength and future health outcomes does not differ if grip strength is used in absolute or relative terms: a prospective cohort study. Age and Ageing, 48, pp. 683-691. (doi: 10.1093/ageing/afz068)

Elliott, E., Drozdowska, B. A., Taylor-Rowan, M., Shaw, R. C., Cuthbertson, G., Quinn, T. J. (2019) Who is classified as untestable on brief cognitive screens in an acute stroke setting? Diagnostics, 9, (doi: 10.3390/diagnostics9030095)

Ferreira, J. P., Kraus, S., Mitchell, S., Perel, P., Piñeiro, D., Chioncel, O., Colque, R., de Boer, R., Gomez-Mesa, J. E., Grancelli, H., Lam, C. S. P., Martinez-Rubio, A., McMurray, J. J.V., Mebazaa, A., Panjrath, G., Piña, I. L., Sani, M., Sim, D., Walsh, M., Yancy, C., Zannad, F., Sliwa, K. (2019) World Heart Federation Roadmap for heart failure. Global Heart, 14, pp. 197-214. (doi: 10.1016/j.gheart.2019.07.004)

Gerstein, H. C., McMurray, J., Holman, R. R. (2019) The importance of randomised vs non-randomised trials - authors' reply. Lancet, 394, pp. 635. (doi: 10.1016/S0140-6736(19)31111-0)

Metra, M. et al. (2019) Effects of serelaxin in patients with acute heart failure. New England Journal of Medicine, 381, pp. 716-726. (doi: 10.1056/NEJMoa1801291)

McMurray, J. J.V., Docherty, K. F. (2019) Phosphodiesterase-9 inhibition in heart failure: a further opportunity to augment the effects of natriuretic peptides? Journal of the American College of Cardiology, 74, pp. 902-904. (doi: 10.1016/j.jacc.2019.07.008)

Täger, T., Fröhlich, H., Grundtvig, M., Seiz, M., Schellberg, D., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L. (2019) Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – a multicenter propensity score matched analysis. International Journal of Cardiology, 289, pp. 83-90. (doi: 10.1016/j.ijcard.2019.01.109)

Yang, Y., Gao, H., Berry, C., Radjenovic, A., Husmeier, D. (2019) Quantification of Myocardial Perfusion Lesions Using Spatially Variant Finite Mixture Modelling of DCE-MRI. (doi: 10.11159/icsta19.26)

Husmeier, D., Lazarus, A., Noè, U., Davies, V., Borowska, A., Macdonald, B., Gao, H., Berry, C., Luo, X. (2019) Statistical Emulation of Cardiac Mechanics: an Important Step Towards a Clinical Decision Support System. (doi: 10.11159/icsta19.29)

Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., Cleland, J. G., Jhund, P. S., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2019) Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation, 140, pp. 542-552. (doi: 10.1161/CIRCULATIONAHA.119.041149)

Cleland, J. G.F., Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140, pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523)

Tromp, J., Shen, L., Jhund, P. S., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Køber, L., Swedberg, K., Zile, M. R., Pitt, B., Lam, C. S.P., McMurray, J. J.V. (2019) Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 74, pp. 601-612. (doi: 10.1016/j.jacc.2019.05.052)

Leong, D. P., McMurray, J. J.V., Joseph, P. G., Yusuf, S. (2019) From ACE inhibitors/ARBs to ARNIs in coronary artery disease and heart failure (Part 2/5) Journal of the American College of Cardiology, 74, pp. 683-698. (doi: 10.1016/j.jacc.2019.04.068)

Wang, L., Morotti, S., Tapa, S., Francis Stuart, S. D., Jiang, Y., Wang, Z., Myles, R. C., Brack, K. E., Ng, G. A., Bers, D. M., Grandi, E., Ripplinger, C. M. (2019) Different paths, same destination: divergent action potential responses produce conserved cardiac fight-or-flight response in mouse and rabbit hearts. Journal of Physiology, 597, pp. 3867-3883. (doi: 10.1113/jp278016)

Johnson, N. P., Li, W., Chen, X., Hennigan, B., Watkins, S., Berry, C., Fearon, W. F., Oldroyd, K. G. (2019) Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio. European Heart Journal, 40, pp. 2585-2594. (doi: 10.1093/eurheartj/ehz230)

Gray, S., Celis-Morales, C. A., Lyall, D. M., Petermann, F., Anderson, J., Ward, J., Iliodromiti, S., Mackay, D. F., Welsh, P., Bailey, M. E.S., Pell, J., Sattar, N., Gill, J. M.R., Gray, S. R. (2019) Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study. International Journal of Obesity, 43, pp. 1526-1538. (doi: 10.1038/s41366-019-0381-5)

Rørth, R., Dewan, P., Kristensen, S. L., Jhund, P. S., Petrie, M. C., Køber, L., McMurray, J. J.V. (2019) Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction. Clinical Research in Cardiology, 108, pp. 868-877. (doi: 10.1007/s00392-019-01415-z)

Fröhlich, H., Rosenfeld, N., Täger, T., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L., Grundtvig, M. (2019) Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart, 105, pp. 1252-1259. (doi: 10.1136/heartjnl-2018-314256)

Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., Granger, C. B., Komajda, M., McKelvie, R. S., Solomon, S. D., Staszewsky, L., Swedberg, K., Huynh, T., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2019) Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. European Journal of Heart Failure, 21, pp. 974-984. (doi: 10.1002/ejhf.1535)

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.007830)

Crea, F., Bairey Merz, C. N., Beltrame, J. F., Berry, C., Camici, P. G., Kaski, J. C., Ong, P., Pepine, C. J., Sechtem, U., Shimokawa, H. (2019) Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. European Heart Journal, 40, pp. 2455-2462. (doi: 10.1093/eurheartj/ehy857)

Halliday, B. P., Baksi, A. J., Gulati, A., Ali, A., Newsome, S., Izgi, C., Arzanauskaite, M., Lota, A., Tayal, U., Vassiliou, V. S., Gregson, J., Alpendurada, F., Frenneaux, M. P., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2019) Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement. JACC: Cardiovascular Imaging, 12, pp. 1645-1655. (doi: 10.1016/j.jcmg.2018.07.015)

Whiteley, E. L., Tejeda, G. S., Baillie, G. S., Brandon, N. J. (2019) PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders. Cellular Signalling, 60, pp. 31-38. (doi: 10.1016/j.cellsig.2019.04.001)

Felker, G. M., Borentain, M., Cleland, J. G.F., DeSouza, M. M., Kessler, P. D., O'Connor, C. M., Seiffert, D., Teerlink, J. R., Voors, A. A., McMurray, J. J.V. (2019) Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. European Journal of Heart Failure, 21, pp. 1022-1031. (doi: 10.1002/ejhf.1504)

Welsh, C. E., Welsh, P., Jhund, P., Sattar, N., Mark, P. B. (2019) Response by Welsh et al to letter regarding article “Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease” Hypertension, 74, pp. e27-e28. (doi: 10.1161/HYPERTENSIONAHA.119.13349)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Devalaraja, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., Zwinderman, A. H., Hillege, H. L., van Veldhuisen, D. J., Kakkar, R., Voors, A. A., van der Meer, P. (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF Study. European Journal of Heart Failure, 21, pp. 965-973. (doi: 10.1002/ejhf.1482)

Noè, U., Lazarus, A., Gao, H., Davies, V., Macdonald, B., Mangion, K., Berry, C., Luo, X., Husmeier, D. (2019) Gaussian process emulation to accelerate parameter estimation in a mechanical model of the left ventricle: a critical step towards clinical end-user relevance. Journal of the Royal Society: Interface, 16, (doi: 10.1098/rsif.2019.0114)

Bowman, P. R.T., Smith, G. L., Gould, G. W. (2019) GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes. PLoS ONE, 14, (doi: 10.1371/journal.pone.0217885)

Halliday, B. P., Cleland, J. G.F., Prasad, S. K. (2019) When can heart failure treatment be stopped safely? – Authors' reply. Lancet, 394, pp. 217-218. (doi: 10.1016/S0140-6736(19)30499-4)

Ibanez, B., Aletras, A. H., Arai, A. E., Arheden, H., Bax, J., Berry, C., Bucciarelli-Ducci, C., Croisille, P., Dall'Armellina, E., Dharmakumar, R., Eitel, I., Fernández-Jiménez, R., Friedrich, M. G., García-Dorado, D., Hausenloy, D. J., Kim, R. J., Kozerke, S., Kramer, C. M., Salerno, M., Sánchez-González, J., Sanz, J., Fuster, V. (2019) Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. Journal of the American College of Cardiology, 74, pp. 238-256. (doi: 10.1016/j.jacc.2019.05.024)

Rankin, J., Rowen, D., Howe, A., Cleland, J. G.F., Whitty, J. A. (2019) Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses. Heart Failure Reviews, 24, pp. 549-563. (doi: 10.1007/s10741-019-09780-7)

Omar, F., Findlay, J. E., Carfray, G., Allcock, R. W., Jiang, Z., Moore, C., Muir, A. L., Lannoy, M., Fertig, B. A., Maie, D., Day, J. P., Bolger, G., Baillie, G. S., Schwiebert, E., Klussmann, E., Pyne, N. J., Ong, A. C.M., Bowers, K., Adam, J. M., Adams, D. R., Houslay, M. D., Hendersona, D. J.P. (2019) Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases. Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 13320-13329. (doi: 10.1073/pnas.1822113116)

Valli, A., Morotti, M., Zois, C. E., Albers, P. K., Soga, T., Feldinger, K., Fischer, R., Frejno, M., McIntyre, A., Bridges, E., Haider, S., Buffa, F. M., Baban, D., Rodriguez, M., Yanes, O., Whittington, H. J., Lake, H. A., Zervou, S., Lygate, C. A., Kessler, B. M., Harris, A. L. (2019) Adaptation to HIF1α deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism. Molecular Cancer Research, 17, pp. 1531-1544. (doi: 10.1158/1541-7786.MCR-18-0315)

Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J.L., Chan, D. C.S., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., Ng, L. L. (2019) Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure (from BIOSTAT‐CHF) European Journal of Heart Failure, 21, pp. 877-886. (doi: 10.1002/ejhf.1338)

Ubaid, S., Ford, T. J., Berry, C., Murray, H. M., Wrigley, B., Khan, N., Thomas, M. R., Armesilla, A. L., Townend, J. N., Khogali, S. S., Munir, S., Martins, J., Hothi, S. S., McAlindon, E. J., Cotton, J. M. (2019) Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: impact on platelet activity, myocardial microvascular function and infarct size: a randomized controlled trial. Thrombosis and Haemostasis, 119, pp. 1171-1181. (doi: 10.1055/s-0039-1688789)

Nuzzi, V., Pellicori, P., Nikolaidou, T., Kallvikbacka-Bennett, A., Torromeo, C., Barilla, F., Damien, S., Kaur, K., Monzo, L., Cleland, J. G.F., Clark, A. L. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20, pp. 442-449. (doi: 10.2459/JCM.0000000000000802)

Beverborg, N. G., van der Wal, H., Klip, I. T., Anker, S. D., Cleland, J. G.F., Dickstein, K., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiology, 4, pp. 696-701. (doi: 10.1001/jamacardio.2019.1739)

Kettlewell, S., Saxena, P., Dempster, J., Colman, M. A., Myles, R. C., Smith, G. L., Workman, A. J. (2019) Dynamic‐clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarisations. Journal of Physiology, 597, pp. 3619-3638. (doi: 10.1113/JP277827)

Wongpiyabovorn, J., Soonthornchai, W., Wilantho, A., Palasuk, M., Payungporn, S., Sodsai, P., Poomipak, W., Weschawalit, S., Ruchusatsawat, K., Baillie, G. S., Hirankarn, N., Somboonna, N. (2019) Effect of tarcolimus on skin microbiome in atopic dermatitis. Allergy, 74, pp. 1400-1406. (doi: 10.1111/all.13743)

Platz, E., Jhund, P. S., Girerd, N., Pivetta, E., McMurray, J. J.V., Peacock, W. F., Masip, J., Martin-Sanchez, F. J., Miro, Ò., Price, S., Cullen, L., Maisel, A. S., Vrints, C., Cowie, M. R., DiSomma, S., Bueno, H., Mebazaa, A., Gualandro, D. M., Tavares, M., Metra, M., Coats, A. J.S., Ruschitzka, F., Seferovic, P. M., Mueller, C. (2019) Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. European Journal of Heart Failure, 21, pp. 844-851. (doi: 10.1002/ejhf.1499)

Robertson, J., Schaufelberger, M., Lindgren, M., Adiels, M., Schiöler, L., Torén, K., McMurray, J., Sattar, N., Åberg, M., Rosengren, A. (2019) Higher body mass index in adolescence predicts cardiomyopathy risk in midlife: long-term follow-up among Swedish men. Circulation, 140, pp. 117-125. (doi: 10.1161/circulationaha.118.039132)

Doszpoly, A., de la Cuesta, F., Lopez-Gordo, E., Bénézech, C., Nicklin, S. A., Baker, A. H. (2019) Human adenovirus serotype 5 is sensitive to IgM-independent neutralization in vitro and in vivo. Viruses, 11, (doi: 10.3390/v11070616)

Chin, K. L., Collier, T., Pocock, S., Pitt, B., McMurray, J. J.V., van Veldhuisen, D. J., Swedberg, K., Vincent, J., Zannad, F., Liew, D. (2019) Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate. Clinical Research in Cardiology, 108, pp. 806-814. (doi: 10.1007/s00392-018-1410-4)

Niccoli, G., Montone, R. A., Ibanez, B., Thiele, H., Crea, F., Heusch, G., Bulluck, H., Hausenloy, D. J., Berry, C., Stiermaier, T., Camici, P. G., Eitel, I. (2019) Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. Circulation Research, 125, pp. 245-258. (doi: 10.1161/circresaha.119.315344)

Bauersachs, J., König, T., Meer, P., Petrie, M. C., Hilfiker‐Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A. M., Forsyth, P., Boer, R. A., Mueller, C., Lyon, A. R., Lund, L. H., Piepoli, M. F., Heymans, S., Chioncel, O., Anker, S. D., Ponikowski, P., Seferovic, P. M., Johnson, M. R., Mebazaa, A., Sliwa, K. (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21, pp. 827-843. (doi: 10.1002/ejhf.1493)

Houslay, K.F., Fertig, B.A., Christian, F., Tibbo, A.J., Ling, J., Findlay, J.E., Houslay, M.D., Baillie, G.S. (2019) Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling. Journal of Biochemistry, 166, pp. 97-106. (doi: 10.1093/jb/mvz016)

Pellicori, P., Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L., Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21, pp. 904-916. (doi: 10.1002/ejhf.1383)

Mordi, I. R., Santema, B. T., Kloosterman, M., Choy, A.-M., Rienstra, M., van Gelder, I., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Metra, M., Ng, L. L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Voors, A. A., Lang, C. C. (2019) Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Clinical Research in Cardiology, 108, pp. 797-805. (doi: 10.1007/s00392-018-1409-x)

Cleland, J. G.F., Hindricks, G., Petrie, M. (2019) The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization. European Heart Journal, 40, pp. 2128-2130. (doi: 10.1093/eurheartj/ehz409)

Stewart, S., Moholdt, T. T., Burrell, L. M., Sliwa, K., Mocumbi, A. O., McMurray, J. J.V., Keates, A. K., Hawley, J. A. (2019) Winter peaks in heart failure: an inevitable or preventable consequence of seasonal vulnerability? Cardiac Failure Review, 5, pp. 83-85. (doi: 10.15420/cfr.2018.40.2)

Clister, T., Greenwald, E. C., Baillie, G. S., Zhang, J. (2019) AKAP95 organizes a nuclear microdomain to control local cAMP for regulating nuclear PKA. Cell Chemical Biology, 26, pp. 885-891. (doi: 10.1016/j.chembiol.2019.03.003)

Nagel, E., Greenwood, J. P., McCann, G. P., Bettencourt, N., Shah, A. M., Hussain, S. T., Perera, D., Plein, S., Bucciarelli-Ducci, C., Paul, M., Westwood, M. A., Marber, M., Richter, W.-S., Puntmann, V. O., Schwenke, C., Schulz-Menger, J., Das, R., Wong, J., Hausenloy, D. J., Steen, H., Berry, C. (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. New England Journal of Medicine, 380, pp. 2418-2428. (doi: 10.1056/NEJMoa1716734)

Shoaib, A., Mamas, M. A., Ahmad, Q. S., McDonagh, T. M., Hardman, S. M.C., Rashid, M., Butler, R., Duckett, S., Satchithananda, D., Nolan, J., Dargie, H. J., Clark, A. L., Cleland, J. G.F. (2019) Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema. International Journal of Cardiology, 285, pp. 40-46. (doi: 10.1016/j.ijcard.2019.03.020)

Henderson, A., Iwagami, M., Bottomley, C., Tomlinson, L., Mansfield, K., Nitsch, D. (2019) Paediatric acute kidney injury hospital admissions in England 1997–2014: burden and risk factors. Clinical Kidney Journal, 12, pp. 859-860. (doi: 10.1093/ckj/sfz075)

Van Strijp, D., De Witz, C., Heitkoetter, B., Huss, S., Boegemann, M., Baillie, G. S., Houslay, M. D., Bangma, C., Semjonow, A., Hoffmann, R. (2019) The association of the long prostate cancer expressed PDE4D transcripts to poor patient outcome depends on the tumor’s TMPRSS2-ERG fusion status. Prostate Cancer, 2019, (doi: 10.1155/2019/8107807)

Dewan, P., Docherty, K. F., McMurray, J. J.V. (2019) Sacubitril/valsartan in Asian patients with heart failure with reduced ejection fraction. Korean Circulation Journal, 49, pp. 469-484. (doi: 10.4070/kcj.2019.0136)

Simpson, J., Benson, L., Jhund, P.S., Dahlström, U., McMurray, J.J.V., Lund, L.H. (2019) "Real world" eligibility for sacubitril/valsartan in unselected heart failure patients: data from the Swedish Heart Failure Registry. Cardiovascular Drugs and Therapy, 33, pp. 315-322. (doi: 10.1007/s10557-019-06873-1)

Greenberg, B., Neaton, J. D., Anker, S. D., Byra, W. M., Cleland, J. G.F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Vanden Boom, C. M., Zannad, F. (2019) Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiology, 4, pp. 515-523. (doi: 10.1001/jamacardio.2019.1049)

ter Maaten, J. M., Kremer, D., Demissei, B. G., Struck, J., Bergmann, A., Anker, S. D., Ng, L. L., Dickstein, K., Metra, M., Samani, N. J., Romaine, S. P.R., Cleland, J., Girerd, N., Lang, C. C., van Veldhuisen, D. J., Voors, A. A. (2019) Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure. European Journal of Heart Failure, 21, pp. 732-743. (doi: 10.1002/ejhf.1437)

Welsh, P., Preiss, D., Hayward, C., Shah, A. S.V., McAllister, D., Briggs, A., Boachie, C., McConnachie, A., Padmanabhan, S., Welsh, C., Woodward, M., Campbell, A., Porteous, D., Mills, N. L., Sattar, N. (2019) Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes. Circulation, 139, pp. 2754-2764. (doi: 10.1161/CIRCULATIONAHA.118.038529)

Clark, A. L., Kalra, P. R., Petrie, M. C., Mark, P. B., Tomlinson, L. A., Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105, pp. 904-910. (doi: 10.1136/heartjnl-2018-314158)

Haig, C., Carrick, D., Carberry, J., Mangion, K., Maznyczka, A., Wetherall, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ahmed, N., May, V. T. Y., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Current smoking and prognosis after acute ST-segment elevation myocardial infarction: new pathophysiological insights. JACC: Cardiovascular Imaging, 12, pp. 993-1003. (doi: 10.1016/j.jcmg.2018.05.022)

Shah, S. J., Voors, A. A., McMurray, J. J.V., Kitzman, D. W., Viethen, T., Bomfim Wirtz, A., Huang, E., Pap, A. F., Solomon, S. D. (2019) Effect of neladenoson bialanate on exercise capacity among patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321, pp. 2101-2112. (doi: 10.1001/jama.2019.6717)

Mueller, C., McDonald, K., deBoer, R. A., Maisel, A., Cleland, J. G.F., Kozhuharov, N., Coats, A. J.S., Metra, M., Mebazaa, A., Ruschitzka, F., Lainscak, M., Filippatos, G., Seferovic, P. M., Meijers, W. C., Bayes-Genis, A., Mueller, T., Richards, M., Januzzi, J. L. (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure, 21, pp. 715-731. (doi: 10.1002/ejhf.1494)

House, A. A. et al. (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies conference. Kidney International, 95, pp. 1304-1317. (doi: 10.1016/j.kint.2019.02.022)

Clarke, W. T., Peterzan, M. A., Rayner, J. J., Sayeed, R. A., Petrou, M., Krasopoulos, G., Lake, H. A., Raman, B., Watson, W. D., Cox, P., Hundertmark, M. J., Apps, A. P., Lygate, C. A., Neubauer, S., Rider, O. J., Rodgers, C. T. (2019) Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T. NMR in Biomedicine, 32, (doi: 10.1002/nbm.4085)

Balmforth, C., Simpson, J., Shen, L., Jhund, P. S., Lefkowitz, M., Rizkala, A. R., Rouleau, J. L., Shi, V., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2019) Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC: Heart Failure, 7, pp. 457-465. (doi: 10.1016/j.jchf.2019.02.015)

Ahmad, F. A., Petrie, M. C., McMurray, J. J.V., Lang, N. N. (2019) Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it. European Journal of Heart Failure, 21, pp. 699-702. (doi: 10.1002/ejhf.1463)

Quinn, T. J., Drozdowska, B. A. (2019) Stroke prediction and the future of prognosis research. Nature Reviews Neurology, 15, pp. 311-312. (doi: 10.1038/s41582-019-0181-5)

Welsh, C., Welsh, P., Jhund, P., Delles, C., Celis-Morales, C., Lewsey, J., Gray, S., Lyall, D., Iliodromiti, S., Gill, J., Sattar, N., Mark, P. (2019) Urinary sodium excretion, blood pressure and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension, 73, pp. 1202-1209. (doi: 10.1161/HYPERTENSIONAHA.119.12726)

Donaldson, A. I.C., Neal, S. R., McAlpine, C. H., Quinn, T., Shenkin, S. D., Ellis, G., Myint, P. K. (2019) Variation in acute and community service provision of care of the elderly services across Scotland: findings from the Scottish Care of Older People (SCoOP) initial scoping survey. Journal of the Royal College of Physicians of Edinburgh, 49, pp. 105-111. (doi: 10.4997/JRCPE.2019.204)

Verma, S., McMurray, J. J.V. (2019) The serendipitous story of SGLT2 inhibitors in heart failure: new insights from DECLARE-TIMI 58. Circulation, 139, pp. 2537-2541. (doi: 10.1161/circulationaha.119.040514)

Maznyczka, A. M., Oldroyd, K. G., McCartney, P., McEntegart, M., Berry, C. (2019) The potential use of the index of microcirculatory resistance to guide stratification of patients for adjunctive therapy in acute myocardial infarction. JACC: Cardiovascular Interventions, 12, pp. 951-966. (doi: 10.1016/j.jcin.2019.01.246)

Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G.F., Blumenthal, R. S., McEvoy, J. W. (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet, 393, pp. 2155-2167. (doi: 10.1016/S0140-6736(19)30541-0)

Ford, T., Berry, C. (2019) How to diagnose and manage angina without obstructive coronary artery disease: Lessons from the British Heart Foundation CorMicA trial. Interventional Cardiology Review, 14, pp. 76-82. (doi: 10.15420/icr.2019.04.R1)

Cleland, J. G.F., Pellicori, P., Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73, pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471)

Jhund, P. S. (2019) Improving recruitment for clinical trials: the human touch. Medical Journal of Australia, 210, pp. 401-402. (doi: 10.5694/mja2.50161)

Schanstra, J. P., Luong, T. T.D., Makridakis, M., Van Linthout, S., Lygirou, V., Latosinska, A., Alesutan, I., Boehme, B., Schelski, N., Von Lewinski, D., Mullen, W., Nicklin, S., Delles, C., Feuillet, G., Denis, C., Lang, F., Pieske, B., Bascands, J.-L., Mischak, H., Saulnier-Blache, J.-S., Voelkl, J., Vlahou, A., Klein, J. (2019) Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment. JCI Insight, 4, (doi: 10.1172/jci.insight.125638)

Smith, G. L., Eisner, D. A. (2019) Calcium buffering in the heart in health and disease. Circulation, 139, pp. 2358-2371. (doi: 10.1161/circulationaha.118.039329)

Stienen, S., Ferreira, J. P., Vincent, J., Busselen, M., Li, B., McMurray, J. J.V., Pitt, B., Girerd, N., Rossignol, P., Zannad, F. (2019) Estimated long-term survival with eplerenone. Journal of the American College of Cardiology, 73, pp. 2357-2359. (doi: 10.1016/j.jacc.2019.02.043)

Rossello, X., Ariti, C., Pocock, S. J., Ferreira, J. P., Girerd, N., McMurray, J. J.V., Van Veldhuisen, D. J., Pitt, B., Zannad, F. (2019) Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials. Clinical Research in Cardiology, 108, pp. 477-486. (doi: 10.1007/s00392-018-1378-0)

Vagena, E., Ryu, J. K., Baeza-Raja, B., Walsh, N. M., Syme, C., Day, J. P., Houslay, M., Baillie, G. (2019) A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signalling. Translational Psychiatry, 9, (doi: 10.1038/s41398-019-0470-1)

McMurray, J. J.V. et al. (2019) A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF) European Journal of Heart Failure, 21, pp. 665-675. (doi: 10.1002/ejhf.1432)

Singh, A., Horsfield, M. A., Bekele, S., Greenwood, J. P., Dawson, D. K., Berry, C., Hogrefe, K., Kelly, D. J., Houston, J. G., Guntur Ramkumar, P., Uddin, A., Suzuki, T., McCann, G. P. (2019) Aortic stiffness in aortic stenosis assessed by cardiovascular MRI: a comparison between bicuspid and tricuspid valves. European Radiology, 29, pp. 2340-2349. (doi: 10.1007/s00330-018-5775-6)

Heerspink, H. H.L., Parving, H.-H., Andress, D. L., Bakris, G., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J.V., Melnick, J. Z., Miller, M. G., Pergola, P. E., Perkovic, V., Tobe, S., Yi, T., Wigderson, M., de Zeeuw, D. (2019) Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet, 393, pp. 1937-1947. (doi: 10.1016/S0140-6736(19)30772-X)

Conrad, N., Judge, A., Canoy, D., Tran, J., O’Donnell, J., Nazarzadeh, M., Salimi-Khorshidi, G., Hobbs, F.D. R., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 UK patients. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002805)

Lean, M. E.J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K., Rodrigues, A. M., Rehackova, L., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., Ross, H. M., McIlvenna, Y., Welsh, P., Kean, S., Ford, I., McConnachie, A., Messow, C.-M., Sattar, N., Taylor, R. (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes and Endocrinology, 7, pp. 344-355. (doi: 10.1016/S2213-8587(19)30068-3)

Dewan, P. et al. (2019) Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. European Journal of Heart Failure, 21, pp. 577-587. (doi: 10.1002/ejhf.1347)

McDermid, I., Barber, M., Dennis, M., Langhorne, P., Macleod, M. J., McAlpine, C. H., Quinn, T. J. (2019) Home-time is a feasible and valid stroke outcome measure in national datasets. Stroke, 50, pp. 1282-1285. (doi: 10.1161/STROKEAHA.118.023916)

Shoaib, A., Farag, M., Nolan, J., Rigby, A., Patwala, A., Rashid, M., Kwok, C.S., Perveen, R., Clark, A.L., Komajda, M., Cleland, J.G.F. (2019) Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from The First Euro Heart Failure Survey. Clinical Research in Cardiology, 108, pp. 510-519. (doi: 10.1007/s00392-018-1380-6)

Taylor-Rowan, M., Keir, R., Cuthbertson, G., Shaw, R., Drozdowska, B., Elliott, E., Evans, J., Stott J, D., Quinn, T. J. (2019) Pre-stroke frailty is independently associated with post-stroke cognition: A cross-sectional study. Journal of the International Neuropsychological Society, 25, pp. 501-506. (doi: 10.1017/S1355617719000092)

Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Prior pacemaker implantation and clinical outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 7, pp. 418-427. (doi: 10.1016/j.jchf.2018.12.006)

Ferreira, J. P. et al. (2019) Proteomic bioprofiles and mechanistic pathways of progression to heart failure: the HOMAGE study. Circulation, 12, (doi: 10.1161/CIRCHEARTFAILURE.118.005897)

McMurray, J. J.V. (2019) Urinalysis: a window to the heart. JACC: Heart Failure, 7, pp. 402-403. (doi: 10.1016/j.jchf.2019.04.002)

Shah, P., Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Pan, D., Clark, A. L. (2019) Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology, 108, pp. 468-476. (doi: 10.1007/s00392-018-1376-2)

Freeman, S. C., Kerby, C. R., Patel, A., Cooper, N. J., Quinn, T., Sutton, A. J. (2019) Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA. BMC Medical Research Methodology, 19, (doi: 10.1186/s12874-019-0724-x)

Docherty, K. F., McMurray, J. J.V. (2019) Angiotensin receptor-neprilysin inhibitors: a new paradigm in heart failure with reduced ejection fraction. International Journal of Cardiology, 281, pp. 179-185. (doi: 10.1016/j.ijcard.2018.05.124)

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G., Hardman, S. M., McDonagh, T. A., Dargie, H., Keavney, B., Garratt, C. J., Mamas, M. A. (2019) Does rhythm matter in Acute Heart Failure? An insight from the British Society for Heart Failure National Audit. Clinical Research in Cardiology, (doi: 10.1007/s00392-019-01463-5)

Ghouri, I. A., Kelly, A., Salerno, S., Garten, K., Stølen, T., Kemi, O.-J., Smith, G. L. (2019) Corrigendum: Characterization of electrical activity in post-myocardial infarction scar tissue in rat hearts using multiphoton microscopy. Frontiers in Physiology, 10, (doi: 10.3389/fphys.2019.00364)

Rossello, X., Ferreira, J. P., McMurray, J. J.V., Aguilar, D., Pfeffer, M. A., Pitt, B., Dickstein, K., Girerd, N., Rossignol, P., Zannad, F. (2019) Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction. European Heart Journal: Acute Cardiovascular Care, 8, pp. 231-241. (doi: 10.1177/2048872618803701)

Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S.P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Møller, J. E., Gustafsson, F. (2019) Central and peripheral determinants of exercise capacity in heart failure patients with preserved ejection fraction. JACC: Heart Failure, 7, pp. 321-332. (doi: 10.1016/j.jchf.2019.01.006)

Battle, C. E., Abdul-Rahim, A. H., Shenkin, S. D., Hewitt, J., Quinn, T. J. (2019) Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a networkmeta-analysis (Protocol) Cochrane Database of Systematic Reviews, 4, (doi: 10.1002/14651858.CD013306)

Welsh, P., Papacosta, O., Ramsay, S., Whincup, P., McMurray, J., Wannamethee, G., Sattar, N. (2019) High sensitivity troponin T and incident heart failure in older men: British Regional Heart Study. Journal of Cardiac Failure, 25, pp. 230-237. (doi: 10.1016/j.cardfail.2018.08.002)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2019) Identification of frailty in chronic heart failure. JACC: Heart Failure, 7, pp. 291-302. (doi: 10.1016/j.jchf.2018.11.017)

Dewan, P., Rørth, R., Jhund, P. S., Ferreira, J. P., Zannad, F., Shen, L., Køber, L., Abraham, W. T., Desai, A. S., Dickstein, K., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Income inequality and outcomes in heart failure: a global between-country analysis. JACC: Heart Failure, 7, pp. 336-346. (doi: 10.1016/j.jchf.2018.11.005)

Maznyczka, A. M., Carrick, D., Carberry, J., Mangion, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Ford, I., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart, 6, (doi: 10.1136/openhrt-2018-000979)

Kuh, D., Cooper, R., Sattar, N., Welsh, P., Hardy, R., Ben-Shlomo, Y. (2019) Systemic inflammation and cardio-renal organ damage biomarkers in middle age are associated with physical capability up to 9 years later: findings from a British birth cohort study. Circulation, 139, pp. 1988-1999. (doi: 10.1161/CIRCULATIONAHA.118.037332)

Celis-Morales, C. A., Lyall, D. M., Bailey, M. E.S., Petermann-Rocha, F., Anderson, J., Ward, J., Mackay, D. F., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R. (2019) The combination of physical activity and sedentary behaviors modifies the genetic predisposition to obesity. Obesity, 27, pp. 653-661. (doi: 10.1002/oby.22417)

Pettit, S. J., Petrie, M. C. (2019) Transplantation of hearts donated after circulatory-determined death: a song of fire and ice. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.005991)

Myhre, P. L., Vaduganathan, M., Claggett, B., Packer, M., Desai, A. S., Rouleau, J. L., Zile, M. R., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2019) B-type natriuretic peptide during treatment with sacubitril/valsartan: the PARADIGM-HF trial. Journal of the American College of Cardiology, 73, pp. 1264-1272. (doi: 10.1016/j.jacc.2019.01.018)

Drozdowska, B. A., Singh, S., Quinn, T. J. (2019) Thinking about the future: a review of prognostic scales used in acute stroke. Frontiers in Neurology, 10, (doi: 10.3389/fneur.2019.00274)

Hanley, D. F. et al. (2019) Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet, 393, pp. 1021-1032. (doi: 10.1016/S0140-6736(19)30195-3)

Beishon, L. C., Batterham, A. P., Quinn, T. J., Nelson, C. P., Panerai, R. B., Robinson, T., Haunton, V. J. (2019) Addenbrooke’s Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews, 3, (doi: 10.1002/14651858.cd013282)

Hendry, K., Green, C., McShane, R., Noel-Storr, A. H., Stott J, D. J., Anwer, S., Sutton, A. J., Burton, J. K., Quinn, T. J. (2019) AD-8 for detection of dementia across a variety of healthcare settings. Cochrane Database of Systematic Reviews, 3, (doi: 10.1002/14651858.CD011121.pub2)

Rankin, N. J., Burgess, K., Weidt, S., Wannamethee, G., Sattar, N., Welsh, P. (2019) High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry. Annals of Clinical Biochemistry, 56, pp. 397-407. (doi: 10.1177/0004563219830432)

Charytan, D. M., Solomon, S. D., Ivanovich, P., Remuzzi, G., Cooper, M. E., McGill, J. B., Parving, H.-H., Parfrey, P., Singh, A. K., Burdmann, E. A., Levey, A. S., Eckardt, K.-U., McMurray, J. J.V., Weinrauch, L. A., Liu, J., Claggett, B., Lewis, E. F., Pfeffer, M. A. (2019) Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes, Obesity and Metabolism, 21, pp. 1199-1208. (doi: 10.1111/dom.13642)

Sokoreli, I., Cleland, J.G., Pauws, S.C., Steyerberg, E.W., de Vries, J.J.G., Riistama, J.M., Dobbs, K., Bulemfu, J., Clark, A.L. (2019) Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: an analysis from OPERA-HF. International Journal of Cardiology, 278, pp. 167-172. (doi: 10.1016/j.ijcard.2018.12.030)

Mangion, K., Burke, N. M.M., Mccomb, C., Carrick, D., Woodward, R., Berry, C. (2019) Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla. Scientific Reports, 9, (doi: 10.1038/s41598-019-39807-w)

Bastug-Özel, Z., Wright, P. T., Kraft, A. E., Pavlovic, D., Howie, J., Froese, A., Fuller, W., Gorelik, J., Shattock, M. J., Nikolaev, V. O. (2019) Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain. Cardiovascular Research, 115, pp. 546-555. (doi: 10.1093/cvr/cvy221)

Dietrichs, E. S., Tveita, T., Smith, G. (2019) Hypothermia and cardiac electrophysiology: a systematic review of clinical and experimental data. Cardiovascular Research, 115, pp. 501-509. (doi: 10.1093/cvr/cvy305)

Steell, L., Sillars, A., Welsh, P., Iliodromiti, S., Wong, S.C., Pell, J.P., Sattar, N., Gill, J.M.R., Celis, C., Gray, S.R. (2019) Associations of dietary protein intake with bone mineral density: an observational study in 70,215 UK Biobank participants. Bone, 120, pp. 38-43. (doi: 10.1016/j.bone.2018.10.003)

Januzzi, J., Ferreira, J. P., Böhm, M., Kaul, S., Wanner, C., Brueckmann, M., Petrie, M., Ofstad, A.-P., Zeller, C., George, J., Fitchett, D., Zannad, F. (2019) Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline. European Journal of Heart Failure, 21, pp. 386-388. (doi: 10.1002/ejhf.1419)

Kristensen, S. L., Mogensen, U. M., Jhund, P. S., Rørth, R., Anand, I. S., Carson, P. E., Desai, A. S., Pitt, B., Pfeffer, M. A., Solomon, S. D., Zile, M. R., Køber, L., McMurray, J. J.V. (2019) N-terminal pro-B-type natriuretic peptide levels for risk prediction in patients with heart failure and preserved ejection fraction according to atrial fibrillation status. Circulation: Heart Failure, 12, (doi: 10.1161/circheartfailure.118.005766)

Elliott, E., Haldane, D., Quinn, T. J. (2019) Pitfalls of neurocognitive testing in an occupational medical setting. Occupational Medicine, 69, pp. 83-85. (doi: 10.1093/occmed/kqy127)

Mangion, K., Carrick, D., Clerfond, G., Rush, C., McComb, C., Oldroyd, K. G., Petrie, M. C., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Watkins, S., Davie, A., Auger, D. A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Predictors of segmental myocardial functional recovery in patients after an acute ST-elevation myocardial infarction. European Journal of Radiology, 112, pp. 121-129. (doi: 10.1016/j.ejrad.2019.01.010)

Loader, J., Chan, Y.-K., A Hawley, J., Moholdt, T., McDonald, C. F., Jhund, P., Petrie, M. C., McMurray, J. J., Scuffham, P. A., Ramchand, J., Burrell, L. M., Stewart, S. (2019) Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: analysis of 1598 patients and 4588 patient-years follow-up. International Journal of Cardiology, 279, pp. 126-132. (doi: 10.1016/j.ijcard.2018.12.060)

Taylor-Rowan, M., Momoh, O., Ayerbe, L., Evans, J. J., Stott, D. J., Quinn, T. J. (2019) Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis. Psychological Medicine, 49, pp. 685-696. (doi: 10.1017/S0033291718002003)

Vardeny, O., Claggett, B., Kachadourian, J., Desai, A. S., Packer, M., Rouleau, J., Zile, M. R., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2019) Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. European Journal of Heart Failure, pp. 337-341. (doi: 10.1002/ejhf.1402)

de Boer, R. A. et al. (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 272-285. (doi: 10.1002/ejhf.1406)

McCausland, F. R., Claggett, B., Burdmann, E. A., Chertow, G. M., Cooper, M. E., Eckardt, K.-U., Ivanovich, P., Levey, A. S., Lewis, E. F., McGill, J. B., McMurray, J. J.V., Parfrey, P., Parving, H.-H., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R. D., Pfeffer, M. A. (2019) Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) American Journal of Kidney Diseases, 73, pp. 309-315. (doi: 10.1053/j.ajkd.2018.10.006)

Mamet, H., Petrie, M. C., Rocchiccioli, P. (2019) Type 1 diabetes mellitus and coronary revascularization. Cardiovascular Endocrinology and Metabolism, 8, pp. 35-38. (doi: 10.1097/XCE.0000000000000166)

Celis-Morales, C. A., Gray, S., Petermann, F., Iliodromiti, S., Welsh, P., Lyall, D. M., Anderson, J., Pellicori, P., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51, pp. 472-480. (doi: 10.1249/MSS.0000000000001795)

Quinn, T. J., McCleery, J., Flicker, L., Richard, E. (2019) When is Alzheimer’s not dementia—Cochrane commentary on The National Institute on Ageing and Alzheimer’s Association Research Framework for Alzheimer’s Disease. Age and Ageing, 48, pp. 174-177. (doi: 10.1093/ageing/afy167)

Zile, M. R., O'Meara, E., Claggett, B., Prescott, M. F., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V., Shi, V., Lefkowitz, M., Rouleau, J. (2019) Effects of sacubitril/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF. Journal of the American College of Cardiology, 73, pp. 795-806. (doi: 10.1016/j.jacc.2018.11.042)

Cleland, J. G.F., van Veldhuisen, D. J., Ponikowski, P. (2019) The year in cardiology 2018: heart failure. European Heart Journal, 40, pp. 651-661. (doi: 10.1093/eurheartj/ehz010)

Drozdowska, B. A., Celis-Morales, C. A., Lyall, D. M., Quinn, T. J. (2019) Social engagement after stroke – is it relevant to cognitive function? A cross-sectional analysis of UK Biobank data. AMRC Open Research, 1, (doi: 10.12688/amrcopenres.12862.2)

Arroja, M.M.C., Reid, E., Roy, L.A., Vallatos, A.V., Holmes, W.M., Nicklin, S.A., Work, L.M., McCabe, C. (2019) Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion. Scientific Reports, 9, (doi: 10.1038/s41598-019-39102-8)

Brooksbank, K., O'Donnell, J., Corbett, V., Shield, S., Ainsworth, R., Shearer, R., Montgomery, S., Gallagher, A., Duncan, H., Hamilton, L., Laszlo, V., Noone, R., Baxendale, A., Blane, D., Logue, J. (2019) Discussing weight management with type 2 diabetes patients in primary care using the Small Talk Big Difference intervention: Protocol for a randomised controlled trial. JMIR Research Protocols, 8, (doi: 10.2196/12162)

Abdul-Rahim, A. H., Dickie, D. A., Selvarajah, J. R., Lees, K. R., Quinn, T. J. (2019) Stroke aetiological classification reliability and effect on trial sample size: systematic review, meta-analysis and statistical modelling. Trials, 20, (doi: 10.1186/s13063-019-3222-x)

Abraityte, A., Aukrust, P., Kou, L., Anand, I. S., Young, J., McMurray, J. J.V., van Veldhuisen, D. J., Gullestad, L., Ueland, T. (2019) T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF. Clinical Research in Cardiology, 108, pp. 133-141. (doi: 10.1007/s00392-018-1331-2)

Avtaar Singh, S. S., Das De, S., Nappi, F., Al-Adhami, A., Hegazy, Y., Dalzell, J., Doshi, H., Sinclair, A., Curry, P., Petrie, M., Berry, C., Al-Attar, N. (2019) Mechanical circulatory support for refractory cardiogenic shock post-acute myocardial infarction-a decade of lessons. Journal of Thoracic Disease, 11, pp. 542-548. (doi: 10.21037/jtd.2019.01.21)

Palazzuoli, A., Ruocco, G., Pellicori, P., Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R., Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108)

Zhang, J., Begley, A., Jackson, R., Harrison, M., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis. Clinical Research in Cardiology, 108, pp. 119-132. (doi: 10.1007/s00392-018-1302-7)

Mangion, K., Carrick, D., Carberry, J., Mahrous, A., McComb, C., Oldroyd, K. G., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Petrie, M. C., Watkins, S., Davie, A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Circumferential strain predicts major adverse cardiovascular events following an acute ST-segment-elevation myocardial infarction. Radiology, 290, pp. 329-337. (doi: 10.1148/radiol.2018181253)

Ferreira, J. P., Metra, M., Anker, S. D., Dickstein, K., Lang, C. C., Ng, L., Samani, N. J., Cleland, J. G., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2019) Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. European Journal of Heart Failure, 21, pp. 218-226. (doi: 10.1002/ejhf.1380)

Osmanska, J., Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36, pp. 137-146. (doi: 10.1007/s40266-018-0625-4)

Avtaar Singh, S. S., Banner, N. R., Rushton, S., Simon, A. R., Berry, C., Al-Attar, N. (2019) ISHLT primary graft dysfunction incidence, risk factors and outcome: a UK national study. Transplantation, 103, pp. 336-343. (doi: 10.1097/TP.0000000000002220)

Kaye, D. M., Petrie, M. C., McKenzie, S., Hasenfuβ, G., Malek, F., Post, M., Doughty, R. N., Trochu, J.-N., Gustafsson, F., Lang, I., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Hausleiter, J., Raake, P., Jondeau, G., Bergmann, M. W., Spelman, T., Aytug, H., Ponikowski, P., Hayward, C. (2019) Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Failure, 6, pp. 62-69. (doi: 10.1002/ehf2.12350)

Bekfani, T., Pellicori, P., Morris, D., Ebner, N., Valentova, M., Sandek, A., Doehner, W., Cleland, J. G., Lainscak, M., Schulze, P. C., Anker, S. D., von Haehling, S. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108, pp. 203-211. (doi: 10.1007/s00392-018-1344-x)

Ford, T., Corcoran, D., Sidik, N., Oldroyd, K. G., Rocchiccioli, P., McEntegart, M., Berry, C. (2019) MINOCA: Requirement for definitive diagnostic work-up. Heart, Lung and Circulation, 28, pp. e4-e6. (doi: 10.1016/j.hlc.2018.04.001)

Sze, S., Pellicori, P., Zhang, J., Clark, A. L. (2019) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart, 105, pp. 297-306. (doi: 10.1136/heartjnl-2018-313312)

Ferreira, J. P., Rossignol, P., Pizard, A., Machu, J.-L., Collier, T., Girerd, N., Huby, A.-C., Gonzalez, A., Diez, J., López, B., Sattar, N., Cleland, J. G., Sever, P. S., Zannad, F. (2019) Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart, 105, pp. 307-314. (doi: 10.1136/heartjnl-2018-313182)

McCartney, P. J., Berry, C. (2019) Redefining successful primary PCI. European Heart Journal, 20, pp. 133-135. (doi: 10.1093/ehjci/jey159)

Berry, C., Sidik, N., Pereira, A. C., Ford, T. J., Touyz, R. M., Kaski, J.-C., Hainsworth, A. H. (2019) Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. Journal of the American Heart Association, 8, (doi: 10.1161/JAHA.118.011104)

Quinn, T. J., Mooijaart, S. P., Gallacher, K., Burton, J. K. (2019) Acute care assessment of older adults living with frailty. British Medical Journal, 364, (doi: 10.1136/bmj.l13)

Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Karla, P. A., McMurray, J. J.V., Murray, H., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., Ford, I. (2019) Correction: Intravenous iron in patients undergoing maintenance hemodialysis. New England Journal of Medicine, 380, pp. 502. (doi: 10.1056/NEJMx180044)

Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J.V., Murray, H., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., Ford, I. (2019) Intravenous iron in patients undergoing maintenance hemodialysis. New England Journal of Medicine, 380, pp. 447-458. (doi: 10.1056/NEJMoa1810742)

Ambrosy, A. P., Stevens, S. R., Al-Khalidi, H. R., Rouleau, J. L., Bouabdallaoui, N., Carson, P. E., Adlbrecht, C., Cleland, J. G.F., Dabrowski, R., Golba, K. S., Pina, I. L., Sueta, C. A., Roy, A., Sopko, G., Bonow, R. O., Velazquez, E. J. (2019) Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal of Heart Failure, 21, pp. 373-381. (doi: 10.1002/ejhf.1404)

Lee, M. M.Y., Campbell, R. T., Kelly, R., Petrie, M. C., Sonecki, P. (2019) Does “Scar” at Rest Echocardiography Predict Lack of Contractility Reserve at Dobutamine Stress Echocardiography. (doi: 10.1093/ehjci/jey266)

Gerstein, H. C., McMurray, J., Holman, R. R. (2019) Real-world studies no substitute for RCTs in establishing efficacy. Lancet, 393, pp. 210-211. (doi: 10.1016/S0140-6736(18)32840-X)

Keeble, T. R., Karamasis, G. V., Rothman, M. T., Ricksten, S.-E., Ferrari, M., Hullin, R., Scherstén, F., Reitan, O., Kirking, S. T., Cleland, J. G.F., Smith, E. J. (2019) Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP) International Journal of Cardiology, 275, pp. 53-58. (doi: 10.1016/j.ijcard.2018.09.085)

Claggett, B., Pocock, S., Wei, L. J., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2019) Response by Claggett et al to letter regarding article, “Comparison of time-to-first event and recurrent-event methods in randomized clinical trials” Circulation, 139, pp. 422-423. (doi: 10.1161/CIRCULATIONAHA.118.038478)

Dewan, P., Rørth, R., Jhund, P. S., Shen, L., Raparelli, V., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Mogensen, U. M., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Differential impact of heart failure with reduced ejection fraction on men and women. Journal of the American College of Cardiology, 73, pp. 29-40. (doi: 10.1016/j.jacc.2018.09.081)

Halliday, B. P. et al. (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet, 393, pp. 61-73. (doi: 10.1016/S0140-6736(18)32484-X)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321, pp. 56-68. (doi: 10.1001/jama.2018.19802)

Kerr, D. M.I., Brooksbank, K. J.M., Taylor, R. G., Pinel, K., Rios, F. J., Touyz, R. M., Delles, C. (2019) Acute effects of electronic and tobacco cigarettes on vascular and respiratory function in healthy volunteers: a cross-over study. Journal of Hypertension, 37, pp. 154-166. (doi: 10.1097/HJH.0000000000001890)

Berry, C., Corcoran, D., Mangion, K. (2019) Cardiovascular health technology assessment: recommendations to improve the quality of evidence. Open Heart, 6, (doi: 10.1136/openhrt-2018-000930)

Mazlan-Kepli, W., Dawson, J., Berry, C., Walters, M. (2019) Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome. Heart, 105, pp. 67-74. (doi: 10.1136/heartjnl-2018-313148)

Lee, M. M. Y., McMurray, J. J.V., Lorenzo-Almorós, A., Kristensen, S. L., Sattar, N., Jhund, P. S., Petrie, M. C. (2019) Diabetic cardiomyopathy. Heart, 105, pp. 337-345. (doi: 10.1136/heartjnl-2016-310342)

Sabater-Lleal, M. et al. (2019) Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels. Circulation, 139, pp. 620-635. (doi: 10.1161/CIRCULATIONAHA.118.034532)

Findlay, M. D., Dawson, J., Dickie, D. A., Forbes, K. P., McGlynn, D., Quinn, T., Mark, P. B. (2019) Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients. Journal of the American Society of Nephrology, 30, pp. 147-158. (doi: 10.1681/ASN.2018050462)

Rørth, R., Jhund, P. S., Kristensen, S. L., Desai, A. S., Køber, L., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2019) The prognostic value of troponin T and N‐terminal pro B‐type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. European Journal of Heart Failure, 21, pp. 40-49. (doi: 10.1002/ejhf.1359)

Morrow, A., Nordin, S., O'Boyle, P., Berry, C. (2019) 'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy. BMJ Case Reports, 12, (doi: 10.1136/bcr-2019-229618)

Quinn, T. J., Lane, D. A. (2019) Anticoagulation for atrial fibrillation in older adults—using big data for big questions. Thrombosis and Haemostasis, 119, pp. 855-857. (doi: 10.1055/s-0039-1688482)

Cameron, A. C., Rossitto, G., Lang, N. N., Touyz, R. M. (2019) Antihypertensive drugs and vascular health. Springer

Quinn, T. J., Makin, S., Doubal, F., Staals, J. (2019) Cerebral small vessel disease and vascular cognitive impairment. Springer

Purnama Sidik, N., McCartney, P., Berry, C. (2019) Coronary microvascular disease. Springer

Burton, J. K., Quinn, T. J., Fisher, M. (2019) Diabetes and stroke. Practical Diabetes, 36, pp. 126-131. (doi: 10.1002/pdi.2230)

Schultheiss, H.-P., Fairweather, D., Caforio, A. L.P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., Priori, S. G. (2019) Dilated cardiomyopathy. Nature Reviews Disease Primers, 5, (doi: 10.1038/s41572-019-0084-1)

Pfeiffer-Kaushik, E. R., Smith, G. L., Cai, B., Dempsey, G. T., Hortigon-Vinagre, M. P., Zamora, V., Feng, S., Ingermanson, R., Zhu, R., Hariharan, V., Nguyen, C., Pierson, J., Gintant, G. A., Tung, L. (2019) Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms. Journal of Pharmacological and Toxicological Methods, 99, (doi: 10.1016/j.vascn.2019.106612)

Welsh, P., Iliodromiti, S. (2019) Epidemiology of vascular diseases. Springer

Rush, C. J., Petrie, M. C. (2019) Heart failure with preserved ejection fraction. Springer

Jackson, A. M., Jhund, P. S. (2019) Heart failure with reduced ejection fraction. Springer

Stienen, S., Ferreira, J. P., Girerd, N., Duarte, K., Lamiral, Z., McMurray, J. J.V., Pitt, B., Dickstein, K., Zannad, F., Rossignol, P. (2019) Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative. Clinical Research in Cardiology, 108, pp. 1215-1225. (doi: 10.1007/s00392-019-01453-7)

Tibbo, A. J., Busiau, T., Baillie, G. S. (2019) Methods to investigate arrestins in complex with phosphodiesterases. Springer

Ferreira, J. P., Abreu, P., McMurray, J. J.V., van Veldhuisen, D. J., Swedberg, K., Pocock, S. J., Vincent, J., Lins, K., Rossignol, P., Pitt, B., Zannad, F. (2019) Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial. European Journal of Heart Failure, 21, pp. 345-351. (doi: 10.1002/ejhf.1400)

Corcoran, D., Ford, T. J., Berry, C. (2019) Stable coronary syndromes. Springer

Blair, C. M., Walsh, N., Littman, B. H., Marcoux, F. W., Baillie, G. S. (2019) Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf. BMC Cancer, 19, (doi: 10.1186/s12885-019-5489-4)

Taylor-Rowan, M., Cuthbertson, G., Keir, R., Shaw, R., Drozdowska, B., Elliott, E., Stott, D., Quinn, T. J. (2019) The prevalence of frailty amongst acute stroke patients, and evaluation of method of assessment. Clinical Rehabilitation, 33, pp. 1688-1696. (doi: 10.1177/0269215519841417)

Bhatt, D. L. et al. (2019) Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. Lancet, 394, pp. 1169-1180. (doi: 10.1016/S0140-6736(19)31887-2)

Cameron, A. C., Touyz, R. M., Lang, N. N. (2019) Vascular biology of cancer chemotherapeutic drugs. Springer

Nather, K., Loughrey, C. M., Nicklin, S. A. (2019) Vasoactive peptides: renin-angiotensin-aldosterone system. Springer

Lemme, M., Ulmer, B. M., Lemoine, M. D., Zech, A. T.L., Flenner, F., Ravens, U., Reichenspurner, H., Rol-Garcia, M., Smith, G., Hansen, A., Christ, T., Eschenhagen, T. (2018) Atrial-like engineered heart tissue: an in vitro model of the human atrium. Stem Cell Reports, 11, pp. 1378-1390. (doi: 10.1016/j.stemcr.2018.10.008)

Tromp, J., MacDonald, M. R., Tay, W. T., Teng, T.-H. K., Hung, C.-L., Narasimhan, C., Shimizu, W., Ling, L. H., Ng, T. P., Yap, J., McMurray, J. J.V., Zile, M. R., Richards, A. M., Anand, I. S., Lam, C. S.P. (2018) Heart failure with preserved ejection fraction in the young. Circulation, 138, pp. 2763-2773. (doi: 10.1161/CIRCULATIONAHA.118.034720)

Ford, T. J., Stanley, B., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., Sidik, N., McCartney, P., Corcoran, D., Collison, D., Rush, C., McConnachie, A., Touyz, R., Oldroyd, K., Berry, C. (2018) Stratified medical therapy using invasive coronary function testing in angina: CorMicA trial. Journal of the American College of Cardiology, 72, pp. 2841-2855. (doi: 10.1016/j.jacc.2018.09.006)

Ford, T. J., Rocchiccioli, P., Good, R., McEntegart, M., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., Yii, E., Sidik, N., Harvey, A., Montezano, A. C., Beattie, E., Haddow, L., Oldroyd, K. G., Touyz, R. M., Berry, C. (2018) Systemic microvascular dysfunction in microvascular and vasospastic angina. European Heart Journal, 39, pp. 4086-4097. (doi: 10.1093/eurheartj/ehy529)

Strembitska, A., Mancini, S. J., Gamwell, J. M., Palmer, T. M., Baillie, G. S., Salt, I. P. (2018) A769662 inhibits insulin-stimulated Akt activation in human macrovascular endothelial cells independent of AMP-activated protein kinase. International Journal of Molecular Sciences, 19, (doi: 10.3390/ijms19123886)

Srivastava, P. K., Claggett, B. L., Solomon, S. D., McMurray, J. J.V., Packer, M., Zile, M. R., Desai, A. S., Rouleau, J. L., Swedberg, K., Fonarow, G. C. (2018) Estimated 5-year number needed to treat to prevent cardiovascular death or heart failure hospitalization with angiotensin receptor-neprilysin inhibition vs standard therapy for patients with heart failure with reduced ejection fraction: an analysis of data from the PARADIGM-HF trial. JAMA Cardiology, 3, pp. 1226-1231. (doi: 10.1001/jamacardio.2018.3957)

Bouabdallaoui, N., Claggett, B., Zile, M. R., McMurray, J. J.V., O'Meara, E., Packer, M., Prescott, M. F., Swedberg, K., Solomon, S. D., Rouleau, J. L. (2018) Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial. European Journal of Heart Failure, 20, pp. 1701-1709. (doi: 10.1002/ejhf.1301)

Rossitto, G., Touyz, R. M., Petrie, M. C., Delles, C. (2018) Much Ado about N...atrium: modelling tissuesodium as a highly sensitive marker of subclinicaland localized oedema. Clinical Science, 132, pp. 2609-2613. (doi: 10.1042/CS20180575)

Tromp, J., Ouwerkerk, W., Demissei, B.G., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., Metra, M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Zwinderman, A.H., Voors, A.A., van der Meer, P. (2018) Novel endotypes in heart failure: effects on guideline-directed medical therapy. European Heart Journal, 39, pp. 4269-4276. (doi: 10.1093/eurheartj/ehy712)

Idzerda, N. M.A., Persson, F., Pena, M. J., Brenner, B. M., Brunel, P., Chaturvedi, N., McMurray, J. J., Parving, H.-H., de Zeeuw, D., Heerspink, H. J.L. (2018) N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk. Diabetes, Obesity and Metabolism, 20, pp. 2899-2904. (doi: 10.1111/dom.13465)

Shiraishi, Y., Nagai, T., Kohsaka, S., Goda, A., Nagatomo, Y., Mizuno, A., Kohno, T., Rigby, A., Fukuda, K., Yoshikawa, T., Clark, A. L., Cleland, J. G.F. (2018) Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide. Clinical Research in Cardiology, 107, pp. 1103-1110. (doi: 10.1007/s00392-018-1283-6)

Ramires, F. J.A., Martinez, F., Gómez, E. A., Demacq, C., Gimpelewicz, C. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2018) Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. ESC Heart Failure, 5, pp. 1069-1071. (doi: 10.1002/ehf2.12355)

Abuosa, A. M., Elshiekh, A. H., Qureshi, K., Abrar, M. B., Kholeif, M. A., Kinsara, A. J., Andejani, A., Ahmed, A. H., Cleland, J. G.F. (2018) Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin. Indian Heart Journal, 70, pp. S96-S100. (doi: 10.1016/j.ihj.2018.06.011)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Redefining heart failure phenotypes based on ejection fraction. European Journal of Heart Failure, 20, pp. 1634-1635. (doi: 10.1002/ejhf.1325)

Chauhan, A. et al. (2018) Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland. QJM: An International Journal of Medicine, 111, pp. 920-924. (doi: 10.1093/qjmed/hcy193)

Henry, A. D., MacQuaide, N., Burton, F.L., Rankin, A.C., Rowan, E.G., Drummond, R.M. (2018) Spontaneous Ca2+ transients in rat pulmonary vein cardiomyocytes are increased in frequency and become more synchronous following electrical stimulation. Cell calcium, 76, pp. 36-47. (doi: 10.1016/j.ceca.2018.09.001)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Talking to patients with heart failure about end of life. European Journal of Heart Failure, 20, pp. 1763-1765. (doi: 10.1002/ejhf.1321)

Dobbin, S. J.H., Cameron, A. C., Petrie, M. C., Jones, R. J., Touyz, R. M., Lang, N. N. (2018) Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart, 104, pp. 1995-2002. (doi: 10.1136/heartjnl-2018-313726)

Connolly, A., Kelly, A., Campos, F. O., Myles, R., Smith, G., Bishop, M. J. (2018) Ventricular endocardial tissue geometry affects stimulus threshold and effective refractory period. Biophysical Journal, 115, pp. 2486-2498. (doi: 10.1016/j.bpj.2018.11.003)

Beggs, S. A.S., Gardner, R. S., McMurray, J. J.V. (2018) Who benefits from a defibrillator—balancing the risk of sudden versus non-sudden death. Current Heart Failure Reports, 15, pp. 376-389. (doi: 10.1007/s11897-018-0416-6)

Streng, K. W., Nauta, J. F., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Voors, A. A. (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology, 271, pp. 132-139. (doi: 10.1016/j.ijcard.2018.04.001)

Santema, B. T., Kloosterman, M., Van Gelder, I. C., Mordi, I., Lang, C. C., Lam, C. S.P., Anker, S., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Ter Maaten, J. M., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Rienstra, M., Voors, A. A. (2018) Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. European Heart Journal, 39, pp. 3867-3875. (doi: 10.1093/eurheartj/ehy421)

Maziarz, M., Broselid, S., DiGiacomo, V., Park, J.-C., Luebbers, A., Garcia-Navarrete, L., Blanco-Canosa, J. B., Baillie, G. S., Garcia-Marcos, M. (2018) A biochemical and genetic discovery pipeline identifies PLCδ4b as a non-receptor activator of heterotrimeric G proteins. Journal of Biological Chemistry, 293, pp. 16964-16983. (doi: 10.1074/jbc.RA118.003580)

Cao, T. H., Jones, D. J. L., Quinn, P. A., Chan, D. C. S., Hafid, N., Parry, H. M., Mohan, M., Sandhu, J. K., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Voors, A. A., Lang, C. C., Ng, L. L. (2018) Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical Proteomics, 15, (doi: 10.1186/s12014-018-9213-1)

Fudim, M., Parikh, K. S., Dunning, A., DeVore, A. D., Mentz, R. J., Schulte, P. J., Armstrong, P. W., Ezekowitz, J. A., Tang, W.H. W., McMurray, J. J.V., Voors, A. A., Drazner, M. H., O'Connor, C. M., Hernandez, A. F., Patel, C. B. (2018) Relation of volume overload to clinical outcomes in acute heart failure (from ASCEND-HF) American Journal of Cardiology, 122, pp. 1506-1512. (doi: 10.1016/j.amjcard.2018.07.023)

Celis-Morales, C.A., Petermann, F., Steell, L., Anderson, J., Welsh, P., Mackay, D.F., Iliodromiti, S., Lyall, D.M., Lean, M.E., Pell, J.P., Sattar, N., Gill, J.M.R., Gray, S.R. (2018) Associations of dietary protein intake with fat free mass and grip strength: cross-sectional study in 146,816 UK Biobank participants. American Journal of Epidemiology, 187, pp. 2405-2414. (doi: 10.1093/aje/kwy134)

Welsh, P., Preiss, D., Shah, A. S.V., McAllister, D., Briggs, A., Boachie, C., McConnachie, A., Hayward, C., Padmanabhan, S., Welsh, C., Woodward, M., Campbell, A., Porteous, D., Mills, N. L., Sattar, N. (2018) Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clinical Chemistry, 64, pp. 1607-1616. (doi: 10.1373/clinchem.2018.292086)

Docherty, K. F., Jhund, P. S. (2018) Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early? Heart, 104, pp. 1812-1813. (doi: 10.1136/heartjnl-2018-313371)

MacDonald, E., Quinn, T. A. (2018) Mechanical Determinants of the Chronotropic Response to Sinoatrial Stretch. (doi: 10.1016/j.yjmcc.2018.07.030)

Sliz, E. et al. (2018) Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. Circulation, 138, pp. 2499-2512. (doi: 10.1161/CIRCULATIONAHA.118.034942)

Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M.Y., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial. European Journal of Heart Failure, 20, pp. 1549-1556. (doi: 10.1002/ejhf.1201)

Narang, R., Saxena, A., Desai, A., Ramakrishnan, S., Thangjam, R. S., Kulkarni, S., Narvencar, K., Jacques' e Costa, A. K., Dias, A., Sukharamwala, R., Cleland, J. (2018) Prevalence and determinants of hypertension in apparently healthy schoolchildren in India: a multi-center study. European Journal of Preventive Cardiology, 25, pp. 1775-1784. (doi: 10.1177/2047487318790056)

Voors, A. A., Shah, S. J., Bax, J. J., Butler, J., Gheorghiade, M., Hernandez, A. F., Kitzman, D. W., McMurray, J. J.V., Wirtz, A. B., Lanius, V., van der Laan, M., Solomon, S. D. (2018) Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction. European Journal of Heart Failure, 20, pp. 1601-16010. (doi: 10.1002/ejhf.1295)

Hietamies, T. M., Ostrowski, C., Pei, Z., Feng, L., McCabe, C., Work, L. M., Quinn, T. J. (2018) Variability of functional outcome measures used in animal models of stroke and vascular cognitive impairment – a review of contemporary studies. Journal of Cerebral Blood Flow and Metabolism, 38, pp. 1872-1884. (doi: 10.1177/0271678X18799858)

Hernandez, A. F. et al. (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet, 392, pp. 1519-1529. (doi: 10.1016/S0140-6736(18)32261-X)

Ghouri, I. A., Kelly, A., Salerno, S., Garten, K., Stølen, T., Kemi, O.-J., Smith, G. L. (2018) Characterization of electrical activity in post-myocardial infarction scar tissue in rat hearts using multiphoton microscopy. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.01454)

Zhang, J., Pellicori, P., Pan, D., Dierckx, R., Clark, A.L., Cleland, J.G.F. (2018) Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology, 269, pp. 196-200. (doi: 10.1016/j.ijcard.2018.06.070)

Haynes, R., Judge, P. K., Staplin, N., Herrington, W. G., Storey, B. C., Bethel, A., Bowman, L., Brunskill, N., Cockwell, P., Hill, M., Kalra, P. A., McMurray, J. J.V., Taal, M., Wheeler, D. C., Landray, M. J., Baigent, C. (2018) Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomised double-blind trial. Circulation, 138, pp. 1505-1514. (doi: 10.1161/CIRCULATIONAHA.118.034818)

Maack, C. et al. (2018) Treatments targeting inotropy. European Heart Journal, (doi: 10.1093/eurheartj/ehy600)

Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G.F., Fu, M., Gheorghiade, M., Lam, C. S.P., Mehra, M. R., Neaton, J. D., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B. (2018) Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. New England Journal of Medicine, 379, pp. 1332-1342. (doi: 10.1056/NEJMoa1808848)

Feller, M., Snel, M., Moutzouri, E., Bauer, D. C., de Montmollin, M., Aujesky, D., Ford, I., Gussekloo, J., Kearney, P. M., Mooijaart, S., Quinn, T., Stott, D., Westendorp, R., Rodondi, N., Dekkers, O. M. (2018) Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA: Journal of the American Medical Association, 320, pp. 1349-1359. (doi: 10.1001/jama.2018.13770)

Rush, C. J., Campbell, R. T., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2018) Association is not causation: treatment effects cannot be estimated from observational data in heart failure. European Heart Journal, 39, pp. 3417-3438. (doi: 10.1093/eurheartj/ehy407)

Shah, P., Pellicori, P., Rimmer, S., Rigby, A. S., Clark, A. L. (2018) Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. International Journal of Cardiology, 268, pp. 166-169. (doi: 10.1016/j.ijcard.2018.05.029)

Guzik, T. J., Antoniades, C., Baker, A. H., Harrison, D. G., Loughrey, C. M., Maffia, P., Murphy, E., Nicklin, S. A., Peter, K., Pearson, J., Casadei, B. (2018) What matters in Cardiovascular Research? Scientific discovery driving clinical delivery. Cardiovascular Research, 114, pp. 1565-1568. (doi: 10.1093/cvr/cvy214)

Januzzi, J. L., Packer, M., Claggett, B., Liu, J., Shah, A. M., Zile, M. R., Pieske, B., Voors, A., Gandhi, P. U., Prescott, M. F., Shi, V., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2018) IGFBP7 (insulin-like growth factor–binding protein-7) and neprilysin inhibition in patients with heart failure. Circulation: Heart Failure, 11, (doi: 10.1161/circheartfailure.118.005133)

Cuthbert, J. J., Pellicori, P., Rigby, A., Pan, D., Kazmi, S., Shah, P., Clark, A. L. (2018) Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure, 20, pp. 1426-1435. (doi: 10.1002/ejhf.1247)

Shah, S. J. et al. (2018) One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiology, 3, pp. 968-977. (doi: 10.1001/jamacardio.2018.2936)

van Meer, B. J., Sala, L., Tertoolen, L. G.J., Smith, G. L., Burton, F. L., Mummery, C. L. (2018) Quantification of muscle contraction in vitro and in vivo using MUSCLEMOTION software: from stem cell-derived cardiomyocytes to zebrafish and human hearts. Current Protocols in Human Genetics, 99, (doi: 10.1002/cphg.67)

Keene, D., Arnold, A., Shun-Shin, M. J., Howard, J. P., Sohaib, S. A., Moore, P., Tanner, M., Quereshi, N., Muthumala, A., Chandresekeran, B., Foley, P., Leyva, F., Adhya, S., Falaschetti, E., Tsang, H., Vijayaraman, P., Cleland, J. G.F., Stegemann, B., Francis, D. P., Whinnett, Z. I. (2018) Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Failure, 5, pp. 965-976. (doi: 10.1002/ehf2.12315)

Cosmi, F., Staszewsky, L., McMurray, J. J.V., Latini, R. (2018) Risk stratification according to insulin type: reply. European Journal of Heart Failure, 20, pp. 1498. (doi: 10.1002/ejhf.1218)

Halliday, B. P., Gulati, A., Ali, A., Newsome, S., Lota, A., Tayal, U., Vassiliou, V. S., Arzanauskaite, M., Izgi, C., Krishnathasan, K., Singhal, A., Chiew, K., Gregson, J., Frenneaux, M. P., Cook, S. A., Pennell, D. J., Collins, P., Cleland, J. G.F., Prasad, S. K. (2018) Sex and age-based differences in the natural history and outcome of dilated cardiomyopathy. European Journal of Heart Failure, 20, pp. 1392-1400. (doi: 10.1002/ejhf.1216)

Berry, C., Mangion, K., Pathan, F. (2018) Spotlight on strain following myocardial infarction. JACC: Cardiovascular Imaging, 11, pp. 1445-1447. (doi: 10.1016/j.jcmg.2018.01.004)

Blinova, K., Dang, Q., Millard, D., Smith, G., Pierson, J., Guo, L., Brock, M., Lu, H. R., Kraushaar, U., Zeng, H., Shi, H., Zhang, X., Sawada, K., Osada, T., Kanda, Y., Sekino, Y., Pang, L., Feaster, T. K., Kettenhofen, R., Stockbridge, N., Strauss, D. G., Gintant, G. (2018) International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Reports, 24, pp. 3582-3592. (doi: 10.1016/j.celrep.2018.08.079)

Cleland, J. G.F., Clark, R. A. (2018) Telehealth: delivering high-quality care for heart failure. Lancet, 392, pp. 990-991. (doi: 10.1016/S0140-6736(18)31995-0)

Cao, F., Zervou, S., Lygate, C. A. (2018) The creatine kinase system as a therapeutic target for myocardial ischaemia–reperfusion injury. Biochemical Society Transactions, 46, pp. 1119-1127. (doi: 10.1042/BST20170504)

Elliott, C., Rojo, A. I., Ribe, E., Broadstock, M., Xia, W., Morin, P., Semenov, M., Baillie, G., Cuadrado, A., Al-Shawi, R., Ballard, C. G., Simons, P., Killick, R. (2018) A role for APP in Wnt signalling links synapse loss with β-amyloid production. Translational Psychiatry, 8, (doi: 10.1038/s41398-018-0231-6)

Puntmann, V. O., Valbuena, S., Hinojar, R., Petersen, S. E., Greenwood, J. P., Kramer, C. M., Kwong, R. Y., McCann, G. P., Berry, C., Nagel, E. (2018) Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. Journal of Cardiovascular Magnetic Resonance, 20, (doi: 10.1186/s12968-018-0484-5)

Shah, A. S.V. et al. (2018) High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet, 392, pp. 919-928. (doi: 10.1016/S0140-6736(18)31923-8)

Nagai, T., Sundaram, V., Rothnie, K., Quint, J. K., Shoaib, A., Shiraishi, Y., Kohsaka, S., Piper, S., McDonagh, T. A., Hardman, S. M. C., Goda, A., Mizuno, A., Kohno, T., Rigsby, A. S., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Mortality after admission for heart failure in the United Kingdom compared to Japan. Open Heart, 5, (doi: 10.1136/openhrt-2018-000811)

Miranda, F., Arevalo-Rodriguez, I., Díaz, G., Gonzalez, F., Plana, M. N., Zamora, J., Quinn, T. J., Seron, P. (2018) Confusion Assessment Method for the intensive care unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings. Cochrane Database of Systematic Reviews, 9, (doi: 10.1002/14651858.cd013126)

Colman, M. A., Saxena, P., Kettlewell, S., Workman, A. J. (2018) Description of the human atrial action potential derived from a single, congruent data source: novel computational models for integrated experimental-numerical study of atrial arrhythmia mechanisms. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.01211)

The SCOT-HEART Investigators, et al. (2018) Coronary CT angiography and 5-year risk of myocardial infarction. New England Journal of Medicine, 379, pp. 924-933. (doi: 10.1056/NEJMoa1805971)

Tromp, J., Westenbrink, B. D., Oowerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Ng, L. L., Zannad, F., Zwinderman, A. H., Hillege, H. L., van der Meer, P., Voors, A. A. (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. Journal of the American College of Cardiology, 72, pp. 1081-1090. (doi: 10.1016/j.jacc.2018.06.050)

Williams, B. et al. (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39, pp. 3021-3104. (doi: 10.1093/eurheartj/ehy339)

Corcoran, D., Young, R., Adlam, D., McConnachie, A., Mangion, K., Ripley, D., Cairns, D., Brown, J., Bucciarelli-Ducci, C., Baumbach, A., Kharbanda, R., Oldroyd, K. G., McCann, G. P., Greenwood, J. P., Berry, C. (2018) Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study. International Journal of Cardiology, 266, pp. 7-14. (doi: 10.1016/j.ijcard.2018.04.061)

Panahi, M., Papanikolaou, A., Torabi, A., Zhang, J.-G., Khan, H., Vazir, A., Hasham, M. G., Cleland, J. G.F., Rosenthal, N. A., Harding, S. E., Sattler, S. (2018) Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition. Cardiovascular Research, 114, pp. 1445-1461. (doi: 10.1093/cvr/cvy145)

Gulati, A., Japp, A. G., Raza, S., Halliday, B. P., Jones, D. A., Newsome, S., Ismail, N. A., Morarji, K., Khwaja, J., Spath, N., Shakespeare, C., Kalra, P. R., Lloyd, G., Mathur, A., Cleland, J. G.F., Cowie, M. R., Assomull, R. G., Pennell, D. J., Ismail, T. F., Prasad, S. K. (2018) Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure: a cardiovascular magnetic resonance study. Circulation: Cardiovascular Imaging, 11, (doi: 10.1161/CIRCIMAGING.118.007722)

McDowell, K., Petrie, M. C., Raihan, N. A., Logue, J. (2018) Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obesity Reviews, 19, pp. 1189-1204. (doi: 10.1111/obr.12707)

Debette, S. et al. (2018) Fourth European stroke science workshop. European Stroke Journal, 3, pp. 206-219. (doi: 10.1177/2396987318774443)

Green, J. B., Hernandez, A. F., D'Agostino, R. B., Granger, C. B., Janmohamed, S., Jones, N. P., Leiter, L. A., Noronha, D., Russell, R., Sigmon, K., Del Prato, S., McMurray, J. J.V. (2018) Harmony outcomes: a randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-rationale, design, and baseline characteristics. American Heart Journal, 203, pp. 30-38. (doi: 10.1016/j.ahj.2018.03.030)

Carrick, D., Haig, C., Maznyczka, A. M., Carberry, J., Mangion, K., Ahmed, N., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Wetherall, K., Oldroyd, K. G., Berry, C. (2018) Hypertension, microvascular pathology and prognosis after an acute myocardial infarction. Hypertension, 72, pp. 720-730. (doi: 10.1161/HYPERTENSIONAHA.117.10786)

McEntegart, M. B., Corcoran, D., Carrick, D., Clerfond, G., Sidik, N., Collison, D., Robertson, K. R., Shaukat, A., Watkins, S., Rocchicholi, P. R., Eteiba, H., Petrie, M. P., Lindsay, M. M., Oldroyd, K. G., Berry, C. (2018) Incidence of procedural myocardial infarction and cardiac magnetic resonance imaging-detected myocardial injury following percutaneous coronary intervention with rotational atherectomy. EuroIntervention, 14, pp. 819-823. (doi: 10.4244/EIJ-D-17-01077)

Kim, S. S., Yamamoto, M. H., Maehara, A., Sidik, N., Koyama, K., Berry, C., Oldroyd, K. G., Mintz, G. S., McEntegart, M. (2018) Intravascular ultrasound assessment of the effects of rotational atherectomy in calcified coronary artery lesions. International Journal of Cardiovascular Imaging, 34, pp. 1365-1371. (doi: 10.1007/s10554-018-1352-y)

Engelhardt, B., Holze, J., Elliott, C., Baillie, G.S., Kschischo, M., Fröhlich, H. (2018) Modelling and mathematical analysis of the M2 receptor-dependent joint signalling and secondary messenger network in CHO cells. Mathematical Medicine and Biology, 35, pp. 279-297. (doi: 10.1093/imammb/dqx003)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2018) Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes. JACC: Cardiovascular Imaging, 11, pp. 1248-1256. (doi: 10.1016/j.jcmg.2017.08.027)

Kobayashi, Y., Lønborg, J., Jong, A., Nishi, T., De Bruyne, B., Høfsten, D. E., Kelbæk, H., Layland, J., Nam, C.-W., Pijls, N. H.J., Tonino, P. A.L., Warnøe, J., Oldroyd, K. G., Berry, C., Engstrøm, T., Fearon, W. F. (2018) Prognostic value of the residual SYNTAX score after functionally complete revascularization in ACS. Journal of the American College of Cardiology, 72, pp. 1321-1329. (doi: 10.1016/j.jacc.2018.06.069)

Divorty, N., Milligan, G., Graham, D., Nicklin, S. A. (2018) The orphan receptor GPR35 contributes to angiotensin II–induced hypertension and cardiac dysfunction in mice. American Journal of Hypertension, 31, pp. 1049-1058. (doi: 10.1093/ajh/hpy073)

Svanerud, J., Ahn, J.-M., Jeremias, A., van 't Veer, M., Gore, A., Maehara, A., Crowley, A., Pijls, N. H.J., De Bruyne, B., Johnson, N. P., Hennigan, B., Watkins, S., Berry, C., Oldroyd, K. G., Park, S.-J., Ali, Z. A. (2018) Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention, 14, pp. 806-814. (doi: 10.4244/EIJ-D-18-00342)

Streng, K. W., Voors, A. A., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhusen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Lang, C. C. (2018) Waist-to-hip ratio and mortality in heart failure. European Journal of Heart Failure, 20, pp. 1269-1277. (doi: 10.1002/ejhf.1244)

Campbell, R. T., Petrie, M. C., Jackson, C. E., Jhund, P. S., Wright, A., Gardner, R. S., Sonecki, P., Pozzi, A., McSkimming, P., McConnachie, A., Finlay, F., Davidson, P., Denvir, M. A., Johnson, M. J., Hogg, K. J., McMurray, J. J.V. (2018) Which patients with heart failure should receive specialist palliative care? European Journal of Heart Failure, 20, pp. 1338-1347. (doi: 10.1002/ejhf.1240)

Dawson, J., Broomfield, N., Dani, K., Dickie, D. A., Doney, A., Forbes, K., Houston, G., Kean, S., Lees, K., McConnachie, A., Muir, K. W., Quinn, T., Struthers, A., Walters, M. (2018) Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) – Protocol for a randomised double blind placebo-controlled clinical trial. European Stroke Journal, 3, pp. 281-290. (doi: 10.1177/2396987318771426)

Ueland, T., Gullestad, L., Kou, L., Aukrust, P., Anand, I. S., Broughton, M. N., McMurray, J. J., van Veldhuisen, D. J., Warren, D. J., Bolstad, N. (2018) Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study. ESC Heart Failure, 5, pp. 1052-1059. (doi: 10.1002/ehf2.12312)

Kucharski, A.J., Kama, M., Watson, C.H., Aubry, M., Funk, S., Henderson, A.D., Brady, O.J., Vanhomwegen, J., Manuguerra, J.-C., Lau, C.L., Edmunds, W.J., Aaskov, J., Nilles, E.J., Cao-Lormeau, V.-M., Hué, S., Hibberd, M.L. (2018) Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji. eLife, 7, (doi: 10.7554/eLife.34848)

Claggett, B., Pocock, S., Wei, L.J., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2018) Comparison of time-to-first event and recurrent event methods in randomized clinical trials. Circulation, 138, pp. 570-577. (doi: 10.1161/CIRCULATIONAHA.117.033065)

Docherty, K. F., Jhund, P. S., McMurray, J. J.V. (2018) Catheter ablation for atrial fibrillation with heart failure. New England Journal of Medicine, 379, pp. 491-492. (doi: 10.1056/NEJMc1806519)

Sze, S., Pellicori, P., Kamzi, S., Anton, A., Clark, A. L. (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. International Journal of Cardiology, 264, pp. 104-112. (doi: 10.1016/j.ijcard.2018.03.089)

Bodde, M. C., Welsh, P., Bergheanu, S. C., Lijfering, W. M., Mertens, B., Liem, A.-H., van der Laarse, A., Sattar, N., Jukema, J.W. (2018) A rapid (differential) effect of rosuvastatin and atorvastatin on high-sensitivity cardiac Troponin-I in subjects with stable cardiovascular disease. Clinical Pharmacology and Therapeutics, 104, pp. 311-316. (doi: 10.1002/cpt.1095)

Ford, T. J., McEntegart, M., Berry, C., Oldroyd, K. G. (2018) Arterial access for invasive coronary angiography: the 'left backhander' Heart, Lung and Circulation, 27, pp. e98-e99. (doi: 10.1016/j.hlc.2018.02.021)

Heerspink, H. J.L., Andress, D. L., Bakris, G., Brennan, J. J., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J., Perkovic, V., Tobe, S., Wigderson, M., Yi, T., Parving, H.-H., de Zeeuw, D. (2018) Baseline characteristics and enrichment results from the SONAR trial. Diabetes, Obesity and Metabolism, 20, pp. 1829-1835. (doi: 10.1111/dom.13315)

Grodin, J. L., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J., Armstrong, P. W., Hernandez, A. F., O'Connor, C., Starling, R. C., Tang, W.H. W. (2018) Circulating cardiac troponin I levels measured by a novel highly sensitive assay in acute decompensated heart failure: insights from the ASCEND-HF trial. Journal of Cardiac Failure, 24, pp. 512-519. (doi: 10.1016/j.cardfail.2018.06.008)

Yew, S. N., Carrick, D., Corcoran, D., Ahmed, N., Carberry, J., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Oldroyd, K. G., Berry, C. (2018) Coronary thermodilution waveforms after acute reperfused ST‐segment–elevation myocardial infarction: relation to microvascular obstruction and prognosis. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.008957)

Lund, L. H., Claggett, B., Liu, J., Lam, C. S., Jhund, P. S., Rosano, G. M., Swedberg, K., Yusuf, S., Granger, C. B., Pfeffer, M. A., McMurray, J. J.V., Solomon, S. D. (2018) Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. European Journal of Heart Failure, 20, pp. 1230-1239. (doi: 10.1002/ejhf.1149)

Wilkinson, T., Ly, A., Schnier, C., Rannikmäe, K., Bush, K., Brayne, C., Quinn, T. J., Sudlow, C. L.M. (2018) Identifying dementia cases with routinely-collected health data: a systematic review. Alzheimer's and Dementia, 14, pp. 1038-1051. (doi: 10.1016/j.jalz.2018.02.016)

Wessler, J., Kaye, D., Gustafsson, F., Petrie, M. C., Hasenfuβ, G., Lam, C. S.P., Borlaug, B. A., Komtebedde, J., Feldman, T., Shah, S. J., Burkhoff, D. (2018) Impact of baseline hemodynamics on the effects of a transcatheter interatrial shunt device in heart failure with preserved ejection fraction. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004540)

Jenkins, A. J., Welsh, P., Petrie, J. R. (2018) Metformin, lipids and atherosclerosis prevention. Current Opinion in Lipidology, 29, pp. 346-353. (doi: 10.1097/MOL.0000000000000532)

Daly, J. P., Whiteley, E., Freeley, M., Long, A., Malacrida, B., Kiely, P., Baillie, G. S. (2018) RAB40C regulates RACK1 stability via the ubiquitin-proteasome system. Future Science OA, 4, (doi: 10.4155/fsoa-2018-0022)

Shah, S. V., Zimmermann, F. M., Johnson, N. P., Nishi, T., Kobayashi, Y., Witt, N., Berry, C., Jeremias, A., Koo, B.-K., Esposito, G., Rioufol, G., Park, S.-J., Oldroyd, K. G., Barbato, E., Pijls, N. H.J., De Bruyne, B., Fearon, W. F. (2018) Sex differences in adenosine-free coronary pressure indexes: a CONTRAST substudy. JACC: Cardiovascular Interventions, 11, pp. 1454-1463. (doi: 10.1016/j.jcin.2018.03.030)

Nagai, T., Sundaram, V., Shoaib, A., Shiraishi, Y., Kohsaka, S., Rothnie, K. J., Piper, S., McDonagh, T. A., Hardman, S. M.C., Goda, A., Mizuno, A., Sawano, M., Rigby, A. S., Quint, J. K., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan. European Journal of Heart Failure, 20, pp. 1179-1190. (doi: 10.1002/ejhf.1210)

Ferreira, J. P., Duarte, K., Pitt, B., Dickstein, K., McMurray, J. J.V., Zannad, F., Rossignol, P. (2018) Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials. Journal of Hypertension, 36, pp. 1736-1742. (doi: 10.1097/HJH.0000000000001742)

Ford, T. J., Corcoran, D., Sidik, N., McEntegart, M., Berry, C. (2018) Coronary microvascular dysfunction: Assessment of both structure and function. Journal of the American College of Cardiology, 72, pp. 584-586. (doi: 10.1016/j.jacc.2018.03.545)

van Strijp, D., de Witz, C., Vos, P. C., den Biezen, E., van Brussel, A., Wrobel, J., Baillie, G. S., Tennstedt, P., Schlomm, T., Heitkötter, B., Huss, S., Bögemann, M., Houslay, M. D., Bangma, C. H., Semjonow, A., Hoffmann, R. (2018) The prognostic PDE4D7 score in a diagnostic biopsy prostate cancer patient cohort with longitudinal biological outcomes. Prostate Cancer, 2018, (doi: 10.1155/2018/5821616)

Colombo, M., Looker, H. C., Farran, B., Agakov, F., Brosnan, M.J., Welsh, P., Sattar, N., Livingstone, S., Durrington, P. N., Betteridge, D.J., McKeigue, P. M., Colhoun, H. M. (2018) Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. Atherosclerosis, 274, pp. 182-190. (doi: 10.1016/j.atherosclerosis.2018.05.014)

Solomon, S. D. et al. (2018) Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.118.004962)

Welsh, P., Rankin, N., Li, Q., Mark, P. B., Würtz, P., Ala-Korpela, M., Marre, M., Poulter, N., Hamet, P., Chalmers, J., Woodward, M., Sattar, N. (2018) Circulating amino acids and the risk of macrovascular, microvascular, and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia, 61, pp. 1581-1591. (doi: 10.1007/s00125-018-4619-x)

Palazzuoli, A., Ruocco, G., Beltrami, M., Nuti, R., Cleland, J. G. (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clinical Research in Cardiology, 107, pp. 586-596. (doi: 10.1007/s00392-018-1221-7)

Ferreira, J. P., Duarte, K., McMurray, J. J.V., Pitt, B., van Veldhuisen, D. J., Vincent, J., Ahmad, T., Tromp, J., Rossignol, P., Zannad, F. (2018) Data-driven approach to identify subgroups of heart failure with reduced ejection fraction patients with different prognoses and aldosterone antagonist response patterns. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.118.004926)

Abdul-Rahim, A. H., Shen, L., Rush, C. J., Jhund, P. S., Lees, K. R., McMurray, J. J.V. (2018) Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. European Journal of Heart Failure, 20, pp. 1139-1145. (doi: 10.1002/ejhf.1160)

Packer, M., Claggett, B., Lefkowitz, M. P., McMurray, J. J.V., Rouleau, J. L., Solomon, S. D., Zile, M. R. (2018) Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. Lancet Diabetes and Endocrinology, 6, pp. 547-554. (doi: 10.1016/S2213-8587(18)30100-1)

Nichols, S., Gleadall-Siddall, D.O., Antony, R., Clark, A.L., Cleland, J.G.F., Carroll, S., Ingle, L. (2018) Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation? Clinical Physiology and Functional Imaging, 38, pp. 681-688. (doi: 10.1111/cpf.12468)

Findlay, I., Morris, T., Zhang, R., Mccowan, C., Shield, S., Forbes, B., McConnachie, A., Mangion, K., Berry, C. (2018) Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in NHS Scotland. European Heart Journal: Quality of Care and Clinical Outcomes, 4, pp. 155-167. (doi: 10.1093/ehjqcco/qcy007)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2018) Losing track by tracking speckles. JACC: Cardiovascular Imaging, 11, pp. 1038-1039. (doi: 10.1016/j.jcmg.2018.04.027)

Sartor, F., Papini, G., Cox, L. G. E., Cleland, J. (2018) Methodological shortcomings of wrist-worn heart rate monitors validations. Journal of Medical Internet Research, 20, (doi: 10.2196/10108)

Vaduganathan, M., Claggett, B., Packer, M., McMurray, J. J.V., Rouleau, J. L., Zile, M. R., Swedberg, K., Solomon, S. D. (2018) Natriuretic peptides as biomarkers of treatment response in clinical trials of heart failure. JACC: Heart Failure, 6, pp. 564-569. (doi: 10.1016/j.jchf.2018.02.007)

Owen, R. K., Cooper, N. J., Quinn, T. J., Lees, R., Sutton, A. J. (2018) Network meta-analysis of diagnostic test accuracy studies identifies and ranks the optimal diagnostic tests and thresholds for healthcare policy and decision making. Journal of Clinical Epidemiology, 99, pp. 64-74. (doi: 10.1016/j.jclinepi.2018.03.005)

Baylan, S., McGinlay, M., MacDonald, M., Easto, J., Cullen, B., Haig, C., Mercer, S. W., Murray, H., Quinn, T. J., Stott, D., Broomfield, N. M., Stiles, C., Evans, J. J. (2018) Participants’ experiences of music, mindful music, and audiobook listening interventions for people recovering from stroke. Annals of the New York Academy of Sciences, 1423, pp. 349-359. (doi: 10.1111/nyas.13618)

Ford, T. J., Corcoran, D., Oldroyd, K. G., McEntegart, M., Rocchiccioli, P., Watkins, S., Brooksbank, K., Padmanabhan, S., Sattar, N., Briggs, A., McConnachie, A., Touyz, R., Berry, C. (2018) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. American Heart Journal, 201, pp. 86-94. (doi: 10.1016/j.ahj.2018.03.010)

Burton, J. K., Papworth, R., Haig, C., McCowan, C., Ford, I., Stott, D. J., Quinn, T. J. (2018) Statin use is not associated with future long-term care admission - extended follow-up of two randomised controlled trials. Drugs and Aging, 35, pp. 657-663. (doi: 10.1007/s40266-018-0560-4)

Stockebrand, M., Sasani, A., Das, D., Hornig, S., Hermans-Borgmeyer, I., Lake, H. A., Isbrandt, D., Lygate, C. A., Heerschap, A., Neu, A., Choe, C.-U. (2018) A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.00773)

McMurray, J. J.V. (2018) Only trials tell the truth about treatment effects. Journal of the American College of Cardiology, 71, pp. 2640-2642. (doi: 10.1016/j.jacc.2018.04.019)

Rørth, R., Jhund, P. S., Mogensen, U. M., Kristensen, S. L., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Diabetes Care, 41, pp. 1285-1291. (doi: 10.2337/dc17-2583)

Ford, T. J., McCartney, P., Corcoran, D., Collison, D., Hennigan, B., McEntegart, M., Hildick-Smith, D., Oldroyd, K. G., Berry, C. (2018) Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.008730)

Welsh, C., Welsh, P., Mark, P. B., Celis-Morales, C. A., Lewsey, J., Gray, S. R., Lyall, D. M., Iliodromiti, S., Gill, J. M.R., Pell, J., Jhund, P. S., Sattar, N. (2018) Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, pp. 1415-1423. (doi: 10.1161/ATVBAHA.118.310945)

Dickstein, K. et al. (2018) CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? European Journal of Heart Failure, 20, pp. 1039-1051. (doi: 10.1002/ejhf.1142)

McMurray, J. J.V., Trueman, D., Hancock, E., Cowie, M. R., Briggs, A., Taylor, M., Mumby-Croft, J., Woodcock, F., Lacey, M., Haroun, R., Deschaseaux, C. (2018) Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. Heart, 104, pp. 1006-1013. (doi: 10.1136/heartjnl-2016-310661)

Chanfra, A., Lewis, E. F., Claggett, B. L., Desai, A. S., Packer, M., Zile, M. R., Swedberg, K., Rouleau, J. L., Shi, V. C., Lefkowitz, M. P., Katova, T., McMurray, J. J.V., Solomon, S. D. (2018) Effects of sacubitril/valsartan on physical and social activity limitations in patients with heart failure: a secondary analysis of the PARADIGM-HF trial. JAMA Cardiology, 3, pp. 498-505. (doi: 10.1001/jamacardio.2018.0398)

Høydal, M. A., Kirkeby-Garstad, I., Karevold, A., Wiseth, R., Haaverstad, R., Wahba, A., Stølen, T. L., Contu, R., Ellingsen, Ø., Smith, G. L. S., Kemi, O. J., Wisløff, U. (2018) Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure. ESC Heart Failure, 5, pp. 332-342. (doi: 10.1002/ehf2.12271)

Zymliński, R., Biegus, J., Sokolski, M., Siwołowski, P., Nawrocka-Millward, S., Todd, J., Jankowska, E. A., Banasiak, W., Cotter, G., Cleland, J. G., Ponikowski, P. (2018) Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion. European Journal of Heart Failure, 20, pp. 1011-1018. (doi: 10.1002/ejhf.1156)

Sliwa, K., Petrie, M. C., Hilfiker-Kleiner, D., Mebazaa, A., Jackson, A., Johnson, M. R., van der Meer, P., Mbakwem, A., Bauersachs, J. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 20, pp. 951-962. (doi: 10.1002/ejhf.1178)

Bruegmann, T., Smith, G. L. (2018) Macrophages: new players in cardiac ageing? Cardiovascular Research, 114, pp. e47-e49. (doi: 10.1093/cvr/cvy047)

Perera, D., Clayton, T., Petrie, M. C., Greenwood, J. P., O'Kane, P. D., Evans, R., Sculpher, M., Mcdonagh, T., Gershlick, A., de Belder, M., Redwood, S., Carr-White, G., Marber, M. (2018) Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy. JACC: Heart Failure, 6, pp. 517-526. (doi: 10.1016/j.jchf.2018.01.024)

Sze, S., Pellicori, P., Kazmi, S., Rigby, A., Cleland, J. G.F., Wong, K., Clark, A. L. (2018) Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC: Heart Failure, 6, pp. 476-486. (doi: 10.1016/j.jchf.2018.02.018)

Simpson, J., McMurray, J. J.V. (2018) Prognostic modeling in heart failure: time for a reboot. JACC: Heart Failure, 6, pp. 463-464. (doi: 10.1016/j.jchf.2018.03.020)

Corcoran, D., Ford, T. J., Hsu, L.-Y., Chiribiri, A., Orchard, V., Mangion, K., McEntegart, M., Rocchiccioli, P., Watkins, S., Good, R., Brooksbank, K., Padmanabhan, S., Sattar, N., McConnachie, A., Oldroyd, K. G., Touyz, R. M., Arai, A., Berry, C. (2018) Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study. Open Heart, 5, (doi: 10.1136/openhrt-2018-000924)

Heerspink, H. J.L., Andress, D. L., Bakris, G., Brennan, J. J., Correa-Rotter, R., Dey, J., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J., Perkovic, V., Tobe, S., Wigderson, M., Parving, H.-H., de Zeeuw, D. (2018) Rationale and protocol of the Study of Diabetic Nephropathy with Atrasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Diabetes, Obesity and Metabolism, 20, pp. 1369-1376. (doi: 10.1111/dom.13245)

Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., Zile, M. R., Packer, M., Desai, A. S., Solomon, S. D., McMurray, J. J.V. (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC: Heart Failure, 6, pp. 489-498. (doi: 10.1016/j.jchf.2018.02.004)

Ambrosy, A. P., Mentz, R. J., Fiuzat, M., Cleland, J. G.F., Greene, S. J., O'Connor, C. M., Teerlink, J. R., Zannad, F., Solomon, S. D. (2018) The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions. European Journal of Heart Failure, 20, pp. 963-972. (doi: 10.1002/ejhf.1159)

Celis-Morales, C., Lyall, D. M., Steell, L., Gray, S. R., Iliodromiti, S., Anderson, J., Mackay, D. F., Welsh, P., Yates, T., Pell, J. P., Sattar, N., Gill, J. M.R. (2018) Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study. BMC Medicine, 16, (doi: 10.1186/s12916-018-1063-1)

Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., Pell, J. P., Gill, J. M.R., Sattar, N., Gray, S. R. (2018) Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. British Medical Journal, 361, (doi: 10.1136/bmj.k1651)

Armfield, K., Baillie, G., Wilson, J.B. (2018) Development of Therapeutic Approaches to Targeting Epstein-Barr virus Related Malignancies.

Bulluck, H., Dharmakumar, R., Arai, A. E., Berry, C., Hausenloy, D. J. (2018) Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation, 137, pp. 1949-1964. (doi: 10.1161/CIRCULATIONAHA.117.030693)

Whittington, H. J., Ostrowski, P. J., McAndrew, D. J., Cao, F., Shaw, A., Eykyn, T. R., Lake, H. A., Tyler, J., Schneider, J. E., Neubauer, S., Zervou, S., Lygate, C. A. (2018) Over-expression of mitochondrial creatine kinase in the murine heart improves functional recovery and protects against injury following ischaemia–reperfusion. Cardiovascular Research, 114, pp. 858-869. (doi: 10.1093/cvr/cvy054)

Rubio-Gracia, J., Demissei, B. G., ter Maaten, J. M., Cleland, J. G., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., Damman, K., Pérez-Calvo, J. I., Voors, A. A. (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. International Journal of Cardiology, 258, pp. 185-191. (doi: 10.1016/j.ijcard.2018.01.067)

Frikha, Z., Ferreira, J. P., Bozec, E., McMurray, J. J.V., Pitt, B., Dickstein, K., Rossignol, P., Zannad, F., Girerd, N. (2018) Relation of high serum bilirubin to short-term mortality following a myocardial infarction complicated by left ventricular systolic dysfunction (from the High-Risk Myocardial Infarction Database Initiative) American Journal of Cardiology, 121, pp. 1015-1020. (doi: 10.1016/j.amjcard.2018.01.012)

Iliodromiti, S., Celis-Morales, C. A., Lyall, D. M., Anderson, J., Gray, S. R., Mackay, D. F., Nelson, S. M., Welsh, P., Pell, J. P., Gill, J. M.R., Sattar, N. (2018) The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. European Heart Journal, 39, pp. 1514-1520. (doi: 10.1093/eurheartj/ehy057)

Ferrari, R., Bueno, H., Chioncel, O., Cleland, J. G., Stough, W. G., Lettino, M., Metra, M., Parissis, J. T., Pinto, F., Ponikowski, P., Ruschitzka, F., Tavazzi, L. (2018) Acute heart failure: lessons learned, roads ahead. European Journal of Heart Failure, 20, pp. 842-850. (doi: 10.1002/ejhf.1169)

Salvi, D., Ottaviano, M., Muuraiskangas, S., Martınez-Romero, A., Vera-Munoz, C., Triantafyllidis, A., Cabrera Umpierrez, M. F., Arredondo Waldmeyer, M. T., Skobel, E., Knackstedt, C., Liedes, H., Honka, A., Luprano, J., Cleland, J. G.F., Stut, W., Deighan, C. (2018) An m-health system for education and motivation in cardiac rehabilitation: the experience of heartcycle guided exercise. Journal of Telemedicine and Telecare, 24, pp. 303-316. (doi: 10.1177/1357633X17697501)

Lupón, J., Simpson, J., McMurray, J. J.V., de Antonio, M., Vila, J., Subirana, I., Barallat, J., Moliner, P., Domingo, M., Zamora, E., Bayes-Genis, A. (2018) Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. European Journal of Heart Failure, 20, pp. 938-940. (doi: 10.1002/ejhf.949)

Theodorakis, M. J., Coleman, R. L., Feng, H., Chan, J., Chiasson, J.-L., Ge, J., Gerstein, H. C., Huo, Y., Lang, Z., McMurray, J. J., Rydén, L., Schröder, S., Tendera, M., Tuomilehto, J., Yang, W., Hu, D., Pan, C., Holman, R. R. (2018) Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants. American Heart Journal, 199, pp. 170-175. (doi: 10.1016/j.ahj.2017.09.001)

O'Meara, E., Prescott, M. F., Claggett, B., Rouleau, J. L., Chiang, L.-M., Solomon, S. D., Packer, M., McMurray, J. J.V., Zile, M. R. (2018) Independent prognostic value of serum soluble ST2 measurements in patients with heart failure and a reduced ejection fraction in the PARADIGM-HF Trial (prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure) Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004446)

Jackson, A. M., Dalzell, J. R., Walker, N. L., Coats, C. J., Jhund, P. S., Petrie, M. C. (2018) Peripartum cardiomyopathy: diagnosis and management. Heart, 104, pp. 779-786. (doi: 10.1136/heartjnl-2016-310599)

Beusekamp, J. C., Tromp, J., van der Wal, H. H., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Rossignol, P., Zannad, F., Voors, A. A., van der Meer, P. (2018) Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction. European Journal of Heart Failure, 20, pp. 923-930. (doi: 10.1002/ejhf.1079)

Metra, M., Cotter, G., Senger, S., Edwards, C., Cleland, J. G., Ponikowski, P., Cursack, G. C., Milo, O., Teerlink, J. R., Givertz, M. M., O’Connor, C. M., Dittrich, H. C., Bloomfield, D. M., Voors, A. A., Davison, B. A. (2018) Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004644)

Takwoingi, Y., Quinn, T. (2018) Review of Diagnostic Test Accuracy (DTA) studies in older people. Age and Ageing, 47, pp. 349-355. (doi: 10.1093/ageing/afy023)

Cosmi, F. et al. (2018) Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. European Journal of Heart Failure, 20, pp. 888-895. (doi: 10.1002/ejhf.1146)

Seferović, P. M. et al. (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20, pp. 853-872. (doi: 10.1002/ejhf.1170)

de Inda, M. A., van Strijp, D., den Biezen-Timmermans, E., van Brussel, A., Wrobel, J., van Zon, H., Vos, P., Baillie, G. S., Tennstedt, P., Schlomm, T., Houslay, M. D., Bangma, C., Hoffmann, R. (2018) Validation of cyclic adenosine monophosphate phosphodiesterase-4D7 for its independent contribution to risk stratification in a prostate cancer patient cohort with longitudinal biological outcomes. European Urology Focus, 4, pp. 376-384. (doi: 10.1016/j.euf.2017.05.010)

Jhund, P. S. (2018) Analysing registries in heart failure: the case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction. International Journal of Cardiology, 257, pp. 224-225. (doi: 10.1016/j.ijcard.2018.01.061)

Kelly, A., Salerno, S., Connolly, A., Bishop, M., Charpentier, F., Stølen, T., Smith, G. L. (2018) Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome. Cardiovascular Research, 114, pp. 724-736. (doi: 10.1093/cvr/cvx244)

Mangion, K., Gao, H., Husmeier, D., Luo, X., Berry, C. (2018) Advances in computational modelling for personalised medicine after myocardial infarction. Heart, 104, pp. 550-557. (doi: 10.1136/heartjnl-2017-311449)

Boyden, P. A., Smith, G. L. (2018) Ca2+ leak, what is it? Why should we care? Can it be managed? Heart Rhythm, 15, pp. 607-614. (doi: 10.1016/j.hrthm.2017.11.018)

Fröhlich, H., Henning, F., Täger, T., Schellberg, D., Grundtvig, M., Goode, K., Corletto, A., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Frankenstein, L., Clark, A. L. (2018) Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study. European Heart Journal: Cardiovascular Pharmacotherapy, 4, pp. 82-92. (doi: 10.1093/ehjcvp/pvx013)

Petrie, M. C., Rocchiccioli, P. (2018) Coronary angiography in heart failure: when and why? Uncertainty reigns. Heart, 104, pp. 548-549. (doi: 10.1136/heartjnl-2017-312200)

Ferreira, J. P., Rossignol, P., Demissei, B., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2018) Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart, 104, pp. 606-613. (doi: 10.1136/heartjnl-2017-311750)

Mogensen, U. M., Gong, J., Jhund, P. S., Shen, L., Køber, L., Desai, A. S., Lefkowitz, M. P., Packer, M., Rouleau, J. L., Solomon, S. D., Claggett, B. L., Swedberg, K., Zile, M. R., Mueller-Velten, G., McMurray, J. J.V. (2018) Effect of sacubitril/valsartan on recurrent events in the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF) European Journal of Heart Failure, 20, pp. 760-768. (doi: 10.1002/ejhf.1139)

Vardeny, O., Claggett, B., Kachadourian, J., Pearson, S. M., Desai, A. S., Packer, M., Rouleau, J., Zile, M. R., Swedberg, K., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2018) Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF trial (prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin-converting enzyme inhibitor to determine impact on global mortality and morbidity in heart failure) Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004745)

Delles, C., Rankin, N. J., Boachie, C., McConnachie, A., Ford, I., Kangas, A., Soininen, P., Trompet, S., Mooijaart, S. P., Jukema, J. W., Zannad, F., Ala-Korpela, M., Salomaa, V., Havulinna, A. S., Welsh, P., Würtz, P., Sattar, N. (2018) Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. European Journal of Heart Failure, 20, pp. 663-673. (doi: 10.1002/ejhf.1076)

Sokoreli, I., Pauws, S. C., Steyerberg, E. W., de Vries, G.-J., Riistama, J. M., Tesanovic, A., Kazmi, S., Pellicori, P., Cleland, J. G., Clark, A. L. (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. European Journal of Heart Failure, 20, pp. 689-696. (doi: 10.1002/ejhf.1112)

McMurray, J. J.V. (2018) Renin–angiotensin system inhibition—it's been a long but fruitful journey. European Journal of Heart Failure, 20, pp. 687-688. (doi: 10.1002/ejhf.1155)

Horsburgh, K. et al. (2018) Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology. Clinical Science, 132, pp. 851-868. (doi: 10.1042/CS20171620)

Botha, S., Forde, L., MacNaughton, S., Shearer, R., Lindsay, R., Sattar, N., Morrison, D., Welsh, P., Logue, J. (2018) The effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: a comparison of interventional and non-interventional outcomes at three years. Diabetes, Obesity and Metabolism, 20, pp. 879-888. (doi: 10.1111/dom.13171)

Linde, C., Cleland, J. G.F., Gold, M. R., Daubert, J. C., Tang, A. S.L., Young, J. B., Sherfesee, L., Abraham, W. T. (2018) The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. European Journal of Heart Failure, 20, pp. 780-791. (doi: 10.1002/ejhf.1133)

Quinn, T. J., Livingstone, I., Weir, A., Shaw, R., Breckenridge, A., McAlpine, C., Tarbert, C. M. (2018) Accuracy and feasibility of an android-based digital assessment tool for post stroke visual disorders - The StrokeVision App. Frontiers in Neurology, 9, (doi: 10.3389/fneur.2018.00146)

Lang, N. N., Walker, N. L. (2018) Adult congenital heart disease and radiation exposure: the malignant price of cardiac care. Circulation, 137, pp. 1346-1348. (doi: 10.1161/CIRCULATIONAHA.117.032815)

Tromp, J., Tay, W. T., Ouwerkerk, W., Teng, T.-H. K., Yap, J., MacDonald, M. R., Leineweber, K., McMurray, J. J.V., Zile, M. R., Anand, I. S., Lam, C. S.P. (2018) Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Medicine, 15, (doi: 10.1371/journal.pmed.1002541)

Taylor-Rowan, M., Wilson, A., Dawson, J., Quinn, T. J. (2018) Functional assessment for acute stroke trials: properties, analysis, and application. Frontiers in Neurology, 9, (doi: 10.3389/fneur.2018.00191)

Bethel, M. A., McMurray, J. J.V. (2018) Class effect for sodium glucose-cotransporter-2 inhibitors in cardiovascular outcomes: implications for the cardiovascular disease specialist. Circulation, 137, pp. 1218-1220. (doi: 10.1161/CIRCULATIONAHA.117.030117)

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. (doi: 10.1016/S0735-1097(18)30586-2)

Malmo, V., Kelly, A., Garten, K. S., Stolen, T., Rolim, N. P. L., Wisloff, U., Smith, G., Loennechen, J. P. (2018) Aerobic interval training prevents age-dependent vulnerability to atrial fibrillation in rodents. Frontiers in Physiology, 9, (doi: 10.3389/fphys.2018.00206)

Faller, K. M. E., Atzler, D., McAndrew, D. J., Zervou, S., Whittington, H. J., Simon, J. N., Aksentijevic, D., ten Hove, M., Choe, C.-u., Isbrandt, D., Casadei, B., Schneider, J. E., Neubauer, S., Lygate, C. A. (2018) Impaired cardiac contractile function in arginine:glycine amidinotransferase knockout mice devoid of creatine is rescued by homoarginine but not creatine. Cardiovascular Research, 114, pp. 417-430. (doi: 10.1093/cvr/cvx242)

Parsons, T. J., Sartini, C., Welsh, P., Sattar, N., Ash, S., Lennon, L. T., Wannamethee, S. G., Lee, I.-M., Whincup, P. H., Jefferis, B. J. (2018) Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men. International Journal of Cardiology, 254, pp. 322-327. (doi: 10.1016/j.ijcard.2017.11.003)

Sellers, K. J., Elliott, C., Jackson, J., Ghosh, A., Ribe, E., Rojo, A. I., Jarosz-Griffiths, H. H., Watson, I. A., Xia, W., Semenov, M., Morin, P., Hooper, N. M., Porter, R., Preston, J., Al-Shawi, R., Baillie, G., Lovestone, S., Cuadrado, A., Harte, M., Simons, P., Srivastava, D. P., Killick, R. (2018) Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil. Alzheimer's and Dementia, 14, pp. 306-317. (doi: 10.1016/j.jalz.2017.09.008)

Gho, J. M.I.H., Schmidt, A. F., Pasea, L., Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Shah, A. D., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G., Hemingway, H., Asselbergs, F. W. (2018) An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. BMJ Open, 8, (doi: 10.1136/bmjopen-2017-018331)

Mackinnon, S., Drozdowska, B. A., Hamilton, M., Noel-Storr, A. H., McShane, R., Quinn, T. (2018) Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies. BMJ Open, 8, (doi: 10.1136/bmjopen-2017-020331)

Taylor, R., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Sattar, N., Welsh, P., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Al-Mrabeh, A., Rodrigues, A. M., Rehackova, L., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., Ross, H. M., McIlvenna, Y., Kean, S., Ford, I., McConnachie, A., Lean, M. E.J. (2018) Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia, 61, pp. 589-598. (doi: 10.1007/s00125-017-4503-0)

Wolsk, E., Claggett, B., Køber, L., Pocock, S., Yusuf, S., Swedberg, K., McMurray, J. J.V., Granger, C. B., Pfeffer, M. A., Solomon, S. D. (2018) Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. European Journal of Heart Failure, 20, pp. 504-510. (doi: 10.1002/ejhf.1073)

Jorsal, A., Wiggers, H., McMurray, J. J.V. (2018) Heart failure: epidemiology, pathophysiology, and management of heart failure in diabetes mellitus. Endocrinology and Metabolism Clinics of North America, 47, pp. 117-135. (doi: 10.1016/j.ecl.2017.10.007)

Mogensen, U. M., Køber, L., Jhund, P. S., Desai, A. S., Senni, M., Kristensen, S. L., Dukát, A., Chen, C.-H., Ramires, F., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V. (2018) Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF. European Journal of Heart Failure, 20, pp. 514-522. (doi: 10.1002/ejhf.1056)

Stewart, R. A.H., Szalewska, D., Stebbins, A., Al-Khalidi, H. R., Cleland, J. G.H., Rynkiewicz, A., Drazner, M. H., White, H. D., Mark, D. B., Roy, A., Kosevic, D., Rajda, M., Jasinski, M., Leng, C. Y., Tungsubutra, W., Desvigne-Nickens, P., Velazquez, E. J., Petrie, M. C. (2018) Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy. Open Heart, 5, (doi: 10.1136/openhrt-2017-000752)

Makin, S. D.J., Doubal, F. N., Quinn, T. J., Bath, P. M.W., Dennis, M. S., Wardlaw, J. M. (2018) The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke. European Stroke Journal, 3, pp. 66-73. (doi: 10.1177/2396987317728854)

Seferovic, J. P., Pfeffer, M. A., Claggett, B., Desai, A. S., de Zeeuw, D., Haffner, S. M., McMurray, J. J.V., Parving, H.-H., Solomon, S. D., Chaturvedi, N. (2018) Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. Diabetologia, 61, pp. 581-588. (doi: 10.1007/s00125-017-4485-y)

Petrie, M. C., Connelly, D. T., Gardner, R. S. (2018) Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISH. European Journal of Heart Failure, 20, pp. 413-416. (doi: 10.1002/ejhf.1135)

Hallow, K. M., Helmlinger, G., Greasley, P. J., McMurray, J. J.V., Boulton, D. W. (2018) Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes, Obesity and Metabolism, 20, pp. 479-487. (doi: 10.1111/dom.13126)

Hicks, K. A. et al. (2018) 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation, 137, pp. 961-972. (doi: 10.1161/CIRCULATIONAHA.117.033502)

Velazquez, E. J., Petrie, M. C. (2018) CABG or PCI for diabetic patients with left ventricular dysfunction: closing in on the truth? Journal of the American College of Cardiology, 71, pp. 828-831. (doi: 10.1016/j.jacc.2018.01.014)

Ferreira, J. P., Girerd, N., Gregson, J., Latar, I., Sharma, A., Pfeffer, M. A., McMurray, J. J.V., Abdul-Rahim, A., Pitt, B., Dickstein, K., Rossignol, P., Zannad, F. (2018) Stroke risk in patients with reduced ejection fraction after myocardial infarction without atrial fibrillation. Journal of the American College of Cardiology, 71, pp. 727-735. (doi: 10.1016/j.jacc.2017.12.011)

ter Maaten, J. M., Voors, A. A., Damman, K., van der Meer, P., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Navis, G., Ng, L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., de Borst, M. H. (2018) Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. International Journal of Cardiology, 253, pp. 84-90. (doi: 10.1016/j.ijcard.2017.10.010)

Lean, M. E.J. et al. (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet, 391, pp. 541-551. (doi: 10.1016/S0140-6736(17)33102-1)

Conrad, N., Judge, A., Tran, J., Mohseni, H., Hedgecott, D., Crespillo, A. P., Allison, M., Hemingway, H., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet, 391, pp. 10-16. (doi: 10.1016/S0140-6736(17)32520-5)

Sala, L. et al. (2018) MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circulation Research, 122, pp. e5-e16. (doi: 10.1161/CIRCRESAHA.117.312067)

Corcoran, D., Young, R., Cialdella, P., McCartney, P., Bajrangee, A., Hennigan, B., Collison, D., Carrick, D., Shaukat, A., Good, R., Watkins, S., McEntegart, M., Watt, J., Welsh, P., Sattar, N., McConnachie, A., Oldroyd, K.G., Berry, C. (2018) The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease. International Journal of Cardiology, 252, pp. 24-30. (doi: 10.1016/j.ijcard.2017.10.082)

Ferreira, J. P., Duarte, K., Pfeffer, M. A., McMurray, J. J.V., Pitt, B., Dickstein, K., Zannad, F., Rossignol, P. (2018) Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative. European Journal of Heart Failure, 20, pp. 323-331. (doi: 10.1002/ejhf.1131)

Schwartz, G. G., Ballantyne, C. M., Barter, P. J., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J.V., Nicholls, S. J., Olsson, A. G., Shah, P. K., Tardif, J.-C., Kittelson, J. (2018) Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome. JAMA Cardiology, 3, pp. 164-168. (doi: 10.1001/jamacardio.2017.3833)

Norman, R., Fuller, W., Calaghan, S. (2018) Caveolae and the cardiac myocyte. Current Opinion in Physiology, 1, pp. 59-67. (doi: 10.1016/j.cophys.2017.08.005)

Quinn, T. J., Elliott, E., Langhorne, P. (2018) Cognitive and mood assessment tools for use in stroke. Stroke, 49, pp. 483-490. (doi: 10.1161/STROKEAHA.117.016994)

Welsh, P. (2018) Correlating changes in metabolic status with arterial health: modest associations but any clinical implications? Hypertension, 71, pp. 227-228. (doi: 10.1161/HYPERTENSIONAHA.117.10595)

Adamson, P. D., Hunter, A., Williams, M. C., Shah, A. S.V., McAllister, D. A., Pawade, T. A., Dweck, M. R., Mills, N. L., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2018) Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial. Heart, 104, pp. 207-214. (doi: 10.1136/heartjnl-2017-311508)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Numé, A.-k., Gislason, G. H.,, Jhund, P. S., Petrie, M. C., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Employment status at time of first hospitalization for heart failure is associated with death and rehospitalization for heart failure. European Journal of Heart Failure, 20, pp. 240-247. (doi: 10.1002/ejhf.1046)

Adamson, P. D., Hunter, A., Madsen, D. M., Shah, A. S.V., McAllister, D. A., Pawade, T. A., Williams, M. C., Berry, C., Boon, N. A., Flather, M., Forbes, J., McLean, S., Roditi, G., Timmis, A. D., van Beek, E. J.R., Dweck, M. R., Mickley, H., Mills, N. L., Newby, D. E. (2018) High-sensitivity cardiac troponin I and the diagnosis of coronary artery disease in patients with suspected angina pectoris. Circulation: Cardiovascular Quality and Outcomes, 11, (doi: 10.1161/CIRCOUTCOMES.117.004227)

van der Meer, P., Grote Beverborg, N., Pfeffer, M. A., Olson, K., Anand, I. S., Westenbrink, B. D., McMurray, J. J.V., Swedberg, K., Young, J. B., Solomon, S. D., van Veldhuisen, D. J. (2018) Hyporesponsiveness to darbepoetin alfa in patients with heart failure and anemia in the RED-HF study (Reduction of Events by Darbepoetin Alfa in Heart Failure): clinical and prognostic associations. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004431)

Cleland, J. G.F. (2018) Physicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) Syndrome: the headache of nonevidence-based medicine for ischemic heart disease? JACC: Heart Failure, 6, pp. 168-171. (doi: 10.1016/j.jchf.2017.11.014)

Platz, E., Jhund, P. S., Claggett, B. L., Pfeffer, M. A., Swedberg, K., Granger, C. B., Yusuf, S., Solomon, S. D., McMurray, J. J. (2018) Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. European Journal of Heart Failure, 20, pp. 295-303. (doi: 10.1002/ejhf.901)

Nikolaidou, T., Pellicori, P., Zhang, J., Kazmi, S., Goode, K. M., Cleland, J. G., Clark, A. L. (2018) Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure. Clinical Research in Cardiology, 107, pp. 108-119. (doi: 10.1007/s00392-017-1162-6)

Welsh, P., Kou, L., Yu, C., Anand, I., van Veldhuisen, D. J., Maggioni, A. P., Desai, A. S., Solomon, S. D., Pfeffer, M. A., Cheng, S., Gullestad, L., Aukrust, P., Ueland, T., Swedberg, K., Young, J. B., Kattan, M. W., Sattar, N., McMurray, J. J.V. (2018) Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. European Journal of Heart Failure, 20, pp. 268-277. (doi: 10.1002/ejhf.988)

Emmens, J. E., Jones, D. J.L., Cao, T. H., Chan, D. C.S., Romaine, S. P.R., Quinn, P. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., de Boer, R. A., Voors, A. A., Ng, L. L. (2018) Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. European Journal of Heart Failure, 20, pp. 260-267. (doi: 10.1002/ejhf.1101)

Ford, T. J., Corcoran, D., Berry, C. (2018) Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart, 104, pp. 284-292. (doi: 10.1136/heartjnl-2017-311446)

Cotter, G., Metra, M., Davison, B. A., Jondeau, G., Cleland, J. G.F., Bourge, R. C., Milo, O., O'Connor, C. M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2018) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? European Journal of Heart Failure, 20, pp. 317-322. (doi: 10.1002/ejhf.889)

Gallacher, K., Quinn, T. J. (2018) The LAST word on coaching as a stroke intervention? Stroke, 49, pp. 279-280. (doi: 10.1161/STROKEAHA.117.020001)

Stoumpos, S., Lees, J., Welsh, P., Hund, M., Geddes, C. C., Nelson, S. M., Mark, P. B. (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reproductive BioMedicine Online, 36, pp. 219-226. (doi: 10.1016/j.rbmo.2017.11.003)

Fertig, B. A., Baillie, G. S. (2018) PDE4-mediated cAMP signalling. Journal of Cardiovascular Development and Disease, 5, (doi: 10.3390/jcdd5010008)

Ouwerkerk, W., Zwinderman, A. H., Ng, L. L., Demissei, B., Hillege, H. L., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., ter Maaten, J. M., Lang, C. C., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G., Anker, S. D., Voors, A. A. (2018) Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF. Journal of the American College of Cardiology, 71, pp. 386-398. (doi: 10.1016/j.jacc.2017.11.041)

Feldman, T., Mauri, L., Kahwash, R., Litwin, S., Ricciardi, M. J., van der Harst, P., Penicka, M., Fail, P. S., Kaye, D. M., Petrie, M. C., Basuray, A., Hummel, S. L., Forde-McLean, R., Nielsen, C. D., Lilly, S., Massaro, J. M., Burkhoff, D., Shah, S. J. (2018) Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial. Circulation, 137, pp. 364-375. (doi: 10.1161/CIRCULATIONAHA.117.032094)

Williams, J. J.L., Al-Otaiq, N., Mullen, W., Burchmore, R., Liu, L., Baillie, G. S., Schaper, F., Pilch, P. F., Palmer, T. M. (2018) Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability. Nature Communications, 9, (doi: 10.1038/s41467-017-02585-y)

Cleland, J. G.F., Flather, M. D., Altman, D. G., Kotecha, D. (2018) Reply: an incomplete story. Journal of the American College of Cardiology, 71, pp. 105. (doi: 10.1016/j.jacc.2017.10.078)

McCarroll, C. S. et al. (2018) Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation, 137, pp. 57-70. (doi: 10.1161/CIRCULATIONAHA.117.028911)

Cleland, J. G.F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J.S., Manzano, L., McMurray, J. J.V., Ruschitzka, F., van Veldhuisen, D. J., von Lueder, T. G., Böhm, M., Andersson, B., Kjekshus, J., Packer, M., Rigby, A. S., Rosano, G., Wedel, H., Hjalmarson, Å., Wikstrand, J., Kotecha, D. (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. European Heart Journal, 39, pp. 26-35. (doi: 10.1093/eurheartj/ehx564)

Rodrigues, A. L., Brescia, M., Kolshinski, A., Moreira, T. H., Cameron, R. T., Baillie, G., Beirão, P. S.L., Zaccollo, M., Cruz, J. S. (2018) Increase in Ca2+ current by sustained cAMP levels enhances proliferation rate in GH3 cells. Life Sciences, 192, pp. 144-150. (doi: 10.1016/j.lfs.2017.11.040)

Masip, J., Peacock, W. F., Price, S., Cullen, L., Martin-Sanchez, F. J., Seferovic, P., Maisel, A. S., Miro, O., Filippatos, G., Vrints, C., Christ, M., Cowie, M., Platz, E., McMurray, J., DiSomma, S., Zeymer, U., Bueno, H., Gale, C. P., Lettino, M., Tavares, M., Ruschitzka, F., Mebazaa, A., Harjola, V.-P., Mueller, C. (2018) Indications and practical approach to non-invasive ventilation in acute heart failure. European Heart Journal, 39, pp. 17-25. (doi: 10.1093/eurheartj/ehx580)

Kristensen, S. L., Mogensen, U. M., Tarnesby, G., Gimpelewicz, C. R., Ali, M. A., Shao, Q., Chiang, Y., Jhund, P. S., Abraham, W. T., Dickstein, K., McMurray, J. J.V., Køber, L. (2018) Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. European Journal of Heart Failure, 20, pp. 136-147. (doi: 10.1002/ejhf.896)

Pellicori, P., Urbinati, A., Zhang, J., Joseph, A. C., Costanzo, P., Lukaschuk, E., Capucci, A., Cleland, J. G.F., Clark, A. L. (2018) Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study. Clinical Cardiology, 41, pp. 20-27. (doi: 10.1002/clc.22840)

Patel, N., Hellmuth, C., Uhl, O., Godfrey, K., Briley, A., Welsh, P., Pasupathy, D., Seed, P., Koletzko, B., Poston, L. (2018) Cord metabolic profiles In obese pregnant women; insights into offspring growth and body composition. Journal of Clinical Endocrinology and Metabolism, 103, pp. 346-355. (doi: 10.1210/jc.2017-00876)

McMurray, J. J.V., Ponikowski, P., Bolli, G. B., Lukashevich, V., Kozlovski, P., Kothny, W., Lewsey, J. D., Krum, H. (2018) Effects of vildagliptin on ventricular function in patients with type 2 diabetes mellitus and heart failure: a randomized placebo-controlled trial. JACC: Heart Failure, 6, pp. 8-17. (doi: 10.1016/j.jchf.2017.08.004)

Arba, F., Quinn, T. J., Hankey, G. J., Lees, K. R., Wardlaw, J. M., Ali, M., Inzitari, D. (2018) Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack. International Journal of Stroke, 13, pp. 47-56. (doi: 10.1177/1747493016666091)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Schou, M., Gislason, G. H., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Evidence based therapy and its association with workforce detachment following first hospitalization for heart failure. JACC: Heart Failure, 6, pp. 41-48. (doi: 10.1016/j.jchf.2017.09.019)

Beggs, S. A.S., Jhund, P. S., Jackson, C. E., McMurray, J. J.V., Gardner, R. S. (2018) Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis. Heart, 104, pp. 144-150. (doi: 10.1136/heartjnl-2016-310850)

Burton, J. K., Ferguson, E. E.C., Barugh, A. J., Walesby, K. E., MacLullich, A. M.J., Shenkin, S. D., Quinn, T. J. (2018) Predicting discharge to institutional long-term care after stroke: a systematic review and metaanalysis. Journal of the American Geriatrics Society, 66, pp. 161-169. (doi: 10.1111/jgs.15101)

Maznyczka, A. M., McCartney, P., Berry, C. (2018) Reference invasive tests of microvascular injury in myocardial infarction. BMJ Open, 104, pp. 90-92. (doi: 10.1136/heartjnl-2017-311695)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. (doi: 10.1136/heartjnl-2018-BCIS.9)

Quinn, T. J. (2018) Stroke literature synopses: clinical science. Stroke, 49, pp. e5-e6. (doi: 10.1161/STROKEAHA.117.019655)

Taylor-Rowan, M. et al. (2018) Assessing the psychometric properties of the his "Think Frailty" tool. Age and Ageing, 47, pp. iii20-iii23. (doi: 10.1093/ageing/afy127.02)

Souteyrand, G., Valladier, M., Amabile, N., Derimay, F., Harbaoui, B., Leddet, P., Barnay, P., Malcles, G., Mulliez, A., Berry, C., Eschalier, R., Combaret, N., Motreff, P. (2018) Diagnosis and management of spontaneously recanalized coronary thrombus guided by optical coherence tomography ― lessons from the French “Lotus Root” registry ― Circulation Journal, 82, pp. 783-790. (doi: 10.1253/circj.cj-17-0810)

Chuaiphichai, S., Rashbrook, V. S., Hale, A. B., Trelfa, L., Patel, J., McNeill, E., Lygate, C. A., Channon, K. M., Douglas, G. (2018) Endothelial cell tetrahydrobiopterin modulates sensitivity to ang (angiotensin) II–induced vascular remodeling, blood pressure, and abdominal aortic aneurysm. Hypertension, 72, pp. 128-138. (doi: 10.1161/HYPERTENSIONAHA.118.11144)

Yalla, K., Elliott, C., Day, J.P., Findlay, J., Barratt, S., Hughes, Z.A., Wilson, L., Whiteley, E., Popiolek, M., Li, Y., Dunlop, J., Killick, R., Adams, D.R., Brandon, N.J., Houslay, M.D., Hao, B., Baillie, G.S. (2018) FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system. Molecular Psychiatry, 23, pp. 1278-1286. (doi: 10.1038/mp.2017.138)

Howie, J., Wypijewski, K. J., Plain, F., Tulloch, L. B., Fraser, N. J., Fuller, W. (2018) Greasing the wheels or a spanner in the works? Regulation of the cardiac sodium pump by palmitoylation. Critical Reviews in Biochemistry and Molecular Biology, 53, pp. 175-191. (doi: 10.1080/10409238.2018.1432560)

Lachaud, Q., MacQuaide, N., Burton, F., Smith, G. (2018) High-throughput study of rabbit ventricle action potential populations in MI model. Biophysical Journal, 114, pp. 625A. (doi: 10.1016/j.bpj.2017.11.3377)

Berry, C., Carberry, J., Mangion, K. (2018) How to mend a broken heart? JACC: Cardiovascular Imaging, 11, pp. 420-422. (doi: 10.1016/j.jcmg.2017.02.017)

McAllister, D. A., Read, S., Kerssens, J., Livingstone, S., McGurnaghan, S., Jhund, P., Petrie, J., Sattar, N., Fischbacher, C., Kristensen, S. L., McMurray, J., Colhoun, H. M., Wild, S. (2018) Incidence of hospitalisation for heart failure and case-fatality among 3.25 million people with and without diabetes. Circulation, 138, pp. 2774-2785. (doi: 10.1161/CIRCULATIONAHA.118.034986)

Ioannou, A., Carin-Levy, G., Cheyne, J. D., Clarke, D., Cowey, E., Fallon, M., Morton, S., Klinkhamer, L., Kyriakou, G., Fleetwood-Walker, S., Quinn, T., Rush, R., Sande, T., Smith, M., Whalley-Sibley, H., Woodfield, R., Mead, G. (2018) Incidence, types and nature of post-stroke pain: systematic review of literature and meta-analysis [Protocol]

Rørth, R., Fosbøl, E. L., Kragholm, K., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2018) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure: a nationwide cohort study. Clinical Epidemiology, 10, pp. 917-930. (doi: 10.2147/CLEP.S164795)

Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J.V., Murray, H., Steenkamp, R., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., Ford, I. (2018) Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data. American Journal of Nephrology, 48, pp. 260-268. (doi: 10.1159/000493551)

Kraus, W. E., Yates, T., Tuomilehto, J., Sun, J.-L., Thomas, L., McMurray, J. J.V., Bethel, M. A., Holman, R. R. (2018) Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial. BMJ Open Diabetes Research and Care, 6, (doi: 10.1136/bmjdrc-2018-000523)

Seferovic, J. P., Bentley-Lewis, R., Claggett, B., Diaz, R., Gerstein, H. C., Køber, L. V., Lawson, F. C., Lewis, E. F., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Solomon, S. D., Tardif, J.-C., Pfeffer, M. A. (2018) Retinopathy, neuropathy, and subsequent cardiovascular events in patients with type 2 diabetes and acute coronary syndrome in the ELIXA: the importance of disease duration. Journal of Diabetes Research, 2018, (doi: 10.1155/2018/1631263)

Verma, S., McMurray, J. J.V. (2018) SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia, 61, pp. 2108-2117. (doi: 10.1007/s00125-018-4670-7)

Layland, J., Tong, D., Lee, M., Berry, C. (2018) ST and T-Wave Abnormality as Footprint of Myocardial Oedema in Non–ST-Elevation Myocardial Infarction. (doi: 10.1016/j.hlc.2018.06.515)

Bouabdallaoui, N. et al. (2018) Society of Thoracic Surgeons risk score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left ventricular dysfunction undergoing surgical revascularization. Circulation: Heart Failure, 11, (doi: 10.1161/circheartfailure.118.005531)

Delles, C., Carrick, E., Graham, D., Nicklin, S. A. (2018) Utilising proteomics to understand and define hypertension: where are we and where do we go? Expert Review of Proteomics, 15, pp. 581-592. (doi: 10.1080/14789450.2018.1493927)

Avtaar Singh, S. S., Das De, S., Spadaccio, C., Berry, C., Al-Attar, N. (2017) An overview of different methods of myocardial protection currently employed peri-transplantation. Vessel Plus, 1, pp. 213-229. (doi: 10.20517/2574-1209.2017.26)

Van't Veer, M., Pijls, N. H.J., Hennigan, B., Watkins, S., Ali, Z. A., De Bruyne, B., Zimmermann, F. M., van Nunen, L. X., Barbato, E., Berry, C., Oldroyd, K. G. (2017) Comparison of different diastolic resting indexes to iFR: are they all equal? Journal of the American College of Cardiology, 70, pp. 3088-3096. (doi: 10.1016/j.jacc.2017.10.066)

Ford, T. J., Berry, C., De Bruyne, B., Yong, A. C.S., Barlis, P., Fearon, W. F., Ng, M. K.C. (2017) Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient. JACC: Cardiovascular Interventions, 10, pp. 2539-2547. (doi: 10.1016/j.jcin.2017.08.059)

Logie, L., Van Aalten, L., Knebel, A., Force, T., Hastie, C. J., MacLauchlan, H., Campbell, D. G., Gourlay, R., Prescott, A., Davidson, J., Fuller, W., Sutherland, C. (2017) Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3) Scientific Reports, 7, (doi: 10.1038/s41598-017-17087-6)

Berry, C., McClure, J. D., Oldroyd, K. G. (2017) Meta-analysis of death and myocardial infarction in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a hypothesis generating note of caution. Circulation, 136, pp. 2389-2391. (doi: 10.1161/CIRCULATIONAHA.117.030430)

Lei, C. L., Wang, K., Clerx, M., Johnstone, R. H., Hortigon-Vinagre, M. P., Zamora, V., Allan, A., Smith, G. L., Gavaghan, D. J., Mirams, G. R., Polonchuk, L. (2017) Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology. Frontiers in Physiology, 8, (doi: 10.3389/fphys.2017.00986)

Duncan, G., Firth, K., George, V., Hoang, M. D., Staniforth, A., Smith, G., Denning, C. (2017) Drug-mediated shortening of action potentials in LQTS2 human induced pluripotent stem cell-derived cardiomyocytes. Stem Cells and Development, 26, pp. 1695-1705. (doi: 10.1089/scd.2017.0172)

Celis-Morales, C. A., Petermann, F., Hui, L., Lyall, D. M., Iliodromiti, S., McLaren, J., Anderson, J., Welsh, P., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R. (2017) Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: evidence from UK Biobank, a prospective population-based cohort study. Diabetes Care, 40, pp. 1710-1718. (doi: 10.2337/dc17-0921)

Kaye, D. M., Silvestry, F. E., Gustafsson, F., Cleland, J. G., van Veldhuisen, D. J., Ponikowski, P., Komtebedde, J., Nanayakkara, S., Burkhoff, D., Shah, S. J. (2017) Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction. European Journal of Heart Failure, 19, pp. 1690-1697. (doi: 10.1002/ejhf.930)

Hilfiker-Kleiner, D., Haghikia, A., Masuko, D., Nonhoff, J., Held, D., Libhaber, E., Petrie, M. C., Walker, N. L., Podewski, E., Berliner, D., Bauersachs, J., Sliwa, K. (2017) Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. European Journal of Heart Failure, 19, pp. 1723-1728. (doi: 10.1002/ejhf.808)

Basole, C. P., Nguyen, R. K., Lamothe, K., Vang, A., Clark, R., Baillie, G. S., Epstein, P. M., Brocke, S. (2017) PDE8 controls CD4(+) T cell motility through the PDE8A-Raf-1 kinase signaling complex. Cellular Signalling, 40, pp. 62-72. (doi: 10.1016/j.cellsig.2017.08.007)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2017) Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications. Circulation: Cardiovascular Imaging, 10, (doi: 10.1161/CIRCIMAGING.117.006586)

Kristensen, S. L., Jhund, P. S., Lee, M. M.Y., Køber, L., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., McMurray, J. J.V. (2017) Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes. Cardiovascular Drugs and Therapy, 31, pp. 545-549. (doi: 10.1007/s10557-017-6754-x)

Senni, M., McMurray, J. J.V., Wachter, R., McIntyre, H. F., Anand, I. S., Duino, V., Sarkar, A., Shi, V., Charney, A. (2017) Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study. European Journal of Heart Failure, 20, pp. 491-500. (doi: 10.1002/ejhf.1054)

Vieira, M. C., White, S. L., Patel, N., Seed, P. T., Briley, A. L., Sandall, J., Welsh, P., Sattar, N., Nelson, S. M., Lawlor, D. A., Poston, L., Pasupathy, D. (2017) Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study. BMC Medicine, 15, (doi: 10.1186/s12916-017-0956-8)

Sartini, C., Whincup, P. H., Wannamethee, S. G., Jefferis, B. J., Lennon, L., Lowe, G. D.O., Welsh, P., Sattar, N., Morris, R. W. (2017) Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study. BMJ Open, 7, (doi: 10.1136/bmjopen-2017-018264)

Shah, P., Pellicori, P., Macnamara, A., Urbinati, A., Clark, A. L. (2017) Is swimming safe in heart failure? A systematic review. Cardiology in Review, 25, pp. 321-325. (doi: 10.1097/CRD.0000000000000154)

Shen, L., Ramires, F., Martinez, F., Bodanese, L. C., Echeverría, L. E., Gómez, E. a., Abraham, W. t., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Jhund, P. S., Gimpelewicz, C. R., McMurray, J. J.V. (2017) Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004361)

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., McMurray, J. J., Rydén, L., Schröder, S., Sun, Y., Theodorakis, M. J., Tendera, M., Tucker, L., Tuomilehto, J., Wei, Y., Yang, W., Wang, D., Hu, D., Pan, C., ACE Study Group, (2017) Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5, pp. 877-886. (doi: 10.1016/S2213-8587(17)30309-1)

Wong, C. M., Hawkins, N. M., Ezekowitz, J. A., Jhund, P. S., Savu, A., MacDonald, M. R., Kristensen, S. L., Petrie, M. C., McMurray, J. J.V., McAlister, F. A., Kaul, P. (2017) Heart failure in young adults is associated with high mortality: a contemporary population-level analysis. Canadian Journal of Cardiology, 33, pp. 1472-1477. (doi: 10.1016/j.cjca.2017.05.009)

MacDonald, E. A., Stoyek, M. R., Rose, R. A., Quinn, T. A. (2017) Intrinsic regulation of sinoatrial node function and the zebrafish as a model of stretch effects on pacemaking. Progress in Biophysics and Molecular Biology, 130, pp. 198-211. (doi: 10.1016/j.pbiomolbio.2017.07.012)

McDonald, M. A., Ashley, E. A., Fedak, P. W.M., Hawkins, N., Januzzi, J. L., McMurray, J. J.V., Parikh, V. N., Rao, V., Svystonyuk, D., Teerlink, J. R., Virani, S. (2017) Mind the gap: current challenges and future state of heart failure care. Canadian Journal of Cardiology, 33, pp. 1434-1449. (doi: 10.1016/j.cjca.2017.08.023)

Stewart, S., Keates, A. K., Redfern, A., McMurray, J. J.V. (2017) Seasonal variations in cardiovascular disease. Nature Reviews Cardiology, 14, pp. 654-664. (doi: 10.1038/nrcardio.2017.76)

Welsh, P., Grassia, G., Botha, S., Sattar, N., Maffia, P. (2017) Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? British Journal of Pharmacology, 174, pp. 3898-3913. (doi: 10.1111/bph.13818)

Mogensen, U. M., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Køber, L., McMurray, J. J.V. (2017) Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction. Journal of the American College of Cardiology, 70, pp. 2490-2500. (doi: 10.1016/j.jacc.2017.09.027)

Rutherford, E., Mangion, K., Mccomb, C., Bell, E., Cockburn, S., Talle, M., Roditi, G., Welsh, P., Woodward, R., Radjenovic, A., Struthers, A. D., Jardine, A., Berry, C., Patel, R. K., Mark, P. B. (2017) Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study. Scientific Reports, 7, (doi: 10.1038/s41598-017-14481-y)

Kobayashi, Y., Johnson, N. P., Zimmermann, F. M., Witt, N., Berry, C., Jeremias, A., Koo, B.-K., Esposito, G., Rioufol, G., Park, S.-J., Nishi, T., Choi, D.-H., Oldroyd, K. G., Barbato, E., Pijls, N. H. J., De Bruyne, B., Fearon, W. F. (2017) Agreement of the resting distal to aortic coronary pressure with the instantaneous wave-free ratio. Journal of the American College of Cardiology, 70, pp. 2105-2113. (doi: 10.1016/j.jacc.2017.08.049)

Bayes-Genis, A., Núñez, J., Zannad, F., Ferreira, J. P., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Metra, M., Lupón, J., Voors, A. A. (2017) The PCSK9-LDL receptor axis and outcomes in heart failure: BIOSTAT-CHF subanalysis. Journal of the American College of Cardiology, 70, pp. 2128-2136. (doi: 10.1016/j.jacc.2017.08.057)

Lemonidis, K., MacLeod, R., Baillie, G. S., Chamberlain, L. H. (2017) Peptide array based screening reveals a large number of proteins interacting with the ankyrin repeat domain of the zDHHC17 S-acyltransferase. Journal of Biological Chemistry, 292, pp. 17190-17202. (doi: 10.1074/jbc.M117.799650)

Gao, H., Mangion, K., Carrick, D., Husmeier, D., Luo, X., Berry, C. (2017) Estimating prognosis in patients with acute myocardial infarction using personalized computational heart models. Scientific Reports, 7, (doi: 10.1038/s41598-017-13635-2)

Wolsk, E., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L., Lawson, F. C., Lewis, E. F., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Solomon, S. D., Tardif, J.-C., Pfeffer, M. A. (2017) Increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes mellitus. Circulation, 136, pp. 1560-1562. (doi: 10.1161/CIRCULATIONAHA.117.029503)

Sharma, A., Demissei, B. G., Tromp, J., Hillege, H. L., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Cotter, G., Ezekowitz, J. A., Khan, M. A.F., Voors, A. A. (2017) A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. European Journal of Heart Failure, 19, pp. 1310-1320. (doi: 10.1002/ejhf.912)

Oldroyd, C., Scholz, A. F.M., Hinchcliffe, R. J., McCarthy, K., Hewitt, J., Quinn, T. J. (2017) A systematic review and meta-analysis of factors for delirium in vascular surgical patients. Journal of Vascular Surgery, 66, pp. 1269-1279.e9. (doi: 10.1016/j.jvs.2017.04.077)

Lees, R. A., Hendry, K., Broomfield, N., Stott, D., Larner, A. J., Quinn, T. (2017) Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. International Journal of Geriatric Psychiatry, 32, pp. 1072-1078. (doi: 10.1002/gps.4568)

Petrushanko, I. Y., Mitkevich, V. A., Lakunina, V. A., Anashkina, A. A., Spirin, P. V., Rubtsov, P. M., Prassolov, V. S., Bogdanov, N. B., Hänggi, P., Fuller, W., Makarov, A. A., Bogdanova, A. (2017) Cysteine residues 244 and 458–459 within the catalytic subunit of Na,K-ATPase control the enzyme's hydrolytic and signaling function under hypoxic conditions. Redox Biology, 13, pp. 310-319. (doi: 10.1016/j.redox.2017.05.021)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B., Kettlewell, S., Smith, G. L., Clancy, M. J., Delles, C., Jardine, A. G. (2017) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, 32, pp. 1617-1627. (doi: 10.1093/ndt/gfw252)

Charytan, D. M., Solomon, S. D., Ivanovich, P., Remuzzi, G., Cooper, M. E., McGill, J. B., Parving, H.-H., Parfrey, P., Singh, A. K., Burdmann, E. A., Levey, A. S., de Zeeuw, D., Eckardt, K.-U., McMurray, J. J.V., Claggett, B., Lewis, E. F., Pfeffer, M. A. (2017) ESRD after heart failure, myocardial infarction, or stroke in type 2 diabetic patients with CKD. American Journal of Kidney Diseases, 70, pp. 522-531. (doi: 10.1053/j.ajkd.2017.04.018)

Nishi, T., Johnson, N. P., De Bruyne, B., Berry, C., Gould, K. L., Jeremias, A., Oldroyd, K. G., Kobayashi, Y., Choi, D.-H., Pijls, N. H.J., Fearon, W. F. (2017) Influence of contrast media dose and osmolality on the diagnostic performance of contrast fractional flow reserve. Circulation: Cardiovascular Interventions, 10, (doi: 10.1161/CIRCINTERVENTIONS.117.004985)

White, S. L., Pasupathy, D., Sattar, N., Nelson, S. M., Lawlor, D. A., Briley, A. L., Seed, P. T., Welsh, P., Poston, L. (2017) Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia, 60, pp. 1903-1912. (doi: 10.1007/s00125-017-4380-6)

Ferreira, J. P., Rossignol, P., Machu, J.-L., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ter Maaten, J., Metra, M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2017) Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. European Journal of Heart Failure, 19, pp. 1284-1293. (doi: 10.1002/ejhf.900)

Gao, H., Qi, N., Feng, L., Ma, X., Danton, M., Berry, C., Luo, X. (2017) Modelling mitral valvular dynamics–current trend and future directions. International Journal for Numerical Methods in Biomedical Engineering, 33, (doi: 10.1002/cnm.2858)

Nassif, M. E., Tang, Y., Cleland, J. G.F., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Schaber, D., Tang, A. S.L., Jones, P. G., Arnold, S. V., Spertus, J. A. (2017) Precision medicine for cardiac resynchronization: predicting quality of life benefits for individual patients-an analysis from 5 clinical trials. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004111)

Kristensen, S. L., Jhund, P. S., Mogensen, U. M., Rørth, R., Abraham, W. T., Desai, A., Dickstein, K., Rouleau, J. L., Zile, M. R., Swedberg, K., Packer, M., Solomon, S. D., Køber, L., McMurray, J. J.V. (2017) Prognostic value of N-terminal pro-B-type natriuretic peptide levels in heart failure patients with and without atrial fibrillation. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004409)

Quinn, T. (2017) Review: Real-world use of nonsteroidal antiinflammatory drugs is associated with acute myocardial infarction. Annals of Internal Medicine, 167, (doi: 10.7326/acpjc-2017-167-6-030)

Cleland, J. G.F., Halliday, B. P., Prasad, S. K. (2017) Selecting patients with nonischemic dilated cardiomyopathy for ICDs. Journal of the American College of Cardiology, 70, pp. 1228-1231. (doi: 10.1016/j.jacc.2017.07.748)

Quinn, T. J., Singh, S., Lees, K. R., Bath, P. M., Myint, P. K. (2017) Validating and comparing stroke prognosis scales. Neurology, 89, pp. 997-1002. (doi: 10.1212/WNL.0000000000004332)

Noh, R. M., Venkatasubramanian, S., Daga, S., Langrish, J., Mills, N. L., Lang, N. N., Hoffmann, E., Waterhouse, B., Newby, D. E., Frier, B. M. (2017) Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus. Open Heart, 4, (doi: 10.1136/openhrt-2017-000647)

Peterzan, M. A., Lygate, C. A., Neubauer, S., Rider, O. J. (2017) Metabolic remodeling in hypertrophied and failing myocardium: a review. American Journal of Physiology: Heart and Circulatory Physiology, 313, pp. H597-H616. (doi: 10.1152/ajpheart.00731.2016)

Gao, H., Feng, L., Qi, N., Berry, C., Griffith, B. E., Luo, X. (2017) A coupled mitral valve - left ventricle model with fluid-structure interaction. Medical Engineering and Physics, 47, pp. 128-136. (doi: 10.1016/j.medengphy.2017.06.042)

Lu, H.R., Hortigon-Vinagre, M.P., Zamora, V., Kopljar, I., De Bondt, A., Gallacher, D.J., Smith, G. (2017) Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias. Journal of Pharmacological and Toxicological Methods, 87, pp. 53-67. (doi: 10.1016/j.vascn.2017.05.001)

Fröhlich, H., Torres, L., Täger, T., Schellberg, D., Corletto, A., Kazmi, S., Goode, K., Grundtvig, M., Hole, T., Katus, H. A., Cleland, J. G.F., Atar, D., Clark, A. L., Agewall, S., Frankenstein, L. (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical Research in Cardiology, 106, pp. 711-721. (doi: 10.1007/s00392-017-1115-0)

Wannamethee, S. G., Welsh, P., Papacosta, O., Ellins, E. A., Halcox, J. P.J., Whincup, P. H., Sattar, N. (2017) Circulating soluble receptor for advanced glycation end product: cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis, 264, pp. 36-43. (doi: 10.1016/j.atherosclerosis.2017.07.008)

Sliwa, K., Mebazaa, A., Hilfiker-Kleiner, D., Petrie, M. C., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van der Meer, P., Roos-Hesselink, J. W., Seferovic, P., van Spandonck-Zwarts, K., Mbakwem, A., Böhm, M., Mouquet, F., Pieske, B., Hall, R., Ponikowski, P., Bauersachs, J. (2017) Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) European Journal of Heart Failure, 19, pp. 1131-1141. (doi: 10.1002/ejhf.780)

Price, A. H., Weir, C. J., Welsh, P., McLachlan, S., Strachan, M. W.J., Sattar, N., Price, J. F. (2017) Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Atherosclerosis, 264, pp. 67-73. (doi: 10.1016/j.atherosclerosis.2017.07.009)

Saxena, P., Hortigon-Vinagre, M.P., Beyl, S., Baburin, I., Andranovits, S., Iqbal, S.M., Costa, A., IJzerman, A.P., Kügler, P., Timin, E., Smith, G.L., Hering, S. (2017) Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation. British Journal of Pharmacology, 174, pp. 3081-3093. (doi: 10.1111/bph.13942)

Griffin, E. A., Wonderling, D., Ludman, A. J., Al-Mohammad, A., Cowie, M. R., Hardman, S. M.C., McMurray, J. J.V., Kendall, J., Mitchell, P., Shote, A., Dworzynski, K., Mant, J. (2017) Cost-effectiveness analysis of natriuretic peptide testing and specialist management in patients with suspected acute heart failure. Value in Health, 20, pp. 1025-1033. (doi: 10.1016/j.jval.2017.05.007)

Cleland, J. G.F. (2017) Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! European Journal of Heart Failure, 19, pp. 1086-1088. (doi: 10.1002/ejhf.697)

Platz, E., Merz, A. A., Jhund, P. S., Vazir, A., Campbell, R., McMurray, J. J. (2017) Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. European Journal of Heart Failure, 19, pp. 1154-1163. (doi: 10.1002/ejhf.839)

Olivier, A., Pitt, B., Girerd, N., Lamiral, Z., Machu, J.-L., McMurray, J. J.V., Swedberg, K., van Veldhuisen, D. J., Collier, T. J., Pocock, S. J., Rossignol, P., Zannad, F., Pizard, A. (2017) Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: insight from the EMPHASIS-HF trial. European Journal of Heart Failure, 19, pp. 1186-1197. (doi: 10.1002/ejhf.792)

Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Gho, J. M.I.H., Shah, A. D., Yu, N., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G.F., Asselbergs, F. W., Hemingway, H. (2017) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. European Journal of Heart Failure, 19, pp. 1119-1127. (doi: 10.1002/ejhf.709)

Quinn, T. J. (2017) Stroke literature synopses: clinical science. Stroke, 48, pp. e243-e244. (doi: 10.1161/STROKEAHA.117.018510)

Verma, S., McMurray, J. J.V., Cherney, D. Z.I. (2017) The metabolodiuretic promise of sodium-dependent glucose cotransporter 2 inhibition: the search for the sweet spot in heart failure. JAMA Cardiology, 2, pp. 939-940. (doi: 10.1001/jamacardio.2017.1891)

Murphy, S. R., Wang, L., Wang, Z., Domondon, P., Lang, D., Habecker, B. A., Myles, R. C., Ripplinger, C. M. (2017) β-adrenergic inhibition prevents action potential and calcium handling changes during regional myocardial ischemia. Frontiers in Physiology, 8, (doi: 10.3389/fphys.2017.00630)

Gallyas, F., Zervou, S., Whittington, H. J., Ostrowski, P. J., Cao, F., Tyler, J., Lake, H. A., Neubauer, S., Lygate, C. A. (2017) Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitro. PLoS ONE, 12, (doi: 10.1371/journal.pone.0182994)

Willeit, P., Welsh, P., Evans, J. D.W., Tschiderer, L., Boachie, C., Jukema, J. W., Ford, I., Trompet, S., Stott, D. J., Kearney, P. M., Mooijaart, S. P., Kiechl, S., Di Angelantonio, E., Sattar, N. (2017) High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes: literature-based meta-analysis involving 154,052 participants. Journal of the American College of Cardiology, 70, pp. 558-568. (doi: 10.1016/j.jacc.2017.05.062)

Berry, C. (2017) Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease. Circulation, 136, pp. 437-439. (doi: 10.1161/CIRCULATIONAHA.117.028991)

Shen, L., Jhund, P. S., Mogensen, U. M., Køber, L., Claggett, B., Rogers, J. K., McMurray, J. J.V. (2017) A re-examination of the BEST Trial using composite outcomes, including emergency department visits. JACC: Heart Failure, 5, pp. 591-599. (doi: 10.1016/j.jchf.2017.04.005)

Newby, D. et al. (2017) Aortic wall inflammation predicts abdominal aortic aneurysm expansion, rupture, and need for surgical repair. Circulation, 136, pp. 787-797. (doi: 10.1161/CIRCULATIONAHA.117.028433)

Jenks, S. J., Conway, B. R., McLachlan, S., Teoh, W. L., Williamson, R. M., Webb, D. J., Welsh, P., Sattar, N., Strachan, M. W.J., Price, J. F. (2017) Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes. Diabetologia, 60, pp. 1400-1408. (doi: 10.1007/s00125-017-4297-0)

Baigent, C., Herrington, W. G., Coresh, J., Landray, M. J., Levin, A., Perkovic, V., Pfeffer, M. A., Rossing, P., Walsh, M., Wanner, C., Wheeler, D. C., Winkelmayer, W. C., McMurray, J. J.V. (2017) Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 92, pp. 297-305. (doi: 10.1016/j.kint.2017.04.019)

Gimpelewicz, C., Metra, M., Cleland, J. G.F., Szecsödy, P., Chang Wun, C.-C., Boer-Martins, L., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P., Ponikowski, P., Severin, T., Voors, A. A., Teerlink, J. R. (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. American Heart Journal, 190, pp. 113-122. (doi: 10.1016/j.ahj.2017.05.012)

Lewis, E. F., Claggett, B. L., McMurray, J. J.V., Packer, M., Lefkowitz, M. P., Rouleau, J. L., Liu, J., Shi, V. C., Zile, M. R., Desai, A. S., Solomon, S. D., Swedberg, K. (2017) Health-related quality of life outcomes in PARADIGM-HF. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003430)

Mangion, K., McComb, C., Auger, D. A., Epstein, F. H., Berry, C. (2017) Magnetic resonance imaging of myocardial strain after acute ST-segment-elevation myocardial infarction: a systematic review. Circulation: Cardiovascular Imaging, 10, (doi: 10.1161/CIRCIMAGING.117.006498)

Lygate, C. A. (2017) Metabolic arithmetic: do two wrongs make a right? Cardiovascular Research, 113, pp. 1093-1095. (doi: 10.1093/cvr/cvx121)

Linde, C., Abraham, W. T., Gold, M. R., Daubert, C., Tang, A. S.L., Young, J. B., Sherfesee, L., Hudnall, H., Fagan, D. H., Cleland, J. G. (2017) Predictors of short-term clinical response to cardiac resynchronization therapy. European Journal of Heart Failure, 19, pp. 1056-1063. (doi: 10.1002/ejhf.795)

Touyz, R. M., Lang, N. N., Herrmann, J., van den Meiracker, A. H., Danser, A.H. J. (2017) Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor inhibition. Hypertension, 70, pp. 220-226. (doi: 10.1161/HYPERTENSIONAHA.117.08856)

Cleland, J. G.F. (2017) What do cardiology and homeopathy have in common? : A belief in aspirin? JACC: Heart Failure, 5, pp. 611-614. (doi: 10.1016/j.jchf.2017.06.009)

Halliday, B. P., Cleland, J. G.F., Goldberger, J. J., Prasad, S. K. (2017) Personalizing sudden death risk stratification in dilated cardiomyopathy: past, present and future. Circulation, 136, pp. 215-231. (doi: 10.1161/CIRCULATIONAHA.116.027134)

Damman, K., Valente, M. A.E., van Veldhuisen, D. J., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Hillege, H. L., Voors, A. A. (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. International Journal of Molecular Sciences, 18, (doi: 10.3390/ijms18071470)

Ohkuma, T., Jun, M., Woodward, M., Zoungas, S., Cooper, M. E., Grobbee, D. E., Hamet, P., Mancia, G., Williams, B., Welsh, P., Sattar, N., Shaw, J. E., Rahimi, K., Chalmers, J. (2017) Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial. Diabetes Care, 40, pp. 1203-1209. (doi: 10.2337/dc17-0509)

Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G.F., Dargie, H. J., Granger, C. B., Kjekshus, J., Køber, L., Latini, R., Maggioni, A. P., Packer, M., Pitt, B., Solomon, S. D., Swedberg, K., Tavazzi, L., Wikstrand, J., Zannad, F., Zile, M. R., McMurray, J. J.V. (2017) Declining risk of sudden death in heart failure. New England Journal of Medicine, 377, pp. 41-51. (doi: 10.1056/NEJMoa1609758)

Ford, T. J., Corcoran, D., Berry, C. (2017) Coronary artery disease: physiology and prognosis. European Heart Journal, 38, pp. 1990-1992. (doi: 10.1093/eurheartj/ehx226)

Lamore, S. D., Ahlberg, E., Boyer, S., Lamb, M. L., Hortigon-Vinagre, M. P., Rodriguez, V., Smith, G. L., Sagemark, J., Carlsson, L., Bates, S. M., Choy, A. L., Stålring, J., Scott, C. W., Peters, M. F. (2017) Deconvoluting kinase inhibitor induced cardiotoxicity. Toxicological Sciences, 158, pp. 213-226. (doi: 10.1093/toxsci/kfx082)

Fröhlich, H., Raman, N., Täger, T., Schellberg, D., Goode, K. M., Kazmi, S., Grundtvig, M., Hole, T., Cleland, J. G.F., Katus, H. A., Agewall, S., Clark, A. L., Atar, D., Frankenstein, L. (2017) Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International Journal of Cardiology, 238, pp. 97-104. (doi: 10.1016/j.ijcard.2017.03.028)

Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., Lam, C. S.P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., Desai, A. S., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V. (2017) Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction. JACC: Heart Failure, 5, pp. 471-482. (doi: 10.1016/j.jchf.2017.04.013)

Wehling, M., Collins, R., Gil, V. M., Hanon, O., Hardt, R., Hoffmeister, M., Monteiro, P., Quinn, T. J., Ropers, D., Sergi, G., Verheugt, F. W.A. (2017) Appropriateness of oral anticoagulants for long-term treatment of atrial fibrillation in older people: results of an evidence-based review and international consensus validation process (OAC-FORTA 2016) Drugs and Aging, 34, pp. 499-507. (doi: 10.1007/s40266-017-0466-6)

Nishi, K., Luo, H., Ishikura, S., Doi, K., Iwaihara, Y., Wills, L., Baillie, G. S., Sakata, T., Shirasawa, S., Tsunoda, T. (2017) Apremilast induces apoptosis of human colorectal cancer cells with mutant KRAS. Anticancer Research, 37, pp. 3833-3839. (doi: 10.21873/anticanres.11762)

Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC: Heart Failure, 5, pp. 507-517. (doi: 10.1016/j.jchf.2017.04.007)

Gao, H., Aderhold, A., Mangion, K., Luo, X., Husmeier, D., Berry, C. (2017) Changes and classification in myocardial contractile function in the left ventricle following acute myocardial infarction. Journal of the Royal Society: Interface, 14, (doi: 10.1098/rsif.2017.0203)

Price, S., Platz, E., Cullen, L., Tavazzi, G., Christ, M., Cowie, M. R., Maisel, A. S., Masip, J., Miro, O., McMurray, J. J., Peacock, W. F., Martin-Sanchez, F. J., Di Somma, S., Bueno, H., Zeymer, U., Mueller, C. (2017) Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nature Reviews Cardiology, 14, pp. 427-440. (doi: 10.1038/nrcardio.2017.56)

Corcoran, D., Hennigan, B., Berry, C. (2017) Fractional flow reserve: a clinical perspective. International Journal of Cardiovascular Imaging, 33, pp. 961-974. (doi: 10.1007/s10554-017-1159-2)

Pellicori, P., Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D., Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19, pp. 883-892. (doi: 10.1002/ejhf.825)

Harrison, J. K., Walesby, K. E., Hamilton, L., Armstrong, C., Starr, J. M., Reynish, E. L., MacLullich, A. M.J., Quinn, T., Shenkin, S. D. (2017) Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis. Age and Ageing, 46, pp. 547-558. (doi: 10.1093/ageing/afx047)

Sze, S., Zhang, J., Pellicori, P., Morgan, D., Hoye, A., Clark, A.L. (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clinical Research in Cardiology, 106, pp. 533-541. (doi: 10.1007/s00392-017-1082-5)

Kiely, M., Adams, D. R., Hayes, S. L., O'Connor, R., Baillie, G. S., Kiely, P. A. (2017) RACK1 stabilises the activity of PP2A to regulate the transformed phenotype in mammary epithelial cells. Cellular Signalling, 35, pp. 290-300. (doi: 10.1016/j.cellsig.2016.09.001)

Williams, M. C., Hunter, A., Shah, A., Assi, V., Lewis, S., Mangion, K., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2017) Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial. Heart, 103, pp. 995-1001. (doi: 10.1136/heartjnl-2016-310129)

Cleland, J. G.F., Pellicori, P., Clark, A. L., Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5, pp. 538-540. (doi: 10.1016/j.jchf.2017.04.003)

Hennigan, B., Johnson, N., McClure, J., Corcoran, D., Watkins, S., Berry, C., Oldroyd, K. G. (2017) Validation of the "smart" minimum FFR Algorithm in an unselected all comer population of patients with intermediate coronary stenoses. International Journal of Cardiovascular Imaging, 33, pp. 991-997. (doi: 10.1007/s10554-017-1126-y)

Plain, F., Congreve, S. D., Yee, R. S. Z., Kennedy, J., Howie, J., Kuo, C.-W., Fraser, N. J., Fuller, W. (2017) An amphipathic α-helix directs palmitoylation of the large intracellular loop of the sodium/calcium exchanger. Journal of Biological Chemistry, 292, pp. 10745-10752. (doi: 10.1074/jbc.M116.773945)

Ouwerkerk, W., Voors, A.A., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., ter Maaten, J.M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Metra, M., Zwinderman, A.H. (2017) Determinants and clinical outcome of uptitration of ACE-inhibitor and beta-blocker in patients with heart failure: a prospective European study. European Heart Journal, 38, pp. 1883-1890. (doi: 10.1093/eurheartj/ehx026)

Jhund, P. S. (2017) Obesity and heart failure: when 'epidemics' collide. European Heart Journal, 38, pp. 1934-1936. (doi: 10.1093/eurheartj/ehw357)

Kotecha, D., Flather, M. D., Altman, D. G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Coats, A. J.S., Manzano, L., Böhm, M., van Veldhuisen, D. J., Andersson, B., Wedel, H., von Lueder, T. G., Rigby, A. S., Hjalmarson, Å., Kjekshus, J., Cleland, J. G.F. (2017) Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis. Journal of the American College of Cardiology, 69, pp. 2885-2896. (doi: 10.1016/j.jacc.2017.04.001)

MacDonald, T. M., Hawkey, C. J., Ford, I., McMurray, J. J.V., Scheiman, J. M., Hallas, J., Findlay, E., Grobbee, D. E., Hobbs, F.D. R., Ralston, S. H., Reid, D. M., Walters, M. R., Webster, J., Ruschitzka, F., Ritchie, L. D., Perez-Gutthann, S., Connolly, E., Greenlaw, N., Wilson, A., Wei, L., Mackenzie, I. S. (2017) Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT) European Heart Journal, 38, pp. 1843-1850. (doi: 10.1093/eurheartj/ehw387)

Quinn, T. J., Taylor-Rowan, M., Coyte, A., Clark, A. B., Musgrave, S. D., Metcalf, A. K., Day, D. J., Bachman, M. O., Warburton, E. A., Potter, J. F., Myint, P. K. (2017) Pre-stroke modified Rankin scale: evaluation of validity, prognostic accuracy and association with treatment. Frontiers in Neurology, 8, (doi: 10.3389/fneur.2017.00275)

Aetesam-ur-Rahman, M., Berry, C. (2017) Cardiovascular Diagnosis and Therapy (CDT) editorial: the Minimalist Immediate Mechanical Intervention study. Cardiovascular Diagnosis and Therapy, 7, pp. S73-S76. (doi: 10.21037/cdt.2017.01.13)

Lopez-Gordo, E., Doszpoly, A., Duffy, M. R., Coughlan, L., Bradshaw, A. C., White, K. M., Denby, L., Nicklin, S. A., Baker, A. H. (2017) Defining a novel role for the coxsackie and adenovirus receptor in human adenovirus serotype 5 transduction in vitro in the presence of mouse serum. Journal of Virology, 91, (doi: 10.1128/JVI.02487-16)

Arba, F., Quinn, T., Hankey, G.J., Inzitari, D., Ali, M., Lees, K. R. (2017) Determinants of post-stroke cognitive impairment: analysis from VISTA. Acta Neurologica Scandinavica, 136, pp. 603-607. (doi: 10.1111/ane.12637)

Guimarães, P. O., Lopes, R. D., Wojdyla, D. M., Abdul-Rahim, A. H., Connolly, S. J., Flaker, G. C., Wang, J., Hanna, M., Granger, C. B., Wallentin, L., Lees, K. R., Alexander, J. H., McMurray, J. J.V. (2017) Effect of Apixaban on all-cause death in patients with atrial fibrillation: a meta-analysis based on imputed placebo effect. Cardiovascular Drugs and Therapy, 31, pp. 295-301. (doi: 10.1007/s10557-017-6728-z)

Ritchie, J., Green, D., Chrysochou, T., Hegarty, J., Handley, K., Ives, N., Wheatley, K., Houston, G., Wright, J., Neyses, L., Chalmers, N., Mark, P., Patel, R., Moss, J., Roditi, G., Eadington, D., Lukaschuk, E., Cleland, J., Kalra, P. A. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32, pp. 1006-1013. (doi: 10.1093/ndt/gfw107)

Currie, G., Bethel, M. A., Holzhauer, B., Haffner, S. M., Holman, R. R., McMurray, J. J.V. (2017) Effect of valsartan on kidney outcomes in people with impaired glucose tolerance. Diabetes, Obesity and Metabolism, 19, pp. 791-799. (doi: 10.1111/dom.12877)

Liu, L. C.Y., Valente, M. A.E., Postmus, D., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., van der Meer, P., Voors, A. A. (2017) Identifying subpopulations with distinct response to treatment using plasma biomarkers in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, 31, pp. 281-293. (doi: 10.1007/s10557-017-6726-1)

Rossignol, P., Girerd, N., Bakris, G., Vardeny, O., Claggett, B., McMurray, J. J.V., Swedberg, K., Krum, H., van Veldhuisen, D. J., Shi, H., Spanyers, S., Vincent, J., Fay, R., Lamiral, Z., Solomon, S. D., Zannad, F., Pitt, B. (2017) Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia. European Journal of Heart Failure, 19, pp. 792-799. (doi: 10.1002/ejhf.688)

Cleland, J. G.F., Teerlink, J. R., Davison, B. A., Shoaib, A., Metra, M., Senger, S., Milo, O., Cotter, G., Bourge, R. C., Parker, J. D., Jondeau, G., Krum, H., O'Connor, C. M., Torre-Amione, G., van Veldhuisen, D. J., McMurray, J. J.V. (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS) European Journal of Heart Failure, 19, pp. 739-747. (doi: 10.1002/ejhf.786)

Cowie, M. R. et al. (2017) New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. European Journal of Heart Failure, 19, pp. 718-727. (doi: 10.1002/ejhf.809)

McCoy, J., Bates, M., Eggett, C., Siervo, M., Cassidy, S., Newman, J., Moore, S. A., Gorman, G., Trenell, M. I., Velicki, L., Seferovic, P. M., Cleland, J. G.F., MacGowan, G. A., Turnbull, D. M., Jakovljevic, D. G. (2017) Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart, 4, (doi: 10.1136/openhrt-2017-000632)

Shah, P., Pellicori, P., Cuthbert, J., Clark, A. L. (2017) Pharmacological and non-pharmacological treatment for decompensated heart failure: what is new? Current Heart Failure Reports, 14, pp. 147-157. (doi: 10.1007/s11897-017-0328-x)

Demissei, B. G., Postmus, D., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Dittrich, H., Hillege, H. L., Voors, A. A. (2017) Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission. European Journal of Heart Failure, 19, pp. 728-738. (doi: 10.1002/ejhf.766)

Wolsk, E., Claggett, B., Pfeffer, M. A., Diaz, R., Dickstein, K., Gerstein, H. C., Lawson, F. C., Lewis, E. F., Maggioni, A. P., McMurray, J. J.V., Probstfield, J. L., Riddle, M. C., Solomon, S. D., Tardif, J.-C., Køber, L. (2017) Role of b-type natriuretic peptide and n-terminal prohormone BNP as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and type 2 diabetes mellitus. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.004743)

Mogensen, U. M., Køber, L., Kristensen, S. L., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2017) The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF. American Heart Journal, 188, pp. 35-41. (doi: 10.1016/j.ahj.2017.02.034)

Stott, D. J. et al. (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine, 376, pp. 2534-2544. (doi: 10.1056/NEJMoa1603825)

Pellicori, P., Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F., Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, 19, pp. 768-778. (doi: 10.1002/ejhf.788)

Halliday, B. P. et al. (2017) Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, 135, pp. 2106-2115. (doi: 10.1161/CIRCULATIONAHA.116.026910)

Sattar, N., Petrie, M. C., Zinman, B., Januzzi Jr., J. L. (2017) Novel diabetes drugs and the cardiovascular specialist. Journal of the American College of Cardiology, 69, pp. 2646-2656. (doi: 10.1016/j.jacc.2017.04.014)

Packer, M., O'Connor, C., McMurray, J. J.V., Wittes, J., Abraham, W. T., Anker, S. D., Dickstein, K., Filippatos, G., Holcomb, R., Krum, H., Maggioni, A. P., Mebazaa, A., Peacock, W. F., Petrie, M. C., Ponikowski, P., Ruschitzka, F., van Veldhuisen, D. J., Kowarski, L. S., Schactman, M., Holzmeister, J. (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. New England Journal of Medicine, 376, pp. 1956-1964. (doi: 10.1056/NEJMoa1601895)

Ibáñez de Opakua, A., Parag-Sharma, K., DiGiacomo, V., Merino, N., Leyme, A., Marivin, A., Villate, M., Nguyen, L. T., de la Cruz-Morcillo, M. A., Blanco-Canosa, J. B., Ramachandran, S., Baillie, G. S., Cerione, R. A., Blanco, F. J., Garcia-Marcos, M. (2017) Molecular mechanism of Gαi activation by non-GPCR proteins with a Gα-Binding and Activating motif. Nature Communications, 8, (doi: 10.1038/ncomms15163)

Diamantopoulou, Z., White, G., Fadlullah, M. Z.H., Dreger, M., Pickering, K., Maltas, J., Ashton, G., MacLeod, R., Baillie, G. S., Kouskoff, V., Lacaud, G., Murray, G. I., Sansom, O. J., Hurlstone, A. F.L., Malliri, A. (2017) TIAM1 antagonizes TAZ/YAP both in the destruction complex in the cytoplasm and in the nucleus to inhibit invasion of intestinal epithelial cells. Cancer Cell, 31, pp. 621-634. (doi: 10.1016/j.ccell.2017.03.007)

Packer, M., McMurray, J. J.V. (2017) Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure. Lancet, 389, pp. 1831-1840. (doi: 10.1016/S0140-6736(16)30969-2)

Monterisi, S., Lobo, M. J., Livie, C., Castle, J. C., Weinberger, M., Baillie, G., Surdo, N. C., Musheshe, N., Stangherlin, A., Gottlieb, E., Maizels, R., Bortolozzi, M., Micaroni, M., Zaccolo, M. (2017) PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling. eLife, 6, (doi: 10.7554/eLife.21374)

Voors, A. A., Ouwerkerk, W., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Ng, L. L., Metra, M., ter Maaten, J. M., Lang, C. C., Hillege, H. L., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G.F., Anker, S. D., Zwinderman, A. H. (2017) Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, 19, pp. 627-634. (doi: 10.1002/ejhf.785)

Cowper, P. A., Sheng, S., Lopes, R. D., Anstrom, K. J., Stafford, J. A., Davidson-Ray, L., Al-Khatib, S. M., Ansell, J., Dorian, P., Husted, S., McMurray, J. J.V., Steg, P. G., Alexander, J. H., Wallentin, L., Granger, C. B., Mark, D. B. (2017) Economic analysis of apixaban therapy for patients with atrial fibrillation from a US perspective: results from the ARISTOTLE randomized clinical trial. JAMA Cardiology, 2, pp. 525-534. (doi: 10.1001/jamacardio.2017.0065)

Seferovic, J. P., Claggett, B., Seidelmann, S. B., Seely, E. W., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, K., Lefkowitz, M., Shi, V. C., Desai, A. S., McMurray, J. J.V., Solomon, S. D. (2017) Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. Lancet Diabetes and Endocrinology, 5, pp. 333-340. (doi: 10.1016/S2213-8587(17)30087-6)

Packer, M. et al. (2017) Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure : primary results of the ENABLE Trials. JACC: Heart Failure, 5, pp. 317-326. (doi: 10.1016/j.jchf.2017.02.021)

Packer, M., Holcomb, R., Abraham, W. T., Anker, S., Dickstein, K., Filippatos, G., Krum, H., Maggioni, A. P., McMurray, J. J.V., Mebazaa, A., O'Connor, C., Peacock, F., Ponikowski, P., Ruschitzka, F., van Veldhuisen, D. J., Holzmeister, J. (2017) Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. European Journal of Heart Failure, 19, pp. 673-681. (doi: 10.1002/ejhf.698)

Jacobs, L., Efremov, L., Ferreira, J. P., Thijis, L., Yang, W.-Y., Zhang, Z.-Y., Latini, R., Masson, S., Agabiti, N., Sever, P., Delles, C., Sattar, N., Butler, J., Cleland, J., Kuznetsova, T., Staessen, J. A., Zannad, F. (2017) Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) study. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.005231)

Zakeri, R., Van Wagoner, D. R., Calkins, H., Wong, T., Ross, H. M., Heist, E. K., Meyer, T. E., Kowey, P. R., Mentz, R. J., Cleland, J. G.F., Pitt, B., Zannad, F., Linde, C. (2017) The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm, 14, pp. 763-782. (doi: 10.1016/j.hrthm.2017.01.032)

Bethel, M. A., Hyland, K. A., Chacra, A. R., Deedwania, P., Fulcher, G. R., Holman, R. R., Jenssen, T., Levitt, N. S., McMurray, J. J.V., Boutati, E., Thomas, L., Sun, J.-L., Haffner, S. M. (2017) Updated risk factors should be used to predict development of diabetes. Journal of Diabetes and its Complications, 31, pp. 859-863. (doi: 10.1016/j.jdiacomp.2017.02.012)

Harrison, J. K., Reid, J., Quinn, T. J., Shenkin, S. D. (2017) Using quality assessment tools to critically appraise ageing research: a guide for clinicians. Age and Ageing, 46, pp. 359-365. (doi: 10.1093/ageing/afw223)

Ho, C. Y., McMurray, J. J.V., Cirino, A. L., Colan, S. D., Day, S. M., Desai, A. S., Lipshultz, S. E., MacRae, C. A., Shi, L., Solomon, S. D., Orav, E. J., Braunwald, E. (2017) Valsartan for attenuating disease evolution in early sarcomeric hypertrophic cardiomyopathy: the design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) trial. American Heart Journal, 187, pp. 145-155. (doi: 10.1016/j.ahj.2017.02.008)

Singh, A., Greenwood, J. P., Berry, C., Dawson, D. K., Hogrefe, K., Kelly, D. J., Dhakshinamurthy, V., Lang, C. C.,, Khoo, J. P., Sprigings, D., Steeds, R. P., Jerosch-Herold, M., Neubauer, S., Prendergast, B., Williams, B., Zhang, R., Hudson, I., Squire, I. B., Ford, I., Samani, N. J., McCann, G. P. (2017) Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) study. European Heart Journal, 38, pp. 1222-1229. (doi: 10.1093/eurheartj/ehx001)

Celis-Morales, C. A., Lyall, D. M., Welsh, P., Anderson, J., Steell, L., Guo, Y., Maldonado, R., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2017) Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study. British Medical Journal, 357, (doi: 10.1136/bmj.j1456)

Cannon, J. A., Moffitt, P., Perez-Moreno, A. C., Walters, M. R., Broomfield, N. M., McMurray, J. J.V., Quinn, T. J. (2017) Cognitive impairment and heart failure: systematic review and meta-analysis. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2017.04.007)

Doubal, F. N., Ali, M., Batty, G. D., Charidimou, A., Eriksdotter, M., Hofmann-Apitius, M., Kim, Y.-H., Levine, D. A., Mead, G., Mucke, H. A.M., Ritchie, C., Roberts, C., Russ, T. C., Stewart, R., Whiteley, W., Quinn, T. J. (2017) Big data and data repurposing - using existing data to answer new questions in vascular dementia research. BMC Neurology, 17, (doi: 10.1186/s12883-017-0841-2)

Zhang, J., Wong, K. Y.-K., Clark, A. L., Cleland, J. G.F. (2017) Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling. International Journal of Cardiology, 233, pp. 67-72. (doi: 10.1016/j.ijcard.2017.01.127)

Quinn, T. J., McCleery, J. (2017) Diagnosis in vascular dementia, applying ‘Cochrane diagnosis rules’ to ‘dementia diagnostic tools’ Clinical Science, 131, pp. 729-732. (doi: 10.1042/CS20170025)

Young, C., Hall, A. M., Gonçalves-Bradley, D. C., Quinn, T. J., Hooft, L., van Munster, B. C., Stott, D. J. (2017) Home or foster home care versus institutional long-term care for functionally dependent older people. Cochrane Database of Systematic Reviews, 2017, (doi: 10.1002/14651858.CD009844.pub2)

McDiarmid, A. K., Pellicori, P., Cleland, J. G.F., Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38, pp. 942-954. (doi: 10.1093/eurheartj/ehw140)

Layland, J., Rauhalammi, S., Lee, M. M.Y., Ahmed, N., Carberry, J., Teng Yue May, V., Watkins, S., McComb, C., Mangion, K., McClure, J. D., Carrick, D., O'Donnell, A., Sood, A., McEntegart, M., Oldroyd, K. G., Radjenovic, A., Berry, C. (2017) Diagnostic accuracy of 3.0-T magnetic resonance T1 and T2 mapping and T2-weighted dark-blood imaging for the infarct-related coronary artery in Non-ST-segment elevation myocardial infarction. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.004759)

Wilson, S. J., Newby, D. E., Dawson, D., Irving, J., Berry, C. (2017) Duration of dual antiplatelet therapy in acute coronary syndrome. Heart, 103, pp. 573-580. (doi: 10.1136/heartjnl-2016-309871)

Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G.F., Colucci, W. S.,, Butler, J., Voors, A. A., Anker, S. D., Pitt, B., Pieske, B., Filippatos, G., Greene, S. J., Gheorghiade, M. (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14, pp. 238-250. (doi: 10.1038/nrcardio.2016.203)

Filippatos, G. S. et al. (2017) Independent academic data monitoring committees for clinical trials in cardiovascular and cardiometabolic diseases. European Journal of Heart Failure, 19, pp. 449-456. (doi: 10.1002/ejhf.761)

Skobel, E., Knackstedt, C., Martinez-Romero, A., Salvi, D., Vera-Munoz, C., Napp, A., Luprano, J., Bover, R., Glöggler, S., Bjarnason-Wehrens, B., Marx, N., Rigby, A., Cleland, J. G.F. (2017) Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels, 32, pp. 408-418. (doi: 10.1007/s00380-016-0897-8)

Nymo, S. H., Aukrust, P., Kjekshus, J., McMurray, J. J.V., Cleland, J. G.F., Wikstrand, J., Muntendam, P., Wienhues-Thelen, U., Latini, R., Tandberg Askevold, E., Gravning, J., Dahl, C. P., Broch, K., Yndestad, A., Gullestad, L., Ueland, T. (2017) Limited added value of circulating inflammatory biomarkers in chronic heart failure. JACC: Heart Failure, 5, pp. 256-264. (doi: 10.1016/j.jchf.2017.01.008)

Böhm, M., Young, R., Jhund, P., Solomon, S. D., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2017) Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. European Heart Journal, 38, pp. 1132-1143. (doi: 10.1093/eurheartj/ehw570)

Urbinati, A., Pellicori, P., Guerra, F., Capucci, A., Clark, A. L. (2017) Takotsubo syndrome in the paediatric population. Journal of Cardiovascular Medicine, 18, pp. 262-267. (doi: 10.2459/JCM.0000000000000446)

Cleland, J. G.F., Mueller, C. (2017) What can we learn from SOCRATES: more questions than answers? European Heart Journal, 38, pp. 1128-1131. (doi: 10.1093/eurheartj/ehw561)

Schoenherr, C., Byron, A., Sandilands, E., Paliashvili, K., Baillie, G. S., Valacca, C., Cecconi, F., Serrels, B., Frame, M. C. (2017) Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks. eLife, 6, (doi: 10.7554/eLife.23172)

Layland, J. J., Carberry, J., May, V. T.Y., Lee, M., Eteiba, H., Lindsay, M., Petrie, M., McEntegart, M., Watkins, S., Shaukat, A., Oldroyd, K., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Hannah, A., Stewart, A., Henderson, R., McConnachie, A., Berry, C. (2017) Decision Making Using Fractional Flow Reserve is Associated With Lower Rates of Incomplete Revascularization Compared With Angiographic Guided Decision Making Amongst Patients With NSTEMI. (doi: 10.1016/s0735-1097(17)34446-7)

Rao, M. P., Al-Khatib, S. M., Pokorney, S., She, L., Romanov, A., Nicolau, J. C., Lee, K. L., Carson, P. E., Selzman, C. H., Stepinska, J., Cleland, J. G.F., Tungsubutra, W., Desvigne-Nickens, P. M., Sueta, C., Siepe, M., Lang, I. M., Feldman, A. M., Yii, M., Rouleau, J. L., Velazquez, E. J. (2017) Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 135, pp. 1136-1144. (doi: 10.1161/CIRCULATIONAHA.116.026075)

Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L., Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.748)

Abdul-Rahim, A. H., Perez, A.-C., MacIsaac, R. L., Jhund, P. S., Claggett, B. L., Carson, P. E., Komajda, M., McKelvie, R. S., Zile, M. R., Swedberg, K., Yusuf, S., Pfeffer, M. A., Solomon, S. D., Lip, G. Y.H., Lees, K. R., McMurray, J. J.V. (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. European Heart Journal, 38, pp. 742-750. (doi: 10.1093/eurheartj/ehw509)

Matsue, Y., van der Meer, P., Damman, K., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Gansevoort, R. T., Bakker, S. J.L., van der Harst, P., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A. (2017) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart, 103, pp. 407-413. (doi: 10.1136/heartjnl-2016-310112)

Matsue, Y., ter Maaten, J. M., Struck, J., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., van der Meer, P., Damman, K., Voors, A. A. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23, pp. 231-239. (doi: 10.1016/j.cardfail.2016.09.007)

Ali, M., MacIsaac, R., Quinn, T. J., Bath, P. M., Veenstra, D. L., Xu, Y., Brady, M. C., Patel, A., Lees, K. R. (2017) Dependency and health utilities in stroke: Data to inform cost-effectiveness analyses. European Stroke Journal, 2, pp. 70-76. (doi: 10.1177/2396987316683780)

Cuthbert, J. J., Pellicori, P., Shah, P., Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13, pp. 173-188. (doi: 10.2217/fca-2016-0068)

Parsons, T. J., Sartini, C., Welsh, P., Sattar, N., Ash, S., Lennon, L. T., Wannamethee, S. G., Lee, I.-M., Whincup, P. H., Jefferis, B. J. (2017) Physical activity, sedentary behavior, and inflammatory and hemostatic markers in men. Medicine and Science in Sports and Exercise, 49, pp. 459-465. (doi: 10.1249/MSS.0000000000001113)

Sartini, C., Barry, S. J.E., Whincup, P. H., Wannamethee, S. G., Lowe, G. D.O., Jefferis, B. J., Lennon, L., Welsh, P., Ford, I., Sattar, N., Morris, R. W. (2017) Relationship between outdoor temperature and cardiovascular disease risk factors in older people. European Journal of Preventive Cardiology, 24, pp. 349-356. (doi: 10.1177/2047487316682119)

Masters, J., Morton, G., Anton, I., Szymanski, J., Greenwood, E., Grogono, J., Flett, A. S., Cleland, J. G.F., Cowburn, P. J. (2017) Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team. Open Heart, 4, (doi: 10.1136/openhrt-2016-000547)

Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Koivula, R., Hansen, T. H., Stewart, C., Holman, R. R., Franks, P. W., Walker, M., Pearson, E. R., Sattar, N. (2017) Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes, Obesity and Metabolism, 19, pp. 356-363. (doi: 10.1111/dom.12826)

Dierckx, R., Inglis, S. C., Clark, R. A., Prieto-Merino, D., Cleland, J. G.F. (2017) Telemedicine in heart failure: new insights from the Cochrane meta-analyses. European Journal of Heart Failure, 19, pp. 304-306. (doi: 10.1002/ejhf.759)

Carnicer, R., Suffredini, S., Liu, X., Reilly, S., Simon, J. N., Surdo, N. C., Zhang, Y. H., Lygate, C. A., Channon, K. M., Casadei, B. (2017) The subcellular localization of neuronal nitric oxide synthase determines the downstream effects of NO on myocardial function. Cardiovascular Research, 113, pp. 321-331. (doi: 10.1093/cvr/cvx002)

Carty, D. M., Doogan, F., Welsh, P., Dominiczak, A. F., Delles, C. (2017) Thyroid stimulating hormone (TSH) ≥2.5mU/l in early pregnancy: prevalence and subsequent outcomes. European Journal of Obstetrics and Gynecology and Reproductive Biology, 210, pp. 366-369. (doi: 10.1016/j.ejogrb.2017.01.048)

Wilson, A., Bath, P. M.W., Berge, E., Cadilhac, D. A., Cuche, M., Ford, G. A., Macisaac, R., Quinn, T. J., Taylor, M., Walters, M., Wolff, C., Lees, K. R. (2017) Understanding the relationship between costs and the modified Rankin Scale: A systematic review, multidisciplinary consensus and recommendations for future studies. European Stroke Journal, 2, pp. 3-12. (doi: 10.1177/2396987316684705)

MacIsaac, R. L., Ali, M., Taylor-Rowan, M., Rodgers, H., Lees, K. R., Quinn, T. J. (2017) Use of a 3-item short-form version of the Barthel Index for use in stroke. Stroke, 48, pp. 618-623. (doi: 10.1161/STROKEAHA.116.014789)

Horrocks, S., Wilkinson, T., Schnier, C., Ly, A., Woodfield, R., Rannikmäe, K., Quinn, T. J., Sudlow, C. L.M. (2017) Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: a systematic review. PLoS ONE, 12, (doi: 10.1371/journal.pone.0172639)

Graham-Brown, M. P.M., Rutherford, E., Levelt, E., March, D. S., Churchward, D. R., Stensel, D. J., McComb, C., Mangion, K., Cockburn, S., Berry, C., Moon, J. C., Mark, P. B., Burton, J. O., McCann, G. P. (2017) Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients. Journal of Cardiovascular Magnetic Resonance, 19, (doi: 10.1186/s12968-017-0337-7)

Houslay, K. F., Christian, F., MacLeod, R., Adams, D. R., Houslay, M. D., Baillie, G. S. (2017) Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners. Biochemical Journal, 474, pp. 597-609. (doi: 10.1042/BCJ20160849)

Stott, D. J. et al. (2017) Study protocol; thyroid hormone replacement for untreated older adults with subclinical hypothyroidism - a randomised placebo controlled trial (TRUST) BMC Endocrine Disorders, 17, (doi: 10.1186/s12902-017-0156-8)

Quinn, T. J., McCleery, J., Noel-Storr, A. H., Marcus, S., Flicker, L. (2017) Cochrane dementia group turns 21—older and (slightly) wiser. Journal of the American Medical Directors Association, 18, pp. 96-98. (doi: 10.1016/j.jamda.2016.11.007)

Docherty, K. F., Campbell, R. T., Jhund, P., Petrie, M. C., McMurray, J. J.V. (2017) How robust are clinical trials in heart failure? European Heart Journal, 38, pp. 338-345. (doi: 10.1093/eurheartj/ehw427)

Emdin, C. A., Hsiao, A. J., Kiran, A., Conrad, N., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., McMurray, J. J.V., Cleland, J. G.F., Dargie, H., Hardman, S., McDonagh, T., Rahimi, K. (2017) Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales) American Journal of Cardiology, 119, pp. 440-444. (doi: 10.1016/j.amjcard.2016.10.021)

Arba, F., Quinn, T., Hankey, G.J., Ali, M., Lees, K. R., Inzitari, D. (2017) Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack. European Journal of Neurology, 24, pp. 276-282. (doi: 10.1111/ene.13191)

Deschamps, T., Quentin, B., Leske, D. M., MacLeod, R., Mompelat, D., Tafforeau, L., Lotteau, V., Maréchal, V., Baillie, G. S., Gruffat, H., Wilson, J. B., Manet, E. (2017) Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle. Journal of General Virology, 98, pp. 251-265. (doi: 10.1099/jgv.0.000681)

Mueller, C., Christ, M., Cowie, M., Cullen, L., Maisel, A. S., Masip, J., Miro, O., McMurray, J., Peacock, F. W., Price, S., DiSomma, S., Bueno, H., Zeymer, U., Mebazaa, A. (2017) European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care. European Heart Journal: Acute Cardiovascular Care, 6, pp. 81-86. (doi: 10.1177/2048872615593279)

Kitai, T., Grodin, J. L., Mentz, R. J., Hernandez, A. F., Butler, J., Metra, M., McMurray, J. J., Armstrong, P. W., Starling, R. C., O'Connor, C. M., Swedberg, K., Tang, W.H. W. (2017) Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. European Journal of Heart Failure, 19, pp. 241-249. (doi: 10.1002/ejhf.629)

Hurst, C. H., Turnbull, D., Plain, F., Fuller, W., Hemsley, P. A. (2017) Maleimide scavenging enhances determination of protein S-palmitoylation state in acyl-exchange methods. BioTechniques, 62, pp. 69-75. (doi: 10.2144/000114516)

Gastelurrutia, P., Lupón, J., Domingo, M., Stut, W., Dovancescu, S., Cleland, J., Frankenstein, L., Bayes-Genis, A. (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4, pp. 66-70. (doi: 10.1002/ehf2.12104)

Beldhuis, I. E., Streng, K. W., Ter Maaten, J. M., Voors, A. A., van der Meer, P., Rossignol, P., McMurray, J. J.V., Damman, K. (2017) Renin–angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003588)

Ferreira, J. P., Girerd, N., Duarte, K., Coiro, S., McMurray, J. J.V., Dargie, H. J., Pitt, B., Dickstein, K., Testani, J. M., Zannad, F., Rossignol, P. (2017) Serum chloride and sodium interplay in patients with acute myocardial infarction and heart failure with reduced ejection fraction. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003500)

Wetzel, C., Pifferi, S., Picci, C., Gök, C., Hoffmann, D., Bali, K. K., Lampe, A., Lapatsina, L., Fleischer, R., Smith, E. S. J., Bégay, V., Moroni, M., Estebanez, L., Kühnemund, J., Walcher, J., Specker, E., Neuenschwander, M., von Kries, J. P., Haucke, V., Kuner, R., Poulet, J. F. A., Schmoranzer, J., Poole, K., Lewin, G. R. (2017) Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivity. Nature Neuroscience, 20, pp. 209-218. (doi: 10.1038/nn.4454)

Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., Cleland, J. G.F. (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4, pp. 40-45. (doi: 10.1002/ehf2.12112)

Atzler, D., McAndrew, D. J., Cordts, K., Schneider, J. E., Zervou, S., Schwedhelm, E., Neubauer, S., Lygate, C. A. (2017) Dietary supplementation with homoarginine preserves cardiac function in a murine model of post-myocardial infarction heart failure. Circulation, 135, pp. 400-402. (doi: 10.1161/CIRCULATIONAHA.116.025673)

Paton, D. M., Shamy, M., Fedyk, M., Pfeffer, M. A., McMurray, J. J.V. (2017) Clinical trials involving hypertension [Correspondence] New England Journal of Medicine, 376, pp. 289-290. (doi: 10.1056/NEJMc1615364)

Mijajlović, M. D. et al. (2017) Post-stroke dementia – a comprehensive review. BMC Medicine, 15, (doi: 10.1186/s12916-017-0779-7)

Agewall, S. et al. (2017) 2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS [Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS] Revista Española de Cardiología, 70, pp. 50.e1-50.e84. (doi: 10.1016/j.recesp.2016.11.014)

Hawkins, N. M., Khosla, A., Virani, S. A., McMurray, J. J.V., FitzGerald, J. M. (2017) B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulmonary Medicine, 17, (doi: 10.1186/s12890-016-0345-7)

Gebhard, C., Rhéaume, E., Berry, C., Brand, G., Kernaleguen, A.-E., Théberge-Julien, G., Alam, M. A., Lee, C. Y.W., Boileau, L., Chabot-Blanchet, M., Guertin, M.-C., Lavoie, M.-A., Grégoire, J., Ibrahim, R., L'Allier, P., Tardif, J.-C. (2017) Beneficial effects of reconstituted high-density lipoprotein (rHDL) on circulating CD34+ cells in patients after an acute coronary syndrome. PLoS ONE, 12, (doi: 10.1371/journal.pone.0168448)

Cannon, J. A., Shen, L., Jhund, P. S., Kristensen, S. L., Køber, L., Chen, F., Gong, J., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2017) Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. European Journal of Heart Failure, 19, pp. 129-137. (doi: 10.1002/ejhf.687)

Burnett, H., Earley, A., Voors, A. A., Senni, M., McMurray, J. J.V., Deschaseaux, C., Cope, S. (2017) Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003529)

Smart, N., Riegler, J., Turtle, C. W., Lygate, C. A., McAndrew, D. J., Gehmlich, K., Dubé, K. N., Price, A. N., Muthurangu, V., Taylor, A. M., Lythgoe, M. F., Redwood, C., Riley, P. R. (2017) Aberrant developmental titin splicing and dysregulated sarcomere length in Thymosin β4 knockout mice. Journal of Molecular and Cellular Cardiology, 102, pp. 94-107. (doi: 10.1016/j.yjmcc.2016.10.010)

Streng, K. W., ter Maaten, J. M., Cleland, J. G.F., O’Connor, C. M., Davison, B. A., Metra, M., Givertz, M. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Dittrich, H. C., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2017) Associations of body mass index with laboratory and biomarkers in patients with acute heart failure. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003350)

Kristensen, S. L., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Preiss, D., Win, S., Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Gottdiener, J. S., Carson, P. E., McMurray, J. J.V. (2017) Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve) Circulation, 135, pp. 724-735. (doi: 10.1161/CIRCULATIONAHA.116.024593)

Blinova, K., Stohlman, J., Vicente, J., Chan, D., Johannesen, L., Hortigon-Vinagre, M. P., Zamora Rodriguez, V., Smith, G., Crumb, W. J., Pang, L., Lyn-Cook, B., Ross, J., Brock, M., Chvatal, S., Millard, D., Galeotti, L., Stockbridge, N., Strauss, D. G. (2017) Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias. Toxicological Sciences, 155, pp. 234-247. (doi: 10.1093/toxsci/kfw200)

Stott J., D., Quinn, T. J. (2017) Principles of rehabilitation of older people. Medicine, 45, pp. 1-5. (doi: 10.1016/j.mpmed.2016.10.002)

Gandhi, P. U., Chow, S. L., Rector, T. S., Krum, H., Gaggin, H. K., McMurray, J. J., Zile, M. R., Komajda, M., McKelvie, R. S., Carson, P. E., Januzzi, J. L., Anand, I. S. (2017) Prognostic value of insulin-like growth factor-binding protein 7 in patients with heart failure and preserved ejection fraction. Journal of Cardiac Failure, 23, pp. 20-28. (doi: 10.1016/j.cardfail.2016.06.006)

Desai, A. S., Vardeny, O., Claggett, B., McMurray, J. J.V., Packer, M., Swedberg, K., Rouleau, J. L., Zile, M. R., Lefkowitz, M., Shi, V., Solomon, S. D. (2017) Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of Sacubitril/Valsartan compared with Enalapril: A secondary analysis of the PARADIGM-HF Trial. JAMA Cardiology, 2, pp. 79-85. (doi: 10.1001/jamacardio.2016.4733)

Cameron, R. T., Whiteley, E., Day, J. P., Parachikova, A. I., Baillie, G. S. (2017) Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1-42 mediated cytotoxicity. FEBS Open Bio, 7, pp. 64-73. (doi: 10.1002/2211-5463.12156)

Tromp, J., ter Maaten, J., Damman, K., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van der Wal, M. H.L., Jaarsma, T., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials) American Journal of Cardiology, 119, pp. 290-296. (doi: 10.1016/j.amjcard.2016.09.038)

Quinn, T., Shaw, R., Taylor-Rowan, M. (2017) Abstract TP439: Occurrence (Incidence and Prevalence) Rate of Delirium and Risk Factors in Acute Stroke - Cross-sectional Study. Stroke, 48, (doi: 10.1161/str.48.suppl_1.tp439)

Pitts, R., Gunzburger, E., Ballantyne, C. M., Barter, P. J., Kallend, D., Leiter, L. A., Leitersdorf, E., Nicholls, S. J., Shah, P. K., Tardif, J.-C., Olsson, A. G., McMurray, J. J.V., Kittelson, J., Schwartz, G. G. (2017) Aldosterone does not predict cardiovascular events following acute coronary syndrome in patients initially without heart failure. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.004119)

Quinn, T. J., Takwoingi, Y. (2017) Assessment of the utility of cognitive screening instruments. Springer

Cameron, A. C., Lang, N. N., Touyz, R. M. (2017) Cardiovascular complications from cancer therapy: hypertension-focus on vascular endothelial growth factor inhibitors. Elesvier

Ridker, P. M. et al. (2017) Cardiovascular efficacy and safety of Bococizumab in high-risk patients. New England Journal of Medicine, 376, pp. 1527-1539. (doi: 10.1056/NEJMoa1701488)

Mc Causland, F. R., Claggett, B., Pfeffer, M. A., Burdmann, E. A., Eckardt, K.-U., Levey, A. S., McMurray, J. J.V., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R. D., Parfrey, P. (2017) Change in hemoglobin trajectory and darbepoetin dose approaching end-stage renal disease: data from the trial to reduce cardiovascular events with aranesp therapy trial. American Journal of Nephrology, 46, pp. 488-497. (doi: 10.1159/000485326)

Celis-Morales, C., Lyall, D. M., Gray, S., Steell, L., Anderson, J., Iliodromiti, S., Welsh, P., Guo, Y., Petermann, F., Mackay, D. F., Bailey, M. E.S., Pell, J., Gill, J. M.R., Sattar, N. (2017) Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: evidence from 48 170 UK Biobank participants. International Journal of Obesity, 41, pp. 1761-1768. (doi: 10.1038/ijo.2017.169)

Miro, Ò., Peacock, F. W., McMurray, J. J., Bueno, H., Christ, M., Maisel, A. S., Cullen, L., Cowie, M. R., Di Somma, S., Martin Sanchez, F. J., Platz, E., Masip, J., Zeymer, U., Vrints, C., Price, S., Mebazaa, A., Mueller, C. (2017) European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. European Heart Journal: Acute Cardiovascular Care, 6, pp. 311-320. (doi: 10.1177/2048872616633853)

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2017) Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices: Evidence and Research, 10, pp. 123-132. (doi: 10.2147/mder.s113105)

Harumi Higuchi dos Santos, M., Sharma, A., Sun, J.‐L., Pieper, K., McMurray, J. J.V., Holman, R. R., Lopes, R. D. (2017) International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: insights from the NAVIGATOR Trial. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.003892)

Arain, F., Gullestad, L., Nymo, S., Kjekshus, J., Cleland, J. G.F., Michelsen, A., McMurray, J. J.V., Wikstrand, J., Aukrust, P., Ueland, T. (2017) Low YKL-40 in Chronic Heart Failure may predict beneficial effects of statins: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) Biomarkers, 22, pp. 261-267. (doi: 10.1080/1354750X.2016.1204003)

Javadi, A., Deevi, R. K., Evergren, E., Blondel-Tepaz, E., Baillie, G. S., Scott, M. G.H., Campbell, F. C. (2017) PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex. eLife, 6, (doi: 10.7554/eLife.24578)

Kerr, A., Dawson, J., Robertson, C., Rowe, P., Quinn, T. J. (2017) Sit to stand activity during stroke rehabilitation. Topics in Stroke Rehabilitation, 24, pp. 562-566. (doi: 10.1080/10749357.2017.1374687)

Pellicori, P., Carubelli, V. (2017) Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives. Giornale Italiano di Cardiologia, 18, pp. 129-138. (doi: 10.1714/2663.27298)

Pellicori, P., Salekin, D., Pan, D., Clark, A. L. (2017) This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Review of Cardiovascular Therapy, 15, pp. 389-396. (doi: 10.1080/14779072.2017.1317592)

Plain, F., Turnbull, D., Fraser, N. J., Fuller, W. (2017) Understanding the rules governing NCX1 palmitoylation. Channels, 11, pp. 377-379. (doi: 10.1080/19336950.2017.1342501)

Torabi, A., Cleland, J. G.F., Sherwi, N., Atkin, P., Panahi, H., Kilpatrick, E., Thackray, S., Hoye, A., Alamgir, F., Goode, K., Rigby, A., Clark, A. L. (2016) Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart, 3, (doi: 10.1136/openhrt-2016-000487)

Khder, Y., Shi, V., McMurray, J. J.V., Lefkowitz, M. P. (2016) Sacubitril/valsartan (LCZ696) in heart failure. Springer

Fattah, C., Nather, K., McCarroll, C. S., Hortigon-Vinagre, M. P., Zamora Rodriguez, V., Flores-Munoz, M., McArthur, L., Zentilin, L., Giacca, M., Touyz, R. M., Smith, G. L., Loughrey, C. M., Nicklin, S. A. (2016) Gene therapy with Angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. Journal of the American College of Cardiology, 68, pp. 2652-2666. (doi: 10.1016/j.jacc.2016.09.946)

Mangion, K., Gao, H., Mccomb, C., Carrick, D., Clerfond, G., Zhong, X., Luo, X., Haig, C., Berry, C. (2016) A novel method for estimating myocardial strain: assessment of deformation tracking against reference magnetic resonance methods in healthy volunteers. Scientific Reports, 6, (doi: 10.1038/srep38774)

Huethorst, E., Hortigon, M., Zamora-Rodriguez, V., Reynolds, P.M., Burton, F., Smith, G., Gadegaard, N. (2016) Enhanced human-induced pluripotent stem cell derived cardiomyocyte maturation using a dual microgradient substrate. ACS Biomaterials Science and Engineering, 2, pp. 2231-2239. (doi: 10.1021/acsbiomaterials.6b00426)

Kobayashi, Y., Johnson, N. P., Berry, C., De Bruyne, B., Gould, K. L., Jeremias, A., Oldroyd, K. G., Pijls, N. H.J., Fearon, W. F. (2016) The influence of lesion location on the diagnostic accuracy of adenosine-free coronary pressure wire measurements. JACC: Cardiovascular Interventions, 9, pp. 2390-2399. (doi: 10.1016/j.jcin.2016.08.041)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Solomon, S. D., Adams, Jr., K. F., Cleland, J. G.F., Ezekowitz, J. A., Goudev, A., Macdonald, P., Metra, M., Mitrovic, V., Ponikowski, P., Serpytis, P., Spinar, J., Tomcsányi, J., Vandekerckhove, H. J., Voors, A. A., Monsalvo, M. L., Johnston, J., Malik, F. I., Honarpour, N. (2016) Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet, 388, pp. 2895-2903. (doi: 10.1016/S0140-6736(16)32049-9)

White, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng-Ntim, E., Robson, S. C., Sattar, N., Seed, P. T., Vieira, M. C., Welsh, P., Whitworth, M., Poston, L., Pasupathy, D. (2016) Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLoS ONE, 11, (doi: 10.1371/journal.pone.0167846)

Carrick, D., Haig, C., Ahmed, N., Carberry, J., Teng Yue May, V., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davies, A., Abouzaid, A. M., Mordi, I., Ford, I., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, 134, pp. 1833-1847. (doi: 10.1161/CIRCULATIONAHA.116.022603)

Zile, M. R., Claggett, B. L., Prescott, M. F., McMurray, J. J.V., Packer, M., Rouleau, J. L., Swedberg, K., Desai, A. S., Gong, J., Shi, V. C., Solomon, S. D. (2016) Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure. Journal of the American College of Cardiology, 68, pp. 2425-2436. (doi: 10.1016/j.jacc.2016.09.931)

Teh, I., McClymont, D., Zdora, M.-C., Whittington, H. J., Davidoiu, V., Lee, J., Lygate, C. A., Rau, C., Zanette, I., Schneider, J. E. (2016) Validation of diffusion tensor MRI measurements of cardiac microstructure with structure tensor synchrotron radiation imaging. Journal of Cardiovascular Magnetic Resonance, 19, (doi: 10.1186/s12968-017-0342-x)

Vegter, E. L., Schmitter, D., Hagemeijer, Y., Ovchinnikova, E. S., van der Harst, P., Teerlink, J. R., O'Connor, C. M., Metra, M., Davison, B. A., Bloomfield, D., Cotter, G., Cleland, J. G.F., Givertz, M. M., Ponikowski, P., van Veldhuisen, D. J., van der Meer, P., Berezikov, E., Voors, A. A., Khan, M. A.F. (2016) Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International Journal of Cardiology, 224, pp. 231-239. (doi: 10.1016/j.ijcard.2016.09.010)

Ponikowski, P. et al. (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure [Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica] Revista Española de Cardiología, 69, pp. 1167.e1-1167.e85. (doi: 10.1016/j.recesp.2016.10.014)

Nicklin, S. A. (2016) A novel mechanism of action for angiotensin-(1-7) via the angiotensin type 1 receptor. Hypertension, 68, pp. 1342-1343. (doi: 10.1161/HYPERTENSIONAHA.116.08215)

Zak, J. et al. (2016) ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome. Cell Death and Differentiation, 23, pp. 1973-1984. (doi: 10.1038/cdd.2016.76)

Mc Causland, F. R., Claggett, B., Burdmann, E. A., Eckardt, K.-U., Kewalramani, R., Levey, A. S., McMurray, J. J.V., Parfrey, P., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R. D., Pfeffer, M. A. (2016) C-Reactive protein and risk of ESRD: results from the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) American Journal of Kidney Diseases, 68, pp. 873-881. (doi: 10.1053/j.ajkd.2016.07.022)

Pellicori, P., Cleland, J. G.F., Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30, pp. 599-609. (doi: 10.1007/s10557-016-6697-7)

Nagaraja, V., Ooi, S.-Y., Nolan, J., Large, A., De Belder, M., Ludman, P., Bagur, R., Curzen, N., Matsukage, T., Yoshimachi, F., Kwok, C. S., Berry, C., Mamas, M. A. (2016) Impact of incomplete percutaneous revascularization in patients With multivessel coronary artery disease: a systematic review and meta-analysis. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.116.004598)

METACOHORTS Consortium, et al. (2016) METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimer's and Dementia, 12, pp. 1235-1249. (doi: 10.1016/j.jalz.2016.06.004)

Kaye, D. M., Hasenfuß, G., Neuzil, P., Post, M. C., Doughty, R., Trochu, J.-N., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Walton, A., Muller, D., Walters, D., Hausleiter, J., Raake, P., Petrie, M. C., Bergmann, M., Jondeau, G., Feldman, T., van Veldhuisen, D. J., Ponikowski, P., Silvestry, F. E., Burkhoff, D., Hayward, C. (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003662)

Hortigon-Vinagre, M.P., Zamora, V., Burton, F.L., Green, J., Gintant, G.A., Smith, G.L. (2016) The use of ratiometric fluorescence measurements of the voltage sensitive dye Di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes. Toxicological Sciences, 154, pp. 320-331. (doi: 10.1093/toxsci/kfw171)

Pitts, R., Gunzburger, E., Ballantyne, C. M., Barter, P. J., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J.V., Nicholls, S. J., Niesor, E. J., Olsson, A. G., Shah, P. K., Tardif, J.-C., Kittelson, J., Schwartz, G. G. (2016) Treatment with Dalcetrapib modifies the relationship between high-density lipoprotein cholesterol and C-reactive protein. Journal of the American College of Cardiology, 68, pp. 2488-2490. (doi: 10.1016/j.jacc.2016.09.932)

Damman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., McMurray, J. J.V. (2016) Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. European Journal of Heart Failure, 18, pp. 1508-1517. (doi: 10.1002/ejhf.609)

Harrison, J. K., Stott, D. J., McShane, R., Noel-Storr, A. H., Swann-Price, R. S., Quinn, T. J. (2016) Informant questionnaire on cognitive decline in the elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. Cochrane Database of Systematic Reviews, 2016, (doi: 10.1002/14651858.cd011333.pub2)

Harrison, J. K., Noel-Storr, A. H., Demeyere, N., Reynish, E. L., Quinn, T. J. (2016) Outcomes measures in a decade of dementia and mild cognitive impairment trials. Alzheimer's Research and Therapy, 8, (doi: 10.1186/s13195-016-0216-8)

Napp, A. E. et al. (2016) Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial. European Radiology, 27, pp. 2957-2968. (doi: 10.1007/s00330-016-4620-z)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., Cleland, J. G.F. (2016) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Heart, 103, pp. 255-257. (doi: 10.1136/heartjnl-2015-309191)

Demissei, B. G., Postmus, D., Liu, L. C.Y., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Edwards, C., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Voors, A. A., Hillege, H. L. (2016) Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, pp. 967-975. (doi: 10.1016/j.ijcard.2016.08.271)

Ferreira, J. P., Girerd, N., Pellicori, P., Duarte, K., Girerd, S., Pfeffer, M. A., McMurray, J. J.V., Pitt, B., Dickstein, K., Jacobs, L., Staessen, J. A., Butler, J., Latini, R., Masson, S., Mebazaa, A., Rocca, H. P. B.-L., Delles, C., Heymans, S., Sattar, N., Jukema, J. W., Cleland, J. G.F., Zannad, F., Rossignol, P. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, (doi: 10.1186/s12916-016-0731-2)

Pérez, L. M., Inzitari, M., Quinn, T. J., Montaner, J., Gavaldà, R., Duarte, E., Coll-Planas, L., Cerdà, M., Santaeugenia, S., Closa, C., Gallofré, M. (2016) Rehabilitation profiles of older adult stroke survivors admitted to intermediate care units: a multi-centre study. PLoS ONE, 11, (doi: 10.1371/journal.pone.0166304)

Rutherford, C., Speirs, C., Williams, J. J.L., Ewart, M.-A., Mancini, S. J., Hawley, S. A., Delles, C., Viollet, B., Costa-Pereira, A. P., Baillie, G. S., Salt, I. P., Palmer, T. M. (2016) Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling. Science Signaling, 9, (doi: 10.1126/scisignal.aaf8566)

Jhund, P. S. (2016) Geographic variation in heart failure - a matter of celebration or condemnation? European Journal of Heart Failure, 18, pp. 1329-1330. (doi: 10.1002/ejhf.652)

Pfeffer, M. A., McMurray, J. J.V. (2016) Lessons in uncertainty and humility — Clinical trials involving hypertension. New England Journal of Medicine, 375, pp. 1756-1766. (doi: 10.1056/NEJMra1510067)

Weinberger, F., Breckwoldt, K., Pecha, S., Kelly, A., Geertz, B., Starbatty, J., Yorgan, T., Cheng, K.-H., Lessmann, K., Stolen, T., Scherrer-Crosbie, M., Smith, G., Reichenspurner, H., Hansen, A., Eschenhagen, T. (2016) Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Science Translational Medicine, 8, pp. 363ra148-363ra148. (doi: 10.1126/scitranslmed.aaf8781)

Moffitt, P., Park, H., Lane, D. A., O'Connell, J., Quinn, T. J. (2016) Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review. Age and Ageing, 45, pp. 767-775. (doi: 10.1093/ageing/afw104)

Jongstra, S., Harrison, J. K., Quinn, T. J., Richard, E. (2016) Antihypertensive withdrawal for the prevention of cognitive decline. Cochrane Database of Systematic Reviews, 2016, (doi: 10.1002/14651858.cd011971.pub2)

Martín-Sánchez, F. J., Christ, M., Miró, Ò., Peacock, W. F., McMurray, J. J., Bueno, H., Maisel, A. S., Cullen, L., Cowie, M. R., Di Somma, S., Platz, E., Masip, J., Zeymer, U., Vrints, C., Price, S., Mueller, C. (2016) Practical approach on frail older patients attended for acute heart failure. International Journal of Cardiology, 222, pp. 62-71. (doi: 10.1016/j.ijcard.2016.07.151)

Bekfani, T., Pellicori, P., Morris, D. A., Ebner, N., Valentova, M., Steinbeck, L., Wachter, R., Elsner, S., Sliziuk, V., Schefold, J. C., Sandek, A., Doehner, W., Cleland, J. G.F., Lainscak, M., Anker, S. D., von Haehling, S. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi: 10.1016/j.ijcard.2016.07.135)

Petrie, M. C., Jhund, P. S., She, L., Adlbrecht, C., Doenst, T., Panza, J. A., Hill, J. A., Lee, K. L., Rouleau, J. L., Prior, D. L., Ali, I. S., Maddury, J., Golba, K. S., White, H. D., Carson, P., Chrzanowski, L., Romanov, A., Miller, A. B., Velazquez, E. J. (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 134, pp. 1314-1324. (doi: 10.1161/CIRCULATIONAHA.116.024800)

Desai, A. S., Jhund, P. S. (2016) After TOPCAT: what to do now in heart failure with preserved ejection fraction. European Heart Journal, 37, pp. 3135-3140. (doi: 10.1093/eurheartj/ehw114)

Hennigan, B., Oldroyd, K. G., Berry, C., Johnson, N., McClure, J., McCartney, P., McEntegart, M. B., Eteiba, H., Petrie, M. C., Rocchiccioli, P., Good, R., Lindsay, M. M., Hood, S., Watkins, S. (2016) Discordance between resting and hyperemic indices of coronary stenosis severity: the VERIFY 2 study (a comparative study of resting coronary pressure gradient, instantaneous wave-free ratio and fractional flow reserve in an unselected population referred for invasive angiography) Circulation: Cardiovascular Interventions, 9, (doi: 10.1161/CIRCINTERVENTIONS.116.004016)

Welsh, P., Tuckwell, K., McInnes, I. B., Sattar, N. (2016) Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis, 254, pp. 167-171. (doi: 10.1016/j.atherosclerosis.2016.10.016)

Preiss, D., Rankin, N., Welsh, P., Holman, R.R., Kangas, A.J., Soininen, P., Würtz, P., Ala-Korpela, M., Sattar, N. (2016) Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study. Diabetic Medicine, 33, pp. 1569-1574. (doi: 10.1111/dme.13097)

Savarese, G., Giugliano, R. P., Rosano, G. M.C., McMurray, J., Magnani, G., Filippatos, G., Dellegrottaglie, S., Lund, L. H., Trimarco, B., Perrone-Filardi, P. (2016) Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis. JACC: Heart Failure, 4, pp. 881-884. (doi: 10.1016/j.jchf.2016.07.012)

Sirker, A., Kwok, C. S., Kotronias, R., Bagur, R., Bertrand, O., Butler, R., Berry, C., Nolan, J., Oldroyd, K., Mamas, M. (2016) Influence of access site choice for cardiac catheterization on risk of adverse neurological events: A systematic review and meta-analysis. American Heart Journal, 181, pp. 107-119. (doi: 10.1016/j.ahj.2016.06.027)

Mangion, K., Clerfond, G., Mccomb, C., Carrick, D., Rauhalammi, S. M., McClure, J., Corcoran, D. S., Woodward, R., Orchard, V., Radjenovic, A., Zhong, X., Berry, C. (2016) Myocardial strain in healthy adults across a broad age range as revealed by cardiac magnetic resonance imaging at 1.5 and 3.0T: associations of myocardial strain with myocardial region, age, and sex. Journal of Magnetic Resonance Imaging, 44, pp. 1197-1205. (doi: 10.1002/jmri.25280)

Ahmed, N., Carberry, J., Teng, V., Carrick, D., Berry, C. (2016) Risk assessment in patients with an acute ST-elevation myocardial infarction. Journal of Comparative Effectiveness Research, 5, pp. 581-593. (doi: 10.2217/cer-2016-0017)

Baylan, S., Swann-Price, R., Peryer, G., Quinn, T. (2016) The effects of music listening interventions on cognition and mood post-stroke: a systematic review. Expert Review of Neurotherapeutics, 16, pp. 1241-1249. (doi: 10.1080/14737175.2016.1227241)

Pandit, S. V., Workman, A. (2016) Atrial electrophysiological remodeling and fibrillation in heart failure. Clinical Medicine Insights: Cardiology, 10, pp. 41-46. (doi: 10.4137/CMC.S39713)

Böttcher, R., Dulla, K., van Strijp, D., Dits, N., Verhoef, E. I., Baillie, G. S., Van Leenders, G. J.L.H., Houslay, M. D., Jenster, G., Hoffmann, R. (2016) Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases. Oncotarget, 7, pp. 70669-70684. (doi: 10.18632/oncotarget.12204)

Crocini, C., Ferrantini, C., Coppini, R., Scardigli, M., Yan, P., Loew, L. M., Smith, G., Cerbai, E., Poggesi, C., Pavone, F. S., Sacconi, L. (2016) Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. Scientific Reports, 6, (doi: 10.1038/srep35628)

Tromp, J., Meyer, S., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2016) Acute heart failure in the young: clinical characteristics and biomarker profiles. International Journal of Cardiology, 221, pp. 1067-1072. (doi: 10.1016/j.ijcard.2016.06.339)

Ross, P. D., Guy, J., Selfridge, J., Kamal, B., Bahey, N., Tanner, E., Gillingwater, T. H., Jones, R. A., Loughrey, C. M., McCarroll, C. S., Bailey, M. E.S., Bird, A., Cobb, S. (2016) Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes. Human Molecular Genetics, 25, pp. 4389-4404. (doi: 10.1093/hmg/ddw269)

Rørth, R., Wong, C., Kragholm, K., Fosbøl, E. L., Mogensen, U. M., Lamberts, M., Petrie, M. C., Jhund, P. S., Gerds, T. A., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2016) Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study. Circulation, 134, pp. 999-1009. (doi: 10.1161/CIRCULATIONAHA.116.021859)

Sokoreli, I., de Vries, J.J.G., Riistama, J.M., Pauws, S.C., Steyerberg, E.W., Tesanovic, A., Geleijnse, G., Goode, K.M., Crundall-Goode, A., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2016) Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. International Journal of Cardiology, 220, pp. 202-207. (doi: 10.1016/j.ijcard.2016.06.068)

Corcoran, D., Mangion, K., Berry, C. (2016) Clinical trials for the diagnosis and management of stable ischaemic heart disease: context, status and future implications. European Medical Journal Cardiology, 4, pp. 112-121.

Solomon, S. D., Claggett, B., McMurray, J. J.V., Hernandez, A. F., Fonarow, G. C. (2016) Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. European Journal of Heart Failure, 18, pp. 1238-1243. (doi: 10.1002/ejhf.603)

Rutherford, E., Talle, M. A., Mangion, K., Bell, E., Rauhalammi, S. M., Roditi, G., McComb, C., Radjenovic, A., Welsh, P., Woodward, R., Struthers, A. D., Jardine, A. G., Patel, R. K., Berry, C., Mark, P. B. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90, pp. 845-852. (doi: 10.1016/j.kint.2016.06.014)

Cameron, A. C., Lang, N. N., Touyz, R. M. (2016) Drug treatment of hypertension: focus on vascular health. Drugs, 76, pp. 1529-1550. (doi: 10.1007/s40265-016-0642-8)

Solomon, S. D., Claggett, B., Packer, M., Desai, A., Zile, M. R., Swedberg, K., Rouleau, J., Shi, V., Lefkowitz, M., McMurray, J. J.V. (2016) Efficacy of sacubitril/valsartan relative to a prior decompensation: the PARADIGM-HF trial. JACC: Heart Failure, 4, pp. 816-822. (doi: 10.1016/j.jchf.2016.05.002)

Vardeny, O., Claggett, B., Packer, M., Zile, M. R., Rouleau, J., Swedberg, K., Teerlink, J. R., Desai, A. S., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2016) Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. European Journal of Heart Failure, 18, pp. 1228-1234. (doi: 10.1002/ejhf.580)

Yun, S., Budatha, M., Dahlman, J. E., Coon, B. G., Cameron, R. T., Langer, R., Anderson, D. G., Baillie, G., Schwartz, M. A. (2016) Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling. Nature Cell Biology, 18, pp. 1043-1053. (doi: 10.1038/ncb3405)

Willeit, P. et al. (2016) Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes and Endocrinology, 4, pp. 840-849. (doi: 10.1016/S2213-8587(16)30196-6)

Cleland, J. G.F., Pellicori, P. (2016) PARADIGM-HF: does dose matter? European Journal of Heart Failure, 18, pp. 1235-1237. (doi: 10.1002/ejhf.634)

Cotter, G., Davison, B. A., Milo, O., Bourge, R. C., Cleland, J. G.F., Jondeau, G., Krum, H., O'Connor, C. M., Metra, M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22, pp. 815-822. (doi: 10.1016/j.cardfail.2015.12.017)

Joseph, A. C., Prapa, M., Pellicori, P., Mabote, T., Nasir, M., Clark, A. L. (2016) Tachycardia-induced cardiomyopathy in pregnancy. Journal of Cardiovascular Medicine, 17, pp. 762-766. (doi: 10.2459/jcm.0000000000000209)

McMurray, J. J.V. (2016) The ICD in heart failure - time for a rethink? New England Journal of Medicine, 375, pp. 1283-1284. (doi: 10.1056/NEJMe1609826)

Judge, P.K., Haynes, R., Herrington, W.G., Storey, B.C., Staplin, N., Bethel, A., Bowman, L., Brunskill, N., Cockwell, P., Dayanandan, R., Hill, M., Kalra, P.A., McMurray, J. J., Taal, M., Wheeler, D.C., Landray, M.J., Baigent, C., Baxter, A., Knott, C., Murphy, K., Wheatley, K., Emberson, J., Tomson, C., Roderick, P. (2016) Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfw321)

Greenwood, J. P., Ripley, D. P., Berry, C., McCann, G. P., Plein, S., Bucciarelli-Ducci, C., Dall’Armellina, E., Prasad, A., Bijsterveld, P., Foley, J. R., Mangion, K., Sculpher, M., Walker, S., Everett, C. C., Cairns, D. A., Sharples, L. D., Brown, J. M. (2016) Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA: Journal of the American Medical Association, 316, pp. 1051-1060. (doi: 10.1001/jama.2016.12680)

McMurray, J. J.V. (2016) Site selection and performance in clinical trials. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003490)

Hood, K. Y., Yusuf, H., Findlay, J. E., Santos, R. A., Castro, C. H., Baillie, G. S., Montezano, A. C., MacLean, M. R., Touyz, R. M. (2016) ANG-(1-7) and ET-1, a new partnership. Journal of Hypertension, 34, pp. e382. (doi: 10.1097/01.hjh.0000500977.99529.fe)

Hood, K. Y., Yusuf, H., Findlay, J. E., Santos, R. A., Castro, C. H., Baillie, G. S., MacLean, M. R., Montezano, A., Touyz, R. M. (2016) Ang(1-7) influences ET-1 signaling through Mas: ETBR interactions: implications in pulmonary hypertension. Journal of Hypertension, 34, pp. e216. (doi: 10.1097/01.hjh.0000500475.07008.db)

Chin, K. L., Collier, T. J., Pitt, B., McMurray, J. J.V., Swedberg, K., van Veldhuisen, D. J., Pocock, S. J., Vincent, J., Turgonyi, E., Zannad, F., Krum, H. (2016) Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study. European Journal of Heart Failure, 18, pp. 1175-1181. (doi: 10.1002/ejhf.485)

Stirrat, C. G., Venkatasubramanian, S., Pawade, T., Mitchell, A. J., Shah, A. S., Lang, N. N., Newby, D. E. (2016) Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure. British Journal of Clinical Pharmacology, 82, pp. 974-982. (doi: 10.1111/bcp.13033)

Gaziano, T. A., Fonarow, G. C., Claggett, B., Chan, W. W., Deschaseaux-Voinet, C., Turner, S. J., Rouleau, J. L., Zile, M. R., McMurray, J. J.V., Solomon, S. D. (2016) Cost-effectiveness analysis of sacubitril/valsartan vs enalapril in patients with heart failure and reduced ejection fraction. JAMA Cardiology, 1, pp. 666-672. (doi: 10.1001/jamacardio.2016.1747)

Bauersachs, J., Arrigo, M., Hilfiker-Kleiner, D., Veltmann, C., Coats, A. J.S., Crespo-Leiro, M. G., De Boer, R. A., van der Meer, P., Maack, C., Mouquet, F., Petrie, M. C., Piepoli, M. F., Regitz-Zagrosek, V., Schaufelberger, M., Seferovic, P., Tavazzi, L., Ruschitzka, F., Mebazaa, A., Sliwa, K. (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 18, pp. 1096-1105. (doi: 10.1002/ejhf.586)

Wijsman, L. W., de Craen, A. J.M., Trompet, S., Sabayan, B., Muller, M., Stott, D. J., Ford, I., Welsh, P., Westendorp, R. G.J., Jukema, J. W., Sattar, N., Mooijaart, S. P. (2016) High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk. European Journal of Preventive Cardiology, 23, pp. 1383-1392. (doi: 10.1177/2047487316632364)

Senni, M. et al. (2016) Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. European Journal of Heart Failure, 18, pp. 1193-1202. (doi: 10.1002/ejhf.548)

Rauhalammi, S. M.O., Mangion, K., Barrientos, P. H., Carrick, D. J.A., Clerfond, G., McClure, J., McComb, C., Radjenovic, A., Berry, C. (2016) Native myocardial longitudinal (T1) relaxation time: Regional, age, and sex associations in the healthy adult heart. Journal of Magnetic Resonance Imaging, 44, pp. 541-548. (doi: 10.1002/jmri.25217)

Wilson, M. R., Parakramawansha, R., Quinn, T. J., Tait, R. C. (2016) Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation. Thrombosis and Haemostasis, 116, pp. 578-580. (doi: 10.1160/TH16-01-0025)

Hawkins, N. M., Jhund, P. S., Pozzi, A., O'Meara, E., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., Petrie, M. C., Virani, S., McMurray, J. J.V. (2016) Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European Journal of Heart Failure, 18, pp. 1162-1171. (doi: 10.1002/ejhf.614)

Jhund, P. S., McMurray, J. J.V. (2016) The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan. Heart, 102, pp. 1342-1347. (doi: 10.1136/heartjnl-2014-306775)

Havekes, R., Park, A. J., Tolentino, R. E., Bruinenberg, V. M., Tudor, J. C., Lee, Y., Hansen, R. T., Guercio, L. A., Linton, E., Neves, S. R., Meerlo, P., Baillie, G. W., Houslay, M. D., Abel, T. (2016) Compartmentalized PDE4A5 signaling impairs hippocampal synaptic plasticity and long-term memory. Journal of Neuroscience, 36, pp. 8936-8946. (doi: 10.1523/JNEUROSCI.0248-16.2016)

Havekes, R., Park, A. J., Tudor, J. C., Luczak, V. G., Hansen, R. T., Ferri, S. L., Bruinenberg, V. M., Poplawski, S. G., Day, J. P., Aton, S. J., Radwanska, K., Meerlo, P., Houslay, M. D., Baillie, G. S., Abel, T. (2016) Sleep deprivation causes memory deficits by negatively impacting neuronal connectivity in hippocampal area CA1. eLife, 5, (doi: 10.7554/eLife.13424)

McMurray, J. J.V., Dickstein, K., Kober, L. V. (2016) The author's reply - Aliskiren, Enalapril, or both in heart failure. New England Journal of Medicine, 375, pp. 701-702. (doi: 10.1056/NEJMc1606625)

Kirkham, J. G., Takwoingi, Y., Quinn, T. J., Rapoport, M., Lanctôt, K. L., Maxwell, C. J., Herrmann, N., Gill, S. S., Rochon, P. A., Seitz, D. P. (2016) Depression rating scales for detection of major depression in people with dementia. Cochrane Database of Systematic Reviews, 2016, (doi: 10.1002/14651858.cd012312)

ter Maaten, J. M., Damman, K., Hanberg, J. S., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Cleland, J. G.F., Bloomfield, D. M., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., Testani, J. M. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003109)

Hawkins, N. M., Virani, S. A., Sperrin, M., Buchan, I. E., McMurray, J. J.V., Krahn, A. D. (2016) Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges. European Journal of Heart Failure, 18, pp. 977-986. (doi: 10.1002/ejhf.458)

Carberry, J., Carrick, D., Haig, C., Rauhalammi, S. M., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68, pp. 385-391. (doi: 10.1161/HYPERTENSIONAHA.116.07222)

Robertson, S., Parker, A. L., Clarke, C., Duffy, M. R., Alba, R., Nicklin, S. A., Baker, A. H. (2016) Retargeting FX binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop. Journal of General Virology, 97, pp. 1911-1916. (doi: 10.1099/jgv.0.000505)

Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, T., Dalby, M., Cleland, J. G.F., Baltabaeva, A., Rahman Haley, S. (2016) Classification of aortic stenosis by flow and gradient patterns provides insights into the pathophysiology of disease. Angiology, 67, pp. 664-669. (doi: 10.1177/0003319715611804)

Cannon, J. A., Shen, L., Jhund, P., Anand, I. S., Komajda, M., McKelvie, R. S., Zile, M. R., Carson, P. E., McMurray, J. J. V. (2016) Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-Preserve) trial. European Journal of Heart Failure, 18, pp. 1021-1031. (doi: 10.1002/ejhf.547)

Fröhlich, H., Nelges, C., Täger, T., Schwenger, V., Cebola, R., Schnorbach, J., Goode, K. M., Kazmi, S., Katus, H. A., Cleland, J. G.F., Clark, A. L., Frankenstein, L. (2016) Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal, 178, pp. 28-36. (doi: 10.1016/j.ahj.2016.03.024)

Preiss, D., Welsh, P., Sattar, N. (2016) Metformin therapy and circulating NT-proBNP levels: the CAMERA trial. Diabetes Care, 39, pp. e114-e115. (doi: 10.2337/dc16-0887)

Davison, B. A., Metra, M., Senger, S., Edwards, C., Milo, O., Bloomfield, D. M., Cleland, J. G., Dittrich, H. C., Givertz, M. M., O'Connor, C. M., Massie, B. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., Cotter, G. (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European Journal of Heart Failure, 18, pp. 1041-1050. (doi: 10.1002/ejhf.540)

Cleland, J. G.F., Zhang, J., Pellicori, P., Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K., Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1, pp. 539-547. (doi: 10.1001/jamacardio.2016.1161)

Wilson, M. R., Docherty, K. F., Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27, pp. 15-22. (doi: 10.1002/psb.1487)

Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., Zinman, B., EMPA-REG OUTCOME Investigators, (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine, 375, pp. 323-334. (doi: 10.1056/NEJMoa1515920)

Teh, I., McClymont, D., Burton, R. A. B., Maguire, M. L., Whittington, H. J., Lygate, C. A., Kohl, P., Schneider, J. E. (2016) Resolving fine cardiac structures in rats with high-resolution diffusion tensor imaging. Scientific Reports, 6, (doi: 10.1038/srep30573)

Desai, A. S., Claggett, B. L., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, K., Shi, V., Lefkowitz, M., Starling, R., Teerlink, J., McMurray, J. J.V., Solomon, S. D. (2016) Influence of Sacubitril/Valsartan (LCZ696) on 30-day readmission after heart failure hospitalization. Journal of the American College of Cardiology, 68, pp. 241-248. (doi: 10.1016/j.jacc.2016.04.047)

Roscoe, R. B., Elliott, C., Zarros, A., Baillie, G. S. (2016) Non-genetic therapeutic approaches to Canavan disease. Journal of the Neurological Sciences, 366, pp. 116-124. (doi: 10.1016/j.jns.2016.05.012)

McMurray, J. J.V., Køber, L. V. (2016) End of the road for vagus nerve stimulation? Journal of the American College of Cardiology, 68, pp. 159-160. (doi: 10.1016/j.jacc.2016.05.025)

Bachmann, V. A., Mayrhofer, J. E., Ilouz, R., Tschaikner, P. M., Raffeiner, P., Röck, R., Courcelles, M., Lu, T.-W., Baillie, G. S., Thibault, P., Aanstad, P., Stelzl, U., Taylor, S. S., Stefan, E. (2016) GPR61 anchoring of PKA consolidates GPCR and cAMP signaling. Proceedings of the National Academy of Sciences of the United States of America, 113, pp. 7786-7791. (doi: 10.1073/pnas.1608061113)

Biegus, J., Hillege, H. L., Postmus, D., Valente, M. A.E., Bloomfield, D. M., Cleland, J. G.F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Massie, B. M., Metra, M., Teerlink, J. R., Voors, A. A., O'Connor, C. M., Ponikowski, P. (2016) Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18, pp. 830-839. (doi: 10.1002/ejhf.532)

Mangion, K., Berry, C. (2016) Advances in magnetic resonance imaging of the myocardial area at risk and salvage. Circulation: Cardiovascular Imaging, 9, (doi: 10.1161/circimaging.116.005127)

Baillie, G. S. (2016) Editorial. Cellular Signalling, 28, pp. 699-700. (doi: 10.1016/j.cellsig.2016.02.001)

Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., McMurray, J. J. (2016) Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59, pp. 1573-1574. (doi: 10.1007/s00125-016-3987-3)

Høydal, M. A., Stølen, T. O., Kettlewell, S., Maier, L. S., Brown, J. H., Sowa, T., Catalucc, D., Condorelli, G., Kemi, O. J., Smith, G. L., Wisløff, U. (2016) Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+-homeostasis. Journal of Applied Physiology, 121, pp. 212-220. (doi: 10.1152/japplphysiol.00188.2016)

Khamis, R. Y., Hughes, A. D., Caga-Anan, M., Chang, C. L., Boyle, J. J., Kojima, C., Welsh, P., Sattar, N., Johns, M., Sever, P., Mayet, J., Haskard, D. O. (2016) High serum immunoglobulin g and m levels predict freedom from adverse cardiovascular events in hypertension: a nested case-control substudy of the Anglo-Scandinavian cardiac outcomes trial. EBioMedicine, 9, pp. 372-380. (doi: 10.1016/j.ebiom.2016.06.012)

Wills, L., Ehsan, M., Whiteley, E. L., Baillie, G. S. (2016) Location, location, location: PDE4D5 function is directed by its unique N-terminal region. Cellular Signalling, 28, pp. 701-705. (doi: 10.1016/j.cellsig.2016.01.008)

Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., McMurray, J. J.V. (2016) SGLT2 and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59, pp. 1333-1339. (doi: 10.1007/s00125-016-3956-x)

Duffy, M.R., Doszpoly, A., Turner, G., Nicklin, S.A., Baker, A.H. (2016) The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Therapy, 23, pp. 592-596. (doi: 10.1038/gt.2016.32)

Feldman, T., Komtebedde, J., Burkhoff, D., Massaro, J., Maurer, M. S., Leon, M. B., Kaye, D., Silvestry, F. E., Cleland, J. G.F., Kitzman, D., Kubo, S. H., Van Veldhuisen, D. J., Kleber, F., Trochu, J.-N., Auricchio, A., Gustafsson, F., Hasenfuβ, G., Ponikowski, P., Filippatos, G., Mauri, L., Shah, S. J. (2016) Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I) Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003025)

Quinn, T. (2016) Review: evidence is insufficient to determine the risk–benefit ratio for vision acuity screening in older adults. Annals of Internal Medicine, 164, (doi: 10.7326/ACPJC-2016-164-12-064)

Wannamethee, S. G., Welsh, P., Lennon, L., Papacosta, O., Whincup, P., Sattar, N. (2016) Copeptin and risk of incident stroke, coronary heart disease and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study. Diabetologia, 59, pp. 1904-1912. (doi: 10.1007/s00125-016-4011-7)

Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J. V. (2016) Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF) Circulation, 133, pp. 2254-2262. (doi: 10.1161/CIRCULATIONAHA.115.020729)

Woodcock, J., Ware, J. H., Miller, P. W., McMurray, J. J.V., Harrington, D. P., Drazen, J. M. (2016) Clinical Trials Series. New England Journal of Medicine, 374, pp. 2167-2167. (doi: 10.1056/NEJMe1601510)

Metra, M., Mentz, R. J., Hernandez, A. F., Heizer, G. M., Armstrong, P. W., Clausell, N., Corbalan, R., Costanzo, M. R., Dickstein, K., Dunlap, M. E., Ezekowitz, J. A., Howlett, J. G., Komajda, M., Krum, H., Lombardi, C., Fonarow, G. C., McMurray, J. J.V., Nieminen, M. S., Swedberg, K., Voors, A. A., Starling, R. C., Teerlink, J. R., O'Connor, C. M. (2016) Geographic differences in patients in a global acute heart failure clinical trial (from the ASCEND-HF Trial) American Journal of Cardiology, 117, pp. 1771-1778. (doi: 10.1016/j.amjcard.2016.03.002)

Berry, C., Poppe, K.K., Gamble, G.D., Earle, N.J., Ezekowitz, J.A., Squire, I.B., McMurray, J.J.V., McAlister, F.A., Komajda, M., Swedberg, K., Maggioni, A.P., Ahmed, A., Whalley, G.A., Doughty, R.N., Tarantini, L. (2016) Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. QJM: An International Journal of Medicine, 109, pp. 377-382. (doi: 10.1093/qjmed/hcv087)

Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M. (2016) A systems BIOlogy Study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18, pp. 716-726. (doi: 10.1002/ejhf.531)

Welsh, P., Cezard, G., Gill, J.M., Wallia, S., Douglas, A., Sheikh, A., Wild, S.H., Tuomilehto, J., McKnight, J., Murray, G., Bhopal, R., Lean, M., Sattar, N. (2016) Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA Trial. International Journal of Obesity, 40, pp. 1005-1011. (doi: 10.1038/ijo.2016.35)

ter Maaten, J. M., Valente, M. A.E., Damman, K., Cleland, J. G., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Cotter, G., Davison, B., Subacius, H., van Veldhuisen, D. J., van der Meer, P., Hillege, H. L., Gheorghiade, M., Voors, A. A. (2016) Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002845)

Myint, P. K., Kwok, C. S., Roffe, C., Kontopantelis, E., Zaman, A., Berry, C., Ludman, P. F., de Belder, M. A., Mamas, M. A. (2016) Determinants and outcomes of stroke following percutaneous coronary intervention by indication. Stroke, 47, pp. 1500-1507. (doi: 10.1161/STROKEAHA.116.012700)

Whellan, D. J., Stebbins, A., Hernandez, A. F., Ezekowitz, J. A., McMurray, J. J.V., Mather, P. J., Hasselblad, V., O'Connor, C. M. (2016) Dichotomous relationship between age and 30-day death or rehospitalization in heart failure patients admitted with acute decompensated heart failure: results from the ASCEND-HF trial. Journal of Cardiac Failure, 22, pp. 409-416. (doi: 10.1016/j.cardfail.2016.02.011)

Abdul-Rahim, A. H., Docherty, K. F., Skali, H., Køber, L., Dickstein, K., Maggioni, A. P., Mareev, V., Zannad, F., Velazquez, E. J., Califf, R. M., Pfeffer, M. A., Solomon, S. D., Lees, K. R., McMurray, J. J.V. (2016) Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. European Stroke Journal, 1, pp. 93-100. (doi: 10.1177/2396987316646025)

Anker, S. D. et al. (2016) Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482-489] European Journal of Heart Failure, 18, pp. 727-727. (doi: 10.1002/ejhf.591)

Desai, A. S., Solomon, S., Claggett, B., McMurray, J. J.V., Rouleau, J., Swedberg, K., Zile, M., Lefkowitz, M., Shi, V., Packer, M. (2016) Factors associated with noncompletion during the run-in period before randomization and influence on the estimated benefit of LCZ696 in the PARADIGM-HF trial. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002735)

Wannamethee, G., Shaper, G., Papacosta, O., Lennon, L., Welsh, P., Whincup, P. (2016) Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men—the British regional heart study. Thorax, 71, pp. 526-534. (doi: 10.1136/thoraxjnl-2014-206724)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Todd, J., van Veldhuisen, D. J., Hillege, H. L., Damman, K., van der Meer, P., Voors, A. A. (2016) Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. European Journal of Heart Failure, 18, pp. 641-649. (doi: 10.1002/ejhf.426)

Lopes, R. D., Pieper, K. S., Stevens, S. R., Solomon, S. D., McMurray, J. J.V., Pfeffer, M. A., Leimberger, J. D., Velazquez, E. J. (2016) Predicting outcomes over time in patients with heart failure, left ventricular systolic dysfunction, or both following acute myocardial infarction. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.115.003045)

Al-Alshaikh, S., Quinn, T., Dunn, W., Walters, M., Dawson, J. (2016) Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses. European Stroke Journal, 1, pp. 65-75. (doi: 10.1177/2396987316647187)

Baumert, M., Porta, A., Vos, M. A., Malik, M., Couderc, J.-P., Laguna, P., Piccirillo, G., Smith, G. L., Tereshchenko, L. G., Volders, P. G.A. (2016) QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology. Europace, 18, pp. 925-944. (doi: 10.1093/europace/euv405)

Pedersen, C. M., Venkatasubramanian, S., Vase, H., Hyldebrandt, J. A., Contractor, H., Schmidt, M. R., Bøtker, H. E., Cruden, N. L., Newby, D. E., Kharbanda, R. K., Lang, N. N. (2016) Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury. British Journal of Clinical Pharmacology, 81, pp. 1037-1045. (doi: 10.1111/bcp.12882)

Ballantyne, M. D., Pinel, K., Dakin, R., Vesey, A. T., Diver, L., MacKenzie, R., Garcia, R., Welsh, P., Sattar, N., Hamilton, G., Joshi, N., Dweck, M. R., Miano, J. M., McBride, M. W., Newby, D. E., McDonald, R. A., Baker, A. H. (2016) Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation, 133, pp. 2050-2065. (doi: 10.1161/circulationaha.115.021019)

McMurray, J. J.V. (2016) Disease management programs in cardiology. Circulation, 133, pp. 1836-1837. (doi: 10.1161/circulationaha.116.022480)

Carrick, D., Haig, C., Carberry, J., Teng Tue May, V., Mccartney, P., Welsh, P., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Mahrous, A., Rauhalammi, S. M.O., Mordi, I., Ford, I., Radjenovic, A., Sattar, N., Oldroyd, K. G., Berry, C. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1, (doi: 10.1172/jci.insight.85768)

Pellicori, P., Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L., Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi: 10.1016/j.ijcard.2016.02.081)

Macisaac, R., Ali, M., Peters, M., English, C., Rodgers, H., Jenkinson, C., Quinn, T. J. (2016) Derivation and validation of a modified short form of the Stroke Impact Scale. Journal of the American Heart Association, 2016, (doi: 10.1161/JAHA.115.003108)

Gheorghiade, M., Larson, C. J., Shah, S. J., Greene, S. J., Cleland, J. G.F., Colucci, W. S., Dunnmon, P., Epstein, S. E., Kim, R. J., Parsey, R. V., Stockbridge, N., Carr, J., Dinh, W., Krahn, T., Kramer, F., Wahlander, K., Deckelbaum, L. I., Crandall, D., Okada, S., Senni, M., Sikora, S., Sabbah, H. N., Butler, J. (2016) Developing new treatments for heart failure: focus on the heart. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002727)

Venkatasubramanian, S., Noh, R. M., Daga, S., Langrish, J. P., Mills, N. L., Waterhouse, B. R., Hoffmann, E., Jacobson, E. W., Lang, N. N., Frier, B. M., Newby, D. E. (2016) Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus. Open Heart, 3, (doi: 10.1136/openhrt-2016-000402)

Geue, C., Wu, O., Leyland, A., Lewsey, J., Quinn, T. J. (2016) Geographic variation of inpatient care costs at the end of life. Age and Ageing, 45, pp. 376-381. (doi: 10.1093/ageing/afw040)

Jhund, P., Tavazzi, L. (2016) Has the 'epidemic’ of heart failure been replaced by a tsunami of co-morbidities? European Journal of Heart Failure, 18, pp. 500-502. (doi: 10.1002/ejhf.529)

Shoaib, A., Farag, M., Nasir, M., John, J., Gupta, S., Pellicori, P., Antony, R., Perveen, R., Rigby, A., Goode, K. M., Yassin, A., Clark, A. L., Cleland, J. G.F. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18, pp. 556-563. (doi: 10.1002/ejhf.505)

Pellicori, P., Cleland, J.G.F. (2016) New ways to visualize and combat congestion in heart failure = Nuevos modos de visualizar y combatir la congestión en la insuficiencia cardiaca. Revista Clínica Española, 216, pp. 202-204. (doi: 10.1016/j.rce.2016.03.007)

Nisbet, A. M., Camelliti, P., Walker, N. L., Burton, F. L., Cobbe, S. M., Kohl, P., Smith, G. L. (2016) Prolongation of atrio-ventricular node conduction in a rabbit model of ischaemic cardiomyopathy: role of fibrosis and connexin remodelling. Journal of Molecular and Cellular Cardiology, 94, pp. 54-64. (doi: 10.1016/j.yjmcc.2016.03.011)

Campbell, R. T., Willox, G. P., Jhund, P. S., Hawkins, N. M., Huang, F., Petrie, M. C., McMurray, J. J. V. (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002842)

Anker, S. D. et al. (2016) Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. European Journal of Heart Failure, 18, pp. 482-489. (doi: 10.1002/ejhf.516)

Velazquez, E. J., Lee, K. L., Jones, R. H., Al-Khalidi, H. R., Hill, J. A., Panza, J. A., Michler, R. E., Bonow, R. O., Doenst, T., Petrie, M. C., Oh, J. K., She, L., Moore, V. L., Desvigne-Nickens, P., Sopko, G., Rouleau, J. L. (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. New England Journal of Medicine, 374, pp. 1511-1520. (doi: 10.1056/NEJMoa1602001)

Johnson, N. P. et al. (2016) Continuum of vasodilator stress from rest to contrast medium to adenosine hyperemia for fractional flow reserve assessment. JACC: Cardiovascular Interventions, 9, pp. 757-767. (doi: 10.1016/j.jcin.2015.12.273)

McMurray, J. J.V., Krum, H., Abraham, W. T., Dickstein, K., Køber, L. V., Desai, A. S., Solomon, S. D., Greenlaw, N., Ali, M. A., Chiang, Y., Shao, Q., Tarnesby, G., Massie, B. M. (2016) Aliskiren, enalapril, or aliskiren and enalapril in heart failure. New England Journal of Medicine, 374, pp. 1521-1532. (doi: 10.1056/NEJMoa1514859)

Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., Collins, P. D., Packer, M., Wikstrand, J., Coats, A. J.S., Cleland, J. G.F., Kirchhof, P., von Lueder, T. G., Rigby, A. S., Andersson, B., Lip, G. Y.H., van Veldhuisen, D. J., Shibata, M. C., Wedel, H., Böhm, M., Flather, M. D. (2016) Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. British Medical Journal, 353, (doi: 10.1136/bmj.i1855)

Lee, M. M.Y., Petrie, M. C., Rocchiccioli, P., Simpson, J., Jackson, C., Brown, A., Corcoran, D., Mangion, K., McEntegart, M., Shaukat, A., Rae, A., Hood, S., Peat, E., Findlay, I., Murphy, C., Cormack, A., Bukov, N., Balachandran, K., Papworth, R., Ford, I., Briggs, A., Berry, C. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) Open Heart, 3, (doi: 10.1136/openhrt-2015-000371)

Williams, M. C., Hunter, A., Shah, A. S.V., Assi, V., Lewis, S., Smith, J., Berry, C., Boon, N. A., Clark, E., Flather, M., Forbes, J., McLean, S., Roditi, G., van Beek, E. J.R., Timmis, A. D., Newby, D. E. (2016) Use of coronary computed tomographic angiography to guide management of patients with coronary disease. Journal of the American College of Cardiology, 67, pp. 1759-1768. (doi: 10.1016/j.jacc.2016.02.026)

Berry, C., Carrick, D., Haig, C., Oldroyd, K. G. (2016) “Waves of Edema” seem implausible. Journal of the American College of Cardiology, 67, pp. 1868-1869. (doi: 10.1016/j.jacc.2015.11.073)

Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., McMurray, J. J.V. (2016) Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. International Journal of Cardiology, 209, pp. 310-316. (doi: 10.1016/j.ijcard.2016.02.074)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Lindsay, M., Mahrous, A., Ford, I., Tzemos, N., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37, pp. 1044-1059. (doi: 10.1093/eurheartj/ehv372)

Harrison, J. K., McKay, I. K., Grant, P., Hannah, J., Quinn, T. J. (2016) Appropriateness of unscheduled hospital admissions from care homes. Clinical Medicine, 16, pp. 103-108. (doi: 10.7861/clinmedicine.16-2-103)

Sabe, M. A., Claggett, B., Burdmann, E. A., Desai, A. S., Ivanovich, P., Kewalramani, R., Lewis, E. F., McMurray, J. J.V., Olson, K. A., Parfrey, P., Solomon, S. D., Pfeffer, M. A. (2016) Coronary artery disease is a predictor of progression to dialysis in patients with chronic kidney disease, type 2 diabetes mellitus, and anemia: an analysis of the trial to reduce cardiovascular events with aranesp therapy (TREAT) Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.115.002850)

Arba, F., Ali, M., Quinn, T. J., Hankey, G. J., Lees, K. R., Inzitari, D. (2016) Lacunar Infarcts, depression, and anxiety symptoms one year after stroke. Journal of Stroke and Cerebrovascular Diseases, 25, pp. 831-834. (doi: 10.1016/j.jstrokecerebrovasdis.2015.12.018)

Samsky, M. D., Dunning, A., DeVore, A. D., Schulte, P. J., Starling, R. C., Wilson Tang, W.H., Armstrong, P. W., Ezekowitz, J. A., Butler, J., McMurray, J. J., Teerlink, J. R., Voors, A. A., Metra, M., Mentz, R. J., O'Connor, C. M., Patel, C. B., Hernandez, A. F. (2016) Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. European Journal of Heart Failure, 18, pp. 424-432. (doi: 10.1002/ejhf.440)

Al AlShaikh, S., Quinn, T., Dunn, W., Walters, M., Dawson, J. (2016) Multimodal interventions to enhance adherence to secondary preventive medication after stroke: a systematic review and meta-analyses. Cardiovascular Therapeutics, 34, pp. 85-93. (doi: 10.1111/1755-5922.12176)

Heerspink, H. J.L., Persson, F., Brenner, B. M., Chaturvedi, N., Brunel, P., McMurray, J. J., Desai, A. S., Solomon, S. D., Pfeffer, M. A., Parving, H.-H., de Zeeuw, D. (2016) Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial. Lancet Diabetes and Endocrinology, 4, pp. 309-317. (doi: 10.1016/S2213-8587(15)00469-6)

Ovchinnikova, E. S. et al. (2016) Signature of circulating microRNAs in patients with acute heart failure. European Journal of Heart Failure, 18, pp. 414-423. (doi: 10.1002/ejhf.332)

Koshy, A., Pellicori, P., Clark, A. L. (2016) The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure. Heart, 102, pp. 597-601. (doi: 10.1136/heartjnl-2015-308932)

McMurray, J. J.V., Køber, L. (2016) Trials and the ‘real world’ - how different are they? European Journal of Heart Failure, 18, pp. 411-413. (doi: 10.1002/ejhf.503)

Neisius, U., Koeck, T., Mischak, H., Rossi, S. H., Olson, E., Carty, D. M., Dymott, J. A., Dominiczak, A. F., Berry, C., Oldroyd, K. G., Delles, C. (2016) Urine proteomics in the diagnosis of stable angina. BMC Cardiovascular Disorders, 16, (doi: 10.1186/s12872-016-0246-y)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Ponikowski, P., Metra, M., Filippatos, G. S., Ezekowitz, J. A., Dickstein, K., Cleland, J. G.F., Kim, J. B., Lei, L., Knusel, B., Wolff, A. A., Malik, F. I., Wasserman, S. M. (2016) Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure. Journal of the American College of Cardiology, 67, pp. 1444-1455. (doi: 10.1016/j.jacc.2016.01.031)

Hasenfuß, G., Hayward, C., Burkhoff, D., Silvestry, F. E., McKenzie, S., Gustafsson, F., Malek, F., Van der Heyden, J., Lang, I., Petrie, M. C., Cleland, J. G.F., Leon, M., Kaye, D. M. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387, pp. 1298-1304. (doi: 10.1016/S0140-6736(16)00704-2)

Quinn, T. J. (2016) Forward thinking: where next for delirium prevention research? Cochrane Database of Systematic Reviews, 2016, (doi: 10.1002/14651858.ED000110)

Loomis, A. K., Kabadi, S., Preiss, D., Hyde, C., Bonato, V., St. Louis, M., Desai, J., Gill, J. M.R., Welsh, P., Waterworth, D., Sattar, N. (2016) Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. Journal of Clinical Endocrinology and Metabolism, 101, pp. 945-952. (doi: 10.1210/jc.2015-3444)

Perez, A. L., Grodin, J. L., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J., Armstrong, P. W., Starling, R. C., O'Connor, C. M., Tang, W. H. W. (2016) Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy. European Journal of Heart Failure, 18, pp. 290-297. (doi: 10.1002/ejhf.456)

Solomon, S. D., Claggett, B., Desai, A. S., Packer, M., Zile, M., Swedberg, K., Rouleau, J. L., Shi, V. C., Starling, R. C., Kozan, Ö., Dukat, A., Lefkowitz, M. P., McMurray, J. J.V. (2016) Influence of ejection fraction on outcomes and efficacy of sacubitril/valsartan (lcz696) in heart failure with reduced ejection fraction: the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF) trial. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002744)

Damman, K., Kjekshus, J., Wikstrand, J., Cleland, J. G.F., Komajda, M., Wedel, H., Waagstein, F., McMurray, J. J.V. (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18, pp. 328-336. (doi: 10.1002/ejhf.462)

Demissei, B. G., Valente, M. A.E., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van der Meer, P., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A. (2016) Optimizing clinical use of biomarkers in high-risk acute heart failure patients. European Journal of Heart Failure, 18, pp. 269-280. (doi: 10.1002/ejhf.443)

Ambrosy, A. P., Hernandez, A. F., Armstrong, P. W., Butler, J., Dunning, A., Ezekowitz, J. A., Felker, G. M., Greene, S. J., Kaul, P., McMurray, J. J., Metra, M., O'Connor, C. M., Reed, S. D., Schulte, P. J., Starling, R. C., Wilson Tang, W.H., Voors, A. A., Mentz, R. J. (2016) The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. European Journal of Heart Failure, 18, pp. 306-313. (doi: 10.1002/ejhf.420)

Hafver, T. L., Hodne, K., Wanichawan, P., Aronsen, J. M., Dalhus, B., Lunde, P. K., Lunde, M., Martinsen, M., Enger, U. H., Fuller, W., Sjaastad, I., Louch, W. E., Sejersted, O. M., Carlson, C. R. (2016) Protein phosphatase 1c associated with the cardiac sodium calcium exchanger 1 regulates its activity by dephosphorylating serine 68-phosphorylated phospholemman. Journal of Biological Chemistry, 291, pp. 4561-4579. (doi: 10.1074/jbc.M115.677898)

Wilson, R., Aung, H., Ju, X., Paterson, C., Sayer, R., McIntyre, A., Going, J., Irvine, R., Berry, C. (2016) Optical coherence tomography: an experimental validation for vascular imaging of saphenous vein bypass grafts. Biomedical Physics and Engineering Express, 2, (doi: 10.1088/2057-1976/2/2/025002)

Cuba Gyllensten, I., Bonomi, A. G., Goode, K. M., Reiter, H., Habetha, J., Amft, O., Cleland, J. G.F. (2016) Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Medical Informatics, 4, (doi: 10.2196/medinform.4842)

Demissei, B. G., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., Cotter, G. (2016) Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. International Journal of Cardiology, 204, pp. 164-171. (doi: 10.1016/j.ijcard.2015.11.141)

ter Maaten, J. M., Valente, M. A.E., Metra, M., Bruno, N., O’Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., Hillege, H. L., Damman, K., Voors, A. A. (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clinical Research in Cardiology, 105, pp. 145-153. (doi: 10.1007/s00392-015-0896-2)

Vardeny, O., Claggett, B., Udell, J. A., Packer, M., Zile, M., Rouleau, J., Swedberg, K., Desai, A. S., Lefkowitz, M., Shi, V., McMurray, J. J.V., Solomon, S. D. (2016) Influenza vaccination in patients with chronic heart failure: The PARADIGM-HF Trial. JACC: Heart Failure, 4, pp. 152-158. (doi: 10.1016/j.jchf.2015.10.012)

Heerspink, H.J.L., Ninomiya, T., Persson, F., Brenner, B.M., Brunel, P., Chaturvedi, N., Desai, A.S., Haffner, S.M., McMurray, J.J.V., Solomon, S.D., Pfeffer, M.A., Parving, H.-H., de Zeeuw, D. (2016) Is a reduction in albuminuria associated with renal and cardiovascular protection? A post-hoc analysis of the ALTITUDE trial. Diabetes, Obesity and Metabolism, 18, pp. 169-177. (doi: 10.1111/dom.12600)

Huethorst, E., Krebber, M. M., Fledderus, J. O., Gremmels, H., Xu, Y. J., Pei, J., Verhaar, M. C., Cheng, C. (2016) Lymphatic Vascular Regeneration: The Next Step in Tissue Engineering. Tissue Engineering Part B: Reviews, 22, pp. 1-14. (doi: 10.1089/ten.teb.2015.0231)

Gardner, R. T., Ripplinger, C. M., Myles, R., Habecker, B. A. (2016) Molecular mechanisms of sympathetic remodeling and arrhythmias. Circulation: Arrhythmia and Electrophysiology, 9, (doi: 10.1161/circep.115.001359)

Bhandari, S., Ives, N., Brettell, E. A., Valente, M., Cockwell, P., Topham, P. S., Cleland, J. G.F., Khwaja, A., El Nahas, M. (2016) Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation, 31, pp. 255-261. (doi: 10.1093/ndt/gfv346)

Welsh, P., Hart, C., Papacosta, O., Preiss, D., McConnachie, A., Murray, H., Ramsay, S., Upton, M., Watt, G., Whincup, P., Wannamethee, G., Sattar, N. (2016) Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension, 2016, pp. 309-315. (doi: 10.1161/HYPERTENSIONAHA.115.06501)

Khan, A. A., Quinn, T. J., Hewitt, J., Fan, Y., Dawson, J. (2016) Serum uric acid level, and association with cognitive impairment and dementia: systematic review and meta-analysis. Age, 38, (doi: 10.1007/s11357-016-9871-8)

Carrick, D., Haig, C., Rauhalammi, S., Clerfond, G., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Mahrous, A., Welsh, P., Sattar, N., Ford, I., Oldroyd, K., Radjenovic, A., Berry, C. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.115.002834)

McGovern, A., Pendlebury, S. T., Mishra, N. k., Fan, Y., Quinn, T. J. (2016) Test accuracy of informant-based cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke, 47, pp. 329-335. (doi: 10.1161/strokeaha.115.011218)

Watt, J., Kennedy, S., Ahmed, N., Hayhurst, J., McClure, J. D., Berry, C., Wadsworth, R. M., Oldroyd, K. G. (2016) The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD. Open Heart, 3, (doi: 10.1136/openhrt-2015-000342)

Mangion, K., Gao, H., Radjenovic, A., Luo, X., Haig, C., Berry, C. (2016) Pixel-tracking derived strain using the GlasgowHeart Method. Journal of Cardiovascular Magnetic Resonance, 18, (doi: 10.1186/1532-429X-18-S1-P9)

Bruno, N., ter Maaten, J. M., Ovchinnikova, E. S., Vegter, E. L., Valente, M. A.E., van der Meer, P., de Boer, R. A., van der Harst, P., Schmitter, D., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Pinto, Y. M., van Veldhuisen, D. J., Hillege, H. L., Berezikov, E., Voors, A. A. (2016) MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International Journal of Cardiology, 203, pp. 564-569. (doi: 10.1016/j.ijcard.2015.10.217)

Bertrand, L., Whittington, H. J., McAndrew, D. J., Cross, R. L., Neubauer, S., Lygate, C. A. (2016) Protective effect of creatine elevation against ischaemia reperfusion injury is retained in the presence of co-morbidities and during cardioplegia. PLoS ONE, 11, (doi: 10.1371/journal.pone.0146429)

Dachtler, J., Elliott, C., Rodgers, R. J., Baillie, G. S., Clapcote, S. J. (2016) Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice. Scientific Reports, 6, (doi: 10.1038/srep18748)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi: 10.1016/j.ijcard.2015.09.076)

Ahmed, N., Layland, J., Carrick, D., Petrie, M. C., McEntegart, M., Eteiba, H., Hood, S., Lindsay, M., Watkins, S., Davie, A., Mahrous, A., Carberry, J., Teng, V., McConnachie, A., Curzen, N., Oldroyd, K. G., Berry, C. (2016) Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. International Journal of Cardiology, 202, pp. 305-310. (doi: 10.1016/j.ijcard.2015.09.014)

Abdul-Rahim, A. H., Quinn, T. J., Alder, S., Clark, A. B., Musgrave, S., Langhorne, P., Potter, J. F., Myint, P. K. (2016) Derivation and validation of a novel prognostic scale (modified–stroke subtype, Oxfordshire community stroke project classification, age, and prestroke modified rankin) to predict early mortality in acute stroke. Stroke, 47, pp. 74-79. (doi: 10.1161/strokeaha.115.009898)

McMurray, J. (2016) EMPA-REG – the “diuretic hypothesis” Journal of Diabetes and its Complications, 30, pp. 3-4. (doi: 10.1016/j.jdiacomp.2015.10.012)

Baillie, G. S., Christian, F., Zarros, A. (2016) Editorial: frontiers in the pharmacological manipulation of intracellular cAMP levels. Frontiers in Pharmacology, 7, (doi: 10.3389/fphar.2016.00004)

Zile, M. R., Jhund, P., Baicu, C. F., Claggett, B. L., Pieske, B., Voors, A. A., Prescott, M. F., Shi, V., Lefkowitz, M., McMurray, J., Solomon, S. D. (2016) Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction. Circulation: Heart Failure, 9, (doi: 10.1161/circheartfailure.115.002551)

Tang, W.H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., Metra, M., Voors, A. A., Felker, G. M., Troughton, R. W., Mills, R. M., McMurray, J. J., Armstrong, P. W., O'Connor, C. M., Starling, R. C. (2016) Prognostic value of baseline and changes in circulating soluble ST2 levels and the effects of nesiritide in acute decompensated heart failure. JACC: Heart Failure, 4, pp. 68-77. (doi: 10.1016/j.jchf.2015.07.015)

Theilade, S., Claggett, B., Hansen, T.W., Skali, H., Lewis, E.F., Solomon, S.D., Parving, H.-H., Pfeffer, M., McMurray, J.J., Rossing, P. (2016) Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia-the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Journal of Human Hypertension, 30, pp. 46-52. (doi: 10.1038/jhh.2015.22)

Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V., Packer, M. (2016) Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002560)

Jenkins, P., Sng, S., Brooksbank, K., Brooksbank, A.J. (2016) Socioeconomic deprivation and age are barriers to the online collection of patient reported outcome measures in orthopaedic patients. Annals of the Royal College of Surgeons of England, 98, pp. 40-44. (doi: 10.1308/rcsann.2016.0007)

Scholz, A.F.W., Oldroyd, C., McCarthy, K., Quinn, T.J., Hewitt, J. (2016) Systematic review and meta-analysis of risk factors for postoperative delirium among older patients undergoing gastrointestinal surgery. British Journal of Surgery, 103, pp. e21-e28. (doi: 10.1002/bjs.10062)

Cowie, M. R., Bax, J., Bruining, N., Cleland, J. G.F., Koehler, F., Malik, M., Pinto, F., van der Velde, E., Vardas, P. (2016) e-Health: a position statement of the European Society of Cardiology. European Heart Journal, 37, pp. 63-66. (doi: 10.1093/eurheartj/ehv416)

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G.F., Coats, A. J.S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M.C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., McMurray, J. J.V., Petrie, M. C. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37, pp. 2129-2200. (doi: 10.1093/eurheartj/ehw128)

Kirchhof, P. et al. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal, 37, pp. 2893-2962. (doi: 10.1093/eurheartj/ehw210)

Colman, M. A., Sarathy, P. P., MacQuiaide, N., Workman, A. J. (2016) A new model of the human atrial myocyte with variable T-tubule organization for the study of atrial fibrillation. Computing in Cardiology, 43, pp. 221-224. (doi: 10.23919/CIC.2016.7868719)

Rankin, N. J., Preiss, D., Welsh, P., Sattar, N. (2016) Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. International Journal of Epidemiology, 45, pp. 1351-1371. (doi: 10.1093/ije/dyw271)

Zervou, S., Whittington, H. J., Russell, A. J., Lygate, C. A. (2016) Augmentation of creatine in the heart. Mini-Reviews in Medicinal Chemistry, 16, pp. 19-28. (doi: 10.2174/1389557515666150722102151)

Platz, E., Lewis, E. F., Uno, H., Peck, J., Pivetta, E., Merz, A. A., Hempel, D., Wilson, C., Frasure, S. E., Jhund, P. S., Cheng, S., Solomon, S. D. (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. European Heart Journal, 37, pp. 1244-1251. (doi: 10.1093/eurheartj/ehv745)

Lygate, C. A. (2016) Energetics in the hypertrophied and failing heart. Elsevier (Academic Press)

Hendry, K., Quinn, T. J., Evans, J., Scortichini, V., Miller, H., Burns, J., Cunnington, A., Stott, D. J. (2016) Evaluation of delirium screening tools in geriatric medical inpatients: a diagnostic test accuracy study. Age and Ageing, 45, pp. 832-837. (doi: 10.1093/ageing/afw130)

Stirrat, C. t., Alam, S. R., MacGillivray, T. J., Gray, C. D., Forsythe, R., Dweck, M. R., Payne, J. R., Prasad, S. K., Petrie, M. C., Gardner, R. S., Mirsadraee, S., Henriksen, P. A., Newby, D. E., Semple, S. I.K. (2016) Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. Journal of Cardiovascular Magnetic Resonance, 18, (doi: 10.1186/s12968-016-0261-2)

(2016) Frontiers in the Pharmacological Manipulation of Intracellular cAMP Levels. (doi: 10.3389/978-2-88919-815-3)

McCallum, J. E., Mackenzie, A. E., Divorty, N., Clarke, C., Delles, C., Milligan, G., Nicklin, S. A. (2016) G protein-coupled receptor 35 mediates human saphenous vein vascular smooth muscle cell migration and endothelial cell proliferation. Journal of Vascular Research, 52, pp. 383-395. (doi: 10.1159/000444754)

Kristensen, S. L. et al. (2016) Geographic variations in the PARADIGM-HF heart failure trial. European Heart Journal, 37, pp. 3167-3174. (doi: 10.1093/eurheartj/ehw226)

Corcoran, D., Berry, C. (2016) How to measure myocardial infarct size by cardiac magnetic resonance imaging. Heart and Metabolism, 70, pp. 14-18.

Nadruz, W., Claggett, B. L., McMurray, J. J., Packer, M., Zile, M. R., Rouleau, J. l., Desai, A. S., Swedberg, K., Lefkowitz, M., Shi, V. C., Prescott, M. F., Solomon, S. D. (2016) Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial) Circulation, 134, pp. 1785-1787. (doi: 10.1161/CIRCULATIONAHA.116.024976)

Mangion, K., Carrick, D., Hennigan, B. W., Payne, A. R., McClure, J., Mason, M., Das, R., Wilson, R., Edwards, R. J., Petrie, M. C., McEntegart, M., Eteiba, H., Oldroyd, K. G., Berry, C. (2016) Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention. Heart, 102, pp. 1980-1987. (doi: 10.1136/heartjnl-2015-308660)

Carrick, D., Haig, C., Watkins, S., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Davie, A., Mahrous, A., Mordi, I., Rauhalammi, S., Sattar, N., Welsh, P., Radjenovic, A., Ford, I., Oldroyd, K., Berry, C. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9, (doi: 10.1161/CIRCIMAGING.115.004148)

Mangion, K., Corcoran, D., Carrick, D., Berry, C. (2016) New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction. Expert Review of Cardiovascular Therapy, 14, pp. 843-854. (doi: 10.1586/14779072.2016.1173544)

Zervou, S., Yin, X., Nabeebaccus, A. A., O’Brien, B. A., Cross, R. L., McAndrew, D. J., Atkinson, R. A., Eykyn, T. R., Mayr, M., Neubauer, S., Lygate, C. A. (2016) Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms. Amino Acids, 48, pp. 1969-1981. (doi: 10.1007/s00726-016-2236-x)

Fuller, W., Reilly, L., Hilgemann, D. W. (2016) S-palmitoylation and the regulation of NCX1. Channels, 10, pp. 75-77. (doi: 10.1080/19336950.2015.1099329)

Tankou, S., Ishii, K., Elliott, C., Yalla, K., Kubo, K.-i., Brandon, N. J., Tang, Q., Hayward, G., Nakajima, K., Houslay, M., Kamiya, A., Baillie, G., Ishizuka, K., Sawa, A. (2016) SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex. Molecular Neuropsychiatry, 2, pp. 20-27. (doi: 10.1159/000444257)

Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., Anker, S. D., Sattar, N., Petrie, M. C., Gardner, R. S., McMurray, J. J. V. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, 18, pp. 1491-1498. (doi: 10.1002/ejhf.543)

Emdin, C. A., Conrad, N., Kiran, A., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., Dargie, H. J., Hardman, S. M.C., McDonagh, T., McMurray, J. J.V., Cleland, J. G.F., Rahimi, K. (2016) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart, 103, pp. 55-62. (doi: 10.1136/heartjnl-2016-309706)

Baeza-Raja, B., Sachs, B. D., Li, P., Christian, F., Vagena, E., Davalos, D., Le Moan, N., Ryu, J. K., Sikorski, S. L., Chan, J. P., Scadeng, M., Taylor, S. S., Houslay, M. D., Baillie, G. S., Saltiel, A. R., Olefsky, J. M., Akassoglou, K. (2016) p75 neurotrophin receptor regulates energy balance in obesity. Cell Reports, 14, pp. 255-268. (doi: 10.1016/j.celrep.2015.12.028)